false
0000872625
N-1A
0000872625
tsr:C000018631Member
2025-05-01
2026-04-30
0000872625
tsr:C000018631Member
oef:WithoutSalesLoadMember
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7358Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM2547_7358Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7358Member
2025-05-01
2026-04-30
0000872625
tsr:C000018631Member
2026-04-30
0000872625
tsr:C000018631Member
tsr:bench202409043993_7358Member
2026-04-30
0000872625
tsr:C000018631Member
tsr:bench202409044000_7358Member
2026-04-30
0000872625
tsr:C000018631Member
tsr:bench202409043998_7358Member
2026-04-30
0000872625
tsr:C000018631Member
tsr:bench202409043994_7358Member
2026-04-30
0000872625
tsr:C000018631Member
tsr:bench202409044003_7358Member
2026-04-30
0000872625
tsr:C000018631Member
oef:WithoutSalesLoadMember
2021-05-01
2026-04-30
0000872625
tsr:C000018631Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7358Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM2547_7358Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7358Member
2021-05-01
2026-04-30
0000872625
tsr:C000018631Member
oef:WithoutSalesLoadMember
2016-05-01
2026-04-30
0000872625
tsr:C000018631Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7358Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM2547_7358Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7358Member
2016-05-01
2026-04-30
0000872625
tsr:C000018631Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7358Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM2547_7358Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7358Member
2016-04-30
2016-04-30
0000872625
tsr:C000018631Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7358Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM2547_7358Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7358Member
2017-04-30
2017-04-30
0000872625
tsr:C000018631Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7358Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM2547_7358Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7358Member
2018-04-30
2018-04-30
0000872625
tsr:C000018631Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7358Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM2547_7358Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7358Member
2019-04-30
2019-04-30
0000872625
tsr:C000018631Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7358Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM2547_7358Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7358Member
2020-04-30
2020-04-30
0000872625
tsr:C000018631Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7358Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM2547_7358Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7358Member
2021-04-30
2021-04-30
0000872625
tsr:C000018631Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7358Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM2547_7358Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7358Member
2022-04-30
2022-04-30
0000872625
tsr:C000018631Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7358Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM2547_7358Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7358Member
2023-04-30
2023-04-30
0000872625
tsr:C000018631Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7358Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM2547_7358Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7358Member
2024-04-30
2024-04-30
0000872625
tsr:C000018631Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7358Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM2547_7358Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7358Member
2025-04-30
2025-04-30
0000872625
2025-05-01
2026-04-30
tsr:Years
iso4217:USD
xbrli:pure
xbrli:shares
iso4217:USD
xbrli:shares
0000872625
tsr:C000141458Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7359Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM2547_7359Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7359Member
2025-05-01
2026-04-30
0000872625
tsr:C000141458Member
2026-04-30
0000872625
tsr:C000141458Member
tsr:bench202409043993_7359Member
2026-04-30
0000872625
tsr:C000141458Member
tsr:bench202409044000_7359Member
2026-04-30
0000872625
tsr:C000141458Member
tsr:bench202409043998_7359Member
2026-04-30
0000872625
tsr:C000141458Member
tsr:bench202409043994_7359Member
2026-04-30
0000872625
tsr:C000141458Member
tsr:bench202409044003_7359Member
2026-04-30
0000872625
tsr:C000141458Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7359Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM2547_7359Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7359Member
2021-05-01
2026-04-30
0000872625
tsr:C000141458Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7359Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM2547_7359Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7359Member
2016-05-01
2026-04-30
0000872625
tsr:C000141458Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7359Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM2547_7359Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7359Member
2016-04-30
2016-04-30
0000872625
tsr:C000141458Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7359Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM2547_7359Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7359Member
2017-04-30
2017-04-30
0000872625
tsr:C000141458Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7359Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM2547_7359Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7359Member
2018-04-30
2018-04-30
0000872625
tsr:C000141458Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7359Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM2547_7359Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7359Member
2019-04-30
2019-04-30
0000872625
tsr:C000141458Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7359Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM2547_7359Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7359Member
2020-04-30
2020-04-30
0000872625
tsr:C000141458Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7359Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM2547_7359Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7359Member
2021-04-30
2021-04-30
0000872625
tsr:C000141458Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7359Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM2547_7359Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7359Member
2022-04-30
2022-04-30
0000872625
tsr:C000141458Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7359Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM2547_7359Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7359Member
2023-04-30
2023-04-30
0000872625
tsr:C000141458Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7359Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM2547_7359Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7359Member
2024-04-30
2024-04-30
0000872625
tsr:C000141458Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7359Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM2547_7359Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7359Member
2025-04-30
2025-04-30
0000872625
tsr:C000128862Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7360Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM2547_7360Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7360Member
2025-05-01
2026-04-30
0000872625
tsr:C000128862Member
2026-04-30
0000872625
tsr:C000128862Member
tsr:bench202409043993_7360Member
2026-04-30
0000872625
tsr:C000128862Member
tsr:bench202409044000_7360Member
2026-04-30
0000872625
tsr:C000128862Member
tsr:bench202409043998_7360Member
2026-04-30
0000872625
tsr:C000128862Member
tsr:bench202409043994_7360Member
2026-04-30
0000872625
tsr:C000128862Member
tsr:bench202409044003_7360Member
2026-04-30
0000872625
tsr:C000128862Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7360Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM2547_7360Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7360Member
2021-05-01
2026-04-30
0000872625
tsr:C000128862Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7360Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM2547_7360Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7360Member
2016-05-01
2026-04-30
0000872625
tsr:C000128862Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7360Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM2547_7360Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7360Member
2016-04-30
2016-04-30
0000872625
tsr:C000128862Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7360Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM2547_7360Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7360Member
2017-04-30
2017-04-30
0000872625
tsr:C000128862Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7360Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM2547_7360Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7360Member
2018-04-30
2018-04-30
0000872625
tsr:C000128862Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7360Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM2547_7360Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7360Member
2019-04-30
2019-04-30
0000872625
tsr:C000128862Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7360Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM2547_7360Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7360Member
2020-04-30
2020-04-30
0000872625
tsr:C000128862Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7360Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM2547_7360Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7360Member
2021-04-30
2021-04-30
0000872625
tsr:C000128862Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7360Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM2547_7360Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7360Member
2022-04-30
2022-04-30
0000872625
tsr:C000128862Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7360Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM2547_7360Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7360Member
2023-04-30
2023-04-30
0000872625
tsr:C000128862Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7360Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM2547_7360Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7360Member
2024-04-30
2024-04-30
0000872625
tsr:C000128862Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7360Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM2547_7360Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7360Member
2025-04-30
2025-04-30
0000872625
tsr:C000081539Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7357Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM2547_7357Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7357Member
2025-05-01
2026-04-30
0000872625
tsr:C000081539Member
2026-04-30
0000872625
tsr:C000081539Member
tsr:bench202409043993_7357Member
2026-04-30
0000872625
tsr:C000081539Member
tsr:bench202409044000_7357Member
2026-04-30
0000872625
tsr:C000081539Member
tsr:bench202409043998_7357Member
2026-04-30
0000872625
tsr:C000081539Member
tsr:bench202409043994_7357Member
2026-04-30
0000872625
tsr:C000081539Member
tsr:bench202409044003_7357Member
2026-04-30
0000872625
tsr:C000081539Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7357Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM2547_7357Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7357Member
2021-05-01
2026-04-30
0000872625
tsr:C000081539Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7357Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM2547_7357Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7357Member
2016-05-01
2026-04-30
0000872625
tsr:C000081539Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7357Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM2547_7357Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7357Member
2016-04-30
2016-04-30
0000872625
tsr:C000081539Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7357Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM2547_7357Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7357Member
2017-04-30
2017-04-30
0000872625
tsr:C000081539Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7357Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM2547_7357Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7357Member
2018-04-30
2018-04-30
0000872625
tsr:C000081539Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7357Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM2547_7357Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7357Member
2019-04-30
2019-04-30
0000872625
tsr:C000081539Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7357Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM2547_7357Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7357Member
2020-04-30
2020-04-30
0000872625
tsr:C000081539Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7357Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM2547_7357Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7357Member
2021-04-30
2021-04-30
0000872625
tsr:C000081539Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7357Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM2547_7357Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7357Member
2022-04-30
2022-04-30
0000872625
tsr:C000081539Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7357Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM2547_7357Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7357Member
2023-04-30
2023-04-30
0000872625
tsr:C000081539Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7357Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM2547_7357Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7357Member
2024-04-30
2024-04-30
0000872625
tsr:C000081539Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7357Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM2547_7357Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7357Member
2025-04-30
2025-04-30
0000872625
tsr:C000018620Member
2025-05-01
2026-04-30
0000872625
tsr:C000018620Member
oef:WithoutSalesLoadMember
2025-05-01
2026-04-30
0000872625
tsr:bench202411144434_7432Member
2025-05-01
2026-04-30
0000872625
tsr:C000018620Member
2026-04-30
0000872625
tsr:C000018620Member
tsr:bench202409043987_7432Member
2026-04-30
0000872625
tsr:C000018620Member
tsr:bench202411054313_7432Member
2026-04-30
0000872625
tsr:C000018620Member
tsr:bench202411074342_7432Member
2026-04-30
0000872625
tsr:C000018620Member
tsr:bench202411054316_7432Member
2026-04-30
0000872625
tsr:C000018620Member
tsr:bench202411054315_7432Member
2026-04-30
0000872625
tsr:C000018620Member
tsr:bench202411054317_7432Member
2026-04-30
0000872625
tsr:C000018620Member
tsr:bench202411054314_7432Member
2026-04-30
0000872625
tsr:C000018620Member
tsr:bench202409043986_7432Member
2026-04-30
0000872625
tsr:C000018620Member
tsr:bench202412044922_7432Member
2026-04-30
0000872625
tsr:C000018620Member
tsr:bench202412044924_7432Member
2026-04-30
0000872625
tsr:C000018620Member
tsr:bench202412044923_7432Member
2026-04-30
0000872625
tsr:C000018620Member
tsr:bench202409043989_7432Member
2026-04-30
0000872625
tsr:C000018620Member
tsr:bench202412044925_7432Member
2026-04-30
0000872625
tsr:C000018620Member
tsr:bench202412194975_7432Member
2026-04-30
0000872625
tsr:C000018620Member
tsr:bench202409043991_7432Member
2026-04-30
0000872625
tsr:C000018620Member
oef:WithoutSalesLoadMember
2021-05-01
2026-04-30
0000872625
tsr:C000018620Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411144434_7432Member
2021-05-01
2026-04-30
0000872625
tsr:C000018620Member
oef:WithoutSalesLoadMember
2016-05-01
2026-04-30
0000872625
tsr:C000018620Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411144434_7432Member
2016-05-01
2026-04-30
0000872625
tsr:C000018620Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411144434_7432Member
2016-04-30
2016-04-30
0000872625
tsr:C000018620Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411144434_7432Member
2017-04-30
2017-04-30
0000872625
tsr:C000018620Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411144434_7432Member
2018-04-30
2018-04-30
0000872625
tsr:C000018620Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411144434_7432Member
2019-04-30
2019-04-30
0000872625
tsr:C000018620Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411144434_7432Member
2020-04-30
2020-04-30
0000872625
tsr:C000018620Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411144434_7432Member
2021-04-30
2021-04-30
0000872625
tsr:C000018620Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411144434_7432Member
2022-04-30
2022-04-30
0000872625
tsr:C000018620Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411144434_7432Member
2023-04-30
2023-04-30
0000872625
tsr:C000018620Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411144434_7432Member
2024-04-30
2024-04-30
0000872625
tsr:C000018620Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411144434_7432Member
2025-04-30
2025-04-30
0000872625
tsr:C000018622Member
2025-05-01
2026-04-30
0000872625
tsr:C000018622Member
oef:WithoutSalesLoadMember
2025-05-01
2026-04-30
0000872625
tsr:bench202411144434_7440Member
2025-05-01
2026-04-30
0000872625
tsr:C000018622Member
2026-04-30
0000872625
tsr:C000018622Member
tsr:bench202409043987_7440Member
2026-04-30
0000872625
tsr:C000018622Member
tsr:bench202411054313_7440Member
2026-04-30
0000872625
tsr:C000018622Member
tsr:bench202411074342_7440Member
2026-04-30
0000872625
tsr:C000018622Member
tsr:bench202411054316_7440Member
2026-04-30
0000872625
tsr:C000018622Member
tsr:bench202411054315_7440Member
2026-04-30
0000872625
tsr:C000018622Member
tsr:bench202411054317_7440Member
2026-04-30
0000872625
tsr:C000018622Member
tsr:bench202411054314_7440Member
2026-04-30
0000872625
tsr:C000018622Member
tsr:bench202409043986_7440Member
2026-04-30
0000872625
tsr:C000018622Member
tsr:bench202412044922_7440Member
2026-04-30
0000872625
tsr:C000018622Member
tsr:bench202412044924_7440Member
2026-04-30
0000872625
tsr:C000018622Member
tsr:bench202412044923_7440Member
2026-04-30
0000872625
tsr:C000018622Member
tsr:bench202409043989_7440Member
2026-04-30
0000872625
tsr:C000018622Member
tsr:bench202412044925_7440Member
2026-04-30
0000872625
tsr:C000018622Member
tsr:bench202412194975_7440Member
2026-04-30
0000872625
tsr:C000018622Member
tsr:bench202409043991_7440Member
2026-04-30
0000872625
tsr:C000018622Member
oef:WithoutSalesLoadMember
2021-05-01
2026-04-30
0000872625
tsr:C000018622Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411144434_7440Member
2021-05-01
2026-04-30
0000872625
tsr:C000018622Member
oef:WithoutSalesLoadMember
2016-05-01
2026-04-30
0000872625
tsr:C000018622Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411144434_7440Member
2016-05-01
2026-04-30
0000872625
tsr:C000018622Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411144434_7440Member
2016-04-30
2016-04-30
0000872625
tsr:C000018622Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411144434_7440Member
2017-04-30
2017-04-30
0000872625
tsr:C000018622Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411144434_7440Member
2018-04-30
2018-04-30
0000872625
tsr:C000018622Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411144434_7440Member
2019-04-30
2019-04-30
0000872625
tsr:C000018622Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411144434_7440Member
2020-04-30
2020-04-30
0000872625
tsr:C000018622Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411144434_7440Member
2021-04-30
2021-04-30
0000872625
tsr:C000018622Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411144434_7440Member
2022-04-30
2022-04-30
0000872625
tsr:C000018622Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411144434_7440Member
2023-04-30
2023-04-30
0000872625
tsr:C000018622Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411144434_7440Member
2024-04-30
2024-04-30
0000872625
tsr:C000018622Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411144434_7440Member
2025-04-30
2025-04-30
0000872625
tsr:C000018624Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411144434_7443Member
2025-05-01
2026-04-30
0000872625
tsr:C000018624Member
2026-04-30
0000872625
tsr:C000018624Member
tsr:bench202409043987_7443Member
2026-04-30
0000872625
tsr:C000018624Member
tsr:bench202411054313_7443Member
2026-04-30
0000872625
tsr:C000018624Member
tsr:bench202411074342_7443Member
2026-04-30
0000872625
tsr:C000018624Member
tsr:bench202411054316_7443Member
2026-04-30
0000872625
tsr:C000018624Member
tsr:bench202411054315_7443Member
2026-04-30
0000872625
tsr:C000018624Member
tsr:bench202411054317_7443Member
2026-04-30
0000872625
tsr:C000018624Member
tsr:bench202411054314_7443Member
2026-04-30
0000872625
tsr:C000018624Member
tsr:bench202409043986_7443Member
2026-04-30
0000872625
tsr:C000018624Member
tsr:bench202412044922_7443Member
2026-04-30
0000872625
tsr:C000018624Member
tsr:bench202412044924_7443Member
2026-04-30
0000872625
tsr:C000018624Member
tsr:bench202412044923_7443Member
2026-04-30
0000872625
tsr:C000018624Member
tsr:bench202409043989_7443Member
2026-04-30
0000872625
tsr:C000018624Member
tsr:bench202412044925_7443Member
2026-04-30
0000872625
tsr:C000018624Member
tsr:bench202412194975_7443Member
2026-04-30
0000872625
tsr:C000018624Member
tsr:bench202409043991_7443Member
2026-04-30
0000872625
tsr:C000018624Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411144434_7443Member
2021-05-01
2026-04-30
0000872625
tsr:C000018624Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411144434_7443Member
2016-05-01
2026-04-30
0000872625
tsr:C000018624Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411144434_7443Member
2016-04-30
2016-04-30
0000872625
tsr:C000018624Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411144434_7443Member
2017-04-30
2017-04-30
0000872625
tsr:C000018624Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411144434_7443Member
2018-04-30
2018-04-30
0000872625
tsr:C000018624Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411144434_7443Member
2019-04-30
2019-04-30
0000872625
tsr:C000018624Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411144434_7443Member
2020-04-30
2020-04-30
0000872625
tsr:C000018624Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411144434_7443Member
2021-04-30
2021-04-30
0000872625
tsr:C000018624Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411144434_7443Member
2022-04-30
2022-04-30
0000872625
tsr:C000018624Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411144434_7443Member
2023-04-30
2023-04-30
0000872625
tsr:C000018624Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411144434_7443Member
2024-04-30
2024-04-30
0000872625
tsr:C000018624Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411144434_7443Member
2025-04-30
2025-04-30
0000872625
tsr:C000128861Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411144434_7441Member
2025-05-01
2026-04-30
0000872625
tsr:C000128861Member
2026-04-30
0000872625
tsr:C000128861Member
tsr:bench202409043987_7441Member
2026-04-30
0000872625
tsr:C000128861Member
tsr:bench202411054313_7441Member
2026-04-30
0000872625
tsr:C000128861Member
tsr:bench202411074342_7441Member
2026-04-30
0000872625
tsr:C000128861Member
tsr:bench202411054316_7441Member
2026-04-30
0000872625
tsr:C000128861Member
tsr:bench202411054315_7441Member
2026-04-30
0000872625
tsr:C000128861Member
tsr:bench202411054317_7441Member
2026-04-30
0000872625
tsr:C000128861Member
tsr:bench202411054314_7441Member
2026-04-30
0000872625
tsr:C000128861Member
tsr:bench202409043986_7441Member
2026-04-30
0000872625
tsr:C000128861Member
tsr:bench202412044922_7441Member
2026-04-30
0000872625
tsr:C000128861Member
tsr:bench202412044924_7441Member
2026-04-30
0000872625
tsr:C000128861Member
tsr:bench202412044923_7441Member
2026-04-30
0000872625
tsr:C000128861Member
tsr:bench202409043989_7441Member
2026-04-30
0000872625
tsr:C000128861Member
tsr:bench202412044925_7441Member
2026-04-30
0000872625
tsr:C000128861Member
tsr:bench202412194975_7441Member
2026-04-30
0000872625
tsr:C000128861Member
tsr:bench202409043991_7441Member
2026-04-30
0000872625
tsr:C000128861Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411144434_7441Member
2021-05-01
2026-04-30
0000872625
tsr:C000128861Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411144434_7441Member
2016-05-01
2026-04-30
0000872625
tsr:C000128861Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411144434_7441Member
2016-04-30
2016-04-30
0000872625
tsr:C000128861Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411144434_7441Member
2017-04-30
2017-04-30
0000872625
tsr:C000128861Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411144434_7441Member
2018-04-30
2018-04-30
0000872625
tsr:C000128861Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411144434_7441Member
2019-04-30
2019-04-30
0000872625
tsr:C000128861Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411144434_7441Member
2020-04-30
2020-04-30
0000872625
tsr:C000128861Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411144434_7441Member
2021-04-30
2021-04-30
0000872625
tsr:C000128861Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411144434_7441Member
2022-04-30
2022-04-30
0000872625
tsr:C000128861Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411144434_7441Member
2023-04-30
2023-04-30
0000872625
tsr:C000128861Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411144434_7441Member
2024-04-30
2024-04-30
0000872625
tsr:C000128861Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411144434_7441Member
2025-04-30
2025-04-30
0000872625
tsr:C000018623Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411144434_7431Member
2025-05-01
2026-04-30
0000872625
tsr:C000018623Member
2026-04-30
0000872625
tsr:C000018623Member
tsr:bench202409043987_7431Member
2026-04-30
0000872625
tsr:C000018623Member
tsr:bench202411054313_7431Member
2026-04-30
0000872625
tsr:C000018623Member
tsr:bench202411074342_7431Member
2026-04-30
0000872625
tsr:C000018623Member
tsr:bench202411054316_7431Member
2026-04-30
0000872625
tsr:C000018623Member
tsr:bench202411054315_7431Member
2026-04-30
0000872625
tsr:C000018623Member
tsr:bench202411054317_7431Member
2026-04-30
0000872625
tsr:C000018623Member
tsr:bench202411054314_7431Member
2026-04-30
0000872625
tsr:C000018623Member
tsr:bench202409043986_7431Member
2026-04-30
0000872625
tsr:C000018623Member
tsr:bench202412044922_7431Member
2026-04-30
0000872625
tsr:C000018623Member
tsr:bench202412044924_7431Member
2026-04-30
0000872625
tsr:C000018623Member
tsr:bench202412044923_7431Member
2026-04-30
0000872625
tsr:C000018623Member
tsr:bench202409043989_7431Member
2026-04-30
0000872625
tsr:C000018623Member
tsr:bench202412044925_7431Member
2026-04-30
0000872625
tsr:C000018623Member
tsr:bench202412194975_7431Member
2026-04-30
0000872625
tsr:C000018623Member
tsr:bench202409043991_7431Member
2026-04-30
0000872625
tsr:C000018623Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411144434_7431Member
2021-05-01
2026-04-30
0000872625
tsr:C000018623Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411144434_7431Member
2016-05-01
2026-04-30
0000872625
tsr:C000018623Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411144434_7431Member
2016-04-30
2016-04-30
0000872625
tsr:C000018623Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411144434_7431Member
2017-04-30
2017-04-30
0000872625
tsr:C000018623Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411144434_7431Member
2018-04-30
2018-04-30
0000872625
tsr:C000018623Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411144434_7431Member
2019-04-30
2019-04-30
0000872625
tsr:C000018623Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411144434_7431Member
2020-04-30
2020-04-30
0000872625
tsr:C000018623Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411144434_7431Member
2021-04-30
2021-04-30
0000872625
tsr:C000018623Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411144434_7431Member
2022-04-30
2022-04-30
0000872625
tsr:C000018623Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411144434_7431Member
2023-04-30
2023-04-30
0000872625
tsr:C000018623Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411144434_7431Member
2024-04-30
2024-04-30
0000872625
tsr:C000018623Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411144434_7431Member
2025-04-30
2025-04-30
0000872625
tsr:C000018615Member
2025-05-01
2026-04-30
0000872625
tsr:C000018615Member
oef:WithoutSalesLoadMember
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7485Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM0792_7485Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7485Member
2025-05-01
2026-04-30
0000872625
tsr:C000018615Member
2026-04-30
0000872625
tsr:C000018615Member
tsr:bench202409043992_7485Member
2026-04-30
0000872625
tsr:C000018615Member
tsr:bench202409043997_7485Member
2026-04-30
0000872625
tsr:C000018615Member
tsr:bench202409043995_7485Member
2026-04-30
0000872625
tsr:C000018615Member
tsr:bench202409043996_7485Member
2026-04-30
0000872625
tsr:C000018615Member
tsr:bench202409043993_7485Member
2026-04-30
0000872625
tsr:C000018615Member
tsr:bench202409043998_7485Member
2026-04-30
0000872625
tsr:C000018615Member
tsr:bench202409043994_7485Member
2026-04-30
0000872625
tsr:C000018615Member
tsr:bench202409044001_7485Member
2026-04-30
0000872625
tsr:C000018615Member
tsr:bench202409044002_7485Member
2026-04-30
0000872625
tsr:C000018615Member
tsr:bench202412104943_7485Member
2026-04-30
0000872625
tsr:C000018615Member
tsr:bench202409044003_7485Member
2026-04-30
0000872625
tsr:C000018615Member
oef:WithoutSalesLoadMember
2021-05-01
2026-04-30
0000872625
tsr:C000018615Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7485Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM0792_7485Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7485Member
2021-05-01
2026-04-30
0000872625
tsr:C000018615Member
oef:WithoutSalesLoadMember
2016-05-01
2026-04-30
0000872625
tsr:C000018615Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7485Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM0792_7485Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7485Member
2016-05-01
2026-04-30
0000872625
tsr:C000018615Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7485Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM0792_7485Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7485Member
2016-04-30
2016-04-30
0000872625
tsr:C000018615Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7485Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM0792_7485Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7485Member
2017-04-30
2017-04-30
0000872625
tsr:C000018615Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7485Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM0792_7485Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7485Member
2018-04-30
2018-04-30
0000872625
tsr:C000018615Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7485Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM0792_7485Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7485Member
2019-04-30
2019-04-30
0000872625
tsr:C000018615Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7485Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM0792_7485Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7485Member
2020-04-30
2020-04-30
0000872625
tsr:C000018615Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7485Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM0792_7485Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7485Member
2021-04-30
2021-04-30
0000872625
tsr:C000018615Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7485Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM0792_7485Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7485Member
2022-04-30
2022-04-30
0000872625
tsr:C000018615Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7485Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM0792_7485Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7485Member
2023-04-30
2023-04-30
0000872625
tsr:C000018615Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7485Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM0792_7485Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7485Member
2024-04-30
2024-04-30
0000872625
tsr:C000018615Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7485Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM0792_7485Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7485Member
2025-04-30
2025-04-30
0000872625
tsr:C000018617Member
2025-05-01
2026-04-30
0000872625
tsr:C000018617Member
oef:WithoutSalesLoadMember
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7484Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM0792_7484Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7484Member
2025-05-01
2026-04-30
0000872625
tsr:C000018617Member
2026-04-30
0000872625
tsr:C000018617Member
tsr:bench202409043992_7484Member
2026-04-30
0000872625
tsr:C000018617Member
tsr:bench202409043997_7484Member
2026-04-30
0000872625
tsr:C000018617Member
tsr:bench202409043995_7484Member
2026-04-30
0000872625
tsr:C000018617Member
tsr:bench202409043996_7484Member
2026-04-30
0000872625
tsr:C000018617Member
tsr:bench202409043993_7484Member
2026-04-30
0000872625
tsr:C000018617Member
tsr:bench202409043998_7484Member
2026-04-30
0000872625
tsr:C000018617Member
tsr:bench202409043994_7484Member
2026-04-30
0000872625
tsr:C000018617Member
tsr:bench202409044001_7484Member
2026-04-30
0000872625
tsr:C000018617Member
tsr:bench202409044002_7484Member
2026-04-30
0000872625
tsr:C000018617Member
tsr:bench202412104943_7484Member
2026-04-30
0000872625
tsr:C000018617Member
tsr:bench202409044003_7484Member
2026-04-30
0000872625
tsr:C000018617Member
oef:WithoutSalesLoadMember
2021-05-01
2026-04-30
0000872625
tsr:C000018617Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7484Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM0792_7484Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7484Member
2021-05-01
2026-04-30
0000872625
tsr:C000018617Member
oef:WithoutSalesLoadMember
2016-05-01
2026-04-30
0000872625
tsr:C000018617Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7484Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM0792_7484Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7484Member
2016-05-01
2026-04-30
0000872625
tsr:C000018617Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7484Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM0792_7484Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7484Member
2016-04-30
2016-04-30
0000872625
tsr:C000018617Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7484Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM0792_7484Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7484Member
2017-04-30
2017-04-30
0000872625
tsr:C000018617Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7484Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM0792_7484Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7484Member
2018-04-30
2018-04-30
0000872625
tsr:C000018617Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7484Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM0792_7484Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7484Member
2019-04-30
2019-04-30
0000872625
tsr:C000018617Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7484Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM0792_7484Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7484Member
2020-04-30
2020-04-30
0000872625
tsr:C000018617Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7484Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM0792_7484Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7484Member
2021-04-30
2021-04-30
0000872625
tsr:C000018617Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7484Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM0792_7484Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7484Member
2022-04-30
2022-04-30
0000872625
tsr:C000018617Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7484Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM0792_7484Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7484Member
2023-04-30
2023-04-30
0000872625
tsr:C000018617Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7484Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM0792_7484Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7484Member
2024-04-30
2024-04-30
0000872625
tsr:C000018617Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7484Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM0792_7484Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7484Member
2025-04-30
2025-04-30
0000872625
tsr:C000018619Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7482Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM0792_7482Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7482Member
2025-05-01
2026-04-30
0000872625
tsr:C000018619Member
2026-04-30
0000872625
tsr:C000018619Member
tsr:bench202409043992_7482Member
2026-04-30
0000872625
tsr:C000018619Member
tsr:bench202409043997_7482Member
2026-04-30
0000872625
tsr:C000018619Member
tsr:bench202409043995_7482Member
2026-04-30
0000872625
tsr:C000018619Member
tsr:bench202409043996_7482Member
2026-04-30
0000872625
tsr:C000018619Member
tsr:bench202409043993_7482Member
2026-04-30
0000872625
tsr:C000018619Member
tsr:bench202409043998_7482Member
2026-04-30
0000872625
tsr:C000018619Member
tsr:bench202409043994_7482Member
2026-04-30
0000872625
tsr:C000018619Member
tsr:bench202409044001_7482Member
2026-04-30
0000872625
tsr:C000018619Member
tsr:bench202409044002_7482Member
2026-04-30
0000872625
tsr:C000018619Member
tsr:bench202412104943_7482Member
2026-04-30
0000872625
tsr:C000018619Member
tsr:bench202409044003_7482Member
2026-04-30
0000872625
tsr:C000018619Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7482Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM0792_7482Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7482Member
2021-05-01
2026-04-30
0000872625
tsr:C000018619Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7482Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM0792_7482Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7482Member
2016-05-01
2026-04-30
0000872625
tsr:C000018619Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7482Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM0792_7482Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7482Member
2016-04-30
2016-04-30
0000872625
tsr:C000018619Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7482Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM0792_7482Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7482Member
2017-04-30
2017-04-30
0000872625
tsr:C000018619Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7482Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM0792_7482Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7482Member
2018-04-30
2018-04-30
0000872625
tsr:C000018619Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7482Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM0792_7482Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7482Member
2019-04-30
2019-04-30
0000872625
tsr:C000018619Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7482Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM0792_7482Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7482Member
2020-04-30
2020-04-30
0000872625
tsr:C000018619Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7482Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM0792_7482Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7482Member
2021-04-30
2021-04-30
0000872625
tsr:C000018619Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7482Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM0792_7482Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7482Member
2022-04-30
2022-04-30
0000872625
tsr:C000018619Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7482Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM0792_7482Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7482Member
2023-04-30
2023-04-30
0000872625
tsr:C000018619Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7482Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM0792_7482Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7482Member
2024-04-30
2024-04-30
0000872625
tsr:C000018619Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7482Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM0792_7482Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7482Member
2025-04-30
2025-04-30
0000872625
tsr:C000128860Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7483Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM0792_7483Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7483Member
2025-05-01
2026-04-30
0000872625
tsr:C000128860Member
2026-04-30
0000872625
tsr:C000128860Member
tsr:bench202409043992_7483Member
2026-04-30
0000872625
tsr:C000128860Member
tsr:bench202409043997_7483Member
2026-04-30
0000872625
tsr:C000128860Member
tsr:bench202409043995_7483Member
2026-04-30
0000872625
tsr:C000128860Member
tsr:bench202409043996_7483Member
2026-04-30
0000872625
tsr:C000128860Member
tsr:bench202409043993_7483Member
2026-04-30
0000872625
tsr:C000128860Member
tsr:bench202409043998_7483Member
2026-04-30
0000872625
tsr:C000128860Member
tsr:bench202409043994_7483Member
2026-04-30
0000872625
tsr:C000128860Member
tsr:bench202409044001_7483Member
2026-04-30
0000872625
tsr:C000128860Member
tsr:bench202409044002_7483Member
2026-04-30
0000872625
tsr:C000128860Member
tsr:bench202412104943_7483Member
2026-04-30
0000872625
tsr:C000128860Member
tsr:bench202409044003_7483Member
2026-04-30
0000872625
tsr:C000128860Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7483Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM0792_7483Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7483Member
2021-05-01
2026-04-30
0000872625
tsr:C000128860Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7483Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM0792_7483Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7483Member
2016-05-01
2026-04-30
0000872625
tsr:C000128860Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7483Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM0792_7483Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7483Member
2016-04-30
2016-04-30
0000872625
tsr:C000128860Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7483Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM0792_7483Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7483Member
2017-04-30
2017-04-30
0000872625
tsr:C000128860Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7483Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM0792_7483Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7483Member
2018-04-30
2018-04-30
0000872625
tsr:C000128860Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7483Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM0792_7483Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7483Member
2019-04-30
2019-04-30
0000872625
tsr:C000128860Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7483Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM0792_7483Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7483Member
2020-04-30
2020-04-30
0000872625
tsr:C000128860Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7483Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM0792_7483Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7483Member
2021-04-30
2021-04-30
0000872625
tsr:C000128860Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7483Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM0792_7483Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7483Member
2022-04-30
2022-04-30
0000872625
tsr:C000128860Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7483Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM0792_7483Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7483Member
2023-04-30
2023-04-30
0000872625
tsr:C000128860Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7483Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM0792_7483Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7483Member
2024-04-30
2024-04-30
0000872625
tsr:C000128860Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7483Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM0792_7483Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7483Member
2025-04-30
2025-04-30
0000872625
tsr:C000018618Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7486Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM0792_7486Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7486Member
2025-05-01
2026-04-30
0000872625
tsr:C000018618Member
2026-04-30
0000872625
tsr:C000018618Member
tsr:bench202409043992_7486Member
2026-04-30
0000872625
tsr:C000018618Member
tsr:bench202409043997_7486Member
2026-04-30
0000872625
tsr:C000018618Member
tsr:bench202409043995_7486Member
2026-04-30
0000872625
tsr:C000018618Member
tsr:bench202409043996_7486Member
2026-04-30
0000872625
tsr:C000018618Member
tsr:bench202409043993_7486Member
2026-04-30
0000872625
tsr:C000018618Member
tsr:bench202409043998_7486Member
2026-04-30
0000872625
tsr:C000018618Member
tsr:bench202409043994_7486Member
2026-04-30
0000872625
tsr:C000018618Member
tsr:bench202409044001_7486Member
2026-04-30
0000872625
tsr:C000018618Member
tsr:bench202409044002_7486Member
2026-04-30
0000872625
tsr:C000018618Member
tsr:bench202412104943_7486Member
2026-04-30
0000872625
tsr:C000018618Member
tsr:bench202409044003_7486Member
2026-04-30
0000872625
tsr:C000018618Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7486Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM0792_7486Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7486Member
2021-05-01
2026-04-30
0000872625
tsr:C000018618Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7486Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM0792_7486Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7486Member
2016-05-01
2026-04-30
0000872625
tsr:C000018618Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7486Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM0792_7486Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7486Member
2016-04-30
2016-04-30
0000872625
tsr:C000018618Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7486Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM0792_7486Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7486Member
2017-04-30
2017-04-30
0000872625
tsr:C000018618Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7486Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM0792_7486Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7486Member
2018-04-30
2018-04-30
0000872625
tsr:C000018618Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7486Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM0792_7486Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7486Member
2019-04-30
2019-04-30
0000872625
tsr:C000018618Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7486Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM0792_7486Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7486Member
2020-04-30
2020-04-30
0000872625
tsr:C000018618Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7486Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM0792_7486Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7486Member
2021-04-30
2021-04-30
0000872625
tsr:C000018618Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7486Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM0792_7486Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7486Member
2022-04-30
2022-04-30
0000872625
tsr:C000018618Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7486Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM0792_7486Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7486Member
2023-04-30
2023-04-30
0000872625
tsr:C000018618Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7486Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM0792_7486Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7486Member
2024-04-30
2024-04-30
0000872625
tsr:C000018618Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7486Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM0792_7486Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7486Member
2025-04-30
2025-04-30
0000872625
tsr:C000018648Member
2025-05-01
2026-04-30
0000872625
tsr:C000018648Member
oef:WithoutSalesLoadMember
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7444Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM2285_7444Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM10720_7444Member
2025-05-01
2026-04-30
0000872625
tsr:C000018648Member
2026-04-30
0000872625
tsr:C000018648Member
tsr:bench202409043999_7444Member
2026-04-30
0000872625
tsr:C000018648Member
tsr:bench202409044001_7444Member
2026-04-30
0000872625
tsr:C000018648Member
tsr:bench202409043997_7444Member
2026-04-30
0000872625
tsr:C000018648Member
tsr:bench202409043998_7444Member
2026-04-30
0000872625
tsr:C000018648Member
tsr:bench202409043992_7444Member
2026-04-30
0000872625
tsr:C000018648Member
tsr:bench202409044003_7444Member
2026-04-30
0000872625
tsr:C000018648Member
oef:WithoutSalesLoadMember
2021-05-01
2026-04-30
0000872625
tsr:C000018648Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7444Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM2285_7444Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM10720_7444Member
2021-05-01
2026-04-30
0000872625
tsr:C000018648Member
oef:WithoutSalesLoadMember
2016-05-01
2026-04-30
0000872625
tsr:C000018648Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7444Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM2285_7444Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM10720_7444Member
2016-05-01
2026-04-30
0000872625
tsr:C000018648Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7444Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM2285_7444Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM10720_7444Member
2016-04-30
2016-04-30
0000872625
tsr:C000018648Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7444Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM2285_7444Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM10720_7444Member
2017-04-30
2017-04-30
0000872625
tsr:C000018648Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7444Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM2285_7444Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM10720_7444Member
2018-04-30
2018-04-30
0000872625
tsr:C000018648Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7444Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM2285_7444Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM10720_7444Member
2019-04-30
2019-04-30
0000872625
tsr:C000018648Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7444Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM2285_7444Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM10720_7444Member
2020-04-30
2020-04-30
0000872625
tsr:C000018648Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7444Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM2285_7444Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM10720_7444Member
2021-04-30
2021-04-30
0000872625
tsr:C000018648Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7444Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM2285_7444Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM10720_7444Member
2022-04-30
2022-04-30
0000872625
tsr:C000018648Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7444Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM2285_7444Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM10720_7444Member
2023-04-30
2023-04-30
0000872625
tsr:C000018648Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7444Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM2285_7444Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM10720_7444Member
2024-04-30
2024-04-30
0000872625
tsr:C000018648Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7444Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM2285_7444Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM10720_7444Member
2025-04-30
2025-04-30
0000872625
tsr:C000018647Member
2025-05-01
2026-04-30
0000872625
tsr:C000018647Member
oef:WithoutSalesLoadMember
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7445Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM2285_7445Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM10720_7445Member
2025-05-01
2026-04-30
0000872625
tsr:C000018647Member
2026-04-30
0000872625
tsr:C000018647Member
tsr:bench202409043999_7445Member
2026-04-30
0000872625
tsr:C000018647Member
tsr:bench202409044001_7445Member
2026-04-30
0000872625
tsr:C000018647Member
tsr:bench202409043997_7445Member
2026-04-30
0000872625
tsr:C000018647Member
tsr:bench202409043998_7445Member
2026-04-30
0000872625
tsr:C000018647Member
tsr:bench202409043992_7445Member
2026-04-30
0000872625
tsr:C000018647Member
tsr:bench202409044003_7445Member
2026-04-30
0000872625
tsr:C000018647Member
oef:WithoutSalesLoadMember
2021-05-01
2026-04-30
0000872625
tsr:C000018647Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7445Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM2285_7445Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM10720_7445Member
2021-05-01
2026-04-30
0000872625
tsr:C000018647Member
oef:WithoutSalesLoadMember
2016-05-01
2026-04-30
0000872625
tsr:C000018647Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7445Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM2285_7445Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM10720_7445Member
2016-05-01
2026-04-30
0000872625
tsr:C000018647Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7445Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM2285_7445Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM10720_7445Member
2016-04-30
2016-04-30
0000872625
tsr:C000018647Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7445Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM2285_7445Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM10720_7445Member
2017-04-30
2017-04-30
0000872625
tsr:C000018647Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7445Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM2285_7445Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM10720_7445Member
2018-04-30
2018-04-30
0000872625
tsr:C000018647Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7445Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM2285_7445Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM10720_7445Member
2019-04-30
2019-04-30
0000872625
tsr:C000018647Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7445Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM2285_7445Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM10720_7445Member
2020-04-30
2020-04-30
0000872625
tsr:C000018647Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7445Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM2285_7445Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM10720_7445Member
2021-04-30
2021-04-30
0000872625
tsr:C000018647Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7445Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM2285_7445Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM10720_7445Member
2022-04-30
2022-04-30
0000872625
tsr:C000018647Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7445Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM2285_7445Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM10720_7445Member
2023-04-30
2023-04-30
0000872625
tsr:C000018647Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7445Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM2285_7445Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM10720_7445Member
2024-04-30
2024-04-30
0000872625
tsr:C000018647Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7445Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM2285_7445Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM10720_7445Member
2025-04-30
2025-04-30
0000872625
tsr:C000132949Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7446Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM2285_7446Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM10720_7446Member
2025-05-01
2026-04-30
0000872625
tsr:C000132949Member
2026-04-30
0000872625
tsr:C000132949Member
tsr:bench202409043999_7446Member
2026-04-30
0000872625
tsr:C000132949Member
tsr:bench202409044001_7446Member
2026-04-30
0000872625
tsr:C000132949Member
tsr:bench202409043997_7446Member
2026-04-30
0000872625
tsr:C000132949Member
tsr:bench202409043998_7446Member
2026-04-30
0000872625
tsr:C000132949Member
tsr:bench202409043992_7446Member
2026-04-30
0000872625
tsr:C000132949Member
tsr:bench202409044003_7446Member
2026-04-30
0000872625
tsr:C000132949Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7446Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM2285_7446Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM10720_7446Member
2021-05-01
2026-04-30
0000872625
tsr:C000132949Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7446Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM2285_7446Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM10720_7446Member
2016-05-01
2026-04-30
0000872625
tsr:C000132949Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7446Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM2285_7446Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM10720_7446Member
2016-04-30
2016-04-30
0000872625
tsr:C000132949Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7446Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM2285_7446Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM10720_7446Member
2017-04-30
2017-04-30
0000872625
tsr:C000132949Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7446Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM2285_7446Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM10720_7446Member
2018-04-30
2018-04-30
0000872625
tsr:C000132949Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7446Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM2285_7446Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM10720_7446Member
2019-04-30
2019-04-30
0000872625
tsr:C000132949Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7446Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM2285_7446Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM10720_7446Member
2020-04-30
2020-04-30
0000872625
tsr:C000132949Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7446Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM2285_7446Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM10720_7446Member
2021-04-30
2021-04-30
0000872625
tsr:C000132949Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7446Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM2285_7446Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM10720_7446Member
2022-04-30
2022-04-30
0000872625
tsr:C000132949Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7446Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM2285_7446Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM10720_7446Member
2023-04-30
2023-04-30
0000872625
tsr:C000132949Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7446Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM2285_7446Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM10720_7446Member
2024-04-30
2024-04-30
0000872625
tsr:C000132949Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7446Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM2285_7446Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM10720_7446Member
2025-04-30
2025-04-30
0000872625
tsr:C000018649Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7442Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM2285_7442Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM10720_7442Member
2025-05-01
2026-04-30
0000872625
tsr:C000018649Member
2026-04-30
0000872625
tsr:C000018649Member
tsr:bench202409043999_7442Member
2026-04-30
0000872625
tsr:C000018649Member
tsr:bench202409044001_7442Member
2026-04-30
0000872625
tsr:C000018649Member
tsr:bench202409043997_7442Member
2026-04-30
0000872625
tsr:C000018649Member
tsr:bench202409043998_7442Member
2026-04-30
0000872625
tsr:C000018649Member
tsr:bench202409043992_7442Member
2026-04-30
0000872625
tsr:C000018649Member
tsr:bench202409044003_7442Member
2026-04-30
0000872625
tsr:C000018649Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7442Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM2285_7442Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM10720_7442Member
2021-05-01
2026-04-30
0000872625
tsr:C000018649Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7442Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM2285_7442Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM10720_7442Member
2016-05-01
2026-04-30
0000872625
tsr:C000018649Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7442Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM2285_7442Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM10720_7442Member
2016-04-30
2016-04-30
0000872625
tsr:C000018649Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7442Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM2285_7442Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM10720_7442Member
2017-04-30
2017-04-30
0000872625
tsr:C000018649Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7442Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM2285_7442Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM10720_7442Member
2018-04-30
2018-04-30
0000872625
tsr:C000018649Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7442Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM2285_7442Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM10720_7442Member
2019-04-30
2019-04-30
0000872625
tsr:C000018649Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7442Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM2285_7442Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM10720_7442Member
2020-04-30
2020-04-30
0000872625
tsr:C000018649Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7442Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM2285_7442Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM10720_7442Member
2021-04-30
2021-04-30
0000872625
tsr:C000018649Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7442Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM2285_7442Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM10720_7442Member
2022-04-30
2022-04-30
0000872625
tsr:C000018649Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7442Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM2285_7442Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM10720_7442Member
2023-04-30
2023-04-30
0000872625
tsr:C000018649Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7442Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM2285_7442Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM10720_7442Member
2024-04-30
2024-04-30
0000872625
tsr:C000018649Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7442Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM2285_7442Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM10720_7442Member
2025-04-30
2025-04-30
0000872625
tsr:C000018655Member
2025-05-01
2026-04-30
0000872625
tsr:C000018655Member
oef:WithoutSalesLoadMember
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7463Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM0619_7463Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7463Member
2025-05-01
2026-04-30
0000872625
tsr:C000018655Member
2026-04-30
0000872625
tsr:C000018655Member
tsr:bench202409043993_7463Member
2026-04-30
0000872625
tsr:C000018655Member
tsr:bench202409043997_7463Member
2026-04-30
0000872625
tsr:C000018655Member
tsr:bench202409043992_7463Member
2026-04-30
0000872625
tsr:C000018655Member
tsr:bench202409043996_7463Member
2026-04-30
0000872625
tsr:C000018655Member
tsr:bench202409043994_7463Member
2026-04-30
0000872625
tsr:C000018655Member
tsr:bench202409043999_7463Member
2026-04-30
0000872625
tsr:C000018655Member
tsr:bench202409043998_7463Member
2026-04-30
0000872625
tsr:C000018655Member
tsr:bench202409043995_7463Member
2026-04-30
0000872625
tsr:C000018655Member
tsr:bench202409044000_7463Member
2026-04-30
0000872625
tsr:C000018655Member
tsr:bench202409044001_7463Member
2026-04-30
0000872625
tsr:C000018655Member
tsr:bench202412104943_7463Member
2026-04-30
0000872625
tsr:C000018655Member
tsr:bench202409044003_7463Member
2026-04-30
0000872625
tsr:C000018655Member
oef:WithoutSalesLoadMember
2021-05-01
2026-04-30
0000872625
tsr:C000018655Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7463Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM0619_7463Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7463Member
2021-05-01
2026-04-30
0000872625
tsr:C000018655Member
oef:WithoutSalesLoadMember
2016-05-01
2026-04-30
0000872625
tsr:C000018655Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7463Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM0619_7463Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7463Member
2016-05-01
2026-04-30
0000872625
tsr:C000018655Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7463Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM0619_7463Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7463Member
2016-04-30
2016-04-30
0000872625
tsr:C000018655Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7463Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM0619_7463Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7463Member
2017-04-30
2017-04-30
0000872625
tsr:C000018655Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7463Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM0619_7463Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7463Member
2018-04-30
2018-04-30
0000872625
tsr:C000018655Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7463Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM0619_7463Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7463Member
2019-04-30
2019-04-30
0000872625
tsr:C000018655Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7463Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM0619_7463Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7463Member
2020-04-30
2020-04-30
0000872625
tsr:C000018655Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7463Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM0619_7463Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7463Member
2021-04-30
2021-04-30
0000872625
tsr:C000018655Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7463Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM0619_7463Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7463Member
2022-04-30
2022-04-30
0000872625
tsr:C000018655Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7463Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM0619_7463Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7463Member
2023-04-30
2023-04-30
0000872625
tsr:C000018655Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7463Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM0619_7463Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7463Member
2024-04-30
2024-04-30
0000872625
tsr:C000018655Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7463Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM0619_7463Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7463Member
2025-04-30
2025-04-30
0000872625
tsr:C000018657Member
2025-05-01
2026-04-30
0000872625
tsr:C000018657Member
oef:WithoutSalesLoadMember
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7464Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM0619_7464Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7464Member
2025-05-01
2026-04-30
0000872625
tsr:C000018657Member
2026-04-30
0000872625
tsr:C000018657Member
tsr:bench202409043993_7464Member
2026-04-30
0000872625
tsr:C000018657Member
tsr:bench202409043997_7464Member
2026-04-30
0000872625
tsr:C000018657Member
tsr:bench202409043992_7464Member
2026-04-30
0000872625
tsr:C000018657Member
tsr:bench202409043996_7464Member
2026-04-30
0000872625
tsr:C000018657Member
tsr:bench202409043994_7464Member
2026-04-30
0000872625
tsr:C000018657Member
tsr:bench202409043999_7464Member
2026-04-30
0000872625
tsr:C000018657Member
tsr:bench202409043998_7464Member
2026-04-30
0000872625
tsr:C000018657Member
tsr:bench202409043995_7464Member
2026-04-30
0000872625
tsr:C000018657Member
tsr:bench202409044000_7464Member
2026-04-30
0000872625
tsr:C000018657Member
tsr:bench202409044001_7464Member
2026-04-30
0000872625
tsr:C000018657Member
tsr:bench202412104943_7464Member
2026-04-30
0000872625
tsr:C000018657Member
tsr:bench202409044003_7464Member
2026-04-30
0000872625
tsr:C000018657Member
oef:WithoutSalesLoadMember
2021-05-01
2026-04-30
0000872625
tsr:C000018657Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7464Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM0619_7464Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7464Member
2021-05-01
2026-04-30
0000872625
tsr:C000018657Member
oef:WithoutSalesLoadMember
2016-05-01
2026-04-30
0000872625
tsr:C000018657Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7464Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM0619_7464Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7464Member
2016-05-01
2026-04-30
0000872625
tsr:C000018657Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7464Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM0619_7464Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7464Member
2016-04-30
2016-04-30
0000872625
tsr:C000018657Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7464Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM0619_7464Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7464Member
2017-04-30
2017-04-30
0000872625
tsr:C000018657Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7464Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM0619_7464Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7464Member
2018-04-30
2018-04-30
0000872625
tsr:C000018657Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7464Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM0619_7464Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7464Member
2019-04-30
2019-04-30
0000872625
tsr:C000018657Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7464Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM0619_7464Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7464Member
2020-04-30
2020-04-30
0000872625
tsr:C000018657Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7464Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM0619_7464Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7464Member
2021-04-30
2021-04-30
0000872625
tsr:C000018657Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7464Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM0619_7464Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7464Member
2022-04-30
2022-04-30
0000872625
tsr:C000018657Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7464Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM0619_7464Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7464Member
2023-04-30
2023-04-30
0000872625
tsr:C000018657Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7464Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM0619_7464Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7464Member
2024-04-30
2024-04-30
0000872625
tsr:C000018657Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7464Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM0619_7464Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7464Member
2025-04-30
2025-04-30
0000872625
tsr:C000018659Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7466Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM0619_7466Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7466Member
2025-05-01
2026-04-30
0000872625
tsr:C000018659Member
2026-04-30
0000872625
tsr:C000018659Member
tsr:bench202409043993_7466Member
2026-04-30
0000872625
tsr:C000018659Member
tsr:bench202409043997_7466Member
2026-04-30
0000872625
tsr:C000018659Member
tsr:bench202409043992_7466Member
2026-04-30
0000872625
tsr:C000018659Member
tsr:bench202409043996_7466Member
2026-04-30
0000872625
tsr:C000018659Member
tsr:bench202409043994_7466Member
2026-04-30
0000872625
tsr:C000018659Member
tsr:bench202409043999_7466Member
2026-04-30
0000872625
tsr:C000018659Member
tsr:bench202409043998_7466Member
2026-04-30
0000872625
tsr:C000018659Member
tsr:bench202409043995_7466Member
2026-04-30
0000872625
tsr:C000018659Member
tsr:bench202409044000_7466Member
2026-04-30
0000872625
tsr:C000018659Member
tsr:bench202409044001_7466Member
2026-04-30
0000872625
tsr:C000018659Member
tsr:bench202412104943_7466Member
2026-04-30
0000872625
tsr:C000018659Member
tsr:bench202409044003_7466Member
2026-04-30
0000872625
tsr:C000018659Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7466Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM0619_7466Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7466Member
2021-05-01
2026-04-30
0000872625
tsr:C000018659Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7466Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM0619_7466Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7466Member
2016-05-01
2026-04-30
0000872625
tsr:C000018659Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7466Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM0619_7466Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7466Member
2016-04-30
2016-04-30
0000872625
tsr:C000018659Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7466Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM0619_7466Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7466Member
2017-04-30
2017-04-30
0000872625
tsr:C000018659Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7466Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM0619_7466Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7466Member
2018-04-30
2018-04-30
0000872625
tsr:C000018659Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7466Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM0619_7466Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7466Member
2019-04-30
2019-04-30
0000872625
tsr:C000018659Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7466Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM0619_7466Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7466Member
2020-04-30
2020-04-30
0000872625
tsr:C000018659Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7466Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM0619_7466Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7466Member
2021-04-30
2021-04-30
0000872625
tsr:C000018659Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7466Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM0619_7466Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7466Member
2022-04-30
2022-04-30
0000872625
tsr:C000018659Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7466Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM0619_7466Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7466Member
2023-04-30
2023-04-30
0000872625
tsr:C000018659Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7466Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM0619_7466Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7466Member
2024-04-30
2024-04-30
0000872625
tsr:C000018659Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7466Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM0619_7466Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7466Member
2025-04-30
2025-04-30
0000872625
tsr:C000128865Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7462Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM0619_7462Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7462Member
2025-05-01
2026-04-30
0000872625
tsr:C000128865Member
2026-04-30
0000872625
tsr:C000128865Member
tsr:bench202409043993_7462Member
2026-04-30
0000872625
tsr:C000128865Member
tsr:bench202409043997_7462Member
2026-04-30
0000872625
tsr:C000128865Member
tsr:bench202409043992_7462Member
2026-04-30
0000872625
tsr:C000128865Member
tsr:bench202409043996_7462Member
2026-04-30
0000872625
tsr:C000128865Member
tsr:bench202409043994_7462Member
2026-04-30
0000872625
tsr:C000128865Member
tsr:bench202409043999_7462Member
2026-04-30
0000872625
tsr:C000128865Member
tsr:bench202409043998_7462Member
2026-04-30
0000872625
tsr:C000128865Member
tsr:bench202409043995_7462Member
2026-04-30
0000872625
tsr:C000128865Member
tsr:bench202409044000_7462Member
2026-04-30
0000872625
tsr:C000128865Member
tsr:bench202409044001_7462Member
2026-04-30
0000872625
tsr:C000128865Member
tsr:bench202412104943_7462Member
2026-04-30
0000872625
tsr:C000128865Member
tsr:bench202409044003_7462Member
2026-04-30
0000872625
tsr:C000128865Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7462Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM0619_7462Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7462Member
2021-05-01
2026-04-30
0000872625
tsr:C000128865Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7462Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM0619_7462Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7462Member
2016-05-01
2026-04-30
0000872625
tsr:C000128865Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7462Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM0619_7462Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7462Member
2016-04-30
2016-04-30
0000872625
tsr:C000128865Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7462Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM0619_7462Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7462Member
2017-04-30
2017-04-30
0000872625
tsr:C000128865Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7462Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM0619_7462Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7462Member
2018-04-30
2018-04-30
0000872625
tsr:C000128865Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7462Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM0619_7462Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7462Member
2019-04-30
2019-04-30
0000872625
tsr:C000128865Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7462Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM0619_7462Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7462Member
2020-04-30
2020-04-30
0000872625
tsr:C000128865Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7462Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM0619_7462Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7462Member
2021-04-30
2021-04-30
0000872625
tsr:C000128865Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7462Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM0619_7462Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7462Member
2022-04-30
2022-04-30
0000872625
tsr:C000128865Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7462Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM0619_7462Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7462Member
2023-04-30
2023-04-30
0000872625
tsr:C000128865Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7462Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM0619_7462Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7462Member
2024-04-30
2024-04-30
0000872625
tsr:C000128865Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7462Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM0619_7462Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7462Member
2025-04-30
2025-04-30
0000872625
tsr:C000018658Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7465Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM0619_7465Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7465Member
2025-05-01
2026-04-30
0000872625
tsr:C000018658Member
2026-04-30
0000872625
tsr:C000018658Member
tsr:bench202409043993_7465Member
2026-04-30
0000872625
tsr:C000018658Member
tsr:bench202409043997_7465Member
2026-04-30
0000872625
tsr:C000018658Member
tsr:bench202409043992_7465Member
2026-04-30
0000872625
tsr:C000018658Member
tsr:bench202409043996_7465Member
2026-04-30
0000872625
tsr:C000018658Member
tsr:bench202409043994_7465Member
2026-04-30
0000872625
tsr:C000018658Member
tsr:bench202409043999_7465Member
2026-04-30
0000872625
tsr:C000018658Member
tsr:bench202409043998_7465Member
2026-04-30
0000872625
tsr:C000018658Member
tsr:bench202409043995_7465Member
2026-04-30
0000872625
tsr:C000018658Member
tsr:bench202409044000_7465Member
2026-04-30
0000872625
tsr:C000018658Member
tsr:bench202409044001_7465Member
2026-04-30
0000872625
tsr:C000018658Member
tsr:bench202412104943_7465Member
2026-04-30
0000872625
tsr:C000018658Member
tsr:bench202409044003_7465Member
2026-04-30
0000872625
tsr:C000018658Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7465Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM0619_7465Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7465Member
2021-05-01
2026-04-30
0000872625
tsr:C000018658Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7465Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM0619_7465Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7465Member
2016-05-01
2026-04-30
0000872625
tsr:C000018658Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7465Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM0619_7465Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7465Member
2016-04-30
2016-04-30
0000872625
tsr:C000018658Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7465Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM0619_7465Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7465Member
2017-04-30
2017-04-30
0000872625
tsr:C000018658Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7465Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM0619_7465Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7465Member
2018-04-30
2018-04-30
0000872625
tsr:C000018658Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7465Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM0619_7465Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7465Member
2019-04-30
2019-04-30
0000872625
tsr:C000018658Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7465Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM0619_7465Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7465Member
2020-04-30
2020-04-30
0000872625
tsr:C000018658Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7465Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM0619_7465Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7465Member
2021-04-30
2021-04-30
0000872625
tsr:C000018658Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7465Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM0619_7465Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7465Member
2022-04-30
2022-04-30
0000872625
tsr:C000018658Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7465Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM0619_7465Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7465Member
2023-04-30
2023-04-30
0000872625
tsr:C000018658Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7465Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM0619_7465Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7465Member
2024-04-30
2024-04-30
0000872625
tsr:C000018658Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7465Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM0619_7465Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7465Member
2025-04-30
2025-04-30
0000872625
tsr:C000018650Member
2025-05-01
2026-04-30
0000872625
tsr:C000018650Member
oef:WithoutSalesLoadMember
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7453Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM0824_7453Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7453Member
2025-05-01
2026-04-30
0000872625
tsr:C000018650Member
2026-04-30
0000872625
tsr:C000018650Member
tsr:bench202409043997_7453Member
2026-04-30
0000872625
tsr:C000018650Member
tsr:bench202409043996_7453Member
2026-04-30
0000872625
tsr:C000018650Member
tsr:bench202409043992_7453Member
2026-04-30
0000872625
tsr:C000018650Member
tsr:bench202409043993_7453Member
2026-04-30
0000872625
tsr:C000018650Member
tsr:bench202409043994_7453Member
2026-04-30
0000872625
tsr:C000018650Member
tsr:bench202409043995_7453Member
2026-04-30
0000872625
tsr:C000018650Member
tsr:bench202409043999_7453Member
2026-04-30
0000872625
tsr:C000018650Member
tsr:bench202409044002_7453Member
2026-04-30
0000872625
tsr:C000018650Member
tsr:bench202409043998_7453Member
2026-04-30
0000872625
tsr:C000018650Member
tsr:bench202409044000_7453Member
2026-04-30
0000872625
tsr:C000018650Member
tsr:bench202409044003_7453Member
2026-04-30
0000872625
tsr:C000018650Member
oef:WithoutSalesLoadMember
2021-05-01
2026-04-30
0000872625
tsr:C000018650Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7453Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM0824_7453Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7453Member
2021-05-01
2026-04-30
0000872625
tsr:C000018650Member
oef:WithoutSalesLoadMember
2016-05-01
2026-04-30
0000872625
tsr:C000018650Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7453Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM0824_7453Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7453Member
2016-05-01
2026-04-30
0000872625
tsr:C000018650Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7453Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM0824_7453Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7453Member
2016-04-30
2016-04-30
0000872625
tsr:C000018650Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7453Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM0824_7453Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7453Member
2017-04-30
2017-04-30
0000872625
tsr:C000018650Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7453Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM0824_7453Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7453Member
2018-04-30
2018-04-30
0000872625
tsr:C000018650Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7453Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM0824_7453Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7453Member
2019-04-30
2019-04-30
0000872625
tsr:C000018650Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7453Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM0824_7453Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7453Member
2020-04-30
2020-04-30
0000872625
tsr:C000018650Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7453Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM0824_7453Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7453Member
2021-04-30
2021-04-30
0000872625
tsr:C000018650Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7453Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM0824_7453Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7453Member
2022-04-30
2022-04-30
0000872625
tsr:C000018650Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7453Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM0824_7453Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7453Member
2023-04-30
2023-04-30
0000872625
tsr:C000018650Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7453Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM0824_7453Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7453Member
2024-04-30
2024-04-30
0000872625
tsr:C000018650Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7453Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM0824_7453Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7453Member
2025-04-30
2025-04-30
0000872625
tsr:C000018652Member
2025-05-01
2026-04-30
0000872625
tsr:C000018652Member
oef:WithoutSalesLoadMember
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7454Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM0824_7454Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7454Member
2025-05-01
2026-04-30
0000872625
tsr:C000018652Member
2026-04-30
0000872625
tsr:C000018652Member
tsr:bench202409043997_7454Member
2026-04-30
0000872625
tsr:C000018652Member
tsr:bench202409043996_7454Member
2026-04-30
0000872625
tsr:C000018652Member
tsr:bench202409043992_7454Member
2026-04-30
0000872625
tsr:C000018652Member
tsr:bench202409043993_7454Member
2026-04-30
0000872625
tsr:C000018652Member
tsr:bench202409043994_7454Member
2026-04-30
0000872625
tsr:C000018652Member
tsr:bench202409043995_7454Member
2026-04-30
0000872625
tsr:C000018652Member
tsr:bench202409043999_7454Member
2026-04-30
0000872625
tsr:C000018652Member
tsr:bench202409044002_7454Member
2026-04-30
0000872625
tsr:C000018652Member
tsr:bench202409043998_7454Member
2026-04-30
0000872625
tsr:C000018652Member
tsr:bench202409044000_7454Member
2026-04-30
0000872625
tsr:C000018652Member
tsr:bench202409044003_7454Member
2026-04-30
0000872625
tsr:C000018652Member
oef:WithoutSalesLoadMember
2021-05-01
2026-04-30
0000872625
tsr:C000018652Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7454Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM0824_7454Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7454Member
2021-05-01
2026-04-30
0000872625
tsr:C000018652Member
oef:WithoutSalesLoadMember
2016-05-01
2026-04-30
0000872625
tsr:C000018652Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7454Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM0824_7454Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7454Member
2016-05-01
2026-04-30
0000872625
tsr:C000018652Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7454Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM0824_7454Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7454Member
2016-04-30
2016-04-30
0000872625
tsr:C000018652Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7454Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM0824_7454Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7454Member
2017-04-30
2017-04-30
0000872625
tsr:C000018652Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7454Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM0824_7454Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7454Member
2018-04-30
2018-04-30
0000872625
tsr:C000018652Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7454Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM0824_7454Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7454Member
2019-04-30
2019-04-30
0000872625
tsr:C000018652Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7454Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM0824_7454Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7454Member
2020-04-30
2020-04-30
0000872625
tsr:C000018652Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7454Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM0824_7454Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7454Member
2021-04-30
2021-04-30
0000872625
tsr:C000018652Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7454Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM0824_7454Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7454Member
2022-04-30
2022-04-30
0000872625
tsr:C000018652Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7454Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM0824_7454Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7454Member
2023-04-30
2023-04-30
0000872625
tsr:C000018652Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7454Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM0824_7454Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7454Member
2024-04-30
2024-04-30
0000872625
tsr:C000018652Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7454Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM0824_7454Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7454Member
2025-04-30
2025-04-30
0000872625
tsr:C000018654Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7461Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM0824_7461Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7461Member
2025-05-01
2026-04-30
0000872625
tsr:C000018654Member
2026-04-30
0000872625
tsr:C000018654Member
tsr:bench202409043997_7461Member
2026-04-30
0000872625
tsr:C000018654Member
tsr:bench202409043996_7461Member
2026-04-30
0000872625
tsr:C000018654Member
tsr:bench202409043992_7461Member
2026-04-30
0000872625
tsr:C000018654Member
tsr:bench202409043993_7461Member
2026-04-30
0000872625
tsr:C000018654Member
tsr:bench202409043994_7461Member
2026-04-30
0000872625
tsr:C000018654Member
tsr:bench202409043995_7461Member
2026-04-30
0000872625
tsr:C000018654Member
tsr:bench202409043999_7461Member
2026-04-30
0000872625
tsr:C000018654Member
tsr:bench202409044002_7461Member
2026-04-30
0000872625
tsr:C000018654Member
tsr:bench202409043998_7461Member
2026-04-30
0000872625
tsr:C000018654Member
tsr:bench202409044000_7461Member
2026-04-30
0000872625
tsr:C000018654Member
tsr:bench202409044003_7461Member
2026-04-30
0000872625
tsr:C000018654Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7461Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM0824_7461Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7461Member
2021-05-01
2026-04-30
0000872625
tsr:C000018654Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7461Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM0824_7461Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7461Member
2016-05-01
2026-04-30
0000872625
tsr:C000018654Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7461Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM0824_7461Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7461Member
2016-04-30
2016-04-30
0000872625
tsr:C000018654Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7461Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM0824_7461Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7461Member
2017-04-30
2017-04-30
0000872625
tsr:C000018654Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7461Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM0824_7461Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7461Member
2018-04-30
2018-04-30
0000872625
tsr:C000018654Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7461Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM0824_7461Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7461Member
2019-04-30
2019-04-30
0000872625
tsr:C000018654Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7461Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM0824_7461Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7461Member
2020-04-30
2020-04-30
0000872625
tsr:C000018654Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7461Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM0824_7461Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7461Member
2021-04-30
2021-04-30
0000872625
tsr:C000018654Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7461Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM0824_7461Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7461Member
2022-04-30
2022-04-30
0000872625
tsr:C000018654Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7461Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM0824_7461Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7461Member
2023-04-30
2023-04-30
0000872625
tsr:C000018654Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7461Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM0824_7461Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7461Member
2024-04-30
2024-04-30
0000872625
tsr:C000018654Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7461Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM0824_7461Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7461Member
2025-04-30
2025-04-30
0000872625
tsr:C000128864Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7455Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM0824_7455Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7455Member
2025-05-01
2026-04-30
0000872625
tsr:C000128864Member
2026-04-30
0000872625
tsr:C000128864Member
tsr:bench202409043997_7455Member
2026-04-30
0000872625
tsr:C000128864Member
tsr:bench202409043996_7455Member
2026-04-30
0000872625
tsr:C000128864Member
tsr:bench202409043992_7455Member
2026-04-30
0000872625
tsr:C000128864Member
tsr:bench202409043993_7455Member
2026-04-30
0000872625
tsr:C000128864Member
tsr:bench202409043994_7455Member
2026-04-30
0000872625
tsr:C000128864Member
tsr:bench202409043995_7455Member
2026-04-30
0000872625
tsr:C000128864Member
tsr:bench202409043999_7455Member
2026-04-30
0000872625
tsr:C000128864Member
tsr:bench202409044002_7455Member
2026-04-30
0000872625
tsr:C000128864Member
tsr:bench202409043998_7455Member
2026-04-30
0000872625
tsr:C000128864Member
tsr:bench202409044000_7455Member
2026-04-30
0000872625
tsr:C000128864Member
tsr:bench202409044003_7455Member
2026-04-30
0000872625
tsr:C000128864Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7455Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM0824_7455Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7455Member
2021-05-01
2026-04-30
0000872625
tsr:C000128864Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7455Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM0824_7455Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7455Member
2016-05-01
2026-04-30
0000872625
tsr:C000128864Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7455Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM0824_7455Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7455Member
2016-04-30
2016-04-30
0000872625
tsr:C000128864Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7455Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM0824_7455Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7455Member
2017-04-30
2017-04-30
0000872625
tsr:C000128864Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7455Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM0824_7455Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7455Member
2018-04-30
2018-04-30
0000872625
tsr:C000128864Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7455Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM0824_7455Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7455Member
2019-04-30
2019-04-30
0000872625
tsr:C000128864Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7455Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM0824_7455Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7455Member
2020-04-30
2020-04-30
0000872625
tsr:C000128864Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7455Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM0824_7455Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7455Member
2021-04-30
2021-04-30
0000872625
tsr:C000128864Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7455Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM0824_7455Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7455Member
2022-04-30
2022-04-30
0000872625
tsr:C000128864Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7455Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM0824_7455Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7455Member
2023-04-30
2023-04-30
0000872625
tsr:C000128864Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7455Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM0824_7455Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7455Member
2024-04-30
2024-04-30
0000872625
tsr:C000128864Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7455Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM0824_7455Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7455Member
2025-04-30
2025-04-30
0000872625
tsr:C000018653Member
2025-05-01
2026-04-30
0000872625
tsr:bench202411154435_7460Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkBM0824_7460Member
2025-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7460Member
2025-05-01
2026-04-30
0000872625
tsr:C000018653Member
2026-04-30
0000872625
tsr:C000018653Member
tsr:bench202409043997_7460Member
2026-04-30
0000872625
tsr:C000018653Member
tsr:bench202409043996_7460Member
2026-04-30
0000872625
tsr:C000018653Member
tsr:bench202409043992_7460Member
2026-04-30
0000872625
tsr:C000018653Member
tsr:bench202409043993_7460Member
2026-04-30
0000872625
tsr:C000018653Member
tsr:bench202409043994_7460Member
2026-04-30
0000872625
tsr:C000018653Member
tsr:bench202409043995_7460Member
2026-04-30
0000872625
tsr:C000018653Member
tsr:bench202409043999_7460Member
2026-04-30
0000872625
tsr:C000018653Member
tsr:bench202409044002_7460Member
2026-04-30
0000872625
tsr:C000018653Member
tsr:bench202409043998_7460Member
2026-04-30
0000872625
tsr:C000018653Member
tsr:bench202409044000_7460Member
2026-04-30
0000872625
tsr:C000018653Member
tsr:bench202409044003_7460Member
2026-04-30
0000872625
tsr:C000018653Member
2021-05-01
2026-04-30
0000872625
tsr:bench202411154435_7460Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkBM0824_7460Member
2021-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7460Member
2021-05-01
2026-04-30
0000872625
tsr:C000018653Member
2016-05-01
2026-04-30
0000872625
tsr:bench202411154435_7460Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkBM0824_7460Member
2016-05-01
2026-04-30
0000872625
tsr:benchmarkHB0331_7460Member
2016-05-01
2026-04-30
0000872625
tsr:C000018653Member
2016-04-30
2016-04-30
0000872625
tsr:bench202411154435_7460Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkBM0824_7460Member
2016-04-30
2016-04-30
0000872625
tsr:benchmarkHB0331_7460Member
2016-04-30
2016-04-30
0000872625
tsr:C000018653Member
2017-04-30
2017-04-30
0000872625
tsr:bench202411154435_7460Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkBM0824_7460Member
2017-04-30
2017-04-30
0000872625
tsr:benchmarkHB0331_7460Member
2017-04-30
2017-04-30
0000872625
tsr:C000018653Member
2018-04-30
2018-04-30
0000872625
tsr:bench202411154435_7460Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkBM0824_7460Member
2018-04-30
2018-04-30
0000872625
tsr:benchmarkHB0331_7460Member
2018-04-30
2018-04-30
0000872625
tsr:C000018653Member
2019-04-30
2019-04-30
0000872625
tsr:bench202411154435_7460Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkBM0824_7460Member
2019-04-30
2019-04-30
0000872625
tsr:benchmarkHB0331_7460Member
2019-04-30
2019-04-30
0000872625
tsr:C000018653Member
2020-04-30
2020-04-30
0000872625
tsr:bench202411154435_7460Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkBM0824_7460Member
2020-04-30
2020-04-30
0000872625
tsr:benchmarkHB0331_7460Member
2020-04-30
2020-04-30
0000872625
tsr:C000018653Member
2021-04-30
2021-04-30
0000872625
tsr:bench202411154435_7460Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkBM0824_7460Member
2021-04-30
2021-04-30
0000872625
tsr:benchmarkHB0331_7460Member
2021-04-30
2021-04-30
0000872625
tsr:C000018653Member
2022-04-30
2022-04-30
0000872625
tsr:bench202411154435_7460Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkBM0824_7460Member
2022-04-30
2022-04-30
0000872625
tsr:benchmarkHB0331_7460Member
2022-04-30
2022-04-30
0000872625
tsr:C000018653Member
2023-04-30
2023-04-30
0000872625
tsr:bench202411154435_7460Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkBM0824_7460Member
2023-04-30
2023-04-30
0000872625
tsr:benchmarkHB0331_7460Member
2023-04-30
2023-04-30
0000872625
tsr:C000018653Member
2024-04-30
2024-04-30
0000872625
tsr:bench202411154435_7460Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkBM0824_7460Member
2024-04-30
2024-04-30
0000872625
tsr:benchmarkHB0331_7460Member
2024-04-30
2024-04-30
0000872625
tsr:C000018653Member
2025-04-30
2025-04-30
0000872625
tsr:bench202411154435_7460Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkBM0824_7460Member
2025-04-30
2025-04-30
0000872625
tsr:benchmarkHB0331_7460Member
2025-04-30
2025-04-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR
CERTIFIED SHAREHOLDER REPORT OF
REGISTERED
MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number
811-06243
Franklin Strategic Series
(Exact name of registrant as specified
in charter)
One Franklin Parkway, San Mateo,
CA 94403-1906
(Address of principal executive
offices) (Zip code)
Alison Baur
Franklin Templeton
One Franklin Parkway
San Mateo, CA 94403-1906
(Name and address of agent for
service)
Registrant’s telephone number,
including area code: (650) 312-2000
Date of fiscal year end: April
30
Date of reporting period: April
30, 2026
| ITEM 1. |
REPORT TO STOCKHOLDERS |
(a) The Report
to Shareholders is filed herewith
|
|
|
|
Franklin Biotechnology Discovery Fund
|
|
|
Class A [FBDIX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Biotechnology Discovery Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class A
|
$134
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class A shares of Franklin Biotechnology Discovery Fund returned 65.03%. The Fund compares its performance to the NASDAQ Biotechnology Index and the S&P 500 Index, which returned 37.61% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
Overweighted portfolio exposure to mid-, small-, and micro-cap biotechnology stocks, which generally performed well. Performance also benefited from a focus on companies with proven drug delivery platforms, favorable clinical trial catalysts, and strong balance sheets. In addition, an emphasis on identifying clinically or commercially “de-risked” assets appears to have supported relative returns.
|
|
↑
|
Successful stock selection in the biotech industry, where numerous overweighted or off-benchmark holdings more than doubled in value, including key contributors Abivax, Ascendis Pharma, Praxis Precision Medicines, Merus, Spyre Therapeutics, Oruka Therapeutics, Centessa Pharmaceuticals, Dianthus Therapeutics and uniQure.
|
|
↑
|
Stock selection and overweighting in the pharmaceuticals industry, where much larger-than-index positions in Terns Pharmaceuticals and Jazz Pharmaceuticals topped a fairly long list of contributors. To a lesser extent, additional relative-return gains were achieved in three other industries: health care services (due to overweighting), managed health care (not an index component), and health care equipment (lack of exposure).
|
|
|
|
Top detractors from performance:
|
|
↓
|
Detrimental stock selection created a wide total-return gap in the life sciences tools and services industry; the combined value of the Fund’s related holdings declined, while those tracked by the benchmark index increased sharply.
|
|
↓
|
Several overweighted or off-benchmark biotech and pharma holdings either sold off amid company-specific setbacks or posted muted one-year gains. The key detractors in this regard were LENZ Therapeutics (purchased during the period), Benitec Biopharma, Soleno Therapeutics, ARS Pharmaceuticals, Ionis Pharmaceuticals (purchased during the period), Eli Lilly, MoonLake Immunotherapeutics (bought and sold during the period), Zealand Pharma, Ultragenyx Pharmaceuticals and Day One Biopharmaceuticals. Several of these positions were liquidated by year-end.
|
|
↓
|
The Fund lacked exposure to several index component companies—such as Roivant Sciences, Arrowhead Pharmaceuticals, United Therapeutics, Viatris, and Axsome Therapeutics—that significantly outperformed the benchmark. In addition, the portfolio’s cash allocation (averaging about 2.1% of total net assets) diluted relative performance during a time of robust and broad-based gains across the biotech and pharma industries.
|
| Franklin Biotechnology Discovery Fund
|
PAGE 1
|
402-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT ($9,450 AFTER MAXIMUM APPLICABLE SALES CHARGE) –
Class A 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class A
|
65.03
|
8.13
|
10.09
|
|
Class A (with sales charge)
|
55.94
|
6.91
|
9.47
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
NASDAQ Biotechnology Index
|
37.61
|
3.80
|
7.65
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Total return information is based on net asset values calculated for shareholder transactions. Certain adjustments were made to the net assets of the Fund at the end of the period for financial reporting purposes. Accordingly, adjusted total returns have been disclosed in the Financial Highlights and differ from those reported here.
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
Performance for periods prior to September 10, 2018, has been restated to reflect the current maximum sales charge, which is lower than the maximum sales charge prior to that date.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$1,037,360,270
|
|
Total Number of Portfolio Holdings
|
110
|
|
Total Management Fee Paid
|
$5,300,115
|
|
Portfolio Turnover Rate
|
37.62%
|
| Franklin Biotechnology Discovery Fund
|
PAGE 2
|
402-ATSR-0626 |
Portfolio Composition* (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Biotechnology Discovery Fund
|
PAGE 3
|
402-ATSR-0626 |
94501134211534113491345016712119391320215535149702470310000118581340615106149482256021857221862713330227396011000011103116021191713902173441340514926148371518720899100001179213356151581528922320223672296328167315744137994.00.30.20.15.4
|
|
|
|
Franklin Biotechnology Discovery Fund
|
|
|
Class C [FBTDX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Biotechnology Discovery Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class C
|
$232
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class C shares of Franklin Biotechnology Discovery Fund returned 63.82%. The Fund compares its performance to the NASDAQ Biotechnology Index and the S&P 500 Index, which returned 37.61% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
Overweighted portfolio exposure to mid-, small-, and micro-cap biotechnology stocks, which generally performed well. Performance also benefited from a focus on companies with proven drug delivery platforms, favorable clinical trial catalysts, and strong balance sheets. In addition, an emphasis on identifying clinically or commercially “de-risked” assets appears to have supported relative returns.
|
|
↑
|
Successful stock selection in the biotech industry, where numerous overweighted or off-benchmark holdings more than doubled in value, including key contributors Abivax, Ascendis Pharma, Praxis Precision Medicines, Merus, Spyre Therapeutics, Oruka Therapeutics, Centessa Pharmaceuticals, Dianthus Therapeutics and uniQure.
|
|
↑
|
Stock selection and overweighting in the pharmaceuticals industry, where much larger-than-index positions in Terns Pharmaceuticals and Jazz Pharmaceuticals topped a fairly long list of contributors. To a lesser extent, additional relative-return gains were achieved in three other industries: health care services (due to overweighting), managed health care (not an index component), and health care equipment (lack of exposure).
|
|
|
|
Top detractors from performance:
|
|
↓
|
Detrimental stock selection created a wide total-return gap in the life sciences tools and services industry; the combined value of the Fund’s related holdings declined, while those tracked by the benchmark index increased sharply.
|
|
↓
|
Several overweighted or off-benchmark biotech and pharma holdings either sold off amid company-specific setbacks or posted muted one-year gains. The key detractors in this regard were LENZ Therapeutics (purchased during the period), Benitec Biopharma, Soleno Therapeutics, ARS Pharmaceuticals, Ionis Pharmaceuticals (purchased during the period), Eli Lilly, MoonLake Immunotherapeutics (bought and sold during the period), Zealand Pharma, Ultragenyx Pharmaceuticals and Day One Biopharmaceuticals. Several of these positions were liquidated by year-end.
|
|
↓
|
The Fund lacked exposure to several index component companies—such as Roivant Sciences, Arrowhead Pharmaceuticals, United Therapeutics, Viatris, and Axsome Therapeutics—that significantly outperformed the benchmark. In addition, the portfolio’s cash allocation (averaging about 2.1% of total net assets) diluted relative performance during a time of robust and broad-based gains across the biotech and pharma industries.
|
| Franklin Biotechnology Discovery Fund
|
PAGE 1
|
242-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class C 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class C
|
63.82
|
7.35
|
9.28
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
NASDAQ Biotechnology Index
|
37.61
|
3.80
|
7.65
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Total return information is based on net asset values calculated for shareholder transactions. Certain adjustments were made to the net assets of the Fund at the end of the period for financial reporting purposes. Accordingly, adjusted total returns have been disclosed in the Financial Highlights and differ from those reported here.
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$1,037,360,270
|
|
Total Number of Portfolio Holdings
|
110
|
|
Total Management Fee Paid
|
$5,300,115
|
|
Portfolio Turnover Rate
|
37.62%
|
| Franklin Biotechnology Discovery Fund
|
PAGE 2
|
242-ATSR-0626 |
Portfolio Composition* (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Biotechnology Discovery Fund
|
PAGE 3
|
242-ATSR-0626 |
100001191412024117441381317036120961327615506148292429310000118581340615106149482256021857221862713330227396011000011103116021191713902173441340514926148371518720899100001179213356151581528922320223672296328167315744137994.00.30.20.15.4
|
|
|
|
Franklin Biotechnology Discovery Fund
|
|
|
Class R6 [FRBRX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Biotechnology Discovery Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class R6
|
$89
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class R6 shares of Franklin Biotechnology Discovery Fund returned 65.61%. The Fund compares its performance to the NASDAQ Biotechnology Index and the S&P 500 Index, which returned 37.61% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
Overweighted portfolio exposure to mid-, small-, and micro-cap biotechnology stocks, which generally performed well. Performance also benefited from a focus on companies with proven drug delivery platforms, favorable clinical trial catalysts, and strong balance sheets. In addition, an emphasis on identifying clinically or commercially “de-risked” assets appears to have supported relative returns.
|
|
↑
|
Successful stock selection in the biotech industry, where numerous overweighted or off-benchmark holdings more than doubled in value, including key contributors Abivax, Ascendis Pharma, Praxis Precision Medicines, Merus, Spyre Therapeutics, Oruka Therapeutics, Centessa Pharmaceuticals, Dianthus Therapeutics and uniQure.
|
|
↑
|
Stock selection and overweighting in the pharmaceuticals industry, where much larger-than-index positions in Terns Pharmaceuticals and Jazz Pharmaceuticals topped a fairly long list of contributors. To a lesser extent, additional relative-return gains were achieved in three other industries: health care services (due to overweighting), managed health care (not an index component), and health care equipment (lack of exposure).
|
|
|
|
Top detractors from performance:
|
|
↓
|
Detrimental stock selection created a wide total-return gap in the life sciences tools and services industry; the combined value of the Fund’s related holdings declined, while those tracked by the benchmark index increased sharply.
|
|
↓
|
Several overweighted or off-benchmark biotech and pharma holdings either sold off amid company-specific setbacks or posted muted one-year gains. The key detractors in this regard were LENZ Therapeutics (purchased during the period), Benitec Biopharma, Soleno Therapeutics, ARS Pharmaceuticals, Ionis Pharmaceuticals (purchased during the period), Eli Lilly, MoonLake Immunotherapeutics (bought and sold during the period), Zealand Pharma, Ultragenyx Pharmaceuticals and Day One Biopharmaceuticals. Several of these positions were liquidated by year-end.
|
|
↓
|
The Fund lacked exposure to several index component companies—such as Roivant Sciences, Arrowhead Pharmaceuticals, United Therapeutics, Viatris, and Axsome Therapeutics—that significantly outperformed the benchmark. In addition, the portfolio’s cash allocation (averaging about 2.1% of total net assets) diluted relative performance during a time of robust and broad-based gains across the biotech and pharma industries.
|
| Franklin Biotechnology Discovery Fund
|
PAGE 1
|
342-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class R6 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class R6
|
65.61
|
8.53
|
10.50
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
NASDAQ Biotechnology Index
|
37.61
|
3.80
|
7.65
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Total return information is based on net asset values calculated for shareholder transactions. Certain adjustments were made to the net assets of the Fund at the end of the period for financial reporting purposes. Accordingly, adjusted total returns have been disclosed in the Financial Highlights and differ from those reported here.
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$1,037,360,270
|
|
Total Number of Portfolio Holdings
|
110
|
|
Total Management Fee Paid
|
$5,300,115
|
|
Portfolio Turnover Rate
|
37.62%
|
| Franklin Biotechnology Discovery Fund
|
PAGE 2
|
342-ATSR-0626 |
Portfolio Composition* (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Biotechnology Discovery Fund
|
PAGE 3
|
342-ATSR-0626 |
100001205012305121531445618023129231434916946163862713510000118581340615106149482256021857221862713330227396011000011103116021191713902173441340514926148371518720899100001179213356151581528922320223672296328167315744137994.00.30.20.15.4
|
|
|
|
Franklin Biotechnology Discovery Fund
|
|
|
Advisor Class [FTDZX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Biotechnology Discovery Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Advisor Class
|
$101
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Advisor Class shares of Franklin Biotechnology Discovery Fund returned 65.45%. The Fund compares its performance to the NASDAQ Biotechnology Index and the S&P 500 Index, which returned 37.61% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
Overweighted portfolio exposure to mid-, small-, and micro-cap biotechnology stocks, which generally performed well. Performance also benefited from a focus on companies with proven drug delivery platforms, favorable clinical trial catalysts, and strong balance sheets. In addition, an emphasis on identifying clinically or commercially “de-risked” assets appears to have supported relative returns.
|
|
↑
|
Successful stock selection in the biotech industry, where numerous overweighted or off-benchmark holdings more than doubled in value, including key contributors Abivax, Ascendis Pharma, Praxis Precision Medicines, Merus, Spyre Therapeutics, Oruka Therapeutics, Centessa Pharmaceuticals, Dianthus Therapeutics and uniQure.
|
|
↑
|
Stock selection and overweighting in the pharmaceuticals industry, where much larger-than-index positions in Terns Pharmaceuticals and Jazz Pharmaceuticals topped a fairly long list of contributors. To a lesser extent, additional relative-return gains were achieved in three other industries: health care services (due to overweighting), managed health care (not an index component), and health care equipment (lack of exposure).
|
|
|
|
Top detractors from performance:
|
|
↓
|
Detrimental stock selection created a wide total-return gap in the life sciences tools and services industry; the combined value of the Fund’s related holdings declined, while those tracked by the benchmark index increased sharply.
|
|
↓
|
Several overweighted or off-benchmark biotech and pharma holdings either sold off amid company-specific setbacks or posted muted one-year gains. The key detractors in this regard were LENZ Therapeutics (purchased during the period), Benitec Biopharma, Soleno Therapeutics, ARS Pharmaceuticals, Ionis Pharmaceuticals (purchased during the period), Eli Lilly, MoonLake Immunotherapeutics (bought and sold during the period), Zealand Pharma, Ultragenyx Pharmaceuticals and Day One Biopharmaceuticals. Several of these positions were liquidated by year-end.
|
|
↓
|
The Fund lacked exposure to several index component companies—such as Roivant Sciences, Arrowhead Pharmaceuticals, United Therapeutics, Viatris, and Axsome Therapeutics—that significantly outperformed the benchmark. In addition, the portfolio’s cash allocation (averaging about 2.1% of total net assets) diluted relative performance during a time of robust and broad-based gains across the biotech and pharma industries.
|
| Franklin Biotechnology Discovery Fund
|
PAGE 1
|
42-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Advisor Class 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Advisor Class
|
65.45
|
8.40
|
10.36
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
NASDAQ Biotechnology Index
|
37.61
|
3.80
|
7.65
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Total return information is based on net asset values calculated for shareholder transactions. Certain adjustments were made to the net assets of the Fund at the end of the period for financial reporting purposes. Accordingly, adjusted total returns have been disclosed in the Financial Highlights and differ from those reported here.
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$1,037,360,270
|
|
Total Number of Portfolio Holdings
|
110
|
|
Total Management Fee Paid
|
$5,300,115
|
|
Portfolio Turnover Rate
|
37.62%
|
| Franklin Biotechnology Discovery Fund
|
PAGE 2
|
42-ATSR-0626 |
Portfolio Composition* (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Biotechnology Discovery Fund
|
PAGE 3
|
42-ATSR-0626 |
100001203212266120991437617907128241421716772162012680410000118581340615106149482256021857221862713330227396011000011103116021191713902173441340514926148371518720899100001179213356151581528922320223672296328167315744137994.00.30.20.15.4
|
|
|
|
Franklin Core Plus Bond Fund
|
|
|
Class A [FRSTX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Core Plus Bond Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
This report describes changes to the Fund that occurred during the reporting period.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class A
|
$73
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class A shares of Franklin Core Plus Bond Fund returned 4.78%. The Fund compares its performance to the Bloomberg U.S. Aggregate Index, which returned 4.06% for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
Overweight allocation to high-yield (HY) and investment-grade (IG) corporate bonds, agency mortgage-backed securities (MBS), commercial MBS and sovereign emerging market debt.
|
|
↑
|
Out-of-index exposure to residential MBS and collateralized loan obligations (CLOs).
|
|
↑
|
Exposure to the five-, 20- and 30-year portions of the yield curve.
|
|
|
|
Top detractors from performance:
|
|
↓
|
Security selection in HY corporate bonds, senior secured floating-rate bank loans and IG corporate bonds.
|
|
↓
|
Exposure to the 10-year segment of the yield curve.
|
Use of derivatives and the impact on performance:
The Fund utilized bond futures to manage duration exposure and high-yield credit default swap (CDS) to manage the Fund’s credit exposure. In aggregate, these instruments detracted slightly from performance.
| Franklin Core Plus Bond Fund
|
PAGE 1
|
194-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT ($9,625 AFTER MAXIMUM APPLICABLE SALES CHARGE) –
Class A 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class A
|
4.78
|
1.81
|
2.80
|
|
Class A (with sales charge)
|
0.87
|
1.03
|
2.41
|
|
Bloomberg U.S. Aggregate Index
|
4.06
|
0.18
|
1.67
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
Performance for periods prior to March 1, 2019, has been restated to reflect the current maximum sales charge, which is lower than the maximum sales charge prior to that date.
The Fund was able to successfully meet its monthly distributions under its managed distribution policy without the return of capital.
Effective December 11, 2024, the Fund changed its name and adopted its current investment strategy.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$2,747,319,270
|
|
Total Number of Portfolio Holdings (excludes derivatives, except purchased options, if any)
|
866
|
|
Total Management Fee Paid
|
$6,862,755
|
|
Portfolio Turnover Rate
|
349.54%
|
| Franklin Core Plus Bond Fund
|
PAGE 2
|
194-ATSR-0626 |
Portfolio Composition*,† (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
| † |
Certain categories may represent less than 0.1%. |
HOW HAS THE FUND CHANGED?
Effective September 1, 2025, the Fund’s principal investment strategies were changed to reflect the Fund’s increased investments in collateralized mortgage obligations.
Related risk disclosure was added to the prospectus.
Effective September 30, 2025, Benjamin Cryer and Thomas Runkel no longer serve as portfolio managers of the Fund and Albert Chan was added as a portfolio manager of the Fund.
Effective May 8, 2025, the investment manager contractually agreed to waive fees and/or reimburse operating expenses (excluding the Rule 12b-1 fees and certain non-routine expenses or costs, such as those relating to litigation, indemnification, reorganizations and liquidations) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.47% for each share class except Class R6 and 0.37% for Class R6 until August 31, 2026.
Additionally, effective May 8, 2025, the Fund’s contractual management fee schedule was reduced to a fee equal to an annual rate based on the value of the Fund’s average daily net assets, as follows: 0.350% up to and including $5 billion; 0.330% over $5 billion up to and including $10 billion; 0.310% over $10 billion up to and including $20 billion; and 0.290% over $20 billion.
This is a summary of certain changes and planned changes to the Fund since May 1, 2025. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2026, at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or prospectus.us.franklintempleton@fisglobal.com.
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Core Plus Bond Fund
|
PAGE 3
|
194-ATSR-0626 |
962510347104141088510262116011089710977113191210912688100001008310051105821173011698107031065710500113431180331.824.612.07.65.23.72.52.52.20.80.10.00.00.07.0
|
|
|
|
Franklin Core Plus Bond Fund
|
|
|
Class C [FSGCX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Core Plus Bond Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
This report describes changes to the Fund that occurred during the reporting period.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class C
|
$113
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class C shares of Franklin Core Plus Bond Fund returned 4.35%. The Fund compares its performance to the Bloomberg U.S. Aggregate Index, which returned 4.06% for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
Overweight allocation to high-yield (HY) and investment-grade (IG) corporate bonds, agency mortgage-backed securities (MBS), commercial MBS and sovereign emerging market debt.
|
|
↑
|
Out-of-index exposure to residential MBS and collateralized loan obligations (CLOs).
|
|
↑
|
Exposure to the five-, 20- and 30-year portions of the yield curve.
|
|
|
|
Top detractors from performance:
|
|
↓
|
Security selection in HY corporate bonds, senior secured floating-rate bank loans and IG corporate bonds.
|
|
↓
|
Exposure to the 10-year segment of the yield curve.
|
Use of derivatives and the impact on performance:
The Fund utilized bond futures to manage duration exposure and high-yield credit default swap (CDS) to manage the Fund’s credit exposure. In aggregate, these instruments detracted slightly from performance.
| Franklin Core Plus Bond Fund
|
PAGE 1
|
294-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class C 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class C
|
4.35
|
1.40
|
2.40
|
|
Class C (with sales charge)
|
3.35
|
1.40
|
2.40
|
|
Bloomberg U.S. Aggregate Index
|
4.06
|
0.18
|
1.67
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
The Fund was able to successfully meet its monthly distributions under its managed distribution policy without the return of capital.
Effective December 11, 2024, the Fund changed its name and adopted its current investment strategy.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$2,747,319,270
|
|
Total Number of Portfolio Holdings (excludes derivatives, except purchased options, if any)
|
866
|
|
Total Management Fee Paid
|
$6,862,755
|
|
Portfolio Turnover Rate
|
349.54%
|
| Franklin Core Plus Bond Fund
|
PAGE 2
|
294-ATSR-0626 |
Portfolio Composition*,† (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
| † |
Certain categories may represent less than 0.1%. |
HOW HAS THE FUND CHANGED?
Effective September 1, 2025, the Fund’s principal investment strategies were changed to reflect the Fund’s increased investments in collateralized mortgage obligations.
Related risk disclosure was added to the prospectus.
Effective September 30, 2025, Benjamin Cryer and Thomas Runkel no longer serve as portfolio managers of the Fund and Albert Chan was added as a portfolio manager of the Fund.
Effective May 8, 2025, the investment manager contractually agreed to waive fees and/or reimburse operating expenses (excluding the Rule 12b-1 fees and certain non-routine expenses or costs, such as those relating to litigation, indemnification, reorganizations and liquidations) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.47% for each share class except Class R6 and 0.37% for Class R6 until August 31, 2026.
Additionally, effective May 8, 2025, the Fund’s contractual management fee schedule was reduced to a fee equal to an annual rate based on the value of the Fund’s average daily net assets, as follows: 0.350% up to and including $5 billion; 0.330% over $5 billion up to and including $10 billion; 0.310% over $10 billion up to and including $20 billion; and 0.290% over $20 billion.
This is a summary of certain changes and planned changes to the Fund since May 1, 2025. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2026, at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or prospectus.us.franklintempleton@fisglobal.com.
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Core Plus Bond Fund
|
PAGE 3
|
294-ATSR-0626 |
1000010719107341118410501118221105611089114001214412672100001008310051105821173011698107031065710500113431180331.824.612.07.65.23.72.52.52.20.80.10.00.00.07.0
|
|
|
|
Franklin Core Plus Bond Fund
|
|
|
Class R [FKSRX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Core Plus Bond Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
This report describes changes to the Fund that occurred during the reporting period.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class R
|
$98
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class R shares of Franklin Core Plus Bond Fund returned 4.67%. The Fund compares its performance to the Bloomberg U.S. Aggregate Index, which returned 4.06% for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
Overweight allocation to high-yield (HY) and investment-grade (IG) corporate bonds, agency mortgage-backed securities (MBS), commercial MBS and sovereign emerging market debt.
|
|
↑
|
Out-of-index exposure to residential MBS and collateralized loan obligations (CLOs).
|
|
↑
|
Exposure to the five-, 20- and 30-year portions of the yield curve.
|
|
|
|
Top detractors from performance:
|
|
↓
|
Security selection in HY corporate bonds, senior secured floating-rate bank loans and IG corporate bonds.
|
|
↓
|
Exposure to the 10-year segment of the yield curve.
|
Use of derivatives and the impact on performance:
The Fund utilized bond futures to manage duration exposure and high-yield credit default swap (CDS) to manage the Fund’s credit exposure. In aggregate, these instruments detracted slightly from performance.
| Franklin Core Plus Bond Fund
|
PAGE 1
|
894-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class R 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class R
|
4.67
|
1.56
|
2.56
|
|
Bloomberg U.S. Aggregate Index
|
4.06
|
0.18
|
1.67
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
The Fund was able to successfully meet its monthly distributions under its managed distribution policy without the return of capital.
Effective December 11, 2024, the Fund changed its name and adopted its current investment strategy.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$2,747,319,270
|
|
Total Number of Portfolio Holdings (excludes derivatives, except purchased options, if any)
|
866
|
|
Total Management Fee Paid
|
$6,862,755
|
|
Portfolio Turnover Rate
|
349.54%
|
Portfolio Composition*,† (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
| † |
Certain categories may represent less than 0.1%. |
| Franklin Core Plus Bond Fund
|
PAGE 2
|
894-ATSR-0626 |
HOW HAS THE FUND CHANGED?
Effective September 1, 2025, the Fund’s principal investment strategies were changed to reflect the Fund’s increased investments in collateralized mortgage obligations.
Related risk disclosure was added to the prospectus.
Effective September 30, 2025, Benjamin Cryer and Thomas Runkel no longer serve as portfolio managers of the Fund and Albert Chan was added as a portfolio manager of the Fund.
Effective May 8, 2025, the investment manager contractually agreed to waive fees and/or reimburse operating expenses (excluding the Rule 12b-1 fees and certain non-routine expenses or costs, such as those relating to litigation, indemnification, reorganizations and liquidations) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.47% for each share class except Class R6 and 0.37% for Class R6 until August 31, 2026.
Additionally, effective May 8, 2025, the Fund’s contractual management fee schedule was reduced to a fee equal to an annual rate based on the value of the Fund’s average daily net assets, as follows: 0.350% up to and including $5 billion; 0.330% over $5 billion up to and including $10 billion; 0.310% over $10 billion up to and including $20 billion; and 0.290% over $20 billion.
This is a summary of certain changes and planned changes to the Fund since May 1, 2025. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2026, at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or prospectus.us.franklintempleton@fisglobal.com.
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Core Plus Bond Fund
|
PAGE 3
|
894-ATSR-0626 |
1000010738107691123010558119121115811211115331229712872100001008310051105821173011698107031065710500113431180331.824.612.07.65.23.72.52.52.20.80.10.00.00.07.0
|
|
|
|
Franklin Core Plus Bond Fund
|
|
|
Class R6 [FGKNX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Core Plus Bond Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
This report describes changes to the Fund that occurred during the reporting period.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class R6
|
$37
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class R6 shares of Franklin Core Plus Bond Fund returned 5.27%. The Fund compares its performance to the Bloomberg U.S. Aggregate Index, which returned 4.06% for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
Overweight allocation to high-yield (HY) and investment-grade (IG) corporate bonds, agency mortgage-backed securities (MBS), commercial MBS and sovereign emerging market debt.
|
|
↑
|
Out-of-index exposure to residential MBS and collateralized loan obligations (CLOs).
|
|
↑
|
Exposure to the five-, 20- and 30-year portions of the yield curve.
|
|
|
|
Top detractors from performance:
|
|
↓
|
Security selection in HY corporate bonds, senior secured floating-rate bank loans and IG corporate bonds.
|
|
↓
|
Exposure to the 10-year segment of the yield curve.
|
Use of derivatives and the impact on performance:
The Fund utilized bond futures to manage duration exposure and high-yield credit default swap (CDS) to manage the Fund’s credit exposure. In aggregate, these instruments detracted slightly from performance.
| Franklin Core Plus Bond Fund
|
PAGE 1
|
314-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class R6 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class R6
|
5.27
|
2.20
|
3.19
|
|
Bloomberg U.S. Aggregate Index
|
4.06
|
0.18
|
1.67
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
The Fund was able to successfully meet its monthly distributions under its managed distribution policy without the return of capital.
Effective December 11, 2024, the Fund changed its name and adopted its current investment strategy.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$2,747,319,270
|
|
Total Number of Portfolio Holdings (excludes derivatives, except purchased options, if any)
|
866
|
|
Total Management Fee Paid
|
$6,862,755
|
|
Portfolio Turnover Rate
|
349.54%
|
Portfolio Composition*,† (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
| † |
Certain categories may represent less than 0.1%. |
| Franklin Core Plus Bond Fund
|
PAGE 2
|
314-ATSR-0626 |
HOW HAS THE FUND CHANGED?
Effective September 1, 2025, the Fund’s principal investment strategies were changed to reflect the Fund’s increased investments in collateralized mortgage obligations.
Related risk disclosure was added to the prospectus.
Effective September 30, 2025, Benjamin Cryer and Thomas Runkel no longer serve as portfolio managers of the Fund and Albert Chan was added as a portfolio manager of the Fund.
Effective May 8, 2025, the investment manager contractually agreed to waive fees and/or reimburse operating expenses (excluding the Rule 12b-1 fees and certain non-routine expenses or costs, such as those relating to litigation, indemnification, reorganizations and liquidations) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.47% for each share class except Class R6 and 0.37% for Class R6 until August 31, 2026.
Additionally, effective May 8, 2025, the Fund’s contractual management fee schedule was reduced to a fee equal to an annual rate based on the value of the Fund’s average daily net assets, as follows: 0.350% up to and including $5 billion; 0.330% over $5 billion up to and including $10 billion; 0.310% over $10 billion up to and including $20 billion; and 0.290% over $20 billion.
This is a summary of certain changes and planned changes to the Fund since May 1, 2025. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2026, at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or prospectus.us.franklintempleton@fisglobal.com.
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Core Plus Bond Fund
|
PAGE 3
|
314-ATSR-0626 |
1000010803109051145410828122841158111711121191301013696100001008310051105821173011698107031065710500113431180331.824.612.07.65.23.72.52.52.20.80.10.00.00.07.0
|
|
|
|
Franklin Core Plus Bond Fund
|
|
|
Advisor Class [FKSAX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Core Plus Bond Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
This report describes changes to the Fund that occurred during the reporting period.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Advisor Class
|
$47
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Advisor Class shares of Franklin Core Plus Bond Fund returned 5.04%. The Fund compares its performance to the Bloomberg U.S. Aggregate Index, which returned 4.06% for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
Overweight allocation to high-yield (HY) and investment-grade (IG) corporate bonds, agency mortgage-backed securities (MBS), commercial MBS and sovereign emerging market debt.
|
|
↑
|
Out-of-index exposure to residential MBS and collateralized loan obligations (CLOs).
|
|
↑
|
Exposure to the five-, 20- and 30-year portions of the yield curve.
|
|
|
|
Top detractors from performance:
|
|
↓
|
Security selection in HY corporate bonds, senior secured floating-rate bank loans and IG corporate bonds.
|
|
↓
|
Exposure to the 10-year segment of the yield curve.
|
Use of derivatives and the impact on performance:
The Fund utilized bond futures to manage duration exposure and high-yield credit default swap (CDS) to manage the Fund’s credit exposure. In aggregate, these instruments detracted slightly from performance.
| Franklin Core Plus Bond Fund
|
PAGE 1
|
694-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Advisor Class 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Advisor Class
|
5.04
|
2.06
|
3.05
|
|
Bloomberg U.S. Aggregate Index
|
4.06
|
0.18
|
1.67
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
The Fund was able to successfully meet its monthly distributions under its managed distribution policy without the return of capital.
Effective December 11, 2024, the Fund changed its name and adopted its current investment strategy.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$2,747,319,270
|
|
Total Number of Portfolio Holdings (excludes derivatives, except purchased options, if any)
|
866
|
|
Total Management Fee Paid
|
$6,862,755
|
|
Portfolio Turnover Rate
|
349.54%
|
Portfolio Composition*,† (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
| † |
Certain categories may represent less than 0.1%. |
| Franklin Core Plus Bond Fund
|
PAGE 2
|
694-ATSR-0626 |
HOW HAS THE FUND CHANGED?
Effective September 1, 2025, the Fund’s principal investment strategies were changed to reflect the Fund’s increased investments in collateralized mortgage obligations.
Related risk disclosure was added to the prospectus.
Effective September 30, 2025, Benjamin Cryer and Thomas Runkel no longer serve as portfolio managers of the Fund and Albert Chan was added as a portfolio manager of the Fund.
Effective May 8, 2025, the investment manager contractually agreed to waive fees and/or reimburse operating expenses (excluding the Rule 12b-1 fees and certain non-routine expenses or costs, such as those relating to litigation, indemnification, reorganizations and liquidations) for the Fund so that the ratio of total annual fund operating expenses will not exceed 0.47% for each share class except Class R6 and 0.37% for Class R6 until August 31, 2026.
Additionally, effective May 8, 2025, the Fund’s contractual management fee schedule was reduced to a fee equal to an annual rate based on the value of the Fund’s average daily net assets, as follows: 0.350% up to and including $5 billion; 0.330% over $5 billion up to and including $10 billion; 0.310% over $10 billion up to and including $20 billion; and 0.290% over $20 billion.
This is a summary of certain changes and planned changes to the Fund since May 1, 2025. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2026, at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or prospectus.us.franklintempleton@fisglobal.com.
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Core Plus Bond Fund
|
PAGE 3
|
694-ATSR-0626 |
1000010776108611139210768122021149011603119941286313510100001008310051105821173011698107031065710500113431180331.824.612.07.65.23.72.52.52.20.80.10.00.00.07.0
|
|
|
|
Franklin Growth Opportunities Fund
|
|
|
Class A [FGRAX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Growth Opportunities Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class A
|
$97
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class A shares of Franklin Growth Opportunities Fund returned 20.74%. The Fund compares its performance to the Russell 3000 Growth Index and the S&P 500 Index, which returned 30.98% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
In the communications services sector, Google parent company Alphabet was a leading relative contributor. The company saw a favorable resolution to its antitrust trial and benefited from the positive impacts of artificial intelligence (AI) on its business.
|
|
↑
|
The Fund benefited most from stock selection in the information technology (IT) sector. Within IT, Monolithic Power Systems was the leading contributor to relative returns. Shares of the analog semiconductor manufacturer advanced sharply amid growing confidence around AI infrastructure-related demand, capped by sharp earnings beat and guidance raise.
|
|
↑
|
In the industrials sector, an off index holding in private company Space Exploration Technologies (SpaceX) was a leading contributor to relative returns. The merger with xAI boosted the private market share price of the company, and expectations increased around a 2026 initial public offering for the aerospace and technology company.
|
|
|
|
Top detractors from performance:
|
|
↓
|
By sector, stock selection in communication services sector was the largest detractor from relative returns. Among individual detractors, in the IT sector, underweight in AI chip designer NVIDIA held back relative returns. The company continued to benefit from increased AI infrastructure spending, and demand for its advanced chips remained strong across cloud computing, data centers and enterprise AI applications. NVIDIA was the largest position in the Fund on an absolute basis, but the Fund was underweighted on a relative basis due to position size constraints.
|
|
↓
|
In the consumer staples sector, an off-benchmark holding in BellRing Brands was a leading detractor. The nutrition products company reported shrinking profit margins and saw increased competition in the protein shake category. Retailer inventory adjustments and reduced full year 2025 guidance were also headwinds for the company.
|
|
↓
|
In the industrials sector, Axon shares fell as investors expressed concerns about near-term margin pressure from higher investment spending, even though the company continued to report strong revenue growth and solid demand from public safety agencies.
|
| Franklin Growth Opportunities Fund
|
PAGE 1
|
462-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT ($9,450 AFTER MAXIMUM APPLICABLE SALES CHARGE) –
Class A 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class A
|
20.74
|
6.62
|
13.94
|
|
Class A (with sales charge)
|
14.10
|
5.43
|
13.30
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
Russell 3000 Growth Index
|
30.98
|
13.23
|
17.82
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
Performance for periods prior to September 10, 2018, has been restated to reflect the current maximum sales charge, which is lower than the maximum sales charge prior to that date.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$4,394,400,813
|
|
Total Number of Portfolio Holdings
|
92
|
|
Total Management Fee Paid
|
$24,181,309
|
|
Portfolio Turnover Rate
|
39.14%
|
| Franklin Growth Opportunities Fund
|
PAGE 2
|
462-ATSR-0626 |
Portfolio Composition*,† (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
| † |
Certain categories may represent less than 0.1%. |
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Growth Opportunities Fund
|
PAGE 3
|
462-ATSR-0626 |
94501104513301154171678925291210992004926764288663485310000118581340615106149482256021857221862713330227396011000011983142331659818169276932580226382344933934651536100001179213356151581528922320223672296328167315744137947.713.413.19.27.82.72.21.70.70.01.5
|
|
|
|
Franklin Growth Opportunities Fund
|
|
|
Class C [FKACX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Growth Opportunities Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class C
|
$180
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class C shares of Franklin Growth Opportunities Fund returned 19.82%. The Fund compares its performance to the Russell 3000 Growth Index and the S&P 500 Index, which returned 30.98% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
In the communications services sector, Google parent company Alphabet was a leading relative contributor. The company saw a favorable resolution to its antitrust trial and benefited from the positive impacts of artificial intelligence (AI) on its business.
|
|
↑
|
The Fund benefited most from stock selection in the information technology (IT) sector. Within IT, Monolithic Power Systems was the leading contributor to relative returns. Shares of the analog semiconductor manufacturer advanced sharply amid growing confidence around AI infrastructure-related demand, capped by sharp earnings beat and guidance raise.
|
|
↑
|
In the industrials sector, an off index holding in private company Space Exploration Technologies (SpaceX) was a leading contributor to relative returns. The merger with xAI boosted the private market share price of the company, and expectations increased around a 2026 initial public offering for the aerospace and technology company.
|
|
|
|
Top detractors from performance:
|
|
↓
|
By sector, stock selection in communication services sector was the largest detractor from relative returns. Among individual detractors, in the IT sector, underweight in AI chip designer NVIDIA held back relative returns. The company continued to benefit from increased AI infrastructure spending, and demand for its advanced chips remained strong across cloud computing, data centers and enterprise AI applications. NVIDIA was the largest position in the Fund on an absolute basis, but the Fund was underweighted on a relative basis due to position size constraints.
|
|
↓
|
In the consumer staples sector, an off-benchmark holding in BellRing Brands was a leading detractor. The nutrition products company reported shrinking profit margins and saw increased competition in the protein shake category. Retailer inventory adjustments and reduced full year 2025 guidance were also headwinds for the company.
|
|
↓
|
In the industrials sector, Axon shares fell as investors expressed concerns about near-term margin pressure from higher investment spending, even though the company continued to report strong revenue growth and solid demand from public safety agencies.
|
| Franklin Growth Opportunities Fund
|
PAGE 1
|
562-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class C 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class C
|
19.82
|
5.83
|
13.09
|
|
Class C (with sales charge)
|
18.92
|
5.83
|
13.09
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
Russell 3000 Growth Index
|
30.98
|
13.23
|
17.82
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$4,394,400,813
|
|
Total Number of Portfolio Holdings
|
92
|
|
Total Management Fee Paid
|
$24,181,309
|
|
Portfolio Turnover Rate
|
39.14%
|
| Franklin Growth Opportunities Fund
|
PAGE 2
|
562-ATSR-0626 |
Portfolio Composition*,† (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
| † |
Certain categories may represent less than 0.1%. |
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Growth Opportunities Fund
|
PAGE 3
|
562-ATSR-0626 |
100001159813863159561724925783213492013526683285603421910000118581340615106149482256021857221862713330227396011000011983142331659818169276932580226382344933934651536100001179213356151581528922320223672296328167315744137947.713.413.19.27.82.72.21.70.70.01.5
|
|
|
|
Franklin Growth Opportunities Fund
|
|
|
Class R [FKARX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Growth Opportunities Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class R
|
$126
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class R shares of Franklin Growth Opportunities Fund returned 20.42%. The Fund compares its performance to the Russell 3000 Growth Index and the S&P 500 Index, which returned 30.98% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
In the communications services sector, Google parent company Alphabet was a leading relative contributor. The company saw a favorable resolution to its antitrust trial and benefited from the positive impacts of artificial intelligence (AI) on its business.
|
|
↑
|
The Fund benefited most from stock selection in the information technology (IT) sector. Within IT, Monolithic Power Systems was the leading contributor to relative returns. Shares of the analog semiconductor manufacturer advanced sharply amid growing confidence around AI infrastructure-related demand, capped by sharp earnings beat and guidance raise.
|
|
↑
|
In the industrials sector, an off index holding in private company Space Exploration Technologies (SpaceX) was a leading contributor to relative returns. The merger with xAI boosted the private market share price of the company, and expectations increased around a 2026 initial public offering for the aerospace and technology company.
|
|
|
|
Top detractors from performance:
|
|
↓
|
By sector, stock selection in communication services sector was the largest detractor from relative returns. Among individual detractors, in the IT sector, underweight in AI chip designer NVIDIA held back relative returns. The company continued to benefit from increased AI infrastructure spending, and demand for its advanced chips remained strong across cloud computing, data centers and enterprise AI applications. NVIDIA was the largest position in the Fund on an absolute basis, but the Fund was underweighted on a relative basis due to position size constraints.
|
|
↓
|
In the consumer staples sector, an off-benchmark holding in BellRing Brands was a leading detractor. The nutrition products company reported shrinking profit margins and saw increased competition in the protein shake category. Retailer inventory adjustments and reduced full year 2025 guidance were also headwinds for the company.
|
|
↓
|
In the industrials sector, Axon shares fell as investors expressed concerns about near-term margin pressure from higher investment spending, even though the company continued to report strong revenue growth and solid demand from public safety agencies.
|
| Franklin Growth Opportunities Fund
|
PAGE 1
|
862-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class R 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class R
|
20.42
|
6.35
|
13.66
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
Russell 3000 Growth Index
|
30.98
|
13.23
|
17.82
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$4,394,400,813
|
|
Total Number of Portfolio Holdings
|
92
|
|
Total Management Fee Paid
|
$24,181,309
|
|
Portfolio Turnover Rate
|
39.14%
|
| Franklin Growth Opportunities Fund
|
PAGE 2
|
862-ATSR-0626 |
Portfolio Composition*,† (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
| † |
Certain categories may represent less than 0.1%. |
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Growth Opportunities Fund
|
PAGE 3
|
862-ATSR-0626 |
100001166214010162041760426451220102086327785298883599210000118581340615106149482256021857221862713330227396011000011983142331659818169276932580226382344933934651536100001179213356151581528922320223672296328167315744137947.713.413.19.27.82.72.21.70.70.01.5
|
|
|
|
Franklin Growth Opportunities Fund
|
|
|
Class R6 [FOPPX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Growth Opportunities Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class R6
|
$63
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class R6 shares of Franklin Growth Opportunities Fund returned 21.11%. The Fund compares its performance to the Russell 3000 Growth Index and the S&P 500 Index, which returned 30.98% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
In the communications services sector, Google parent company Alphabet was a leading relative contributor. The company saw a favorable resolution to its antitrust trial and benefited from the positive impacts of artificial intelligence (AI) on its business.
|
|
↑
|
The Fund benefited most from stock selection in the information technology (IT) sector. Within IT, Monolithic Power Systems was the leading contributor to relative returns. Shares of the analog semiconductor manufacturer advanced sharply amid growing confidence around AI infrastructure-related demand, capped by sharp earnings beat and guidance raise.
|
|
↑
|
In the industrials sector, an off index holding in private company Space Exploration Technologies (SpaceX) was a leading contributor to relative returns. The merger with xAI boosted the private market share price of the company, and expectations increased around a 2026 initial public offering for the aerospace and technology company.
|
|
|
|
Top detractors from performance:
|
|
↓
|
By sector, stock selection in communication services sector was the largest detractor from relative returns. Among individual detractors, in the IT sector, underweight in AI chip designer NVIDIA held back relative returns. The company continued to benefit from increased AI infrastructure spending, and demand for its advanced chips remained strong across cloud computing, data centers and enterprise AI applications. NVIDIA was the largest position in the Fund on an absolute basis, but the Fund was underweighted on a relative basis due to position size constraints.
|
|
↓
|
In the consumer staples sector, an off-benchmark holding in BellRing Brands was a leading detractor. The nutrition products company reported shrinking profit margins and saw increased competition in the protein shake category. Retailer inventory adjustments and reduced full year 2025 guidance were also headwinds for the company.
|
|
↓
|
In the industrials sector, Axon shares fell as investors expressed concerns about near-term margin pressure from higher investment spending, even though the company continued to report strong revenue growth and solid demand from public safety agencies.
|
| Franklin Growth Opportunities Fund
|
PAGE 1
|
352-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class R6 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class R6
|
21.11
|
6.97
|
14.35
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
Russell 3000 Growth Index
|
30.98
|
13.23
|
17.82
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$4,394,400,813
|
|
Total Number of Portfolio Holdings
|
92
|
|
Total Management Fee Paid
|
$24,181,309
|
|
Portfolio Turnover Rate
|
39.14%
|
| Franklin Growth Opportunities Fund
|
PAGE 2
|
352-ATSR-0626 |
Portfolio Composition*,† (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
| † |
Certain categories may represent less than 0.1%. |
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Growth Opportunities Fund
|
PAGE 3
|
352-ATSR-0626 |
100001174214206165161805827292228392178429178315683823310000118581340615106149482256021857221862713330227396011000011983142331659818169276932580226382344933934651536100001179213356151581528922320223672296328167315744137947.713.413.19.27.82.72.21.70.70.01.5
|
|
|
|
Franklin Growth Opportunities Fund
|
|
|
Advisor Class [FRAAX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Growth Opportunities Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Advisor Class
|
$70
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Advisor Class shares of Franklin Growth Opportunities Fund returned 21.04%. The Fund compares its performance to the Russell 3000 Growth Index and the S&P 500 Index, which returned 30.98% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
In the communications services sector, Google parent company Alphabet was a leading relative contributor. The company saw a favorable resolution to its antitrust trial and benefited from the positive impacts of artificial intelligence (AI) on its business.
|
|
↑
|
The Fund benefited most from stock selection in the information technology (IT) sector. Within IT, Monolithic Power Systems was the leading contributor to relative returns. Shares of the analog semiconductor manufacturer advanced sharply amid growing confidence around AI infrastructure-related demand, capped by sharp earnings beat and guidance raise.
|
|
↑
|
In the industrials sector, an off index holding in private company Space Exploration Technologies (SpaceX) was a leading contributor to relative returns. The merger with xAI boosted the private market share price of the company, and expectations increased around a 2026 initial public offering for the aerospace and technology company.
|
|
|
|
Top detractors from performance:
|
|
↓
|
By sector, stock selection in communication services sector was the largest detractor from relative returns. Among individual detractors, in the IT sector, underweight in AI chip designer NVIDIA held back relative returns. The company continued to benefit from increased AI infrastructure spending, and demand for its advanced chips remained strong across cloud computing, data centers and enterprise AI applications. NVIDIA was the largest position in the Fund on an absolute basis, but the Fund was underweighted on a relative basis due to position size constraints.
|
|
↓
|
In the consumer staples sector, an off-benchmark holding in BellRing Brands was a leading detractor. The nutrition products company reported shrinking profit margins and saw increased competition in the protein shake category. Retailer inventory adjustments and reduced full year 2025 guidance were also headwinds for the company.
|
|
↓
|
In the industrials sector, Axon shares fell as investors expressed concerns about near-term margin pressure from higher investment spending, even though the company continued to report strong revenue growth and solid demand from public safety agencies.
|
| Franklin Growth Opportunities Fund
|
PAGE 1
|
662-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Advisor Class 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Advisor Class
|
21.04
|
6.89
|
14.23
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
Russell 3000 Growth Index
|
30.98
|
13.23
|
17.82
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$4,394,400,813
|
|
Total Number of Portfolio Holdings
|
92
|
|
Total Management Fee Paid
|
$24,181,309
|
|
Portfolio Turnover Rate
|
39.14%
|
| Franklin Growth Opportunities Fund
|
PAGE 2
|
662-ATSR-0626 |
Portfolio Composition*,† (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
| † |
Certain categories may represent less than 0.1%. |
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Growth Opportunities Fund
|
PAGE 3
|
662-ATSR-0626 |
100001172114148164341794527099226642159628896312423781410000118581340615106149482256021857221862713330227396011000011983142331659818169276932580226382344933934651536100001179213356151581528922320223672296328167315744137947.713.413.19.27.82.72.21.70.70.01.5
|
|
|
|
Franklin Natural Resources Fund
|
|
|
Class A [FRNRX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Natural Resources Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class A
|
$127
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class A shares of Franklin Natural Resources Fund returned 64.73%. The Fund compares its performance to the S&P North American Natural Resources Sector Index and the S&P Global Natural Resources Index, which returned 53.73% and 49.88%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
Among metals producers, exceptionally strong gains for overweighted or off-benchmark positions in the diversified metals and mining industry, including rare earth development and production companies like Aclara Resources, MP Materials and Lindian Resources (purchased during the period); Copper-focused producers like Lundin Mining, ERO Copper and Antofagasta; and gold miners such as Barrick Mining and Newmont. Many of these stocks more than doubled in value as prices for copper, gold, silver, and other metals rose to all-time or multiyear highs.
|
|
↑
|
In the energy sector, beneficial underweighting and stock selection in the oil and gas storage and transportation industry (led by a much lighter-than-index exposure to Enbridge); overweighting and stock selection in oilfield services, where the Fund’s holdings collectively increased more than 100%; and effective stock selection in integrated oil and gas, as well as oil and gas exploration and production.
|
|
↑
|
Triple-digit percentage gains for select off-benchmark industry allocations, including specialty chemicals (led by key contributor Albemarle); electrical components and equipment (led by T1 Energy); and heavy electrical equipment (led by GE Vernova).
|
|
|
|
Top detractors from performance:
|
|
↓
|
Benchmark-lagging gains for off-index positions in Linde, as well as Air Products and Chemicals, in the industrial gases industry and, to a lesser extent, Corteva and Nutrien in fertilizers and agricultural chemicals.
|
|
↓
|
Underweighted exposures to select oil and gas refining and marketing companies that rallied well beyond the benchmark averages, including key detractor Valero Energy. Relative returns were further pressured by underweighting’s in other energy-related outliers to the upside, including uranium fuel producer Cameco and drilling contractor Baker Hughes.
|
|
↓
|
Negative returns in some of the Fund’s single-asset, off-benchmark industry allocations, with the detractors focused on water infrastructure plays such as Badger Meter (electronic equipment and instruments industry) and Xylem (industrial machinery, supplies and components).
|
| Franklin Natural Resources Fund
|
PAGE 1
|
403-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT ($9,450 AFTER MAXIMUM APPLICABLE SALES CHARGE) –
Class A 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class A
|
64.73
|
20.21
|
8.15
|
|
Class A (with sales charge)
|
55.67
|
18.86
|
7.54
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
S&P North American Natural Resources Sector Index
|
53.73
|
20.81
|
10.34
|
|
S&P Global Natural Resources Index
|
49.88
|
12.01
|
10.96
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
Performance for periods prior to September 10, 2018, has been restated to reflect the current maximum sales charge, which is lower than the maximum sales charge prior to that date.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$538,915,982
|
|
Total Number of Portfolio Holdings
|
100
|
|
Total Management Fee Paid
|
$1,953,759
|
|
Portfolio Turnover Rate
|
27.09%
|
| Franklin Natural Resources Fund
|
PAGE 2
|
403-ATSR-0626 |
Portfolio Composition* (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Natural Resources Fund
|
PAGE 3
|
403-ATSR-0626 |
945095801080193225472823911256119941348312556206841000011858134061510614948225602185722186271333022739601100001025911334103017397103991474815613180551740426756100001114713791131261045416042192711909920227188662827753.937.83.30.80.53.7
|
|
|
|
Franklin Natural Resources Fund
|
|
|
Class C [FNCRX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Natural Resources Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class C
|
$225
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class C shares of Franklin Natural Resources Fund returned 63.49%. The Fund compares its performance to the S&P North American Natural Resources Sector Index and the S&P Global Natural Resources Index, which returned 53.73% and 49.88%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
Among metals producers, exceptionally strong gains for overweighted or off-benchmark positions in the diversified metals and mining industry, including rare earth development and production companies like Aclara Resources, MP Materials and Lindian Resources (purchased during the period); Copper-focused producers like Lundin Mining, ERO Copper and Antofagasta; and gold miners such as Barrick Mining and Newmont. Many of these stocks more than doubled in value as prices for copper, gold, silver, and other metals rose to all-time or multiyear highs.
|
|
↑
|
In the energy sector, beneficial underweighting and stock selection in the oil and gas storage and transportation industry (led by a much lighter-than-index exposure to Enbridge); overweighting and stock selection in oilfield services, where the Fund’s holdings collectively increased more than 100%; and effective stock selection in integrated oil and gas, as well as oil and gas exploration and production.
|
|
↑
|
Triple-digit percentage gains for select off-benchmark industry allocations, including specialty chemicals (led by key contributor Albemarle); electrical components and equipment (led by T1 Energy); and heavy electrical equipment (led by GE Vernova).
|
|
|
|
Top detractors from performance:
|
|
↓
|
Benchmark-lagging gains for off-index positions in Linde, as well as Air Products and Chemicals, in the industrial gases industry and, to a lesser extent, Corteva and Nutrien in fertilizers and agricultural chemicals.
|
|
↓
|
Underweighted exposures to select oil and gas refining and marketing companies that rallied well beyond the benchmark averages, including key detractor Valero Energy. Relative returns were further pressured by underweighting’s in other energy-related outliers to the upside, including uranium fuel producer Cameco and drilling contractor Baker Hughes.
|
|
↓
|
Negative returns in some of the Fund’s single-asset, off-benchmark industry allocations, with the detractors focused on water infrastructure plays such as Badger Meter (electronic equipment and instruments industry) and Xylem (industrial machinery, supplies and components).
|
| Franklin Natural Resources Fund
|
PAGE 1
|
503-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class C 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class C
|
63.49
|
19.31
|
7.34
|
|
Class C (with sales charge)
|
62.49
|
19.31
|
7.34
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
S&P North American Natural Resources Sector Index
|
53.73
|
20.81
|
10.34
|
|
S&P Global Natural Resources Index
|
49.88
|
12.01
|
10.96
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$538,915,982
|
|
Total Number of Portfolio Holdings
|
100
|
|
Total Management Fee Paid
|
$1,953,759
|
|
Portfolio Turnover Rate
|
27.09%
|
| Franklin Natural Resources Fund
|
PAGE 2
|
503-ATSR-0626 |
Portfolio Composition* (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Natural Resources Fund
|
PAGE 3
|
503-ATSR-0626 |
10000100631126196425620839711386120401343812419203051000011858134061510614948225602185722186271333022739601100001025911334103017397103991474815613180551740426756100001114713791131261045416042192711909920227188662827753.937.83.30.80.53.7
|
|
|
|
Franklin Natural Resources Fund
|
|
|
Class R6 [FNCSX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Natural Resources Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class R6
|
$78
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class R6 shares of Franklin Natural Resources Fund returned 65.36%. The Fund compares its performance to the S&P North American Natural Resources Sector Index and the S&P Global Natural Resources Index, which returned 53.73% and 49.88%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
Among metals producers, exceptionally strong gains for overweighted or off-benchmark positions in the diversified metals and mining industry, including rare earth development and production companies like Aclara Resources, MP Materials and Lindian Resources (purchased during the period); Copper-focused producers like Lundin Mining, ERO Copper and Antofagasta; and gold miners such as Barrick Mining and Newmont. Many of these stocks more than doubled in value as prices for copper, gold, silver, and other metals rose to all-time or multiyear highs.
|
|
↑
|
In the energy sector, beneficial underweighting and stock selection in the oil and gas storage and transportation industry (led by a much lighter-than-index exposure to Enbridge); overweighting and stock selection in oilfield services, where the Fund’s holdings collectively increased more than 100%; and effective stock selection in integrated oil and gas, as well as oil and gas exploration and production.
|
|
↑
|
Triple-digit percentage gains for select off-benchmark industry allocations, including specialty chemicals (led by key contributor Albemarle); electrical components and equipment (led by T1 Energy); and heavy electrical equipment (led by GE Vernova).
|
|
|
|
Top detractors from performance:
|
|
↓
|
Benchmark-lagging gains for off-index positions in Linde, as well as Air Products and Chemicals, in the industrial gases industry and, to a lesser extent, Corteva and Nutrien in fertilizers and agricultural chemicals.
|
|
↓
|
Underweighted exposures to select oil and gas refining and marketing companies that rallied well beyond the benchmark averages, including key detractor Valero Energy. Relative returns were further pressured by underweighting’s in other energy-related outliers to the upside, including uranium fuel producer Cameco and drilling contractor Baker Hughes.
|
|
↓
|
Negative returns in some of the Fund’s single-asset, off-benchmark industry allocations, with the detractors focused on water infrastructure plays such as Badger Meter (electronic equipment and instruments industry) and Xylem (industrial machinery, supplies and components).
|
| Franklin Natural Resources Fund
|
PAGE 1
|
803-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class R6 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class R6
|
65.36
|
20.70
|
8.64
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
S&P North American Natural Resources Sector Index
|
53.73
|
20.81
|
10.34
|
|
S&P Global Natural Resources Index
|
49.88
|
12.01
|
10.96
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$538,915,982
|
|
Total Number of Portfolio Holdings
|
100
|
|
Total Management Fee Paid
|
$1,953,759
|
|
Portfolio Turnover Rate
|
27.09%
|
| Franklin Natural Resources Fund
|
PAGE 2
|
803-ATSR-0626 |
Portfolio Composition* (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Natural Resources Fund
|
PAGE 3
|
803-ATSR-0626 |
100001018911551100145906894412275131321482613854229081000011858134061510614948225602185722186271333022739601100001025911334103017397103991474815613180551740426756100001114713791131261045416042192711909920227188662827753.937.83.30.80.53.7
|
|
|
|
Franklin Natural Resources Fund
|
|
|
Advisor Class [FNRAX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Natural Resources Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Advisor Class
|
$93
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Advisor Class shares of Franklin Natural Resources Fund returned 65.18%. The Fund compares its performance to the S&P North American Natural Resources Sector Index and the S&P Global Natural Resources Index, which returned 53.73% and 49.88%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
Among metals producers, exceptionally strong gains for overweighted or off-benchmark positions in the diversified metals and mining industry, including rare earth development and production companies like Aclara Resources, MP Materials and Lindian Resources (purchased during the period); Copper-focused producers like Lundin Mining, ERO Copper and Antofagasta; and gold miners such as Barrick Mining and Newmont. Many of these stocks more than doubled in value as prices for copper, gold, silver, and other metals rose to all-time or multiyear highs.
|
|
↑
|
In the energy sector, beneficial underweighting and stock selection in the oil and gas storage and transportation industry (led by a much lighter-than-index exposure to Enbridge); overweighting and stock selection in oilfield services, where the Fund’s holdings collectively increased more than 100%; and effective stock selection in integrated oil and gas, as well as oil and gas exploration and production.
|
|
↑
|
Triple-digit percentage gains for select off-benchmark industry allocations, including specialty chemicals (led by key contributor Albemarle); electrical components and equipment (led by T1 Energy); and heavy electrical equipment (led by GE Vernova).
|
|
|
|
Top detractors from performance:
|
|
↓
|
Benchmark-lagging gains for off-index positions in Linde, as well as Air Products and Chemicals, in the industrial gases industry and, to a lesser extent, Corteva and Nutrien in fertilizers and agricultural chemicals.
|
|
↓
|
Underweighted exposures to select oil and gas refining and marketing companies that rallied well beyond the benchmark averages, including key detractor Valero Energy. Relative returns were further pressured by underweighting’s in other energy-related outliers to the upside, including uranium fuel producer Cameco and drilling contractor Baker Hughes.
|
|
↓
|
Negative returns in some of the Fund’s single-asset, off-benchmark industry allocations, with the detractors focused on water infrastructure plays such as Badger Meter (electronic equipment and instruments industry) and Xylem (industrial machinery, supplies and components).
|
| Franklin Natural Resources Fund
|
PAGE 1
|
613-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Advisor Class 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Advisor Class
|
65.18
|
20.52
|
8.42
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
S&P North American Natural Resources Sector Index
|
53.73
|
20.81
|
10.34
|
|
S&P Global Natural Resources Index
|
49.88
|
12.01
|
10.96
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$538,915,982
|
|
Total Number of Portfolio Holdings
|
100
|
|
Total Management Fee Paid
|
$1,953,759
|
|
Portfolio Turnover Rate
|
27.09%
|
| Franklin Natural Resources Fund
|
PAGE 2
|
613-ATSR-0626 |
Portfolio Composition* (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Natural Resources Fund
|
PAGE 3
|
613-ATSR-0626 |
10000101641148999395849882912089129181456213590224471000011858134061510614948225602185722186271333022739601100001025911334103017397103991474815613180551740426756100001114713791131261045416042192711909920227188662827753.937.83.30.80.53.7
|
|
|
|
Franklin Small Cap Growth Fund
|
|
|
Class A [FSGRX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Small Cap Growth Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
This report describes changes to the Fund that occurred during the reporting period.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class A
|
$123
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class A shares of Franklin Small Cap Growth Fund returned 30.13%. The Fund compares its performance to the Russell 2000 Growth Index and the S&P 500 Index, which returned 42.64% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
By sector, the largest contributor to relative returns was stock selection in the health care sector. However, the largest individual contributors all came from the information technology (IT) sector. An off-benchmark position in phototonics specialist Lumentum Holdings led relative contributors after the company reported strong fiscal second quarter 2026 financial results and upbeat forward guidance, driven by surging demand for artificial intelligence (AI) data center optics.
|
|
↑
|
Semiconductor manufacturer SiTime also advanced relative returns. Shares in the company, which makes precision timing chips, soared late in the period after the company posted strong revenue growth amid increased demand from AI data centers.
|
|
↑
|
Onto Innovation supported relative returns. The process control solutions company benefited from surging demand for advanced semiconductor packaging and metrology tools driven by AI chip growth.
|
|
|
|
Top detractors from performance:
|
|
↓
|
Stock selection and an overweight in the consumer staples sector held back relative returns. Within the sector, an off-benchmark holding in BellRing Brands was the leading detractor. The nutrition products company reported shrinking profit margins and decreasing demand for its protein shakes. Retailer inventory adjustments and reduced full year 2025 guidance were also headwinds for the company.
|
|
↓
|
Within IT, a broader market pivot away from software stocks had a negative impact on shares of software development platform GitLab, despite the company’s positive earnings reports.
|
|
↓
|
In the health care sector, relative performance was hurt by a position in health care software company Phreesia. The company reduced guidance for 2027, reporting that it is losing visibility into spending commitments from some of its clients.
|
| Franklin Small Cap Growth Fund
|
PAGE 1
|
465-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT ($9,450 AFTER MAXIMUM APPLICABLE SALES CHARGE) –
Class A 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class A
|
30.13
|
0.99
|
11.19
|
|
Class A (with sales charge)
|
22.96
|
-0.14
|
10.57
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
Russell 2000 Growth Index
|
42.64
|
4.00
|
11.19
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
Performance for periods prior to September 10, 2018, has been restated to reflect the current maximum sales charge, which is lower than the maximum sales charge prior to that date.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$2,435,287,399
|
|
Total Number of Portfolio Holdings
|
129
|
|
Total Management Fee Paid
|
$15,084,958
|
|
Portfolio Turnover Rate
|
48.01%
|
| Franklin Small Cap Growth Fund
|
PAGE 2
|
465-ATSR-0626 |
Portfolio Composition*,† (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
| † |
Certain categories may represent less than 0.1%. |
HOW HAS THE FUND CHANGED?
Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund and Jacob Swartz was added as a portfolio manager of the Fund.
This is a summary of certain changes to the Fund since May 1, 2025. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2026, at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or
prospectus.us.franklintempleton@fisglobal.com.
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Small Cap Growth Fund
|
PAGE 3
|
465-ATSR-0626 |
94501130913537157121472925986183111781121686209822730310000118581340615106149482256021857221862713330227396011000012406144661546514040237491746917596197752025328889100001179213356151581528922320223672296328167315744137924.624.023.18.07.54.92.81.60.70.30.02.5
|
|
|
|
Franklin Small Cap Growth Fund
|
|
|
Class C [FCSGX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Small Cap Growth Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
This report describes changes to the Fund that occurred during the reporting period.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class C
|
$209
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class C shares of Franklin Small Cap Growth Fund returned 29.21%. The Fund compares its performance to the Russell 2000 Growth Index and the S&P 500 Index, which returned 42.64% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
By sector, the largest contributor to relative returns was stock selection in the health care sector. However, the largest individual contributors all came from the information technology (IT) sector. An off-benchmark position in phototonics specialist Lumentum Holdings led relative contributors after the company reported strong fiscal second quarter 2026 financial results and upbeat forward guidance, driven by surging demand for artificial intelligence (AI) data center optics.
|
|
↑
|
Semiconductor manufacturer SiTime also advanced relative returns. Shares in the company, which makes precision timing chips, soared late in the period after the company posted strong revenue growth amid increased demand from AI data centers.
|
|
↑
|
Onto Innovation supported relative returns. The process control solutions company benefited from surging demand for advanced semiconductor packaging and metrology tools driven by AI chip growth.
|
|
|
|
Top detractors from performance:
|
|
↓
|
Stock selection and an overweight in the consumer staples sector held back relative returns. Within the sector, an off-benchmark holding in BellRing Brands was the leading detractor. The nutrition products company reported shrinking profit margins and decreasing demand for its protein shakes. Retailer inventory adjustments and reduced full year 2025 guidance were also headwinds for the company.
|
|
↓
|
Within IT, a broader market pivot away from software stocks had a negative impact on shares of software development platform GitLab, despite the company’s positive earnings reports.
|
|
↓
|
In the health care sector, relative performance was hurt by a position in health care software company Phreesia. The company reduced guidance for 2027, reporting that it is losing visibility into spending commitments from some of its clients.
|
| Franklin Small Cap Growth Fund
|
PAGE 1
|
565-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class C 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class C
|
29.21
|
0.26
|
10.38
|
|
Class C (with sales charge)
|
28.21
|
0.26
|
10.38
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
Russell 2000 Growth Index
|
42.64
|
4.00
|
11.19
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$2,435,287,399
|
|
Total Number of Portfolio Holdings
|
129
|
|
Total Management Fee Paid
|
$15,084,958
|
|
Portfolio Turnover Rate
|
48.01%
|
| Franklin Small Cap Growth Fund
|
PAGE 2
|
565-ATSR-0626 |
Portfolio Composition*,† (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
| † |
Certain categories may represent less than 0.1%. |
HOW HAS THE FUND CHANGED?
Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund and Jacob Swartz was added as a portfolio manager of the Fund.
This is a summary of certain changes to the Fund since May 1, 2025. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2026, at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or
prospectus.us.franklintempleton@fisglobal.com.
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Small Cap Growth Fund
|
PAGE 3
|
565-ATSR-0626 |
100001187614107162671513326503185341789621644207832685310000118581340615106149482256021857221862713330227396011000012406144661546514040237491746917596197752025328889100001179213356151581528922320223672296328167315744137924.624.023.18.07.54.92.81.60.70.30.02.5
|
|
|
|
Franklin Small Cap Growth Fund
|
|
|
Class R [FSSRX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Small Cap Growth Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
This report describes changes to the Fund that occurred during the reporting period.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class R
|
$152
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class R shares of Franklin Small Cap Growth Fund returned 29.79%. The Fund compares its performance to the Russell 2000 Growth Index and the S&P 500 Index, which returned 42.64% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
By sector, the largest contributor to relative returns was stock selection in the health care sector. However, the largest individual contributors all came from the information technology (IT) sector. An off-benchmark position in phototonics specialist Lumentum Holdings led relative contributors after the company reported strong fiscal second quarter 2026 financial results and upbeat forward guidance, driven by surging demand for artificial intelligence (AI) data center optics.
|
|
↑
|
Semiconductor manufacturer SiTime also advanced relative returns. Shares in the company, which makes precision timing chips, soared late in the period after the company posted strong revenue growth amid increased demand from AI data centers.
|
|
↑
|
Onto Innovation supported relative returns. The process control solutions company benefited from surging demand for advanced semiconductor packaging and metrology tools driven by AI chip growth.
|
|
|
|
Top detractors from performance:
|
|
↓
|
Stock selection and an overweight in the consumer staples sector held back relative returns. Within the sector, an off-benchmark holding in BellRing Brands was the leading detractor. The nutrition products company reported shrinking profit margins and decreasing demand for its protein shakes. Retailer inventory adjustments and reduced full year 2025 guidance were also headwinds for the company.
|
|
↓
|
Within IT, a broader market pivot away from software stocks had a negative impact on shares of software development platform GitLab, despite the company’s positive earnings reports.
|
|
↓
|
In the health care sector, relative performance was hurt by a position in health care software company Phreesia. The company reduced guidance for 2027, reporting that it is losing visibility into spending commitments from some of its clients.
|
| Franklin Small Cap Growth Fund
|
PAGE 1
|
865-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class R 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class R
|
29.79
|
0.74
|
10.91
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
Russell 2000 Growth Index
|
42.64
|
4.00
|
11.19
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$2,435,287,399
|
|
Total Number of Portfolio Holdings
|
129
|
|
Total Management Fee Paid
|
$15,084,958
|
|
Portfolio Turnover Rate
|
48.01%
|
| Franklin Small Cap Growth Fund
|
PAGE 2
|
865-ATSR-0626 |
Portfolio Composition*,† (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
| † |
Certain categories may represent less than 0.1%. |
HOW HAS THE FUND CHANGED?
Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund and Jacob Swartz was added as a portfolio manager of the Fund.
This is a summary of certain changes to the Fund since May 1, 2025. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2026, at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or
prospectus.us.franklintempleton@fisglobal.com.
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Small Cap Growth Fund
|
PAGE 3
|
865-ATSR-0626 |
100001193614248164971543127152190861852222496217092817610000118581340615106149482256021857221862713330227396011000012406144661546514040237491746917596197752025328889100001179213356151581528922320223672296328167315744137924.624.023.18.07.54.92.81.60.70.30.02.5
|
|
|
|
Franklin Small Cap Growth Fund
|
|
|
Class R6 [FSMLX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Small Cap Growth Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
This report describes changes to the Fund that occurred during the reporting period.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class R6
|
$76
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class R6 shares of Franklin Small Cap Growth Fund returned 30.66%. The Fund compares its performance to the Russell 2000 Growth Index and the S&P 500 Index, which returned 42.64% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
By sector, the largest contributor to relative returns was stock selection in the health care sector. However, the largest individual contributors all came from the information technology (IT) sector. An off-benchmark position in phototonics specialist Lumentum Holdings led relative contributors after the company reported strong fiscal second quarter 2026 financial results and upbeat forward guidance, driven by surging demand for artificial intelligence (AI) data center optics.
|
|
↑
|
Semiconductor manufacturer SiTime also advanced relative returns. Shares in the company, which makes precision timing chips, soared late in the period after the company posted strong revenue growth amid increased demand from AI data centers.
|
|
↑
|
Onto Innovation supported relative returns. The process control solutions company benefited from surging demand for advanced semiconductor packaging and metrology tools driven by AI chip growth.
|
|
|
|
Top detractors from performance:
|
|
↓
|
Stock selection and an overweight in the consumer staples sector held back relative returns. Within the sector, an off-benchmark holding in BellRing Brands was the leading detractor. The nutrition products company reported shrinking profit margins and decreasing demand for its protein shakes. Retailer inventory adjustments and reduced full year 2025 guidance were also headwinds for the company.
|
|
↓
|
Within IT, a broader market pivot away from software stocks had a negative impact on shares of software development platform GitLab, despite the company’s positive earnings reports.
|
|
↓
|
In the health care sector, relative performance was hurt by a position in health care software company Phreesia. The company reduced guidance for 2027, reporting that it is losing visibility into spending commitments from some of its clients.
|
| Franklin Small Cap Growth Fund
|
PAGE 1
|
335-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class R6 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class R6
|
30.66
|
1.40
|
11.65
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
Russell 2000 Growth Index
|
42.64
|
4.00
|
11.19
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$2,435,287,399
|
|
Total Number of Portfolio Holdings
|
129
|
|
Total Management Fee Paid
|
$15,084,958
|
|
Portfolio Turnover Rate
|
48.01%
|
| Franklin Small Cap Growth Fund
|
PAGE 2
|
335-ATSR-0626 |
Portfolio Composition*,† (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
| † |
Certain categories may represent less than 0.1%. |
HOW HAS THE FUND CHANGED?
Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund and Jacob Swartz was added as a portfolio manager of the Fund.
This is a summary of certain changes to the Fund since May 1, 2025. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2026, at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or
prospectus.us.franklintempleton@fisglobal.com.
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Small Cap Growth Fund
|
PAGE 3
|
335-ATSR-0626 |
100001202114453168371585028076198621940723721230383010110000118581340615106149482256021857221862713330227396011000012406144661546514040237491746917596197752025328889100001179213356151581528922320223672296328167315744137924.624.023.18.07.54.92.81.60.70.30.02.5
|
|
|
|
Franklin Small Cap Growth Fund
|
|
|
Advisor Class [FSSAX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Small Cap Growth Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
This report describes changes to the Fund that occurred during the reporting period.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Advisor Class
|
$95
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Advisor Class shares of Franklin Small Cap Growth Fund returned 30.50%. The Fund compares its performance to the Russell 2000 Growth Index and the S&P 500 Index, which returned 42.64% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
By sector, the largest contributor to relative returns was stock selection in the health care sector. However, the largest individual contributors all came from the information technology (IT) sector. An off-benchmark position in phototonics specialist Lumentum Holdings led relative contributors after the company reported strong fiscal second quarter 2026 financial results and upbeat forward guidance, driven by surging demand for artificial intelligence (AI) data center optics.
|
|
↑
|
Semiconductor manufacturer SiTime also advanced relative returns. Shares in the company, which makes precision timing chips, soared late in the period after the company posted strong revenue growth amid increased demand from AI data centers.
|
|
↑
|
Onto Innovation supported relative returns. The process control solutions company benefited from surging demand for advanced semiconductor packaging and metrology tools driven by AI chip growth.
|
|
|
|
Top detractors from performance:
|
|
↓
|
Stock selection and an overweight in the consumer staples sector held back relative returns. Within the sector, an off-benchmark holding in BellRing Brands was the leading detractor. The nutrition products company reported shrinking profit margins and decreasing demand for its protein shakes. Retailer inventory adjustments and reduced full year 2025 guidance were also headwinds for the company.
|
|
↓
|
Within IT, a broader market pivot away from software stocks had a negative impact on shares of software development platform GitLab, despite the company’s positive earnings reports.
|
|
↓
|
In the health care sector, relative performance was hurt by a position in health care software company Phreesia. The company reduced guidance for 2027, reporting that it is losing visibility into spending commitments from some of its clients.
|
| Franklin Small Cap Growth Fund
|
PAGE 1
|
665-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Advisor Class 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Advisor Class
|
30.50
|
1.25
|
11.47
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
Russell 2000 Growth Index
|
42.64
|
4.00
|
11.19
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$2,435,287,399
|
|
Total Number of Portfolio Holdings
|
129
|
|
Total Management Fee Paid
|
$15,084,958
|
|
Portfolio Turnover Rate
|
48.01%
|
| Franklin Small Cap Growth Fund
|
PAGE 2
|
665-ATSR-0626 |
Portfolio Composition*,† (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
| † |
Certain categories may represent less than 0.1%. |
HOW HAS THE FUND CHANGED?
Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund and Jacob Swartz was added as a portfolio manager of the Fund.
This is a summary of certain changes to the Fund since May 1, 2025. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2026, at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or
prospectus.us.franklintempleton@fisglobal.com.
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Small Cap Growth Fund
|
PAGE 3
|
665-ATSR-0626 |
100001200014397167431574027838196691917723416227012962510000118581340615106149482256021857221862713330227396011000012406144661546514040237491746917596197752025328889100001179213356151581528922320223672296328167315744137924.624.023.18.07.54.92.81.60.70.30.02.5
|
|
|
|
Franklin Small-Mid Cap Growth Fund
|
|
|
Class A [FRSGX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Small-Mid Cap Growth Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
This report describes changes to the Fund that occurred during the reporting period.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class A
|
$90
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class A shares of Franklin Small-Mid Cap Growth Fund returned 14.38%. The Fund compares its performance to the Russell Midcap Growth Index and the S&P 500 Index, which returned 12.86% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
The Fund was helped most by stock selection in the information technology (IT) sector, where an off-benchmark holding in Arteris was a leading relative contributor. The company, which develops network-on-chip (NoC) technology, has been a beneficiary of the artificial intelligence (AI) chip boom, and has seen strong adoption of its Smart NoC product.
|
|
↑
|
Also in IT, Lattice Semiconductor lifted relative returns. The chipmaker reported solid fourth-quarter 2025 financial results and issued strong forward guidance, highlighting accelerating growth in AI and data-center applications.
|
|
↑
|
In the industrials sector, nuclear power components supplier BWX Technologies was a contributor. Shares in the company traded higher on the back of strong operational momentum and major national security contracts.
|
|
|
|
Top detractors from performance:
|
|
↓
|
Stock selection in the industrials sector weighed on relative returns over the period. Within the sector, data analytics and risk assessment firm, Verisk, was a leading detractor as investors worried that generative AI tools could weaken traditional data and analytics businesses.
|
|
↓
|
In financials, alternative asset manager Blue Owl Capital hampered relative returns. The company put a cap on withdrawals after investors tried to pull over $5 billion from two key funds, amid concerns about unregulated private lending markets.
|
|
↓
|
In the consumer staples sector, an off-benchmark holding in BellRing Brands was the leading detractor. The nutrition products company reported shrinking profit margins and decreasing demand for its protein shakes. Retailer inventory adjustments and reduced full year 2025 guidance were also headwinds for the company.
|
| Franklin Small-Mid Cap Growth Fund
|
PAGE 1
|
198-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT ($9,450 AFTER MAXIMUM APPLICABLE SALES CHARGE) –
Class A 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class A
|
14.38
|
0.50
|
10.62
|
|
Class A (with sales charge)
|
8.08
|
-0.63
|
9.99
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
Russell Midcap Growth Index
|
12.86
|
5.54
|
12.40
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
Performance for periods prior to September 10, 2018, has been restated to reflect the current maximum sales charge, which is lower than the maximum sales charge prior to that date.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$3,532,752,879
|
|
Total Number of Portfolio Holdings
|
87
|
|
Total Management Fee Paid
|
$16,900,774
|
|
Portfolio Turnover Rate
|
32.96%
|
| Franklin Small-Mid Cap Growth Fund
|
PAGE 2
|
198-ATSR-0626 |
Portfolio Composition* (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
HOW HAS THE FUND CHANGED?
Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund.
This is a summary of certain changes to the Fund since May 1, 2025. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2026, at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or prospectus.us.franklintempleton@fisglobal.com.
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Small-Mid Cap Growth Fund
|
PAGE 3
|
198-ATSR-0626 |
94501086812420145851501825284195111871722158226622592110000118581340615106149482256021857221862713330227396011000011583135371592515961245762046420791250942852032187100001179213356151581528922320223672296328167315744137926.119.718.812.29.23.73.42.11.80.92.1
|
|
|
|
Franklin Small-Mid Cap Growth Fund
|
|
|
Class C [FRSIX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Small-Mid Cap Growth Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
This report describes changes to the Fund that occurred during the reporting period.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class C
|
$170
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class C shares of Franklin Small-Mid Cap Growth Fund returned 13.55%. The Fund compares its performance to the Russell Midcap Growth Index and the S&P 500 Index, which returned 12.86% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
The Fund was helped most by stock selection in the information technology (IT) sector, where an off-benchmark holding in Arteris was a leading relative contributor. The company, which develops network-on-chip (NoC) technology, has been a beneficiary of the artificial intelligence (AI) chip boom, and has seen strong adoption of its Smart NoC product.
|
|
↑
|
Also in IT, Lattice Semiconductor lifted relative returns. The chipmaker reported solid fourth-quarter 2025 financial results and issued strong forward guidance, highlighting accelerating growth in AI and data-center applications.
|
|
↑
|
In the industrials sector, nuclear power components supplier BWX Technologies was a contributor. Shares in the company traded higher on the back of strong operational momentum and major national security contracts.
|
|
|
|
Top detractors from performance:
|
|
↓
|
Stock selection in the industrials sector weighed on relative returns over the period. Within the sector, data analytics and risk assessment firm, Verisk, was a leading detractor as investors worried that generative AI tools could weaken traditional data and analytics businesses.
|
|
↓
|
In financials, alternative asset manager Blue Owl Capital hampered relative returns. The company put a cap on withdrawals after investors tried to pull over $5 billion from two key funds, amid concerns about unregulated private lending markets.
|
|
↓
|
In the consumer staples sector, an off-benchmark holding in BellRing Brands was the leading detractor. The nutrition products company reported shrinking profit margins and decreasing demand for its protein shakes. Retailer inventory adjustments and reduced full year 2025 guidance were also headwinds for the company.
|
| Franklin Small-Mid Cap Growth Fund
|
PAGE 1
|
298-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class C 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class C
|
13.55
|
-0.25
|
9.79
|
|
Class C (with sales charge)
|
12.60
|
-0.25
|
9.79
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
Russell Midcap Growth Index
|
12.86
|
5.54
|
12.40
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$3,532,752,879
|
|
Total Number of Portfolio Holdings
|
87
|
|
Total Management Fee Paid
|
$16,900,774
|
|
Portfolio Turnover Rate
|
32.96%
|
| Franklin Small-Mid Cap Growth Fund
|
PAGE 2
|
298-ATSR-0626 |
Portfolio Composition* (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
HOW HAS THE FUND CHANGED?
Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund.
This is a summary of certain changes to the Fund since May 1, 2025. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2026, at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or prospectus.us.franklintempleton@fisglobal.com.
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Small-Mid Cap Growth Fund
|
PAGE 3
|
298-ATSR-0626 |
100001141512944151031542625778197381879822083224182545510000118581340615106149482256021857221862713330227396011000011583135371592515961245762046420791250942852032187100001179213356151581528922320223672296328167315744137926.119.718.812.29.23.73.42.11.80.92.1
|
|
|
|
Franklin Small-Mid Cap Growth Fund
|
|
|
Class R [FSMRX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Small-Mid Cap Growth Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
This report describes changes to the Fund that occurred during the reporting period.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class R
|
$117
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class R shares of Franklin Small-Mid Cap Growth Fund returned 14.07%. The Fund compares its performance to the Russell Midcap Growth Index and the S&P 500 Index, which returned 12.86% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
The Fund was helped most by stock selection in the information technology (IT) sector, where an off-benchmark holding in Arteris was a leading relative contributor. The company, which develops network-on-chip (NoC) technology, has been a beneficiary of the artificial intelligence (AI) chip boom, and has seen strong adoption of its Smart NoC product.
|
|
↑
|
Also in IT, Lattice Semiconductor lifted relative returns. The chipmaker reported solid fourth-quarter 2025 financial results and issued strong forward guidance, highlighting accelerating growth in AI and data-center applications.
|
|
↑
|
In the industrials sector, nuclear power components supplier BWX Technologies was a contributor. Shares in the company traded higher on the back of strong operational momentum and major national security contracts.
|
|
|
|
Top detractors from performance:
|
|
↓
|
Stock selection in the industrials sector weighed on relative returns over the period. Within the sector, data analytics and risk assessment firm, Verisk, was a leading detractor as investors worried that generative AI tools could weaken traditional data and analytics businesses.
|
|
↓
|
In financials, alternative asset manager Blue Owl Capital hampered relative returns. The company put a cap on withdrawals after investors tried to pull over $5 billion from two key funds, amid concerns about unregulated private lending markets.
|
|
↓
|
In the consumer staples sector, an off-benchmark holding in BellRing Brands was the leading detractor. The nutrition products company reported shrinking profit margins and decreasing demand for its protein shakes. Retailer inventory adjustments and reduced full year 2025 guidance were also headwinds for the company.
|
| Franklin Small-Mid Cap Growth Fund
|
PAGE 1
|
898-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class R 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class R
|
14.07
|
0.26
|
10.35
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
Russell Midcap Growth Index
|
12.86
|
5.54
|
12.40
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$3,532,752,879
|
|
Total Number of Portfolio Holdings
|
87
|
|
Total Management Fee Paid
|
$16,900,774
|
|
Portfolio Turnover Rate
|
32.96%
|
| Franklin Small-Mid Cap Growth Fund
|
PAGE 2
|
898-ATSR-0626 |
Portfolio Composition* (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
HOW HAS THE FUND CHANGED?
Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund.
This is a summary of certain changes to the Fund since May 1, 2025. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2026, at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or prospectus.us.franklintempleton@fisglobal.com.
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Small-Mid Cap Growth Fund
|
PAGE 3
|
898-ATSR-0626 |
100001147013077153221573426428203501947522999234672677010000118581340615106149482256021857221862713330227396011000011583135371592515961245762046420791250942852032187100001179213356151581528922320223672296328167315744137926.119.718.812.29.23.73.42.11.80.92.1
|
|
|
|
Franklin Small-Mid Cap Growth Fund
|
|
|
Class R6 [FMGGX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Small-Mid Cap Growth Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
This report describes changes to the Fund that occurred during the reporting period.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Class R6
|
$54
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Class R6 shares of Franklin Small-Mid Cap Growth Fund returned 14.79%. The Fund compares its performance to the Russell Midcap Growth Index and the S&P 500 Index, which returned 12.86% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
The Fund was helped most by stock selection in the information technology (IT) sector, where an off-benchmark holding in Arteris was a leading relative contributor. The company, which develops network-on-chip (NoC) technology, has been a beneficiary of the artificial intelligence (AI) chip boom, and has seen strong adoption of its Smart NoC product.
|
|
↑
|
Also in IT, Lattice Semiconductor lifted relative returns. The chipmaker reported solid fourth-quarter 2025 financial results and issued strong forward guidance, highlighting accelerating growth in AI and data-center applications.
|
|
↑
|
In the industrials sector, nuclear power components supplier BWX Technologies was a contributor. Shares in the company traded higher on the back of strong operational momentum and major national security contracts.
|
|
|
|
Top detractors from performance:
|
|
↓
|
Stock selection in the industrials sector weighed on relative returns over the period. Within the sector, data analytics and risk assessment firm, Verisk, was a leading detractor as investors worried that generative AI tools could weaken traditional data and analytics businesses.
|
|
↓
|
In financials, alternative asset manager Blue Owl Capital hampered relative returns. The company put a cap on withdrawals after investors tried to pull over $5 billion from two key funds, amid concerns about unregulated private lending markets.
|
|
↓
|
In the consumer staples sector, an off-benchmark holding in BellRing Brands was the leading detractor. The nutrition products company reported shrinking profit margins and decreasing demand for its protein shakes. Retailer inventory adjustments and reduced full year 2025 guidance were also headwinds for the company.
|
| Franklin Small-Mid Cap Growth Fund
|
PAGE 1
|
318-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Class R6 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Class R6
|
14.79
|
0.86
|
11.05
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
Russell Midcap Growth Index
|
12.86
|
5.54
|
12.40
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$3,532,752,879
|
|
Total Number of Portfolio Holdings
|
87
|
|
Total Management Fee Paid
|
$16,900,774
|
|
Portfolio Turnover Rate
|
32.96%
|
| Franklin Small-Mid Cap Growth Fund
|
PAGE 2
|
318-ATSR-0626 |
Portfolio Composition* (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
HOW HAS THE FUND CHANGED?
Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund.
This is a summary of certain changes to the Fund since May 1, 2025. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2026, at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or prospectus.us.franklintempleton@fisglobal.com.
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Small-Mid Cap Growth Fund
|
PAGE 3
|
318-ATSR-0626 |
100001155113273156381617027320211552037324208248402851310000118581340615106149482256021857221862713330227396011000011583135371592515961245762046420791250942852032187100001179213356151581528922320223672296328167315744137926.119.718.812.29.23.73.42.11.80.92.1
|
|
|
|
Franklin Small-Mid Cap Growth Fund
|
|
|
Advisor Class [FSGAX]
|
|
Annual Shareholder Report | April 30, 2026
|
|
|
This annual shareholder report contains important information about Franklin Small-Mid Cap Growth Fund for the period May 1, 2025, to April 30, 2026.
You can find additional information about the Fund at https://www.franklintempleton.com/regulatory-fund-documents. You can also request this information by contacting us at (800) DIAL BEN/342-5236.
This report describes changes to the Fund that occurred during the reporting period.
|
|
|
|
Class Name
|
Costs of a $10,000 investment
|
Costs paid as a percentage of a $10,000 investment*
|
|
Advisor Class
|
$63
|
%
|
| * |
Reflects fee waivers and/or expense reimbursements, without which expenses would have been higher. |
HOW DID THE FUND PERFORM LAST YEAR AND WHAT AFFECTED ITS PERFORMANCE?
For the twelve months ended April 30, 2026, Advisor Class shares of Franklin Small-Mid Cap Growth Fund returned 14.69%. The Fund compares its performance to the Russell Midcap Growth Index and the S&P 500 Index, which returned 12.86% and 31.05%, respectively, for the same period.
|
|
|
Top contributors to performance:
|
|
↑
|
The Fund was helped most by stock selection in the information technology (IT) sector, where an off-benchmark holding in Arteris was a leading relative contributor. The company, which develops network-on-chip (NoC) technology, has been a beneficiary of the artificial intelligence (AI) chip boom, and has seen strong adoption of its Smart NoC product.
|
|
↑
|
Also in IT, Lattice Semiconductor lifted relative returns. The chipmaker reported solid fourth-quarter 2025 financial results and issued strong forward guidance, highlighting accelerating growth in AI and data-center applications.
|
|
↑
|
In the industrials sector, nuclear power components supplier BWX Technologies was a contributor. Shares in the company traded higher on the back of strong operational momentum and major national security contracts.
|
|
|
|
Top detractors from performance:
|
|
↓
|
Stock selection in the industrials sector weighed on relative returns over the period. Within the sector, data analytics and risk assessment firm, Verisk, was a leading detractor as investors worried that generative AI tools could weaken traditional data and analytics businesses.
|
|
↓
|
In financials, alternative asset manager Blue Owl Capital hampered relative returns. The company put a cap on withdrawals after investors tried to pull over $5 billion from two key funds, amid concerns about unregulated private lending markets.
|
|
↓
|
In the consumer staples sector, an off-benchmark holding in BellRing Brands was the leading detractor. The nutrition products company reported shrinking profit margins and decreasing demand for its protein shakes. Retailer inventory adjustments and reduced full year 2025 guidance were also headwinds for the company.
|
| Franklin Small-Mid Cap Growth Fund
|
PAGE 1
|
698-ATSR-0626 |
HOW DID THE FUND PERFORM OVER THE LAST 10 YEARS?
The Fund’s past performance is not necessarily an indication of how the Fund will perform in the future. The graph and table do not reflect the deduction of taxes that a shareholder would pay on Fund distributions or redemption of Fund shares.
VALUE OF A $10,000 INVESTMENT – Advisor Class 4/30/2016 — 4/30/2026
AVERAGE ANNUAL TOTAL RETURNS (%) Period Ended April 30, 2026
|
|
|
|
|
|
1 Year
|
5 Year
|
10 Year
|
|
Advisor Class
|
14.69
|
0.75
|
10.89
|
|
Russell 3000 Index
|
31.01
|
11.91
|
14.76
|
|
Russell Midcap Growth Index
|
12.86
|
5.54
|
12.40
|
|
S&P 500 Index
|
31.05
|
13.14
|
15.26
|
Fund performance figures may reflect fee waivers and/or expense reimbursements, without which the performance would have been lower.
For current month-end performance, please call Franklin Templeton at (800) DIAL BEN/342-5236 or visit
https://www.franklintempleton.com/investments/options/mutual-funds.
Important data provider notices and terms available at www.franklintempletondatasources.com.
KEY FUND STATISTICS (as of April 30, 2026)
|
|
|
Total Net Assets
|
$3,532,752,879
|
|
Total Number of Portfolio Holdings
|
87
|
|
Total Management Fee Paid
|
$16,900,774
|
|
Portfolio Turnover Rate
|
32.96%
|
| Franklin Small-Mid Cap Growth Fund
|
PAGE 2
|
698-ATSR-0626 |
Portfolio Composition* (% of Total Investments)
| * |
Does not include derivatives, except purchased options, if any. |
HOW HAS THE FUND CHANGED?
Effective December 31, 2025, Michael McCarthy no longer served as a portfolio manager of the Fund.
This is a summary of certain changes to the Fund since May 1, 2025. For more complete information, you may review the Fund’s current prospectus and any applicable supplements and the Fund’s next prospectus, which we expect to be available by September 1, 2026, at https://www.franklintempleton.com/regulatory-fund-documents or upon request at (800) DIAL BEN/342-5236 or prospectus.us.franklintempleton@fisglobal.com.
|
|
|
|
WHERE CAN I FIND ADDITIONAL INFORMATION ABOUT THE FUND?
|
|
Additional information is available on https://www.franklintempleton.com/regulatory-fund-documents, including its:
|
|
• prospectus • proxy voting information • financial information • holdings • tax information
|
HOUSEHOLDING
You will receive the Fund’s shareholder reports every six months. In addition, you will receive an annual updated summary prospectus (detail prospectus available upon request). To reduce Fund expenses, we try to identify related shareholders in a household and send only one copy of the shareholder reports and summary prospectus. This process, called “householding,” will continue indefinitely unless you instruct us otherwise. If you prefer not to have these documents householded, please call us at (800) DIAL BEN/342-5236. At any time, you may view current prospectuses/summary prospectuses and shareholder reports on our website. If you choose, you may receive these documents through electronic delivery.
| Franklin Small-Mid Cap Growth Fund
|
PAGE 3
|
698-ATSR-0626 |
100001152813208155421604927085209502015123916245182811910000118581340615106149482256021857221862713330227396011000011583135371592515961245762046420791250942852032187100001179213356151581528922320223672296328167315744137926.119.718.812.29.23.73.42.11.80.92.1
(b) Not applicable
(a) The Registrant has adopted a code of ethics that applies to
its principal executive officers and principal financial and accounting officer.
(c) N/A
(d) N/A
(f) Pursuant to Item 19(a) (1), the Registrant is attaching as
an exhibit a copy of its code of ethics that applies to its principal executive officers and principal financial and accounting officer.
| ITEM 3. |
AUDIT COMMITTEE FINANCIAL EXPERT. |
The Board of Trustees of the Registrant has determined that Mary
C. Choksi, possesses the technical attributes identified in Item 3 to Form N-CSR to qualify as an “audit committee financial
expert,” and has designated Mary C. Choksi as the Audit Committee’s financial expert. Mary C. Choksi is an “independent”
Trustee pursuant to paragraph (a)(2) of Item 3 to Form N-CSR.
Under applicable securities laws, a person determined to be an
audit committee financial expert will not be deemed an “expert” for any purpose, including without limitation for the purposes
of Section 11 of the Securities Act of 1933, as a result of being designated or identified as an audit committee financial expert. The
designation or identification of a person as an audit committee financial expert does not impose on such person any duties, obligations,
or liabilities greater than the duties, obligations, and liabilities imposed on such person as a member of the audit committee and board
of directors in the absence of such designation or identification. The designation or identification of a person as an audit committee
financial expert does not affect the duties, obligations, or liability of any other member of the audit committee or board of directors.
|
ITEM 4. |
PRINCIPAL ACCOUNTANT FEES AND SERVICES. |
a) Audit Fees.
The aggregate fees billed in the last two fiscal years ending April 30, 2025 and April 30, 2026 (the “Reporting Periods”)
for professional services rendered by the Registrant’s principal accountant (the “Auditor”) for the audit of the Registrant’s
annual financial statements, or services that are normally provided by the Auditor in connection with the statutory and regulatory filings
or engagements for the Reporting Periods, were $433,006 in April 30, 2025 and $473,742 in April 30, 2026.
b) Audit-Related
Fees. The aggregate fees billed in the Reporting Periods for assurance and related services by the Auditor that are reasonably
related to the performance of the Registrant’s financial statements were $0 in April 30, 2025 and $0 in April 30, 2026.
(c) Tax
Fees. The aggregate fees billed in the Reporting Periods for professional services rendered by the Auditor for tax compliance,
tax advice and tax planning (“Tax Services”) were $60,750 in April 30, 2025 and $60,750 in April 30, 2026. These services
consisted of (i) review or preparation of U.S. federal, state, local and excise tax returns; (ii) U.S. federal, state and local tax planning,
advice and assistance regarding statutory, regulatory or administrative developments, and (iii) tax advice regarding tax qualification
matters and/or treatment of various financial instruments held or proposed to be acquired or held.
There were no fees billed for tax services by the Registrant’s
investment adviser and any entity controlling, controlled by, or under common control with the investment adviser that provides ongoing
services to the Registrant (“Service Affiliates”) during the Reporting Periods that required pre-approval by the Audit Committee.
(d) All Other Fees.
The aggregate fees billed in the Reporting Periods for products and services provided by the Auditor to the Registrant, other than the
services reported in paragraphs (a) through (c) of this item, were $0 in April 30, 2025
and $0 in April 30, 2026.
There were no other non-audit services rendered by the Auditor
to the Service Affiliates requiring pre-approval by the Audit Committee in the Reporting Periods.
(e) Audit Committee’s pre–approval policies and procedures
described in paragraph (c) (7) of Rule 2-01 of Regulation S-X.
(1) The Registrant’s Audit Committee is directly responsible
for approving the services to be provided by the Auditors, including:
(i) pre-approval of all audit and audit
related services;
(ii) pre-approval of all non-audit related
services to be provided to the Registrant by the Auditors;
(iii) pre-approval of all non-audit related
services to be provided by the Auditors to the Registrant and the Service Affiliates where the non-audit services relate directly to the
operations or financial reporting of the Registrant; and
(iv) establishment by the Audit Committee,
if deemed necessary or appropriate, as an alternative to committee pre-approval of services to be provided by the Auditors, as required
by paragraphs (ii) and (iii) above, of policies and procedures to permit such services to be pre-approved by other means, such as through
establishment of guidelines or by action of a designated member or members of the committee; provided the policies and procedures are
detailed as to the particular service and the committee is informed of each service and such policies and procedures do not include delegation
of Audit Committee responsibilities, as contemplated under the Securities Exchange Act of 1934, to management; subject, in the case of
(ii) through (iv), to any waivers, exceptions or exemptions that may be available under applicable law or rules.
(2) None of the services described in paragraphs (b) through (d)
of this Item were performed in reliance on paragraph (c)(7)(i)(C) of Rule 2-01 of Regulation S-X.
(f) Not applicable.
(g) Non-audit fees billed by the Auditor for services rendered
to the Registrant and the Service Affiliates during the reporting period were $377,023 in April 30, 2025 and $1,690,011 in April 30, 2026.
(h) Yes. The Registrant’s Audit Committee has considered
whether the provision of non-audit services that were rendered to Service Affiliates, which were not pre-approved (not requiring pre-approval),
is compatible with maintaining the Auditor’s independence. All services provided by the Auditor to the Registrant or to the Service
Affiliates, which were required to be pre-approved, were pre-approved as required.
(i) Not applicable.
(j) Not applicable.
| ITEM 5. |
AUDIT COMMITTEE OF LISTED REGISTRANTS. |
Not applicable.
| ITEM 6. |
SCHEDULE OF INVESTMENTS. |
|
(a) |
Please see schedule of investments contained in the Financial Statements and Financial
Highlights included under Item 7 of this Form N-CSR. |
|
ITEM 7. |
FINANCIAL STATEMENTS AND FINANCIAL HIGHLIGHTS FOR OPEN-END MANAGEMENT INVESTMENT COMPANIES. |
Franklin
Strategic
Series
Financial
Statements
and
Other
Important
Information
Annual
|
April
30,
2026
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Franklin
Growth
Opportunities
Fund
Franklin
Natural
Resources
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-Mid
Cap
Growth
Fund
If
you
need
assistance
accessing
this
content,
please
reach
out
to
your
sales
representative
or
send
an
email
to
accessibility@franklintempleton.com
.
Financial
Statements
and
Other
Important
Information—Annual
Financial
Highlights
and
Schedules
of
Investments
2
Financial
Statements
109
Notes
to
Financial
Statements
119
Report
of
Independent
Registered
Public
Accounting
Firm
159
Tax
Information
160
Changes
In
and
Disagreements
with
Accountants
161
Results
of
Meeting(s)
of
Shareholders
161
Remuneration
Paid
to
Directors,
Officers
and
Others
161
Board
Approval
of
Management
and
Subadvisory
Agreements
161
Franklin
Strategic
Series
Financial
Highlights
Franklin
Biotechnology
Discovery
Fund
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$116.24
$132.38
$112.50
$101.90
$163.50
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.67)
(0.44)
(0.48)
(0.47)
(0.75)
Net
realized
and
unrealized
gains
(losses)
...........
75.98
(3.94)
20.36
11.21
(43.17)
Total
from
investment
operations
....................
75.31
(4.38)
19.88
10.74
(43.92)
Less
distributions
from:
Net
investment
income
..........................
(3.50)
—
—
(0.14)
(1.01)
Net
realized
gains
.............................
(14.42)
(11.76)
—
—
(16.67)
Total
distributions
...............................
(17.92)
(11.76)
—
(0.14)
(17.68)
Net
asset
value,
end
of
year
.......................
$173.63
$116.24
$132.38
$112.50
$101.90
Total
return
c
...................................
65.28%
(3.64)%
17.67%
10.58%
(28.56)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.02%
1.02%
1.05%
1.06%
1.04%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
1.01%
1.01%
1.04%
d
1.06%
e
1.04%
d,e
Net
investment
(loss)
............................
(0.45)%
(0.33)%
(0.41)%
(0.45)%
(0.54)%
Supplemental
data
Net
assets
,
end
of
year
(000’s)
.....................
$861,886
$588,965
$705,301
$686,534
$705,915
Portfolio
turnover
rate
............................
37.62%
21.87%
35.87%
24.08%
26.25%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
e
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Biotechnology
Discovery
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$104.63
$121.21
$103.78
$94.59
$152.95
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(1.60)
(1.31)
(1.26)
(1.16)
(1.51)
Net
realized
and
unrealized
gains
(losses)
...........
68.13
(3.51)
18.69
10.35
(40.18)
Total
from
investment
operations
....................
66.53
(4.82)
17.43
9.19
(41.69)
Less
distributions
from:
Net
investment
income
..........................
(2.61)
—
—
—
—
Net
realized
gains
.............................
(14.42)
(11.76)
—
—
(16.67)
Total
distributions
...............................
(17.03)
(11.76)
—
—
(16.67)
Net
asset
value,
end
of
year
.......................
$154.13
$104.63
$121.21
$103.78
$94.59
Total
return
c
...................................
64.06%
(4.36)%
16.80%
9.75%
(29.00)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.77%
1.77%
1.80%
1.81%
1.66%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
1.76%
1.76%
1.79%
d
1.81%
e
1.66%
d,e
Net
investment
(loss)
............................
(1.20)%
(1.07)%
(1.16)%
(1.20)%
(1.16)%
Supplemental
data
Net
assets
,
end
of
year
(000’s)
.....................
$22,572
$17,197
$27,332
$29,573
$33,905
Portfolio
turnover
rate
............................
37.62%
21.87%
35.87%
24.08%
26.25%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
e
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Biotechnology
Discovery
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$124.93
$140.93
$119.33
$108.06
$172.21
Income
from
investment
operations
a
:
Net
investment
income
(loss)
b
....................
(0.18)
0.04
(0.06)
(0.08)
(0.23)
Net
realized
and
unrealized
gains
(losses)
...........
81.85
(4.28)
21.66
11.94
(45.64)
Total
from
investment
operations
....................
81.67
(4.24)
21.60
11.86
(45.87)
Less
distributions
from:
Net
investment
income
..........................
(3.98)
—
—
(0.59)
(1.61)
Net
realized
gains
.............................
(14.42)
(11.76)
—
—
(16.67)
Total
distributions
...............................
(18.40)
(11.76)
—
(0.59)
(18.28)
Net
asset
value,
end
of
year
.......................
$188.20
$124.93
$140.93
$119.33
$108.06
Total
return
....................................
65.86%
(3.31)%
18.10%
11.03%
(28.29)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.78%
0.76%
0.76%
0.80%
0.74%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.67%
0.66%
0.68%
c
0.65%
0.66%
c
Net
investment
income
(loss)
......................
(0.11)%
0.03%
(0.05)%
(0.08)%
(0.16)%
Supplemental
data
Net
assets
,
end
of
year
(000’s)
.....................
$13,158
$6,758
$10,333
$11,692
$9,614
Portfolio
turnover
rate
............................
37.62%
21.87%
35.87%
24.08%
26.25%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Biotechnology
Discovery
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$122.62
$138.67
$117.54
$106.46
$169.95
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.31)
(0.09)
(0.19)
(0.22)
(0.42)
Net
realized
and
unrealized
gains
(losses)
...........
80.26
(4.20)
21.32
11.72
(44.99)
Total
from
investment
operations
....................
79.95
(4.29)
21.13
11.50
(45.41)
Less
distributions
from:
Net
investment
income
..........................
(3.81)
—
—
(0.42)
(1.41)
Net
realized
gains
.............................
(14.42)
(11.76)
—
—
(16.67)
Total
distributions
...............................
(18.23)
(11.76)
—
(0.42)
(18.08)
Net
asset
value,
end
of
year
.......................
$184.34
$122.62
$138.67
$117.54
$106.46
Total
return
....................................
65.70%
(3.41)%
17.98%
10.86%
(28.39)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.77%
0.77%
0.80%
0.81%
0.79%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.76%
0.76%
0.79%
c
0.81%
d
0.79%
c,d
Net
investment
(loss)
............................
(0.20)%
(0.07)%
(0.15)%
(0.20)%
(0.29)%
Supplemental
data
Net
assets
,
end
of
year
(000’s)
.....................
$139,744
$94,497
$131,350
$110,607
$110,726
Portfolio
turnover
rate
............................
37.62%
21.87%
35.87%
24.08%
26.25%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
d
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Schedule
of
Investments,
April
30,
2026
Franklin
Biotechnology
Discovery
Fund
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
1
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
95.5%
Biotechnology
76.1%
a
Abivax
SA
,
ADR
....................................
France
141,080
$
16,559,970
a,b,c
Achieve
Life
Sciences,
Inc.
............................
United
States
706,649
2,976,339
a,d
Achieve
Life
Sciences,
Inc.
............................
United
States
1,575,682
6,917,244
a,c
Acumen
Pharmaceuticals,
Inc.
.........................
United
States
223,305
533,699
a
Acumen
Pharmaceuticals,
Inc.
.........................
United
States
826,400
1,975,096
a
Adicet
Bio,
Inc.
.....................................
United
States
225,186
1,700,154
a
Alkermes
plc
.......................................
United
States
232,937
7,852,306
a
Alnylam
Pharmaceuticals,
Inc.
..........................
United
States
54,138
16,755,170
Amgen,
Inc.
.......................................
United
States
141,974
49,158,497
a
Apogee
Therapeutics,
Inc.
.............................
United
States
82,737
6,858,070
a
Arcutis
Biotherapeutics,
Inc.
...........................
United
States
505,651
11,741,216
a
Argenx
SE
,
ADR
....................................
Netherlands
48,962
38,274,575
a,d
Artiva
Biotherapeutics,
Inc.
............................
South
Korea
192,871
1,974,999
a
Ascendis
Pharma
A/S
................................
Denmark
129,742
29,760,220
a,d
Aura
Biosciences,
Inc.
................................
United
States
765,617
5,397,600
a,d
Avalo
Therapeutics,
Inc.
..............................
United
States
111,577
1,495,132
a
Avalyn
Pharma,
Inc.
.................................
United
States
137,059
4,041,870
a
Benitec
Biopharma,
Inc.
..............................
Australia
995,152
11,991,582
a
BeOne
Medicines
Ltd.
,
ADR
...........................
United
States
33,421
9,868,219
a
Bicara
Therapeutics,
Inc.
..............................
United
States
387,402
8,360,135
a
BioNTech
SE
,
ADR
..................................
Germany
73,400
7,593,230
a
Bridgebio
Pharma,
Inc.
...............................
United
States
241,119
17,145,972
a,d
Cardiff
Oncology,
Inc.
................................
United
States
438,961
759,402
a
CG
oncology,
Inc.
...................................
United
States
188,240
12,563,138
a
Cytokinetics,
Inc.
....................................
United
States
161,063
10,303,200
a
Dianthus
Therapeutics,
Inc.
............................
United
States
270,799
23,776,152
a
Dyne
Therapeutics,
Inc.
..............................
United
States
519,232
9,112,522
a,d
Eikon
Therapeutics,
Inc.
..............................
United
States
127,376
1,224,720
a
enGene
Therapeutics,
Inc.
............................
Canada
486,579
3,537,429
Gilead
Sciences,
Inc.
................................
United
States
368,999
48,279,829
a
GRAIL,
Inc.
........................................
United
States
46,433
2,529,670
a
Ideaya
Biosciences,
Inc.
..............................
United
States
81,852
2,381,893
a,d
Immix
Biopharma,
Inc.
...............................
United
States
357,034
3,188,314
a,d
IN8bio,
Inc.
........................................
United
States
332,083
488,162
a
Insmed,
Inc.
.......................................
United
States
214,314
29,217,428
a,d
Inventiva
SACA
,
ADR
................................
France
969,588
4,973,986
a
Ionis
Pharmaceuticals,
Inc.
............................
United
States
205,400
15,355,704
a
Jade
Biosciences,
Inc.
...............................
United
States
148,736
3,629,158
a,d
Kailera
Therapeutics,
Inc.
.............................
United
States
146,385
3,659,625
a
Mineralys
Therapeutics,
Inc.
...........................
United
States
567,545
15,125,074
a
Mirum
Pharmaceuticals,
Inc.
...........................
United
States
215,190
20,940,139
a
Neurocrine
Biosciences,
Inc.
...........................
United
States
135,273
17,811,396
a,d
Newamsterdam
Pharma
Co.
NV
........................
Netherlands
187,726
5,361,455
a
Nuvalent,
Inc.
,
A
....................................
United
States
75,535
7,574,650
a
Olema
Pharmaceuticals,
Inc.
...........................
United
States
379,464
5,468,076
a
ORIC
Pharmaceuticals,
Inc.
...........................
United
States
659,005
6,510,969
a
Oruka
Therapeutics,
Inc.
..............................
United
States
316,426
21,646,703
a
Palisade
Bio,
Inc.
...................................
United
States
2,119,910
4,239,820
a
Praxis
Precision
Medicines,
Inc.
........................
United
States
81,426
25,961,052
a
PTC
Therapeutics,
Inc.
...............................
United
States
319,652
20,796,559
Regeneron
Pharmaceuticals,
Inc.
.......................
United
States
61,019
43,144,094
a
Relay
Therapeutics,
Inc.
..............................
United
States
237,869
3,082,782
a
Revolution
Medicines,
Inc.
.............................
United
States
202,430
29,174,212
a
Satellos
Bioscience,
Inc.
,
(
CAD
Traded)
..................
Canada
96,830
766,314
a
Satellos
Bioscience,
Inc.
,
(
USD
Traded)
..................
Canada
246,407
1,958,936
a,d
Sensei
Biotherapeutics,
Inc.
...........................
United
States
48,771
1,298,284
a,d
Sionna
Therapeutics,
Inc.
.............................
United
States
60,891
2,356,482
a
Solid
Biosciences,
Inc.
...............................
United
States
1,253,978
9,103,880
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Biotechnology
Discovery
Fund
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Biotechnology
(continued)
a
Spyre
Therapeutics,
Inc.
..............................
United
States
323,584
$
24,090,829
a
Syndax
Pharmaceuticals,
Inc.
..........................
United
States
492,743
10,559,482
a
Tango
Therapeutics,
Inc.
..............................
United
States
447,635
9,677,869
a
Ultragenyx
Pharmaceutical,
Inc.
........................
United
States
108,067
2,668,174
a
uniQure
NV
........................................
Netherlands
175,121
3,493,664
a
Vaxcyte,
Inc.
.......................................
United
States
145,674
8,338,380
a
Verastem,
Inc.
......................................
United
States
401,744
2,193,522
a
Vertex
Pharmaceuticals,
Inc.
...........................
United
States
97,436
41,642,198
a
Vicore
Pharma
Holding
AB
............................
Sweden
1,307,598
1,413,428
a
Xenon
Pharmaceuticals,
Inc.
...........................
Canada
123,767
6,935,903
a
Zentalis
Pharmaceuticals,
Inc.
..........................
United
States
440,039
1,764,556
789,010,509
Capital
Markets
0.1%
a
JATT
II
Acquisition
Corp.
..............................
United
States
146,753
1,542,374
Health
Care
Providers
&
Services
2.1%
a
Guardant
Health,
Inc.
................................
United
States
248,985
21,681,614
Life
Sciences
Tools
&
Services
0.6%
Sartorius
Stedim
Biotech
..............................
France
10,100
1,866,598
Thermo
Fisher
Scientific,
Inc.
..........................
United
States
8,579
4,108,998
5,975,596
Pharmaceuticals
16.6%
a
Alto
Neuroscience,
Inc.
...............................
United
States
165,070
4,235,696
a,d
Alto
Neuroscience,
Inc.
...............................
United
States
240,205
6,163,661
a
Amylyx
Pharmaceuticals,
Inc.
..........................
United
States
649,259
10,388,144
AstraZeneca
plc
....................................
United
Kingdom
102,531
19,211,233
a
BioAge
Labs,
Inc.
...................................
United
States
90,709
1,528,447
a
Context
Therapeutics,
Inc.
.............................
United
States
1,398,833
3,301,246
a
Contineum
Therapeutics,
Inc.
,
A
........................
United
States
676,121
8,667,871
Eli
Lilly
&
Co.
......................................
United
States
14,071
13,150,757
a
EyePoint,
Inc.
......................................
United
States
1,123,495
14,830,134
a
Indivior
Pharmaceuticals,
Inc.
..........................
United
States
332,496
12,229,203
a
Jazz
Pharmaceuticals
plc
.............................
United
States
283,073
57,469,480
a,d
LENZ
Therapeutics,
Inc.
..............................
United
States
176,891
1,588,481
a
Neumora
Therapeutics,
Inc.
...........................
United
States
186,984
461,851
a
Phathom
Pharmaceuticals,
Inc.
.........................
United
States
487,012
5,454,534
a,d
SpyGlass
Pharma,
Inc.
...............................
United
States
109,328
2,507,984
a
Structure
Therapeutics,
Inc.
,
ADR
.......................
United
States
136,424
5,654,775
a,d
VeraDermics,
Inc.
...................................
United
States
53,904
5,336,496
172,179,993
Total
Common
Stocks
(Cost
$
479,739,791
)
...................................
990,390,086
Convertible
Preferred
Stocks
0.9%
Biotechnology
0.7%
a,b,c
Ray
Therapeutics,
Inc.
,
B
.............................
United
States
1,389,029
3,399,269
a,b,c
Sensei
Biotherapeutics,
Inc.
,
B
.........................
United
States
132
3,363,564
6,762,833
Household
Products
0.2%
a,b,c
Candid,
Inc.
,
B
.....................................
United
States
1,519,609
2,372,462
Total
Convertible
Preferred
Stocks
(Cost
$
7,322,109
)
..........................
9,135,295
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Biotechnology
Discovery
Fund
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Preferred
Stocks
0.5%
Life
Sciences
Tools
&
Services
0.2%
e
Sartorius
AG
,
0
.34
%
.................................
Germany
9,200
$
2,350,384
Real
Estate
Management
&
Development
0.3%
a,b,c
Lycia
LLC
,
C
.......................................
Japan
859,370
3,017,588
Total
Preferred
Stocks
(Cost
$
5,938,609
)
.....................................
5,367,972
Warrants
Warrants
0.8%
Biotechnology
0.8%
a,b,c
Achieve
Life
Sciences,
Inc.
,
4/10/28
.....................
United
States
706,649
621,851
a,b
Achieve
Life
Sciences,
Inc.
,
6/26/30
.....................
United
States
698,900
1,235,342
a,b
Assembly
Biosciences,
Inc.
,
A
,
8/11/30
...................
United
States
44,450
451,057
a,b
Assembly
Biosciences,
Inc.
,
B
,
12/31/26
..................
United
States
44,450
28,190
a,b
Benitec
Biopharma,
Inc.
,
2/20/49
........................
Australia
310,881
3,746,085
a,b,c
IN8bio,
Inc.
,
C
,
10/04/27
..............................
United
States
69,673
5,665
a,b
Palisade
Bio,
Inc.
,
10/01/30
............................
United
States
1,447,549
2,894,953
8,983,143
Total
Warrants
(Cost
$
1,620,146
)
............................................
8,983,143
Shares
Escrows
and
Litigation
Trusts
0.1%
a,b
Carmot
Therapeutics,
Inc.,
Escrow
Account
................
United
States
83,100
534,289
a
Sanofi
SA,
Escrow
Account
............................
France
2,333,755
—
Total
Escrows
and
Litigation
Trusts
(Cost
$
–
)
.................................
534,289
Total
Long
Term
Investments
(Cost
$
494,620,655
)
.............................
1,014,410,785
a
Short
Term
Investments
5.6%
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Money
Market
Funds
2.5%
f,g
Franklin
Institutional
U.S.
Government
Money
Market
Fund
,
3.593
%
.........................................
United
States
25,985,537
25,985,537
Total
Money
Market
Funds
(Cost
$
25,985,537
)
................................
25,985,537
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Biotechnology
Discovery
Fund
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Short
Term
Investments
(continued)
a
a
Country
Shares
a
Value
a
a
a
a
a
a
h
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
3.1%
Money
Market
Funds
3.1%
f,g
Franklin
Institutional
U.S.
Government
Money
Market
Fund
,
3.593
%
.........................................
United
States
31,626,763
$
31,626,763
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$
31,626,763
)
.........................................................
31,626,763
Total
Short
Term
Investments
(Cost
$
57,612,300
)
..............................
57,612,300
a
Total
Investments
(Cost
$
552,232,955
)
103.4
%
................................
$1,072,023,085
Other
Assets,
less
Liabilities
(
3.4
)
%
.........................................
(34,662,815)
Net
Assets
100.0%
.........................................................
$1,037,360,270
a
a
a
See
Abbreviations
on
page
158.
a
Non-income
producing.
b
Fair
valued
using
significant
unobservable
inputs.
See
Note
13
regarding
fair
value
measurements.
c
See
Note
7
regarding
restricted
securities.
d
A
portion
or
all
of
the
security
is
on
loan
at
April
30,
2026.
See
Note
1
(
e
).
e
Variable
rate
security.
The
rate
shown
represents
the
yield
at
period
end.
f
See
Note
3
(
f
)
regarding
investments
in
affiliated
management
investment
companies.
g
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
h
See
Note
1
(
e
)
regarding
securities
on
loan.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Core
Plus
Bond
Fund
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$8.27
$8.10
$8.23
$8.55
$9.44
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.37
0.38
0.37
0.36
0.29
Net
realized
and
unrealized
gains
(losses)
...........
0.02
0.18
(0.12)
(0.31)
(0.84)
Total
from
investment
operations
....................
0.39
0.56
0.25
0.05
(0.55)
Less
distributions
from:
Net
investment
income
..........................
(0.36)
(0.39)
(0.38)
(0.37)
(0.34)
Net
asset
value,
end
of
year
.......................
$8.30
$8.27
$8.10
$8.23
$8.55
Total
return
c
...................................
4.78%
6.98%
3.12%
0.73%
(6.07)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.80%
0.90%
0.94%
0.94%
0.90%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.71%
0.85%
0.91%
d
0.89%
d
0.84%
d
Net
investment
income
...........................
4.44%
4.64%
4.55%
4.34%
3.11%
Supplemental
data
Net
assets
,
end
of
year
(000’s)
.....................
$2,044,094
$1,989,034
$2,079,060
$2,285,374
$2,609,533
Portfolio
turnover
rate
............................
349.54%
156.08%
65.73%
e
69.77%
52.98%
Portfolio
turnover
rate
excluding
mortgage
dollar
rolls
....
156.76%
f
84.71%
f
55.51%
e,f
69.77%
41.46%
f
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
e
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
f
See
Note
1(f)
regarding
mortgage
dollar
rolls.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$8.28
$8.11
$8.23
$8.55
$9.44
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.34
0.35
0.34
0.32
0.25
Net
realized
and
unrealized
gains
(losses)
...........
0.02
0.17
(0.12)
(0.30)
(0.84)
Total
from
investment
operations
....................
0.36
0.52
0.22
0.02
(0.59)
Less
distributions
from:
Net
investment
income
..........................
(0.33)
(0.35)
(0.34)
(0.34)
(0.30)
Net
asset
value,
end
of
year
.......................
$8.31
$8.28
$8.11
$8.23
$8.55
Total
return
c
...................................
4.35%
6.53%
2.80%
0.30%
(6.48)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.20%
1.30%
1.34%
1.34%
1.29%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
1.11%
1.26%
1.31%
d
1.29%
d
1.24%
d
Net
investment
income
...........................
4.03%
4.24%
4.14%
3.92%
2.70%
Supplemental
data
Net
assets
,
end
of
year
(000’s)
.....................
$45,168
$49,796
$64,894
$100,037
$171,374
Portfolio
turnover
rate
............................
349.54%
156.08%
65.73%
e
69.77%
52.98%
Portfolio
turnover
rate
excluding
mortgage
dollar
rolls
....
156.76%
f
84.71%
f
55.51%
e,f
69.77%
41.46%
f
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
e
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
f
See
Note
1(f)
regarding
mortgage
dollar
rolls.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
R
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$8.23
$8.06
$8.19
$8.51
$9.40
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.35
0.36
0.35
0.33
0.27
Net
realized
and
unrealized
gains
(losses)
...........
0.02
0.18
(0.12)
(0.30)
(0.85)
Total
from
investment
operations
....................
0.37
0.54
0.23
0.03
(0.58)
Less
distributions
from:
Net
investment
income
..........................
(0.34)
(0.37)
(0.36)
(0.35)
(0.31)
Net
asset
value,
end
of
year
.......................
$8.26
$8.23
$8.06
$8.19
$8.51
Total
return
....................................
4.67%
6.62%
2.87%
0.48%
(6.33)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.05%
1.15%
1.19%
1.19%
1.15%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.96%
1.10%
1.16%
c
1.14%
c
1.09%
c
Net
investment
income
...........................
4.19%
4.39%
4.30%
4.09%
2.86%
Supplemental
data
Net
assets
,
end
of
year
(000’s)
.....................
$33,525
$34,949
$36,034
$40,939
$48,447
Portfolio
turnover
rate
............................
349.54%
156.08%
65.73%
d
69.77%
52.98%
Portfolio
turnover
rate
excluding
mortgage
dollar
rolls
....
156.76%
e
84.71%
e
55.51%
d,e
69.77%
41.46%
e
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
d
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
e
See
Note
1(f)
regarding
mortgage
dollar
rolls.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$8.28
$8.11
$8.24
$8.56
$9.45
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.40
0.41
0.40
0.39
0.32
Net
realized
and
unrealized
gains
(losses)
...........
0.03
0.18
(0.12)
(0.31)
(0.84)
Total
from
investment
operations
....................
0.43
0.59
0.28
0.08
(0.52)
Less
distributions
from:
Net
investment
income
..........................
(0.39)
(0.42)
(0.41)
(0.40)
(0.37)
Net
asset
value,
end
of
year
.......................
$8.32
$8.28
$8.11
$8.24
$8.56
Total
return
....................................
5.27%
7.35%
3.49%
1.12%
(5.72)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.45%
0.56%
0.58%
0.58%
0.55%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.36%
0.50%
0.55%
c
0.51%
c
0.48%
c
Net
investment
income
...........................
4.79%
4.99%
4.92%
4.73%
3.47%
Supplemental
data
Net
assets
,
end
of
year
(000’s)
.....................
$282,964
$130,729
$133,098
$132,950
$136,184
Portfolio
turnover
rate
............................
349.54%
156.08%
65.73%
d
69.77%
52.98%
Portfolio
turnover
rate
excluding
mortgage
dollar
rolls
....
156.76%
e
84.71%
e
55.51%
d,e
69.77%
41.46%
e
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
d
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
e
See
Note
1(f)
regarding
mortgage
dollar
rolls.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$8.28
$8.11
$8.24
$8.56
$9.45
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.39
0.41
0.39
0.38
0.31
Net
realized
and
unrealized
gains
(losses)
...........
0.02
0.17
(0.12)
(0.31)
(0.84)
Total
from
investment
operations
....................
0.41
0.58
0.27
0.07
(0.53)
Less
distributions
from:
Net
investment
income
..........................
(0.38)
(0.41)
(0.40)
(0.39)
(0.36)
Net
asset
value,
end
of
year
.......................
$8.31
$8.28
$8.11
$8.24
$8.56
Total
return
....................................
5.04%
7.24%
3.37%
0.98%
(5.83)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.55%
0.65%
0.69%
0.69%
0.65%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.46%
0.60%
0.66%
c
0.64%
c
0.59%
c
Net
investment
income
...........................
4.68%
4.89%
4.80%
4.59%
3.36%
Supplemental
data
Net
assets
,
end
of
year
(000’s)
.....................
$341,568
$263,738
$272,301
$311,142
$390,465
Portfolio
turnover
rate
............................
349.54%
156.08%
65.73%
d
69.77%
52.98%
Portfolio
turnover
rate
excluding
mortgage
dollar
rolls
....
156.76%
e
84.71%
e
55.51%
d,e
69.77%
41.46%
e
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
d
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
e
See
Note
1(f)
regarding
mortgage
dollar
rolls.
Franklin
Strategic
Series
Schedule
of
Investments,
April
30,
2026
Franklin
Core
Plus
Bond
Fund
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
0.1%
Machinery
0.1%
a
UTEX
Industries,
Inc.
................................
United
States
16,788
$
738,049
Oil,
Gas
&
Consumable
Fuels
0.0%
†
b
Amplify
Energy
Corp.
................................
United
States
5,288
33,843
Birch
Permian
Holdings,
Inc.
...........................
United
States
46,176
267,821
301,664
Total
Common
Stocks
(Cost
$11,360,259)
....................................
1,039,713
Principal
Amount
*
Corporate
Bonds
38.6%
Aerospace
&
Defense
1.1%
c
Axon
Enterprise,
Inc.
,
Senior
Note,
144A,
6.125%,
3/15/30
...................
United
States
1,000,000
1,025,016
Senior
Note,
144A,
6.25%,
3/15/33
....................
United
States
750,000
770,078
Boeing
Co.
(The)
,
Senior
Bond,
3.625%,
2/01/31
........................
United
States
5,000,000
4,771,338
Senior
Bond,
6.875%,
3/15/39
........................
United
States
2,600,000
2,883,003
Senior
Note,
5.15%,
5/01/30
.........................
United
States
8,100,000
8,232,960
c
Bombardier,
Inc.
,
Senior
Note
,
144A,
6.75
%
,
6/15/33
.........
Canada
1,025,000
1,070,052
c
Efesto
Bidco
SpA
Efesto
US
LLC
,
XR
,
Senior
Secured
Note
,
144A,
7.5
%
,
2/15/32
...............................
Italy
1,600,000
1,595,551
c
Honeywell
Aerospace,
Inc.
,
Senior
Bond,
144A,
4.95%,
3/16/36
....................
United
States
2,020,000
1,997,843
Senior
Bond,
144A,
5.732%,
3/16/56
...................
United
States
1,150,000
1,131,875
Senior
Bond,
144A,
5.852%,
3/16/66
...................
United
States
770,000
758,494
Senior
Note,
144A,
4.6%,
3/16/33
.....................
United
States
1,010,000
997,586
Howmet
Aerospace,
Inc.
,
Senior
Bond,
4.75%,
4/15/36
.........................
United
States
2,250,000
2,186,554
Senior
Note,
4.85%,
10/15/31
........................
United
States
2,100,000
2,118,620
29,538,970
Air
Freight
&
Logistics
0.0%
†
FedEx
Corp.
,
Senior
Bond
,
4.05
%
,
2/15/48
................
United
States
1,200,000
909,258
Automobile
Components
0.1%
c
Forvia
SE
,
Senior
Note
,
144A,
6.75
%
,
9/15/33
..............
France
2,830,000
2,839,614
Automobiles
0.3%
c
Hyundai
Capital
America
,
Senior
Note,
144A,
5.35%,
3/19/29
....................
United
States
1,300,000
1,323,679
Senior
Note,
144A,
4.75%,
9/26/31
....................
United
States
6,000,000
5,952,364
7,276,043
Banks
4.8%
c
ABN
AMRO
Bank
NV
,
Senior
Non-Preferred
Note
,
144A,
6.339%
to
9/17/26,
FRN
thereafter
,
9/18/27
.....................
Netherlands
2,100,000
2,114,761
Banco
Santander
SA
,
Sub.
Bond
,
2.749
%
,
12/03/30
.........
Spain
3,000,000
2,714,288
Bank
of
America
Corp.
,
Senior
Bond,
2.299%
to
7/20/31,
FRN
thereafter,
7/21/32
...
United
States
3,500,000
3,096,719
Senior
Bond,
4.571%
to
4/26/32,
FRN
thereafter,
4/27/33
...
United
States
8,000,000
7,874,810
Sub.
Bond,
3.846%
to
3/07/32,
FRN
thereafter,
3/08/37
.....
United
States
1,434,000
1,332,564
c
Banque
Federative
du
Credit
Mutuel
SA
,
Senior
Preferred
Note
,
144A,
4.541
%
,
1/15/31
..............................
France
2,070,000
2,046,445
c
BPCE
SA
,
Senior
Non-Preferred
Note
,
144A,
2.045%
to
10/18/26,
FRN
thereafter
,
10/19/27
............................
France
7,900,000
7,810,970
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Banks
(continued)
Citigroup,
Inc.
,
Senior
Bond
,
4.412%
to
3/30/30,
FRN
thereafter
,
3/31/31
.........................................
United
States
5,600,000
$
5,539,991
Fifth
Third
Bancorp
,
Senior
Note
,
5.631%
to
1/28/31,
FRN
thereafter
,
1/29/32
.................................
United
States
7,300,000
7,538,047
HSBC
Holdings
plc
,
Senior
Bond,
2.848%
to
6/03/30,
FRN
thereafter,
6/04/31
...
United
Kingdom
8,300,000
7,689,339
Senior
Note,
5.21%
to
8/10/27,
FRN
thereafter,
8/11/28
.....
United
Kingdom
5,850,000
5,898,578
Huntington
Bancshares,
Inc.
,
Senior
Bond
,
5.709%
to
2/01/34,
FRN
thereafter
,
2/02/35
.............................
United
States
7,300,000
7,473,184
JPMorgan
Chase
&
Co.
,
Senior
Bond,
2.522%
to
4/21/30,
FRN
thereafter,
4/22/31
...
United
States
9,400,000
8,693,278
Senior
Bond,
1.953%
to
2/03/31,
FRN
thereafter,
2/04/32
...
United
States
3,400,000
3,000,967
Senior
Bond,
5.336%
to
1/22/34,
FRN
thereafter,
1/23/35
...
United
States
2,500,000
2,534,809
Sub.
Bond,
5.576%
to
7/22/35,
FRN
thereafter,
7/23/36
.....
United
States
1,620,000
1,644,284
Mizuho
Financial
Group,
Inc.
,
Senior
Note
,
5.778%
to
7/05/28,
FRN
thereafter
,
7/06/29
.............................
Japan
5,100,000
5,237,979
Royal
Bank
of
Canada
,
Senior
Note
,
5.2
%
,
8/01/28
..........
Canada
1,800,000
1,833,938
Santander
UK
Group
Holdings
plc
,
Senior
Note
,
1.673%
to
6/23/26,
FRN
thereafter
,
6/14/27
......................
United
Kingdom
6,700,000
6,675,406
c
Societe
Generale
SA
,
Senior
Non-Preferred
Bond,
144A,
2.889%
to
6/08/31,
FRN
thereafter,
6/09/32
.................................
France
7,500,000
6,762,598
Senior
Non-Preferred
Note,
144A,
1.792%
to
6/08/26,
FRN
thereafter,
6/09/27
.................................
France
7,200,000
7,178,996
Toronto-Dominion
Bank
(The)
,
Senior
Note
,
4.693
%
,
9/15/27
...
Canada
9,900,000
9,954,277
c
UniCredit
SpA
,
Senior
Preferred
Bond
,
144A,
3.127%
to
6/02/31,
FRN
thereafter
,
6/03/32
.............................
Italy
5,300,000
4,885,875
Wells
Fargo
&
Co.
,
Senior
Note,
6.303%
to
10/22/28,
FRN
thereafter,
10/23/29
..
United
States
7,400,000
7,704,007
Senior
Note,
5.198%
to
1/22/29,
FRN
thereafter,
1/23/30
....
United
States
4,400,000
4,475,098
131,711,208
Beverages
0.0%
†
Keurig
Dr.
Pepper,
Inc.
,
Senior
Bond
,
5.3
%
,
3/15/34
.........
United
States
1,330,000
1,327,410
Biotechnology
0.5%
AbbVie,
Inc.
,
Senior
Bond,
4.75%,
3/15/36
.........................
United
States
520,000
508,676
Senior
Note,
4.4%,
3/15/33
..........................
United
States
1,510,000
1,482,798
Amgen,
Inc.
,
Senior
Bond,
4.2%,
3/01/33
..........................
United
States
4,000,000
3,863,207
Senior
Bond,
5.25%,
3/02/33
.........................
United
States
6,600,000
6,756,043
c
Genmab
A/S
/
Genmab
Finance
LLC
,
Senior
Secured
Note
,
144A,
6.25
%
,
12/15/32
..............................
Denmark
2,230,000
2,289,820
14,900,544
Broadline
Retail
0.3%
Amazon.com,
Inc.
,
Senior
Bond,
4.875%,
3/13/36
........................
United
States
1,829,000
1,802,877
Senior
Bond,
5.8%,
3/13/56
..........................
United
States
260,000
256,082
Senior
Bond,
6.05%,
3/13/76
.........................
United
States
1,636,000
1,613,250
Senior
Note,
4.55%,
3/13/33
.........................
United
States
1,235,000
1,220,564
a,c,d
K2016470219
South
Africa
Ltd.
,
Senior
Secured
Note
,
144A,
3
%
,
12/31/22
........................................
South
Africa
10,914,248
—
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Broadline
Retail
(continued)
a,c,d
K2016470260
South
Africa
Ltd.
,
Senior
Secured
Note
,
144A,
25
%
,
12/31/22
....................................
South
Africa
4,807,777
$
—
c
Wayfair
LLC
,
Senior
Secured
Note
,
144A,
7.25
%
,
10/31/29
....
United
States
2,500,000
2,563,532
7,456,305
Building
Products
0.3%
Carlisle
Cos.,
Inc.
,
Senior
Bond
,
5.25
%
,
9/15/35
............
United
States
665,000
668,599
c
JH
North
America
Holdings,
Inc.
,
Senior
Secured
Note
,
144A,
5.875
%
,
1/31/31
...................................
United
States
475,000
475,152
Owens
Corning
,
Senior
Bond
,
5.7
%
,
6/15/34
...............
United
States
7,300,000
7,573,553
8,717,304
Capital
Markets
2.6%
Deutsche
Bank
AG
,
Senior
Preferred
Note
,
5.371
%
,
9/09/27
...
Germany
4,800,000
4,874,083
Goldman
Sachs
Group,
Inc.
(The)
,
Senior
Bond,
2.383%
to
7/20/31,
FRN
thereafter,
7/21/32
...
United
States
6,500,000
5,757,005
Senior
Bond,
5.536%
to
1/27/35,
FRN
thereafter,
1/28/36
...
United
States
9,800,000
9,964,461
Senior
Bond,
5.065%
to
1/20/36,
FRN
thereafter,
1/21/37
...
United
States
1,035,000
1,012,237
Senior
Note,
4.387%
to
6/14/26,
FRN
thereafter,
6/15/27
....
United
States
3,400,000
3,399,696
Senior
Note,
1.948%
to
10/20/26,
FRN
thereafter,
10/21/27
..
United
States
3,000,000
2,965,605
Senior
Note,
5.094%
to
4/19/33,
FRN
thereafter,
4/20/34
....
United
States
895,000
893,149
c
Jane
Street
Group
/
JSG
Finance,
Inc.
,
Senior
Secured
Note
,
144A,
6.125
%
,
11/01/32
.............................
United
States
3,600,000
3,620,979
Morgan
Stanley
,
Senior
Bond,
3.591%,
7/22/28
........................
United
States
10,000,000
9,890,980
Senior
Bond,
1.794%
to
2/12/31,
FRN
thereafter,
2/13/32
...
United
States
5,000,000
4,353,024
Senior
Bond,
5.466%
to
1/17/34,
FRN
thereafter,
1/18/35
...
United
States
1,900,000
1,936,628
Senior
Bond,
5.073%
to
1/29/36,
FRN
thereafter,
1/30/37
...
United
States
1,585,000
1,551,454
Senior
Bond,
5.9%
to
3/12/46,
FRN
thereafter,
3/13/47
.....
United
States
1,615,000
1,618,931
Senior
Note,
4.493%
to
1/15/31,
FRN
thereafter,
1/16/32
....
United
States
1,555,000
1,530,420
Senior
Note,
4.708%
to
3/11/31,
FRN
thereafter,
3/12/32
....
United
States
2,325,000
2,307,571
Sub.
Bond,
5.948%
to
1/18/33,
FRN
thereafter,
1/19/38
.....
United
States
542,000
558,560
c
MSCI,
Inc.
,
Senior
Bond
,
144A,
3.25
%
,
8/15/33
.............
United
States
11,800,000
10,345,681
c
Prologis
Targeted
US
Logistics
Fund
LP
,
Senior
Note
,
144A,
5.25
%
,
4/01/29
...................................
United
States
2,400,000
2,447,541
c
StoneX
Group,
Inc.
,
Secured
Note
,
144A,
7.875
%
,
3/01/31
....
United
States
2,600,000
2,739,329
71,767,334
Chemicals
0.3%
c
Cerdia
Finanz
GmbH
,
Senior
Secured
Note
,
144A,
9.375
%
,
10/03/31
........................................
Germany
1,000,000
962,500
c
Element
Solutions,
Inc.
,
Senior
Note
,
144A,
3.875
%
,
9/01/28
...
United
States
3,000,000
2,926,790
FMC
Corp.
,
Sub.
Bond
,
8.45%
to
10/31/30,
FRN
thereafter
,
11/01/55
........................................
United
States
875,000
580,487
c
Rain
Carbon,
Inc.
,
Senior
Secured
Note
,
144A,
12.25
%
,
9/01/29
United
States
2,550,000
2,686,111
7,155,888
Commercial
Services
&
Supplies
0.5%
c
Neptune
Bidco
US,
Inc.
,
Senior
Secured
Note
,
144A,
9.5
%
,
2/15/33
.........................................
United
States
800,000
801,635
Republic
Services,
Inc.
,
Senior
Note
,
5.15
%
,
3/15/35
.........
United
States
5,300,000
5,401,397
c
RR
Donnelley
&
Sons
Co.
,
Senior
Secured
Note
,
144A,
9.5
%
,
8/01/29
.........................................
United
States
2,000,000
2,066,020
Waste
Connections,
Inc.
,
Senior
Bond
,
4.8
%
,
7/15/36
........
United
States
1,895,000
1,855,795
c
Waste
Pro
USA,
Inc.
,
Senior
Note
,
144A,
7
%
,
2/01/33
........
United
States
800,000
816,964
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Commercial
Services
&
Supplies
(continued)
c
Wrangler
Holdco
Corp.
,
Senior
Note
,
144A,
6.625
%
,
4/01/32
...
Canada
2,500,000
$
2,581,020
13,522,831
Communications
Equipment
0.3%
Motorola
Solutions,
Inc.
,
Senior
Bond
,
5.4
%
,
4/15/34
.........
United
States
7,300,000
7,399,781
Construction
&
Engineering
0.1%
c
Arcosa,
Inc.
,
Senior
Note
,
144A,
4.375
%
,
4/15/29
...........
United
States
2,000,000
1,954,328
Consumer
Finance
1.6%
AerCap
Ireland
Capital
DAC
/
AerCap
Global
Aviation
Trust
,
Senior
Bond,
3.4%,
10/29/33
.........................
Ireland
7,700,000
6,845,494
Senior
Note,
4.125%,
2/28/29
........................
Ireland
710,000
701,375
American
Express
Co.
,
Senior
Bond
,
5.442%
to
1/29/35,
FRN
thereafter
,
1/30/36
.................................
United
States
10,000,000
10,223,177
c
Avolon
Holdings
Funding
Ltd.
,
Senior
Note
,
144A,
4.9
%
,
10/10/30
Ireland
7,735,000
7,697,454
Capital
One
Financial
Corp.
,
Senior
Bond
,
5.268%
to
5/09/32,
FRN
thereafter
,
5/10/33
.............................
United
States
8,600,000
8,633,033
c
FirstCash,
Inc.
,
Senior
Note
,
144A,
6.875
%
,
3/01/32
.........
United
States
3,000,000
3,078,392
General
Motors
Financial
Co.,
Inc.
,
Senior
Bond,
5.45%,
9/06/34
.........................
United
States
1,265,000
1,265,078
Senior
Note,
4.2%,
10/27/28
.........................
United
States
815,000
808,488
c
Jefferson
Capital
Holdings
LLC
,
Senior
Note
,
144A,
8.25
%
,
5/15/30
.........................................
United
States
3,000,000
3,141,123
OneMain
Finance
Corp.
,
Senior
Note
,
6.75
%
,
9/15/33
........
United
States
2,000,000
1,969,696
44,363,310
Consumer
Staples
Distribution
&
Retail
0.1%
c
US
Foods,
Inc.
,
Senior
Note
,
144A,
4.625
%
,
6/01/30
.........
United
States
2,300,000
2,251,194
Containers
&
Packaging
0.2%
AptarGroup,
Inc.
,
Senior
Note
,
4.75
%
,
3/30/31
.............
United
States
1,550,000
1,539,563
c
Clydesdale
Acquisition
Holdings,
Inc.
,
Senior
Secured
Note
,
144A,
6.75
%
,
4/15/32
...............................
United
States
1,300,000
1,224,141
c
Toucan
FinCo
Ltd.
/
Toucan
FinCo
Can,
Inc.
/
Toucan
FinCo
US
LLC
,
Senior
Secured
Note
,
144A,
9.5
%
,
5/15/30
...........
Canada
500,000
438,559
WRKCo,
Inc.
,
Senior
Bond
,
3
%
,
6/15/33
..................
United
States
3,600,000
3,168,733
6,370,996
Diversified
Consumer
Services
0.1%
Grand
Canyon
University
,
Secured
Note
,
5.125
%
,
10/01/28
....
United
States
1,700,000
1,688,571
Diversified
REITs
0.3%
c
Global
Net
Lease,
Inc.
/
Global
Net
Lease
Operating
Partnership
LP
,
Senior
Note
,
144A,
3.75
%
,
12/15/27
.................
United
States
3,000,000
2,934,215
VICI
Properties
LP
,
Senior
Note
,
5.625
%
,
4/01/35
...........
United
States
5,000,000
5,018,152
7,952,367
Diversified
Telecommunication
Services
1.4%
c
APLD
ComputeCo
2
LLC
,
Senior
Secured
Note
,
144A,
6.75
%
,
3/15/31
.........................................
United
States
1,545,000
1,530,624
c
APLD
ComputeCo
LLC
,
Senior
Secured
Note
,
144A,
9.25
%
,
12/15/30
........................................
United
States
2,100,000
2,258,361
AT&T,
Inc.
,
Senior
Bond,
2.55%,
12/01/33
........................
United
States
5,000,000
4,228,974
Senior
Bond,
5.125%,
4/30/36
........................
United
States
1,320,000
1,298,857
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Diversified
Telecommunication
Services
(continued)
AT&T,
Inc.,
(continued)
Senior
Bond,
6.2%,
10/30/56
.........................
United
States
1,150,000
$
1,139,975
Senior
Bond,
3.65%,
9/15/59
.........................
United
States
4,000,000
2,559,604
c
Black
Pearl
Compute
LLC
,
Senior
Secured
Note
,
144A,
6.125
%
,
2/15/31
.........................................
United
States
900,000
914,254
CCO
Holdings
LLC
/
CCO
Holdings
Capital
Corp.
,
Senior
Bond
,
4.5
%
,
5/01/32
....................................
United
States
2,000,000
1,757,535
c
Cipher
Compute
LLC
,
Senior
Secured
Note
,
144A,
7.125
%
,
11/15/30
........................................
United
States
895,000
928,794
Comcast
Corp.
,
Senior
Bond
,
4.8
%
,
5/15/33
...............
United
States
5,200,000
5,167,367
c
PR
RNO
Property
Owner
1
LLC
,
Senior
Secured
Note
,
144A,
6.5
%
,
5/01/31
....................................
United
States
515,000
510,751
c
RD
Michigan
Property
Owner
I
LLC
,
Senior
Secured
Bond
,
144A,
7.5
%
,
3/30/45
....................................
United
States
3,785,000
3,786,144
c
SV
RNO
Property
Owner
1
LLC
,
Senior
Secured
Note
,
144A,
5.875
%
,
3/01/31
...................................
United
States
1,385,000
1,359,791
Verizon
Communications,
Inc.
,
Senior
Bond,
5.25%,
4/02/35
.........................
United
States
697,000
697,123
Senior
Note,
2.355%,
3/15/32
........................
United
States
8,400,000
7,347,287
Senior
Note,
4.75%,
1/15/33
.........................
United
States
1,386,000
1,368,139
c
WULF
Compute
LLC
,
Senior
Secured
Note
,
144A,
7.75
%
,
10/15/30
........................................
United
States
1,310,000
1,377,609
38,231,189
Electric
Utilities
2.6%
American
Electric
Power
Co.,
Inc.
,
C,
Junior
Sub.
Bond,
5.8%
to
3/14/31,
FRN
thereafter,
3/15/56
United
States
2,600,000
2,587,151
D,
Junior
Sub.
Bond,
6.05%
to
3/14/36,
FRN
thereafter,
3/15/56
.........................................
United
States
865,000
862,659
c
California
Buyer
Ltd.
/
Atlantica
Sustainable
Infrastructure
plc
,
Senior
Note
,
144A,
6.375
%
,
2/15/32
....................
United
Kingdom
2,000,000
1,988,921
DTE
Electric
Co.
,
Senior
Bond,
5.25%,
5/15/35
.........................
United
States
740,000
750,779
A,
Senior
Bond,
4.85%,
3/01/36
.......................
United
States
1,530,000
1,496,589
Duke
Energy
Corp.
,
Senior
Bond,
2.45%,
6/01/30
.........................
United
States
6,200,000
5,720,470
Senior
Bond,
3.75%,
9/01/46
.........................
United
States
1,600,000
1,179,350
Duke
Energy
Ohio,
Inc.
,
Senior
Bond
,
5.25
%
,
4/01/33
........
United
States
1,000,000
1,022,487
c
Enel
Finance
International
NV
,
Senior
Note
,
144A,
4.375
%
,
9/30/30
.........................................
Italy
2,770,000
2,725,470
Exelon
Corp.
,
Senior
Bond,
4.05%,
4/15/30
.........................
United
States
13,400,000
13,130,012
Senior
Bond,
4.45%,
4/15/46
.........................
United
States
1,400,000
1,150,667
c
NRG
Energy,
Inc.
,
Senior
Bond
,
144A,
6
%
,
1/15/36
..........
United
States
2,300,000
2,285,387
Pacific
Gas
and
Electric
Co.
,
Senior
Bond,
5.2%,
5/01/36
..........................
United
States
770,000
750,310
Senior
Secured
Bond,
3.25%,
6/01/31
..................
United
States
6,000,000
5,557,790
Southern
Co.
(The)
,
Senior
Bond,
4.4%,
7/01/46
..........................
United
States
5,000,000
4,122,841
Senior
Note,
5.5%,
3/15/29
..........................
United
States
6,100,000
6,273,207
Virginia
Electric
and
Power
Co.
,
Senior
Bond,
4.95%,
3/15/36
.........................
United
States
2,970,000
2,896,597
Senior
Bond,
6.35%,
11/30/37
........................
United
States
820,000
889,500
c
Vistra
Operations
Co.
LLC
,
Senior
Bond,
144A,
5.25%,
10/15/35
...................
United
States
1,000,000
971,037
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Electric
Utilities
(continued)
c
Vistra
Operations
Co.
LLC,
(continued)
Senior
Note,
144A,
4.375%,
5/01/29
...................
United
States
3,000,000
$
2,949,021
Senior
Secured
Bond,
144A,
4.3%,
7/15/29
..............
United
States
6,000,000
5,889,887
Xcel
Energy,
Inc.
,
Senior
Bond,
4.6%,
6/01/32
..........................
United
States
2,900,000
2,855,670
Senior
Bond,
5.45%,
8/15/33
.........................
United
States
4,500,000
4,598,273
72,654,075
Electrical
Equipment
0.2%
Eaton
Corp.
,
Senior
Bond
,
4.8
%
,
3/06/36
.................
United
States
1,600,000
1,575,766
Vertiv
Holdings
Co.
,
Senior
Bond,
4.85%,
3/15/36
.........................
United
States
2,669,000
2,599,221
Senior
Bond,
5.8%,
3/15/56
..........................
United
States
620,000
601,707
4,776,694
Electronic
Equipment,
Instruments
&
Components
0.6%
Amphenol
Corp.
,
Senior
Note
,
4.4
%
,
2/15/33
...............
United
States
2,845,000
2,782,095
CDW
LLC
/
CDW
Finance
Corp.
,
Senior
Note
,
3.25
%
,
2/15/29
..
United
States
5,000,000
4,780,620
Flex
Ltd.
,
Senior
Bond
,
4.875
%
,
5/12/30
..................
United
States
7,100,000
7,105,268
c
TTM
Technologies,
Inc.
,
Senior
Note
,
144A,
4
%
,
3/01/29
......
United
States
2,000,000
1,936,162
16,604,145
Energy
Equipment
&
Services
0.3%
c
Archrock
Services
LP
/
Archrock
Partners
Finance
Corp.
,
Senior
Note
,
144A,
6
%
,
2/01/34
............................
United
States
1,045,000
1,052,274
c
Kodiak
Gas
Services
LLC
,
Senior
Note
,
144A,
5.875
%
,
4/01/31
.
United
States
1,185,000
1,194,125
c
Transocean
International
Ltd.
,
Senior
Secured
Note
,
144A,
8.75
%
,
2/15/30
...................................
United
States
2,800,000
2,934,025
c
Weatherford
International
Ltd.
,
Senior
Note
,
144A,
6.75
%
,
10/15/33
........................................
United
States
1,805,000
1,873,337
7,053,761
Entertainment
0.2%
c
Banijay
Entertainment
SAS
,
Senior
Secured
Note,
144A,
7%,
5/01/29
................
France
1,200,000
EUR
1,452,104
Senior
Secured
Note,
144A,
8.125%,
5/01/29
............
France
308,809
318,943
Discovery
Global
Holdings,
Inc.
,
Senior
Note
,
4.054
%
,
3/15/29
.
United
States
2,100,000
2,045,043
c
OAK-Eagle
Acquireco,
Inc.
,
Senior
Note,
144A,
8.75%,
7/01/34
....................
United
States
590,000
614,330
Senior
Secured
Note,
144A,
7.25%,
7/01/33
.............
United
States
705,000
726,764
5,157,184
Financial
Services
0.3%
Corebridge
Financial,
Inc.
,
Senior
Note
,
6.05
%
,
9/15/33
.......
United
States
4,900,000
5,152,587
c
Freedom
Mortgage
Holdings
LLC
,
Senior
Note
,
144A,
8.375
%
,
4/01/32
.........................................
United
States
2,000,000
2,028,910
c
Petronas
Capital
Ltd.
,
Senior
Note
,
144A,
4.95
%
,
1/03/31
.....
Malaysia
2,540,000
2,601,805
9,783,302
Food
Products
0.7%
c
Froneri
Lux
FinCo
SARL
,
Senior
Secured
Note
,
144A,
6
%
,
8/01/32
.........................................
United
Kingdom
970,000
959,932
c
Industrial
F&B
Investments
III,
Inc.
,
Senior
Secured
Note
,
144A,
7.75
%
,
2/11/33
....................................
United
States
1,075,000
1,087,186
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Food
Products
(continued)
JBS
NV
/
JBS
USA
Foods
Group
Holdings,
Inc.
/
JBS
USA
Food
Co.
Holdings
,
c
Senior
Bond,
144A,
5.625%,
3/10/37
...................
United
States
595,000
$
594,283
c
Senior
Bond,
144A,
6.4%,
5/10/57
.....................
United
States
580,000
571,115
Senior
Note,
3%,
2/02/29
...........................
United
States
1,500,000
1,441,584
Senior
Note,
3.625%,
1/15/32
........................
United
States
3,500,000
3,240,829
Kraft
Heinz
Foods
Co.
,
Senior
Bond
,
5
%
,
6/04/42
...........
United
States
3,175,000
2,808,818
c
Mars,
Inc.
,
Senior
Note
,
144A,
5.2
%
,
3/01/35
...............
United
States
8,580,000
8,659,536
19,363,283
Gas
Utilities
0.1%
Piedmont
Natural
Gas
Co.,
Inc.
,
Senior
Bond
,
3.35
%
,
6/01/50
..
United
States
2,800,000
1,894,327
Ground
Transportation
0.5%
c
Ashtead
Capital,
Inc.
,
Senior
Bond
,
144A,
5.8
%
,
4/15/34
......
United
Kingdom
900,000
923,777
Burlington
Northern
Santa
Fe
LLC
,
Senior
Bond
,
5.55
%
,
3/15/56
United
States
1,355,000
1,311,802
c
SMBC
Aviation
Capital
Finance
DAC
,
Senior
Bond,
144A,
5.7%,
7/25/33
.....................
Ireland
7,300,000
7,490,278
Senior
Note,
144A,
5.1%,
4/01/30
.....................
Ireland
1,400,000
1,411,865
c
Watco
Cos.
LLC
/
Watco
Finance
Corp.
,
Senior
Note
,
144A,
7.125
%
,
8/01/32
...................................
United
States
1,700,000
1,768,002
c
XPO,
Inc.
,
Senior
Note
,
144A,
7.125
%
,
2/01/32
.............
United
States
2,000,000
2,087,104
14,992,828
Health
Care
Equipment
&
Supplies
0.4%
c
Bausch
+
Lomb
Corp.
,
Senior
Secured
Note
,
144A,
8.375
%
,
10/01/28
........................................
United
States
3,000,000
3,101,250
Baxter
International,
Inc.
,
Senior
Note
,
2.272
%
,
12/01/28
......
United
States
4,700,000
4,397,652
c
Medline
Borrower
LP
,
Senior
Secured
Note
,
144A,
3.875
%
,
4/01/29
.........................................
United
States
3,355,000
3,261,270
10,760,172
Health
Care
Providers
&
Services
1.6%
c
CHS/Community
Health
Systems,
Inc.
,
Senior
Secured
Note,
144A,
6%,
1/15/29
................
United
States
1,800,000
1,786,941
Senior
Secured
Note,
144A,
9.75%,
1/15/34
.............
United
States
1,000,000
1,032,660
Cigna
Group
(The)
,
Senior
Bond
,
5.25
%
,
2/15/34
...........
United
States
7,300,000
7,406,102
c
Concentra
Health
Services,
Inc.
,
Senior
Note
,
144A,
6.875
%
,
7/15/32
.........................................
United
States
1,500,000
1,556,311
CVS
Health
Corp.
,
Senior
Bond,
1.75%,
8/21/30
.........................
United
States
4,000,000
3,542,737
Senior
Bond,
1.875%,
2/28/31
........................
United
States
990,000
868,315
Senior
Bond,
5.3%,
6/01/33
..........................
United
States
3,000,000
3,040,921
Senior
Bond,
2.7%,
8/21/40
..........................
United
States
6,300,000
4,416,135
c
DaVita,
Inc.
,
Senior
Note
,
144A,
4.625
%
,
6/01/30
...........
United
States
3,000,000
2,905,508
Elevance
Health,
Inc.
,
Senior
Bond
,
3.7
%
,
9/15/49
..........
United
States
1,400,000
1,002,074
HCA,
Inc.
,
Senior
Bond,
3.5%,
9/01/30
..........................
United
States
11,900,000
11,316,894
Senior
Note,
4.6%,
11/15/32
.........................
United
States
1,385,000
1,351,723
Icon
Investments
Six
DAC
,
Senior
Secured
Bond,
6%,
5/08/34
....................
United
States
460,000
470,295
Senior
Secured
Note,
5.849%,
5/08/29
.................
United
States
765,000
779,639
c
Kedrion
SpA
,
Senior
Secured
Note
,
144A,
6.5
%
,
9/01/29
......
Italy
2,000,000
1,959,972
c,e
MPH
Acquisition
Holdings
LLC
,
Senior
Secured
Note
,
144A,
PIK,
11.5
%
,
12/31/30
...................................
United
States
332
307
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Health
Care
Providers
&
Services
(continued)
c
Tenet
Healthcare
Corp.
,
Senior
Note
,
144A,
6
%
,
11/15/33
.....
United
States
1,360,000
$
1,375,265
44,811,799
Health
Care
REITs
0.3%
Alexandria
Real
Estate
Equities,
Inc.
,
Senior
Bond,
1.875%,
2/01/33
........................
United
States
6,400,000
5,158,376
Senior
Bond,
5.25%,
5/15/36
.........................
United
States
2,200,000
2,144,981
7,303,357
Health
Care
Technology
0.1%
c
IQVIA,
Inc.
,
Senior
Note
,
144A,
6.25
%
,
6/01/32
.............
United
States
3,000,000
3,058,938
Hotel
&
Resort
REITs
0.1%
c
RHP
Hotel
Properties
LP
/
RHP
Finance
Corp.
,
Senior
Note
,
144A,
6.5
%
,
4/01/32
...............................
United
States
2,500,000
2,566,842
Hotels,
Restaurants
&
Leisure
0.7%
c
1011778
BC
ULC
/
New
Red
Finance,
Inc.
,
Secured
Bond
,
144A,
4
%
,
10/15/30
.....................................
Canada
2,000,000
1,903,797
c,f
A&K
Travel
Group
Holdings
Ltd.
,
Senior
Note
,
144A,
7.5
%
,
5/15/33
.........................................
Jersey
570,000
573,522
Airbnb,
Inc.
,
Senior
Bond,
5.25%,
3/16/36
.........................
United
States
605,000
603,599
Senior
Note,
4.65%,
3/16/31
.........................
United
States
1,205,000
1,203,305
c
Carnival
Corp.
,
Senior
Note,
144A,
5.75%,
3/15/30
....................
United
States
2,500,000
2,537,610
Senior
Note,
144A,
5.75%,
8/01/32
....................
United
States
670,000
674,206
Marriott
International,
Inc.
,
Senior
Note
,
4.5
%
,
5/01/33
........
United
States
1,640,000
1,590,047
c
NCL
Corp.
Ltd.
,
Senior
Note
,
144A,
6.25
%
,
9/15/33
..........
United
States
600,000
581,119
c
Rivers
Enterprise
Borrower
LLC
,
Senior
Secured
Note
,
144A,
6.25
%
,
10/15/30
...................................
United
States
645,000
656,447
c
Royal
Caribbean
Cruises
Ltd.
,
Senior
Note,
144A,
5.625%,
9/30/31
...................
United
States
1,500,000
1,520,869
Senior
Note,
144A,
6%,
2/01/33
......................
United
States
5,500,000
5,585,750
c
Viking
Cruises
Ltd.
,
Senior
Note
,
144A,
5.875
%
,
10/15/33
.....
United
States
2,030,000
2,036,163
19,466,434
Household
Durables
0.3%
c
Ashton
Woods
USA
LLC
/
Ashton
Woods
Finance
Co.
,
Senior
Note
,
144A,
6.875
%
,
8/01/33
.........................
United
States
940,000
923,426
Toll
Brothers
Finance
Corp.
,
Senior
Bond
,
3.8
%
,
11/01/29
.....
United
States
4,900,000
4,775,779
c
Weekley
Homes
LLC
/
Weekley
Finance
Corp.
,
Senior
Note
,
144A,
4.875
%
,
9/15/28
..............................
United
States
2,000,000
1,958,565
7,657,770
Independent
Power
and
Renewable
Electricity
Producers
0.6%
c
AES
Andes
SA
,
Senior
Note
,
144A,
6.25
%
,
3/14/32
..........
Chile
1,080,000
1,119,699
c
Atlantica
Sustainable
Infrastructure
Ltd.
,
Senior
Note
,
144A,
4.125
%
,
6/15/28
...................................
Spain
1,528,000
1,493,403
c
Clearway
Energy
Operating
LLC
,
Senior
Note
,
144A,
3.75
%
,
2/15/31
.........................................
United
States
2,800,000
2,621,613
Constellation
Energy
Generation
LLC
,
Senior
Bond,
5.8%,
3/01/33
..........................
United
States
3,000,000
3,146,624
Senior
Bond,
6.125%,
1/15/34
........................
United
States
2,000,000
2,143,845
Senior
Note,
4.4%,
1/15/31
..........................
United
States
1,110,000
1,098,721
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Independent
Power
and
Renewable
Electricity
Producers
(continued)
c
Leeward
Renewable
Energy
Operations
LLC
,
Senior
Note
,
144A,
4.25
%
,
7/01/29
...................................
United
States
2,300,000
$
2,201,767
c
Talen
Energy
Supply
LLC
,
Senior
Note
,
144A,
6.375
%
,
5/01/33
.
United
States
1,740,000
1,743,108
15,568,780
Insurance
1.9%
c
AIA
Group
Ltd.
,
Senior
Bond
,
144A,
4.95
%
,
4/04/33
.........
Hong
Kong
3,100,000
3,171,727
Arch
Capital
Group
Ltd.
,
Senior
Bond
,
3.635
%
,
6/30/50
.......
United
States
6,400,000
4,592,041
Arthur
J
Gallagher
&
Co.
,
Senior
Note
,
5
%
,
2/15/32
..........
United
States
2,075,000
2,081,297
c
Asurion
LLC
/
Asurion
Co-Issuer,
Inc.
,
Senior
Secured
Note,
144A,
8%,
12/31/32
...............
United
States
1,100,000
1,149,719
Senior
Secured
Note,
144A,
8.375%,
2/01/34
............
United
States
1,600,000
1,579,861
c
Athene
Global
Funding
,
Secured
Note,
144A,
5.033%,
7/17/30
..................
United
States
3,800,000
3,765,739
Senior
Secured
Bond,
144A,
5.543%,
8/22/35
............
United
States
1,200,000
1,179,488
Brown
&
Brown,
Inc.
,
Senior
Bond
,
5.65
%
,
6/11/34
..........
United
States
7,300,000
7,379,432
c
Corebridge
Global
Funding
,
Secured
Note
,
144A,
5.9
%
,
9/19/28
United
States
2,100,000
2,163,876
F&G
Annuities
&
Life,
Inc.
,
Senior
Note
,
6.5
%
,
6/04/29
.......
United
States
2,200,000
2,226,921
c
Metropolitan
Life
Global
Funding
I
,
Secured
Note,
144A,
5.05%,
1/06/28
...................
United
States
9,600,000
9,701,735
Secured
Note,
144A,
4.3%,
8/25/29
....................
United
States
3,000,000
2,986,774
c
RGA
Global
Funding
,
Secured
Note
,
144A,
5.5
%
,
1/11/31
.....
United
States
6,400,000
6,599,877
c
Sammons
Financial
Group,
Inc.
,
Senior
Bond
,
144A,
6.875
%
,
4/15/34
.........................................
United
States
3,700,000
3,920,626
52,499,113
Interactive
Media
&
Services
0.1%
Meta
Platforms,
Inc.
,
Senior
Bond,
5.25%,
5/15/36
.........................
United
States
1,790,000
1,787,048
Senior
Bond,
6.3%,
5/15/56
..........................
United
States
1,280,000
1,284,544
3,071,592
IT
Services
0.2%
c
Beignet
Investor
LLC
,
Senior
Secured
Bond
,
144A,
6.581
%
,
5/30/49
.........................................
United
States
1,532,000
1,583,537
c
Cogent
Communications
Group
LLC
/
Cogent
Finance,
Inc.
,
Senior
Secured
Note
,
144A,
6.5
%
,
7/01/32
...............
United
States
2,000,000
1,857,200
c
Fortress
Intermediate
3,
Inc.
,
Senior
Secured
Note
,
144A,
7.5
%
,
6/01/31
.........................................
United
States
2,000,000
2,022,466
5,463,203
Leisure
Products
0.0%
†
Brunswick
Corp.
,
Senior
Bond
,
2.4
%
,
8/18/31
..............
United
States
1,300,000
1,133,408
Life
Sciences
Tools
&
Services
0.0%
†
Thermo
Fisher
Scientific,
Inc.
,
Senior
Bond
,
4.902
%
,
2/12/36
...
United
States
1,380,000
1,366,649
Machinery
0.2%
c
ESAB
Corp.
,
Senior
Note
,
144A,
6.25
%
,
4/15/29
............
United
States
2,900,000
2,941,928
c
Terex
Corp.
,
Senior
Note
,
144A,
6.25
%
,
10/15/32
...........
United
States
2,000,000
2,034,434
4,976,362
Media
1.1%
Charter
Communications
Operating
LLC
/
Charter
Communications
Operating
Capital
Corp.
,
Senior
Secured
Bond,
2.8%,
4/01/31
...................
United
States
15,900,000
14,241,763
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Media
(continued)
Charter
Communications
Operating
LLC
/
Charter
Communications
Operating
Capital
Corp.,
(continued)
Senior
Secured
Bond,
5.85%,
12/01/35
.................
United
States
1,255,000
$
1,225,236
c
Clear
Channel
Outdoor
Holdings,
Inc.
,
Senior
Secured
Note
,
144A,
7.5
%
,
3/15/33
...............................
United
States
2,000,000
2,102,308
c
Directv
Financing
LLC
,
Senior
Secured
Note
,
144A,
8.875
%
,
2/01/30
.........................................
United
States
1,440,000
1,468,399
Fox
Corp.
,
Senior
Bond
,
6.5
%
,
10/13/33
..................
United
States
5,500,000
5,908,094
c
Nexstar
Media,
Inc.
,
Senior
Note
,
144A,
7.25
%
,
4/15/34
......
United
States
1,545,000
1,555,979
c
Sinclair
Television
Group,
Inc.
,
Senior
Secured
Note
,
144A,
8.125
%
,
2/15/33
...................................
United
States
2,000,000
2,072,430
c
Univision
Communications,
Inc.
,
Senior
Secured
Note,
144A,
9.375%,
8/01/32
............
United
States
500,000
517,802
Senior
Secured
Note,
144A,
8.875%,
4/15/33
............
United
States
385,000
387,385
c
VZ
Secured
Financing
BV
,
Senior
Secured
Note
,
144A,
7.5
%
,
1/15/33
.........................................
Netherlands
1,000,000
970,057
30,449,453
Metals
&
Mining
0.3%
c
Anglo
American
Capital
plc
,
Senior
Note
,
144A,
5
%
,
3/21/33
...
South
Africa
2,155,000
2,132,042
c
Commercial
Metals
Co.
,
Senior
Bond,
144A,
6%,
12/15/35
.....................
United
States
1,040,000
1,039,480
Senior
Note,
144A,
5.75%,
11/15/33
...................
United
States
520,000
521,166
c
Glencore
Funding
LLC
,
Senior
Bond
,
144A,
5.508
%
,
4/01/36
...
Australia
2,165,000
2,181,031
c
Mineral
Resources
Ltd.
,
Senior
Note,
144A,
7%,
4/01/31
......................
Australia
685,000
711,625
Senior
Note,
144A,
6%,
5/01/32
......................
Australia
335,000
332,704
c
Novelis
Corp.
,
Senior
Note
,
144A,
6.375
%
,
8/15/33
..........
United
States
2,480,000
2,492,157
9,410,205
Multi-Utilities
0.7%
Dominion
Energy,
Inc.
,
A,
Senior
Note,
4.35%,
8/15/32
.......................
United
States
3,200,000
3,105,315
C,
Senior
Note,
3.375%,
4/01/30
......................
United
States
7,800,000
7,454,317
DTE
Energy
Co.
,
Senior
Note
,
4.875
%
,
6/01/28
.............
United
States
5,700,000
5,745,928
Public
Service
Enterprise
Group,
Inc.
,
Senior
Bond
,
5.4
%
,
3/15/35
United
States
2,225,000
2,248,260
18,553,820
Oil,
Gas
&
Consumable
Fuels
4.2%
c
Aker
BP
ASA
,
Senior
Bond
,
144A,
3.1
%
,
7/15/31
............
Norway
8,700,000
7,970,893
c
Calumet
Specialty
Products
Partners
LP
/
Calumet
Finance
Corp.
,
Senior
Secured
Note
,
144A,
9.25
%
,
7/15/29
..............
United
States
2,400,000
2,436,000
Canadian
Natural
Resources
Ltd.
,
Senior
Bond
,
2.95
%
,
7/15/30
Canada
8,200,000
7,715,757
Cheniere
Energy,
Inc.
,
c
Senior
Bond,
144A,
5.2%,
7/30/36
.....................
United
States
430,000
425,266
Senior
Note,
5.65%,
4/15/34
.........................
United
States
1,600,000
1,648,779
c
Crescent
Energy
Finance
LLC
,
Senior
Note,
144A,
7.375%,
1/15/33
...................
United
States
750,000
768,006
Senior
Note,
144A,
8.375%,
1/15/34
...................
United
States
1,865,000
1,973,291
c
DT
Midstream,
Inc.
,
Senior
Bond
,
144A,
4.375
%
,
6/15/31
.....
United
States
6,600,000
6,381,587
Eastern
Energy
Gas
Holdings
LLC
,
Senior
Bond
,
5.8
%
,
1/15/35
United
States
6,700,000
6,974,226
Energy
Transfer
LP
,
Senior
Note,
6.4%,
12/01/30
.........................
United
States
6,000,000
6,405,926
c
Senior
Note,
144A,
6%,
2/01/29
......................
United
States
4,000,000
4,037,762
c
Hess
Midstream
Operations
LP
,
Senior
Note
,
144A,
6.5
%
,
6/01/29
United
States
2,700,000
2,767,824
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Oil,
Gas
&
Consumable
Fuels
(continued)
c
Hilcorp
Energy
I
LP
/
Hilcorp
Finance
Co.
,
Senior
Bond
,
144A,
6.25
%
,
4/15/32
...................................
United
States
910,000
$
904,616
c
KazMunayGas
National
Co.
JSC
,
Senior
Bond
,
Reg
S,
5.375
%
,
4/24/30
.........................................
Kazakhstan
1,120,000
1,140,864
c
Kinetik
Holdings
LP
,
Senior
Note
,
144A,
5.875
%
,
6/15/30
......
United
States
3,000,000
3,011,799
MPLX
LP
,
Senior
Bond
,
5.4
%
,
4/01/35
....................
United
States
9,100,000
9,100,456
Murphy
Oil
Corp.
,
Senior
Note,
6%,
10/01/32
..........................
United
States
135,000
135,971
Senior
Note,
6.5%,
2/15/34
..........................
United
States
500,000
504,141
ONEOK,
Inc.
,
Senior
Bond,
5.375%,
6/01/29
........................
United
States
10,900,000
11,129,140
c
Senior
Note,
144A,
5.625%,
1/15/28
...................
United
States
1,700,000
1,721,202
c
Pertamina
Hulu
Energi
PT
,
Senior
Note
,
144A,
5.25
%
,
5/21/30
.
Indonesia
1,700,000
1,718,903
Sabine
Pass
Liquefaction
LLC
,
Senior
Secured
Note
,
4.5
%
,
5/15/30
.........................................
United
States
10,000,000
9,990,556
c
Sunoco
LP
,
Senior
Note,
144A,
5.375%,
7/15/31
...................
United
States
1,075,000
1,070,577
Senior
Note,
144A,
5.625%,
7/15/34
...................
United
States
640,000
631,738
Targa
Resources
Corp.
,
Senior
Note
,
4.35
%
,
4/15/31
........
United
States
1,320,000
1,294,342
Transcontinental
Gas
Pipe
Line
Co.
LLC
,
Senior
Note
,
5.1
%
,
3/15/36
.........................................
United
States
1,525,000
1,513,730
c
Var
Energi
ASA
,
Senior
Bond
,
144A,
8
%
,
11/15/32
..........
Norway
9,000,000
10,248,673
c
Venture
Global
Calcasieu
Pass
LLC
,
Senior
Secured
Bond,
144A,
4.125%,
8/15/31
............
United
States
2,600,000
2,437,086
Senior
Secured
Bond,
144A,
6%,
5/01/36
...............
United
States
1,080,000
1,088,913
c
Venture
Global
LNG,
Inc.
,
Senior
Secured
Note
,
144A,
8.375
%
,
6/01/31
.........................................
United
States
2,500,000
2,607,760
c
Venture
Global
Plaquemines
LNG
LLC
,
Senior
Secured
Bond,
144A,
7.75%,
5/01/35
.............
United
States
900,000
1,012,652
Senior
Secured
Bond,
144A,
6.75%,
1/15/36
.............
United
States
730,000
776,366
Senior
Secured
Note,
144A,
7.5%,
5/01/33
..............
United
States
500,000
554,699
Viper
Energy
Partners
LLC
,
Senior
Bond
,
5.7
%
,
8/01/35
......
United
States
1,840,000
1,868,950
c
Western
Midstream
Operating
LP
,
Senior
Note
,
144A,
7.25
%
,
4/01/30
.........................................
United
States
1,900,000
2,003,845
115,972,296
Paper
&
Forest
Products
0.1%
c
Georgia-Pacific
LLC
,
Senior
Note
,
144A,
4.9
%
,
5/15/33
.......
United
States
2,055,000
2,051,461
Personal
Care
Products
0.4%
c
Coty,
Inc.
/
HFC
Prestige
Products,
Inc.
/
HFC
Prestige
International
US
LLC
,
Senior
Secured
Note
,
144A,
4.75
%
,
1/15/29
.........................................
United
States
8,000,000
7,753,960
c
Opal
Bidco
SAS
,
Senior
Secured
Note
,
144A,
6.5
%
,
3/31/32
...
France
2,000,000
2,037,354
9,791,314
Pharmaceuticals
1.1%
c
Bayer
US
Finance
II
LLC
,
Senior
Bond
,
144A,
4.375
%
,
12/15/28
Germany
11,700,000
11,616,909
Merck
&
Co.,
Inc.
,
Senior
Bond,
4.75%,
12/04/35
........................
United
States
1,190,000
1,165,321
Senior
Note,
4.45%,
12/04/32
........................
United
States
740,000
733,254
Novartis
Capital
Corp.
,
Senior
Bond,
4.9%,
3/18/36
..........................
United
States
1,780,000
1,768,360
Senior
Bond,
5.7%,
3/18/56
..........................
United
States
955,000
957,258
Senior
Note,
4.1%,
11/05/30
.........................
United
States
5,305,000
5,237,050
Senior
Note,
4.6%,
3/18/33
..........................
United
States
1,445,000
1,435,440
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Pharmaceuticals
(continued)
Pfizer
Investment
Enterprises
Pte.
Ltd.
,
Senior
Bond
,
4.75
%
,
5/19/33
.........................................
United
States
3,500,000
$
3,486,249
Royalty
Pharma
plc
,
Senior
Bond,
5.2%,
9/25/35
..........................
United
States
1,250,000
1,239,192
Senior
Bond,
3.3%,
9/02/40
..........................
United
States
5,300,000
4,060,787
31,699,820
Residential
REITs
0.1%
Essex
Portfolio
LP
,
Senior
Bond
,
5.375
%
,
4/01/35
...........
United
States
2,600,000
2,644,537
Semiconductors
&
Semiconductor
Equipment
0.7%
Broadcom,
Inc.
,
Senior
Bond,
4.95%,
1/15/36
.........................
United
States
1,230,000
1,218,379
Senior
Bond,
5.7%,
1/15/56
..........................
United
States
185,000
184,048
c
Foundry
JV
Holdco
LLC
,
Senior
Secured
Bond,
144A,
6.25%,
1/25/35
.............
United
States
7,400,000
7,821,414
Senior
Secured
Bond,
144A,
6.4%,
1/25/38
..............
United
States
1,315,000
1,406,272
Senior
Secured
Note,
144A,
5.9%,
1/25/33
..............
United
States
1,565,000
1,629,604
Intel
Corp.
,
Senior
Bond,
5.3%,
5/15/36
..........................
United
States
1,310,206
1,305,208
Senior
Bond,
6.125%,
5/15/56
........................
United
States
806,577
801,129
Marvell
Technology,
Inc.
,
Senior
Bond
,
5.3
%
,
4/15/36
........
United
States
3,370,000
3,373,139
c
Qnity
Electronics,
Inc.
,
Senior
Note,
144A,
6.25%,
8/15/33
....................
United
States
320,000
327,801
Senior
Secured
Note,
144A,
5.75%,
8/15/32
.............
United
States
550,000
555,979
18,622,973
Software
0.7%
c
Gen
Digital,
Inc.
,
Senior
Note
,
144A,
6.25
%
,
4/01/33
.........
United
States
750,000
731,314
Oracle
Corp.
,
Senior
Bond,
4.3%,
7/08/34
..........................
United
States
8,000,000
7,118,896
Senior
Bond,
5.7%,
2/04/36
..........................
United
States
2,855,000
2,743,234
Senior
Bond,
6.7%,
2/04/56
..........................
United
States
935,000
862,388
Senior
Note,
4.8%,
9/26/32
..........................
United
States
915,000
870,385
Salesforce,
Inc.
,
Senior
Note
,
5.2
%
,
3/15/33
...............
United
States
3,505,000
3,499,733
Synopsys,
Inc.
,
Senior
Bond
,
5.15
%
,
4/01/35
...............
United
States
4,631,000
4,633,137
20,459,087
Specialized
REITs
0.2%
American
Tower
Corp.
,
Senior
Note
,
4.7
%
,
12/15/32
.........
United
States
925,000
913,872
c
Iron
Mountain,
Inc.
,
Senior
Note
,
144A,
7
%
,
2/15/29
.........
United
States
2,700,000
2,760,861
c
Millrose
Properties,
Inc.
,
Senior
Note
,
144A,
6.375
%
,
8/01/30
..
United
States
1,995,000
2,021,940
5,696,673
Specialty
Retail
0.1%
AutoNation,
Inc.
,
Senior
Bond
,
4.75
%
,
6/01/30
.............
United
States
1,900,000
1,892,026
Technology
Hardware,
Storage
&
Peripherals
0.5%
Dell
International
LLC
/
EMC
Corp.
,
Senior
Bond
,
5.4
%
,
4/15/34
United
States
7,800,000
7,940,235
Hewlett
Packard
Enterprise
Co.
,
Senior
Note
,
4.85
%
,
10/15/31
.
United
States
4,500,000
4,475,448
c
Seagate
Data
Storage
Technology
Pte.
Ltd.
,
Senior
Note
,
144A,
5.875
%
,
7/15/30
...................................
United
States
1,600,000
1,635,883
14,051,566
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Corporate
Bonds
(continued)
Textiles,
Apparel
&
Luxury
Goods
0.1%
Tapestry,
Inc.
,
Senior
Bond
,
5.5
%
,
3/11/35
.................
United
States
1,820,000
$
1,829,278
Tobacco
0.5%
BAT
Capital
Corp.
,
Senior
Bond,
4.39%,
8/15/37
.........................
United
Kingdom
1,700,000
1,549,053
Senior
Note,
4.625%,
3/22/33
........................
United
Kingdom
4,985,000
4,886,551
Philip
Morris
International,
Inc.
,
Senior
Bond
,
5.375
%
,
2/15/33
..
United
States
7,200,000
7,407,594
13,843,198
Trading
Companies
&
Distributors
0.1%
c
EquipmentShare.com,
Inc.
,
Secured
Note
,
144A,
8.625
%
,
5/15/32
United
States
1,500,000
1,592,722
c
WESCO
Distribution,
Inc.
,
Senior
Note
,
144A,
6.375
%
,
3/15/29
.
United
States
2,000,000
2,041,870
3,634,592
Transportation
Infrastructure
0.0%
†
c,g
Rutas
2
and
7
Finance
Ltd.
,
Senior
Secured
Bond
,
144A,
2.6%
,
9/30/36
.........................................
United
States
196,000
149,940
Wireless
Telecommunication
Services
0.8%
c
Connect
Finco
SARL
/
Connect
US
Finco
LLC
,
Senior
Secured
Note
,
144A,
9
%
,
9/15/29
............................
United
Kingdom
2,500,000
2,639,842
a,g
Digicel
Group
Holdings
Ltd.
,
29.35%,
11/17/33
.................................
Bermuda
677,343
21,434
32.05%,
11/17/33
.................................
Bermuda
72,906
8,936
T-Mobile
USA,
Inc.
,
Senior
Bond,
5%,
2/15/36
...........................
United
States
2,485,000
2,432,675
Senior
Bond,
3.3%,
2/15/51
..........................
United
States
4,800,000
3,113,867
Senior
Note,
3.875%,
4/15/30
........................
United
States
13,400,000
13,050,268
21,267,022
Total
Corporate
Bonds
(Cost
$1,086,608,718)
.................................
1,061,337,724
h
Senior
Floating
Rate
Interests
3.0%
i
Aerospace
&
Defense
0.1%
TransDigm,
Inc.,
First
Lien,
CME
Term
Loan,
K,
5.902%,
(1-month
SOFR
+
2.25%),
3/22/30
............................
United
States
1,020,872
1,023,603
f
TransDigm,
Inc.,
First
Lien,
CME
Term
Loan,
N,
6.152%,
(1-month
SOFR
+
2.5%),
2/14/33
.............................
United
States
1,186,047
1,189,350
f
VSE
Corp.,
First
Lien,
CME
Term
Loan,
B,
5.474%,
(12-month
SOFR
+
2%),
3/17/33
...............................
United
States
150,961
151,842
2,364,795
a
a
a
a
a
a
i
Air
Freight
&
Logistics
0.1%
Rand
Parent
LLC,
First
Lien,
CME
Term
Loan,
B,
6.7%,
(3-month
SOFR
+
3%),
3/18/30
...............................
United
States
392,381
394,454
Stonepeak
Nile
Parent
LLC,
First
Lien,
Amendment
No.
1
CME
Term
Loan,
5.919%,
(3-month
SOFR
+
2.25%),
4/09/32
.....
United
States
1,097,250
1,102,226
1,496,680
a
a
a
a
a
a
i
Automobile
Components
0.0%
†
American
Axle
&
Manufacturing,
Inc.,
First
Lien,
CME
Term
Loan,
C,
6.912%,
(3-month
SOFR
+
3.25%),
2/03/33
............
United
States
292,444
292,809
Clarios
Global
LP,
First
Lien,
Amendment
No.
6
Dollar
CME
Term
Loan,
6.402%,
(1-month
SOFR
+
2.75%),
1/28/32
.........
United
States
766,091
770,722
e
First
Brands
Group
LLC,
First
Lien,
2021
CME
Term
Loan,
PIK,
3.779%,
(1-month
SOFR
+
7%),
3/30/27
................
United
States
71,058
166
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
h
Senior
Floating
Rate
Interests
(continued)
i
Automobile
Components
(continued)
e
First
Brands
Group
LLC,
First
Lien,
Debtor-In-Possession
Roll
Up
CME
Term
Loan,
PIK,
10.661%,
(1-month
SOFR
+
7%),
6/29/26
United
States
705,417
$
2,776
e
First
Brands
Group
LLC,
First
Lien,
USD
Debtor-In-Possession
New
Money
CME
Term
Loan,
PIK,
13.657%,
(1-month
SOFR
+
10%),
6/29/26
....................................
United
States
276,894
68,446
e
First
Brands
Group
LLC,
Second
Lien,
2021
CME
Term
Loan,
PIK,
14.279%,
(1-month
SOFR
+
10.615%),
3/30/28
........
United
States
1,132,040
1,528
1,136,447
a
a
a
a
a
a
Beverages
0.0%
†
i
Primo
Brands
Corp.,
First
Lien,
2026
Refinancing
CME
Term
Loan,
6.45%,
(3-month
SOFR
+
2.75%),
3/31/31
..........
United
States
316,298
318,658
Biotechnology
0.1%
f,i
BioMarin
Pharmaceutical,
Inc.,
First
Lien,
CME
Term
Loan,
B,
5.174%,
(12-month
SOFR
+
1.75%),
1/28/33
.............
United
States
2,657,291
2,668,093
Broadline
Retail
0.0%
†
i
Peer
Holding
III
BV,
First
Lien,
CME
Term
Loan,
B5B,
6.2%,
(3-month
SOFR
+
2.5%),
7/01/31
......................
Netherlands
316,236
317,501
i
Building
Products
0.0%
†
EMRLD
Borrower
LP,
First
Lien,
Second
Amendment
Incremental
CME
Term
Loan,
5.95%,
(1-month
SOFR
+
2.25%),
8/04/31
..
United
States
218,578
219,130
Quikrete
Holdings,
Inc.,
First
Lien,
CME
Term
Loan,
B2,
5.902%,
(1-month
SOFR
+
2.25%),
3/19/29
.....................
United
States
400,116
400,991
Quikrete
Holdings,
Inc.,
First
Lien,
CME
Term
Loan,
B3,
5.902%,
(1-month
SOFR
+
2.25%),
2/10/32
.....................
United
States
273,103
273,641
893,762
a
a
a
a
a
a
i
Capital
Markets
0.2%
Citadel
Securities
Global
Holdings
LLC,
First
Lien,
2024
CME
Term
Loan,
5.7%,
(3-month
SOFR
+
2%),
10/31/31
........
United
States
696,724
700,110
f
CPI
Holdco
B
LLC,
First
Lien,
2025
Fourth
Amendment
Incremental
CME
Term
Loan,
5.652%,
(1-month
SOFR
+
2%),
5/19/31
.........................................
United
States
1,000,000
1,001,020
Jane
Street
Group
LLC,
First
Lien,
Extended
CME
Term
Loan,
5.673%,
(3-month
SOFR
+
2%),
12/15/31
................
United
States
2,696,776
2,695,428
4,396,558
a
a
a
a
a
a
i
Chemicals
0.1%
Albaugh
LLC,
First
Lien,
Initial
CME
Term
Loan,
7.413%,
(1-month
SOFR
+
3.75;
3-month
SOFR
+
3.75),
4/06/29
.....
United
States
611,336
594,742
f
Minerals
Technologies,
Inc.,
First
Lien,
CME
Term
Loan,
B,
5.652%,
(1-month
SOFR
+
2%),
11/26/31
................
United
States
1,000,000
1,003,750
Solstice
Advanced
Materials,
Inc.,
First
Lien,
CME
Term
Loan,
B,
5.413%,
(3-month
SOFR
+
1.75%),
10/29/32
.............
United
States
225,090
226,955
1,825,447
a
a
a
a
a
a
i
Commercial
Services
&
Supplies
0.1%
APi
Group
DE,
Inc.,
First
Lien,
2021
Incremental
CME
Term
Loan,
5.402%,
(1-month
SOFR
+
1.75%),
1/03/29
..............
United
States
1,100,000
1,104,587
Cimpress
USA,
Inc.,
First
Lien,
2024-2
Refinancing
CME
Term
Loan,
B1,
6.168%,
(1-month
SOFR
+
2.5%),
5/17/28
.......
Ireland
459,268
460,990
Prime
Security
Services
Borrower
LLC,
First
Lien,
2025
Incremental
CME
Term
Loan,
B2,
5.407%,
(1-month
SOFR
+
1.75%),
3/08/32
...................................
United
States
1,097,229
1,087,371
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
h
Senior
Floating
Rate
Interests
(continued)
i
Commercial
Services
&
Supplies
(continued)
Spin
Holdco,
Inc.,
First
Lien,
Initial
CME
Term
Loan,
7.928%,
(3-month
SOFR
+
4%),
9/04/30
.......................
United
States
131,898
$
93,318
f
WMB
Holdings,
Inc.,
First
Lien,
USD
CME
Term
Loan,
B,
5.652%,
(1-month
SOFR
+
2%),
11/05/29
......................
United
States
1,042,559
1,046,145
3,792,411
a
a
a
a
a
a
Communications
Equipment
0.0%
†
i
Viavi
Solutions,
Inc.,
First
Lien,
CME
Term
Loan,
6.18%,
(3-month
SOFR
+
2.5%),
10/18/32
............................
United
States
155,709
156,732
i
Containers
&
Packaging
0.1%
Clydesdale
Acquisition
Holdings,
Inc.,
First
Lien,
2025
Incremental
Closing
Date
CME
Term
Loan,
B,
6.902%,
(1-month
SOFR
+
3.25%),
4/01/32
...................................
United
States
585,040
544,368
f
Owens-Brockway
Glass
Container,
Inc.,
First
Lien,
CME
Term
Loan,
B1,
6.652%,
(1-month
SOFR
+
3%),
9/30/32
.........
United
States
1,006,577
995,254
1,539,622
a
a
a
a
a
a
Distributors
0.0%
†
i
Core
&
Main
LP,
First
Lien,
CME
Term
Loan,
D,
5.654%,
(1-month
SOFR
+
2%),
7/27/28
...............................
United
States
453,446
455,239
i
Electric
Utilities
0.3%
Alpha
Generation
LLC,
First
Lien,
Initial
CME
Term
Loan,
B,
5.402%,
(1-month
SOFR
+
1.75%),
9/30/31
..............
United
States
2,643,661
2,646,912
Astoria
Energy
LLC,
First
Lien,
Advance
CME
Term
Loan,
B,
5.919%,
(1-month
SOFR
+
2.25;
3-month
SOFR
+
2.25),
6/23/32
.........................................
United
States
164,017
164,799
Constellation
Renewables
LLC,
First
Lien,
CME
Term
Loan,
5.673%,
(3-month
SOFR
+
2%),
12/15/27
................
United
States
2,700,000
2,704,225
f
NRG
Energy,
Inc.,
First
Lien,
Incremental
CME
Term
Loan,
B,
5.561%,
(12-month
SOFR
+
1.75%),
4/15/33
.............
United
States
2,746,199
2,759,587
8,275,523
a
a
a
a
a
a
i
Entertainment
0.2%
f
Delta
2
(Lux)
SARL,
First
Lien,
CME
Term
Loan,
B,
5.45%,
(1-month
SOFR
+
1.75%),
9/30/31
.....................
Luxembourg
750,000
752,438
f
Live
Nation
Entertainment,
Inc.,
First
Lien,
Initial
CME
Term
Loan,
B,
5.657%,
(1-month
SOFR
+
2%),
10/21/32
.............
United
States
1,000,000
1,002,500
Playtika
Holding
Corp.,
First
Lien,
CME
Term
Loan,
B1,
6.517%,
(1-month
SOFR
+
2.75%),
3/13/28
.....................
United
States
683,423
658,912
f
TKO
Worldwide
Holdings
LLC,
First
Lien,
CME
Term
Loan,
B5,
5.664%,
(3-month
SOFR
+
2%),
11/21/31
................
United
States
2,629,463
2,639,507
5,053,357
a
a
a
a
a
a
i
Financial
Services
0.1%
Colossus
Acquireco
LLC,
First
Lien,
Initial
CME
Term
Loan,
5.38%,
(1-day
SOFR
+
1.75%),
7/30/32
.................
United
States
2,697,243
2,700,615
First
Eagle
Holdings,
Inc.,
First
Lien,
Initial
CME
Term
Loan,
7.2%,
(3-month
SOFR
+
3.5%),
8/16/32
......................
United
States
482,834
482,298
3,182,913
a
a
a
a
a
a
i
Food
Products
0.1%
Chobani
LLC,
First
Lien,
Closing
Date
CME
Term
Loan,
5.918%,
(1-month
SOFR
+
2.25%),
10/28/32
....................
United
States
271,960
273,805
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
h
Senior
Floating
Rate
Interests
(continued)
i
Food
Products
(continued)
f
Froneri
International
Ltd.,
First
Lien,
CME
Term
Loan,
B4,
5.877%,
(6-month
SOFR
+
2.25%),
9/30/31
..............
United
Kingdom
2,374,387
$
2,360,508
f
Wayne-Sanderson
Farms
LLC,
First
Lien,
CME
Term
Loan,
B,
5.652%,
(1-month
SOFR
+
2%),
5/21/32
................
United
States
1,000,000
1,001,250
3,635,563
a
a
a
a
a
a
i
Ground
Transportation
0.2%
Aggreko
Holdings,
Inc.,
First
Lien,
2025
Amended
USD
CME
Term
Loan,
6.664%,
(3-month
SOFR
+
3%),
5/21/31
.......
United
Kingdom
87,316
87,851
f
First
Student
Bidco,
Inc.,
First
Lien,
Initial
CME
Term
Loan,
B,
5.95%,
(3-month
SOFR
+
2.25%),
8/15/30
...............
United
States
1,075,527
1,077,318
f
First
Student
Bidco,
Inc.,
First
Lien,
Initial
CME
Term
Loan,
C,
5.95%,
(3-month
SOFR
+
2.25%),
8/15/30
...............
United
States
196,795
197,123
Genesee
&
Wyoming,
Inc.,
First
Lien,
Initial
CME
Term
Loan,
5.45%,
(3-month
SOFR
+
1.75%),
4/10/31
...............
United
States
2,697,215
2,702,569
4,064,861
a
a
a
a
a
a
Health
Care
Equipment
&
Supplies
0.0%
†
i
Hologic,
Inc.,
First
Lien,
CME
Term
Loan,
B,
5.924%,
(3-month
SOFR
+
2.25%),
4/07/33
............................
United
States
500,000
497,815
i
Health
Care
Providers
&
Services
0.0%
†
Medical
Solutions
Holdings,
Inc.,
First
Lien,
CME
Term
Loan,
7.263%,
(3-month
SOFR
+
3.5%),
11/01/28
..............
United
States
636,821
105,477
Paradigm
Parent
LLC,
First
Lien,
Initial
CME
Term
Loan,
8.2%,
(3-month
SOFR
+
4.5%),
4/16/32
......................
United
States
248,750
217,113
Surgery
Center
Holdings,
Inc.,
First
Lien,
2025
Refinancing
CME
Term
Loan,
6.168%,
(1-month
SOFR
+
2.5%),
12/19/30
.....
United
States
57,487
57,706
380,296
a
a
a
a
a
a
Health
Care
Technology
0.0%
†
i
Cotiviti,
Inc.,
First
Lien,
New
CME
Term
Loan,
B,
6.415%,
(1-month
SOFR
+
2.75%),
5/01/31
.....................
United
States
310,139
285,715
i
Hotels,
Restaurants
&
Leisure
0.3%
1011778
BC
ULC,
First
Lien,
CME
Term
Loan,
B5,
5.418%,
(1-month
SOFR
+
1.75%),
9/20/30
.....................
Canada
2,700,000
2,705,899
Caesars
Entertainment,
Inc.,
First
Lien,
2023
Incremental
CME
Term
Loan,
B,
5.902%,
(1-month
SOFR
+
2.25%),
2/06/30
...
United
States
299,208
291,106
DK
Crown
Holdings,
Inc.,
First
Lien,
CME
Term
Loan,
B,
5.411%,
(1-month
SOFR
+
1.75%),
3/04/32
.....................
United
States
1,097,229
1,100,274
f
Flutter
Financing
BV,
First
Lien,
2024
Refinancing
CME
Term
Loan,
B,
5.45%,
(3-month
SOFR
+
1.75%),
12/02/30
.......
Ireland
1,300,000
1,298,375
f
Raising
Cane's
Restaurants
LLC,
First
Lien,
First
Amendment
New
CME
Term
Loan,
5.652%,
(1-month
SOFR
+
2%),
11/03/32
United
States
2,697,250
2,703,157
8,098,811
a
a
a
a
a
a
Household
Products
0.0%
†
i
Energizer
Holdings,
Inc.,
First
Lien,
Initial
CME
Term
Loan,
5.652%,
(1-month
SOFR
+
2%),
3/19/32
................
United
States
1,096,911
1,100,564
i
Independent
Power
and
Renewable
Electricity
Producers
0.0%
†
Calpine
Construction
Finance
Co.
LP,
First
Lien,
2025
Refinancing
CME
Term
Loan,
5.402%,
(1-month
SOFR
+
1.75%),
7/31/30
...................................
United
States
300,000
301,354
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
h
Senior
Floating
Rate
Interests
(continued)
i
Independent
Power
and
Renewable
Electricity
Producers
(continued)
Talen
Energy
Supply
LLC,
First
Lien,
2024-1
Incremental
CME
Term
Loan,
B,
6.153%,
(3-month
SOFR
+
2.5%),
12/15/31
...
United
States
132,848
$
133,500
434,854
a
a
a
a
a
a
i
Insurance
0.1%
Asurion
LLC,
First
Lien,
New
CME
Term
Loan,
B10,
7.763%,
(3-month
SOFR
+
4%),
8/21/28
.......................
United
States
234,752
235,316
Asurion
LLC,
First
Lien,
New
CME
Term
Loan,
B11,
8.013%,
(3-month
SOFR
+
4.25%),
8/21/28
.....................
United
States
10,216
10,232
f
Lockton,
Inc.,
First
Lien,
CME
Term
Loan,
B,
5.811%,
(12-month
SOFR
+
2%),
4/25/33
...............................
United
States
2,290,000
2,298,587
2,544,135
a
a
a
a
a
a
IT
Services
0.0%
†
i
MH
Sub
I
LLC,
First
Lien,
2024
December
New
CME
Term
Loan,
7.902%,
(1-month
SOFR
+
4.25%),
12/31/31
.............
United
States
101,386
80,405
Machinery
0.0%
†
i
Columbus
McKinnon
Corp.,
First
Lien,
Initial
CME
Term
Loan,
7.2%,
(3-month
SOFR
+
3.5%),
2/03/33
.................
United
States
63,934
64,121
i
Media
0.2%
Advantage
Sales
&
Marketing,
Inc.,
First
Lien,
Exchange
CME
Term
Loan,
9.93%,
(3-month
SOFR
+
6%),
4/19/30
........
United
States
280,556
230,408
Charter
Communications
Operating
LLC,
First
Lien,
CME
Term
Loan
B5,
5.942%,
(3-month
SOFR
+
2.25%),
12/15/31
......
United
States
1,097,222
1,097,853
Nexstar
Media,
Inc.,
First
Lien,
CME
Term
Loan,
B7,
6.402%,
(1-month
SOFR
+
2.75%),
3/18/33
.....................
United
States
2,685,000
2,686,477
4,014,738
a
a
a
a
a
a
Mortgage
Real
Estate
Investment
Trusts
(REITs)
0.0%
†
i
Starwood
Property
Mortgage
LLC,
First
Lien,
CME
Term
Loan,
B5,
5.668%,
(1-month
SOFR
+
2%),
1/02/30
.............
United
States
246,884
248,119
i
Oil,
Gas
&
Consumable
Fuels
0.2%
f
CQP
Holdco
LP,
First
Lien,
CME
Term
Loan,
B,
5.45%,
(3-month
SOFR
+
1.75%),
12/31/32
...........................
United
States
2,700,000
2,701,863
Delek
US
Holdings,
Inc.,
First
Lien,
CME
Term
Loan,
B,
7.268%,
(1-month
SOFR
+
3.5%),
11/19/29
.....................
United
States
446,538
447,690
UGI
Energy
Services
LLC,
First
Lien,
Initial
CME
Term
Loan,
6.152%,
(1-month
SOFR
+
2.5%),
2/22/30
...............
United
States
517,472
521,353
f
Venture
Global
Calcasieu
Pass
LLC,
First
Lien,
Initial
CME
Term
Loan,
6.724%,
(12-month
SOFR
+
3.25%),
4/11/33
........
United
States
2,652,382
2,663,986
6,334,892
a
a
a
a
a
a
i
Passenger
Airlines
0.1%
AAdvantage
Loyalty
IP
Ltd.,
First
Lien,
2025
Incremental
CME
Term
Loan,
6.425%,
(3-month
SOFR
+
2.75%),
5/28/32
.....
United
States
1,097,229
1,094,371
AAdvantage
Loyalty
IP
Ltd.,
First
Lien,
CME
Term
Loan,
5.925%,
(3-month
SOFR
+
2.25%),
4/20/28
.....................
United
States
291,067
289,873
AS
Mileage
Plan
IP
Ltd.,
First
Lien,
Initial
CME
Term
Loan,
5.425%,
(3-month
SOFR
+
1.75%),
10/15/31
.............
United
States
421,541
422,529
United
Airlines,
Inc.,
First
Lien,
CME
Term
Loan,
B,
5.404%,
(1-month
SOFR
+
1.75%),
2/24/31
.....................
United
States
1,059,455
1,063,762
2,870,535
a
a
a
a
a
a
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
h
Senior
Floating
Rate
Interests
(continued)
i
Professional
Services
0.1%
Maximus,
Inc.,
First
Lien,
CME
Term
Loan,
B,
5.652%,
(1-month
SOFR
+
2%),
5/30/31
...............................
United
States
278,276
$
278,536
f
SS&C
Technologies,
Inc.,
First
Lien,
CME
Term
Loan,
B8,
5.652%,
(1-month
SOFR
+
2%),
5/09/31
................
United
States
2,600,000
2,603,237
2,881,773
a
a
a
a
a
a
Real
Estate
Management
&
Development
0.0%
†
f,i
Greystar
Real
Estate
Partners
LLC,
First
Lien,
CME
Term
Loan,
B3,
6.173%,
(3-month
SOFR
+
2.5%),
8/21/30
............
United
States
362,500
363,859
Software
0.1%
i
Adeia,
Inc.,
First
Lien,
Initial
CME
Term
Loan,
B6,
6.168%,
(1-month
SOFR
+
2.5%),
6/08/28
......................
United
States
999,911
1,002,411
i
Gen
Digital,
Inc.,
First
Lien,
CME
Term
Loan,
B,
5.402%,
(1-month
SOFR
+
1.75%),
9/12/29
............................
United
States
1,000,000
986,180
a,d
WorkCapital
BSD
SARL,
Term
Loan,
6.5%,
1/01/38
..........
Luxembourg
20,000,000
—
1,988,591
a
a
a
a
a
a
i
Specialty
Retail
0.1%
e
GNC
Holdings,
Inc.,
Second
Lien,
CME
Term
Loan,
PIK,
9.768%,
(1-month
SOFR
+
6%),
10/07/26
......................
United
States
3,335,320
2,597,380
Great
Outdoors
Group
LLC,
First
Lien,
CME
Term
Loan,
B,
6.902%,
(1-month
SOFR
+
3.25%),
1/23/32
..............
United
States
439,451
442,802
3,040,182
a
a
a
a
a
a
i
Trading
Companies
&
Distributors
0.1%
Herc
Holdings,
Inc.,
First
Lien,
CME
Term
Loan,
B,
5.402%,
(1-month
SOFR
+
1.75%),
6/02/32
.....................
United
States
463,003
465,649
QXO
Building
Products,
Inc.,
First
Lien,
CME
Term
Loan,
B,
5.652%,
(1-month
SOFR
+
2%),
4/30/32
................
United
States
1,100,000
1,101,694
1,567,343
a
a
a
a
a
a
Water
Utilities
0.0%
†
i
Deep
Blue
Operating
I
LLC,
First
Lien,
Initial
CME
Term
Loan,
6.411%,
(1-month
SOFR
+
2.75%),
10/01/32
.............
United
States
124,304
125,081
Total
Senior
Floating
Rate
Interests
(Cost
$104,939,861)
.......................
82,495,991
j
Marketplace
Loans
0.1%
a
Financial
Services
0.1%
a
a
a
a
a
a
Total
Marketplace
Loans
(Cost
$9,189,510)
...................................
2,232,026
Foreign
Government
and
Agency
Securities
2.7%
c
Angola
Government
Bond
,
Senior
Bond
,
144A,
8.25
%
,
5/09/28
.
Angola
1,560,000
1,600,534
c
Bank
Gospodarstwa
Krajowego
,
Senior
Bond
,
Reg
S,
5.375
%
,
5/22/33
.........................................
Poland
1,560,000
1,595,066
c
Benin
Government
Bond
,
Senior
Bond
,
Reg
S,
4.95
%
,
1/22/35
.
Benin
1,660,000
EUR
1,762,612
Brazil
Government
Bond
,
Senior
Bond,
3.875%,
6/12/30
........................
Brazil
3,100,000
2,978,325
Senior
Bond,
6%,
10/20/33
...........................
Brazil
720,000
728,136
c
Bulgaria
Government
Bond
,
Senior
Bond,
Reg
S,
5%,
3/05/37
......................
Bulgaria
530,000
517,453
Senior
Note,
Reg
S,
3.625%,
9/05/32
...................
Bulgaria
1,230,000
EUR
1,460,425
Chile
Government
Bond
,
Senior
Note
,
4.85
%
,
1/22/29
........
Chile
1,660,000
1,682,825
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Foreign
Government
and
Agency
Securities
(continued)
Colombia
Government
Bond
,
Senior
Bond,
7.5%,
2/02/34
..........................
Colombia
1,550,000
$
1,625,175
Senior
Note,
4.5%,
11/26/30
..........................
Colombia
1,030,000
EUR
1,189,578
c
Comision
Federal
de
Electricidad
,
Senior
Bond
,
144A,
3.348
%
,
2/09/31
.........................................
Mexico
2,000,000
1,817,740
c
Corp.
Nacional
del
Cobre
de
Chile
,
Senior
Bond
,
Reg
S,
3.75
%
,
1/15/31
.........................................
Chile
1,570,000
1,495,224
c
Costa
Rica
Government
Bond
,
Senior
Bond
,
144A,
6.125
%
,
2/19/31
.........................................
Costa
Rica
1,930,000
2,010,964
c
Dominican
Republic
Government
Bond
,
Senior
Bond,
Reg
S,
6%,
7/19/28
......................
Dominican
Republic
1,540,000
1,564,871
Senior
Bond,
Reg
S,
4.875%,
9/23/32
..................
Dominican
Republic
1,630,000
1,541,898
c
Eagle
Funding
Luxco
SARL
,
Senior
Note
,
144A,
5.5
%
,
8/17/30
.
Mexico
1,100,000
1,109,845
Ecopetrol
SA
,
Senior
Bond
,
4.625
%
,
11/02/31
..............
Colombia
880,000
793,367
c
Egypt
Government
Bond
,
Senior
Bond
,
Reg
S,
7.6
%
,
3/01/29
..
Egypt
1,120,000
1,151,514
c
El
Salvador
Government
Bond
,
Senior
Bond
,
Reg
S,
8.625
%
,
2/28/29
.........................................
El
Salvador
1,430,000
1,524,401
c
Electricite
de
France
SA
,
Senior
Note
,
144A,
5.7
%
,
5/23/28
....
France
1,700,000
1,738,406
c
Guatemala
Government
Bond
,
Senior
Bond,
Reg
S,
6.6%,
6/13/36
....................
Guatemala
2,200,000
2,365,000
Senior
Note,
144A,
7.05%,
10/04/32
....................
Guatemala
710,000
775,125
c
Hungary
Government
Bond
,
Senior
Note
,
Reg
S,
5.25
%
,
6/16/29
Hungary
1,680,000
1,710,033
c
Indonesia
Government
Bond
,
Senior
Bond
,
Reg
S,
4.35
%
,
1/08/27
.........................................
Indonesia
1,570,000
1,573,672
c
Ivory
Coast
Government
Bond
,
Senior
Bond
,
Reg
S,
6.125
%
,
6/15/33
.........................................
Ivory
Coast
2,470,000
2,418,580
c
Kazakhstan
Government
Bond
,
Senior
Bond
,
Reg
S,
4.714
%
,
4/09/35
.........................................
Kazakhstan
1,890,000
1,864,026
Mexico
Government
Bond
,
Senior
Bond
,
2.659
%
,
5/24/31
.....
Mexico
1,990,000
1,771,399
c
Montenegro
Government
Bond
,
Senior
Note
,
144A,
4.875
%
,
4/01/32
.........................................
Montenegro
990,000
EUR
1,169,647
c
Nigeria
Government
Bond
,
Senior
Note
,
144A,
8.375
%
,
3/24/29
Nigeria
1,450,000
1,551,268
c
North
Macedonia
Government
Bond
,
Senior
Note
,
144A,
4.75
%
,
1/21/34
.........................................
North
Macedonia
450,000
EUR
515,181
c
Paraguay
Government
Bond
,
Senior
Bond
,
144A,
3.849
%
,
6/28/33
.........................................
Paraguay
2,950,000
2,770,787
Peru
Government
Bond
,
Senior
Bond
,
2.783
%
,
1/23/31
.......
Peru
2,660,000
2,451,057
Petroleos
Mexicanos
,
Senior
Note
,
6.7
%
,
2/16/32
...........
Mexico
980,000
983,807
Philippines
Government
Bond
,
Senior
Bond
,
5.5
%
,
2/04/35
....
Philippines
2,360,000
2,424,809
c
Power
Finance
Corp.
Ltd.
,
Senior
Bond
,
Reg
S,
3.95
%
,
4/23/30
.
India
1,690,000
1,636,730
c
Romania
Government
Bond
,
Senior
Bond,
Reg
S,
5.625%,
2/22/36
..................
Romania
1,960,000
EUR
2,243,358
Senior
Note,
Reg
S,
3%,
2/27/27
......................
Romania
1,990,000
1,960,872
c
Serbia
Government
Bond
,
Senior
Note
,
144A,
6.25
%
,
5/26/28
..
Serbia
1,880,000
1,931,326
South
Africa
Government
Bond
,
Senior
Bond,
4.85%,
9/27/27
.........................
South
Africa
1,470,000
1,473,961
Senior
Bond,
5.875%,
4/20/32
........................
South
Africa
1,530,000
1,553,013
Turkiye
Government
Bond
,
Senior
Bond
,
5.95
%
,
1/15/31
......
Turkiye
3,430,000
3,368,805
Uruguay
Government
Bond
,
Senior
Bond
,
4.375
%
,
1/23/31
....
Uruguay
2,660,000
2,672,768
c
Uzbekistan
Government
Bond
,
Senior
Note
,
144A,
6.9
%
,
2/28/32
Uzbekistan
1,620,000
1,739,774
Total
Foreign
Government
and
Agency
Securities
(Cost
$71,803,891)
............
72,813,357
U.S.
Government
and
Agency
Securities
14.6%
FFCB
,
2.1
%,
2/25/36
.................................
United
States
7,700,000
6,160,168
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
U.S.
Government
and
Agency
Securities
(continued)
U.S.
Treasury
Bonds
,
3.875%,
2/15/43
..................................
United
States
19,000,000
$
16,753,399
4.125%,
8/15/44
..................................
United
States
18,500,000
16,638,076
2.5%,
5/15/46
....................................
United
States
40,450,000
27,529,701
2.875%,
5/15/49
..................................
United
States
55,250,000
38,851,973
4.25%,
8/15/54
...................................
United
States
134,700,000
119,175,298
4.75%,
8/15/55
...................................
United
States
1,105,000
1,063,217
U.S.
Treasury
Notes
,
3.625%,
5/15/26
..................................
United
States
3,500,000
3,499,825
4.375%,
8/15/26
..................................
United
States
12,100,000
12,122,817
1.875%,
2/28/27
..................................
United
States
48,200,000
47,464,672
3.875%,
11/30/27
.................................
United
States
43,700,000
43,698,293
2.875%,
5/15/28
..................................
United
States
37,000,000
36,269,395
4.5%,
5/31/29
....................................
United
States
6,930,000
7,045,861
4.375%,
11/30/30
.................................
United
States
24,000,000
24,361,406
Total
U.S.
Government
and
Agency
Securities
(Cost
$415,225,550)
..............
400,634,101
Asset-Backed
Securities
9.2%
Consumer
Finance
0.2%
GM
Financial
Consumer
Automobile
Receivables
Trust
,
2026-2
,
A3
,
4.15
%
,
8/18/31
.
................................
United
States
6,067,000
6,065,334
Financial
Services
9.0%
c,i
Allegro
CLO
XIII
Ltd.
,
2021-1A
,
D1R
,
144A,
FRN
,
6.825
%
,
(
3-month
SOFR
+
3.15
%
),
7/20/38
.
....................
United
States
2,500,000
2,513,595
c,i
Angel
Oak
Mortgage
Trust
,
2025-HB1
,
A1
,
144A,
FRN
,
5.445
%
,
(
30-day
SOFR
Average
+
1.8
%
),
2/25/55
.
................
United
States
1,155,255
1,161,691
c,i
Apex
Credit
CLO
LLC
,
2021-2A
,
A1AR
,
144A,
FRN
,
4.855
%
,
(
3-month
SOFR
+
1.18
%
),
10/20/34
.
...................
United
States
5,100,000
5,105,905
c,i
Bain
Capital
Credit
CLO
Ltd.
,
2022-2A
,
A1R
,
144A,
FRN
,
4.814
%
,
(
3-month
SOFR
+
1.15
%
),
4/22/35
.
....................
United
States
5,200,000
5,205,144
c,i
Black
Diamond
CLO
Ltd.
,
2021-1A
,
A1AR
,
144A,
FRN
,
4.914
%
,
(
3-month
SOFR
+
1.25
%
),
11/22/34
.
....................
United
States
4,132,000
4,137,685
c,i
BlueMountain
CLO
XXXI
Ltd.
,
2021-31A
,
A1R
,
144A,
FRN
,
4.775
%
,
(
3-month
SOFR
+
1.1
%
),
4/19/34
.
...............
United
States
12,470,000
12,481,173
c
BofA
Auto
Trust
,
2026-1A
,
A3
,
144A,
4.18
%
,
10/15/30
.
.......
United
States
8,620,000
8,603,470
c
BRAVO
Residential
Funding
Trust
,
2024-CES1,
A1A,
144A,
6.377%,
4/25/54
................
United
States
2,489,631
2,512,508
i
2025-HE1,
A1,
144A,
FRN,
4.995%,
(30-day
SOFR
Average
+
1.35%),
9/25/72
...................................
United
States
2,612,774
2,620,190
c,i
Carlyle
Global
Market
Strategies
CLO
Ltd.
,
2014-2RA
,
B
,
144A,
FRN
,
5.739
%
,
(
3-month
SOFR
+
2.087
%
),
5/15/31
.
........
United
States
580,000
581,762
CarMax
Auto
Owner
Trust
,
2026-2,
A2A,
4.11%,
8/15/29
.........................
United
States
8,288,000
8,295,857
2026-2,
A3,
4.22%,
6/16/31
..........................
United
States
5,086,000
5,089,342
c,i
CIFC
Funding
Ltd.
,
2017-4A,
A2R,
144A,
FRN,
5.479%,
(3-month
SOFR
+
1.812%),
10/24/30
.................................
United
States
4,319,957
4,320,042
2020-1A,
A1R,
144A,
FRN,
5.085%,
(3-month
SOFR
+
1.412%),
7/15/36
..................................
United
States
6,090,000
6,101,190
c
Compass
Datacenters
Issuer
II
LLC
,
2024-2A,
A1,
144A,
5.022%,
8/25/49
...................
United
States
1,191,000
1,190,676
2025-1A,
A1,
144A,
5.316%,
5/25/50
...................
United
States
1,279,000
1,284,775
2025-2A,
A1,
144A,
4.926%,
11/25/50
..................
United
States
6,207,000
6,101,459
c
Compass
Datacenters
Issuer
III
LLC
,
2025-1A
,
A2
,
144A,
5.656
%
,
2/25/50
.
..................................
United
States
3,900,000
3,926,788
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Asset-Backed
Securities
(continued)
Financial
Services
(continued)
c,i
Dryden
53
CLO
Ltd.
,
2017-53A
,
AR
,
144A,
FRN
,
4.673
%
,
(
3-month
SOFR
+
1
%
),
1/15/31
.
.......................
United
States
3,070,379
$
3,070,414
c,i
Dryden
75
CLO
Ltd.
,
2019-75A
,
AR3
,
144A,
FRN
,
4.713
%
,
(
3-month
SOFR
+
1.04
%
),
4/14/34
.
....................
United
States
12,600,000
12,590,891
c
FIGRE
Trust
,
2025-FL1,
A1,
144A,
5.265%,
7/25/55
..................
United
States
1,917,296
1,917,539
2025-FL2,
A1,
144A,
5.053%,
11/25/55
.................
United
States
1,620,604
1,612,232
k
2025-HE4,
A,
144A,
FRN,
5.408%,
7/25/55
..............
United
States
4,634,844
4,649,144
k
2025-HE5,
A,
144A,
FRN,
5.285%,
8/25/55
..............
United
States
1,390,593
1,390,082
c,i
Greywolf
CLO
II
Ltd.
,
2013-1A
,
A1SR
,
144A,
FRN
,
5.073
%
,
(
3-month
SOFR
+
1.4
%
),
4/15/34
.
.....................
United
States
1,000,000
1,001,665
c
GS
Mortgage-Backed
Securities
Trust
,
2025-CES2,
A1,
144A,
5.18%,
9/25/55
..................
United
States
2,102,907
2,099,132
i
2025-HE1,
A1,
144A,
FRN,
5.195%,
(30-day
SOFR
Average
+
1.55%),
10/25/55
..................................
United
States
3,091,097
3,101,102
c
Home
Partners
of
America
Trust
,
2021-2,
B,
144A,
2.302%,
12/17/26
....................
United
States
11,867,096
11,678,566
2021-3,
B,
144A,
2.649%,
1/17/41
.....................
United
States
4,265,909
3,998,349
c,f
Iskandar
Enterprise
LLC
,
2026-1A
,
A21
,
144A,
5.049
%
,
4/17/56
.
United
States
10,262,000
10,285,730
c
J.P.
Morgan
Mortgage
Trust
,
2024-CES1,
A1A,
144A,
5.919%,
6/25/54
................
United
States
893,964
898,466
k
2025-CES2,
A1,
144A,
FRN,
5.592%,
6/25/55
............
United
States
2,789,998
2,801,106
i
2025-HE3,
A1,
144A,
FRN,
4.99%,
(30-day
SOFR
Average
+
1.35%),
3/20/56
...................................
United
States
1,594,376
1,600,596
c,i
LCM
34
Ltd.
,
34A
,
A1R
,
144A,
FRN
,
4.855
%
,
(
3-month
SOFR
+
1.18
%
),
10/20/34
.
.................................
United
States
10,900,000
10,905,295
c,i
MidOcean
Credit
CLO
XVIII
LLC
,
2025-18A
,
A1
,
144A,
FRN
,
4.845
%
,
(
3-month
SOFR
+
1.17
%
),
10/18/35
.
.............
United
States
10,000,000
10,006,767
c,i
Neuberger
Berman
Loan
Advisers
CLO
45
Ltd.
,
2021-45A
,
AR
,
144A,
FRN
,
4.729
%
,
(
3-month
SOFR
+
1.06
%
),
10/14/36
.
...
United
States
850,000
850,850
c,i
Neuberger
Berman
Loan
Advisers
CLO
50
Ltd.
,
2022-50A
,
AR2
,
144A,
FRN
,
4.706
%
,
(
3-month
SOFR
+
1.04
%
),
7/23/36
.
....
Jersey
1,820,000
1,818,071
c,i
Neuberger
Berman
Loan
Advisers
CLO
51
Ltd.
,
2022-51A
,
AR2
,
144A,
FRN
,
4.666
%
,
(
3-month
SOFR
+
1
%
),
10/23/36
.
......
Jersey
11,300,000
11,276,616
c,i
Octagon
57
Ltd.
,
2021-1A
,
AR
,
144A,
FRN
,
4.743
%
,
(
3-month
SOFR
+
1.07
%
),
10/15/34
.
...........................
United
States
2,125,000
2,125,000
c,i
Octagon
Investment
Partners
45
Ltd.
,
2019-1A
,
A1RR
,
144A,
FRN
,
4.823
%
,
(
3-month
SOFR
+
1.15
%
),
4/15/35
.
.........
United
States
7,180,000
7,187,131
c
PK
ALIFT
Loan
Funding
7
LP
,
2025-2
,
A
,
144A,
4.75
%
,
3/15/43
.
United
States
1,194,037
1,182,830
c
PK
ALIFT
Loan
Funding
8
LP
,
2026-1
,
A
,
144A,
4.614
%
,
9/15/43
.
United
States
1,186,000
1,163,264
c
PRET
LLC
,
2026-NPL3
,
A1
,
144A,
4.968
%
,
2/25/56
.
.........
United
States
8,406,045
8,347,845
c
Sabey
Data
Center
Issuer
LLC
,
2026-1
,
A2
,
144A,
5.482
%
,
1/20/51
.
.........................................
United
States
4,974,000
4,937,821
c,i
Trinitas
CLO
XVIII
Ltd.
,
2021-18A
,
A1R
,
144A,
FRN
,
4.895
%
,
(
3-month
SOFR
+
1.22
%
),
1/20/35
.
....................
United
States
10,000,000
10,013,904
c
Truist
Bank
Auto
Credit-Linked
Notes
,
2025-1
,
B
,
144A,
4.728
%
,
9/26/33
.
.........................................
United
States
2,842,774
2,843,214
c,i
Venture
45
CLO
Ltd.
,
2022-45A
,
A1R
,
144A,
FRN
,
4.945
%
,
(
3-month
SOFR
+
1.27
%
),
7/20/35
.
....................
Jersey
13,000,000
13,019,046
c,i
Voya
CLO
Ltd.
,
2013-2A,
A2AR,
144A,
FRN,
5.328%,
(3-month
SOFR
+
1.662%),
4/25/31
..................................
United
States
1,760,885
1,764,387
2013-2A,
BR,
144A,
FRN,
5.778%,
(3-month
SOFR
+
2.112%),
4/25/31
.........................................
United
States
5,770,000
5,789,907
2016-1A,
BR,
144A,
FRN
,
5.737%,
(3-month
SOFR
+
2.062%),
1/20/31
.........................................
United
States
590,000
591,986
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Asset-Backed
Securities
(continued)
Financial
Services
(continued)
c,i
Voya
CLO
Ltd.,
(continued)
2019-3A,
AR,
144A,
FRN,
5.022%,
(3-month
SOFR
+
1.342%),
10/17/32
........................................
United
States
1,449,634
$
1,449,657
c,i
Wind
River
CLO
Ltd.
,
2021-4A
,
AR
,
144A,
FRN
,
4.902
%
,
(
3-month
SOFR
+
1.23
%
),
1/20/35
.
....................
United
States
6,500,000
6,509,144
245,711,001
a
a
a
a
a
a
Total
Asset-Backed
Securities
(Cost
$252,262,099)
............................
251,776,335
Commercial
Mortgage-Backed
Securities
6.2%
Financial
Services
6.1%
k
Banc
of
America
Commercial
Mortgage
Trust
,
2015-UBS7
,
B
,
FRN
,
4.429
%
,
9/15/48
..............................
United
States
1,059,534
1,049,290
k,l
BANK
,
2020-BN26
,
XA
,
IO,
FRN
,
1.305
%
,
3/15/63
..........
United
States
26,468,234
879,500
k
BANK5
Trust
,
c,l
2025-5YR13,
XA,
IO,
144A,
FRN,
1.284%,
1/15/58
.........
United
States
49,381,938
1,762,244
l
2025-5YR14,
XA,
IO,
FRN,
1.2%,
4/15/58
...............
United
States
50,114,123
1,734,325
2025-5YR18,
AS,
FRN,
5.466%,
12/15/58
...............
United
States
3,758,000
3,793,309
k,l
BBCMS
Mortgage
Trust
,
2024-5C31,
XA,
IO,
FRN,
1.281%,
12/15/57
..............
United
States
38,512,897
1,296,895
2025-5C33,
XA,
IO,
FRN,
1.038%,
3/15/58
...............
United
States
89,250,615
2,508,129
k
BBCMS
Trust
,
2026-5C41
,
C
,
FRN
,
1
%
,
5/15/69
............
United
States
3,000,000
3,029,876
Benchmark
Mortgage
Trust
,
2019-B13,
A2,
2.889%,
8/15/57
.......................
United
States
5,285,807
5,084,721
k,l
2020-B20,
XA,
IO,
FRN,
1.62%,
10/15/53
................
United
States
35,780,061
1,605,999
k,l
2020-B22,
XA,
IO,
FRN,
1.602%,
1/15/54
................
United
States
26,297,137
1,458,952
k,l
2024-V12,
XA,
IO,
FRN,
1.067%,
12/15/57
...............
United
States
51,021,128
1,449,163
k,l
2025-V13,
XA,
IO,
FRN,
1.132%,
2/15/58
................
United
States
46,939,000
1,325,487
k,l
2025-V14,
XA,
IO,
FRN,
0.981%,
4/15/57
................
United
States
78,337,435
2,106,838
k
2025-V19,
AS,
FRN,
5.597%,
1/15/58
...................
United
States
3,779,000
3,858,609
2026-V21,
AS,
5.506%,
3/15/59
.......................
United
States
2,696,000
2,745,892
k,l
2026-V21,
XA,
IO,
FRN,
1.648%,
3/15/59
................
United
States
24,070,864
1,481,304
k,l
BMO
Mortgage
Trust
,
2024-5C8,
XA,
IO,
FRN,
1.239%,
12/15/57
...............
United
States
47,149,769
1,576,669
2025-5C9,
XA,
IO,
FRN,
0.923%,
4/15/58
................
United
States
73,077,203
1,821,895
c,i
BX
Commercial
Mortgage
Trust
,
2026-CSMO
,
B
,
144A,
FRN
,
5.355
%
,
(
1-month
SOFR
+
1.7
%
),
2/15/43
...............
United
States
5,400,000
5,419,508
c
BX
Trust
,
k
2025-ARIA,
C,
144A,
FRN,
5.701%,
12/13/42
.............
United
States
5,210,000
5,233,936
i
2025-VOLT,
A,
144A,
FRN,
5.355%,
(1-month
SOFR
+
1.7%),
12/15/44
........................................
United
States
1,834,000
1,836,043
CFCRE
Commercial
Mortgage
Trust
,
2016-C6,
B,
3.804%,
11/10/49
........................
United
States
3,371,000
3,224,719
2016-C7,
A3,
3.839%,
12/10/54
.......................
United
States
2,540,000
2,527,317
k
CGMS
Commercial
Mortgage
Trust
,
2017-B1
,
AS
,
FRN
,
3.711
%
,
8/15/50
.........................................
United
States
3,326,000
3,259,006
Citigroup
Commercial
Mortgage
Trust
,
2016-C3
,
A4
,
3.154
%
,
11/15/49
........................................
United
States
6,526,137
6,481,947
COMM
Mortgage
Trust
,
c
2012-CR3,
B,
144A,
3.922%,
10/15/45
..................
United
States
3,404,473
3,323,096
2012-CR4,
AM,
3.251%,
10/15/45
.....................
United
States
2,790,000
2,728,436
k
2014-CR14,
C,
FRN,
3.246%,
2/10/47
..................
United
States
1,548,000
1,517,956
2014-CR17,
B,
4.377%,
5/10/47
.......................
United
States
2,634,330
2,611,404
c,k
2014-UBS6,
D,
144A,
FRN,
3.959%,
12/10/47
............
United
States
2,766,321
2,679,672
k
2015-CR26,
B,
FRN,
4.837%,
10/10/48
.................
United
States
905,026
887,859
k
2015-LC19,
C,
FRN,
4.567%,
2/10/48
..................
United
States
1,119,500
1,092,261
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Commercial
Mortgage-Backed
Securities
(continued)
Financial
Services
(continued)
k,l
CSAIL
Commercial
Mortgage
Trust
,
2021-C20
,
XA
,
IO,
FRN
,
1.11
%
,
3/15/54
....................................
United
States
39,258,253
$
1,371,063
c,k
CSTL
Commercial
Mortgage
Trust
,
2025-GATE2
,
A
,
144A,
FRN
,
4.712
%
,
11/10/42
..................................
United
States
3,422,000
3,371,075
GS
Mortgage
Securities
Trust
,
c,k
2013-GC13,
AS,
144A,
FRN,
3.983%,
7/10/46
............
United
States
999,559
992,293
k
2014-GC24,
B,
FRN,
4.447%,
9/10/47
..................
United
States
1,378,580
1,334,969
2016-GS2,
A4,
3.05%,
5/10/49
........................
United
States
412,771
412,159
2016-GS3,
A3,
2.592%,
10/10/49
......................
United
States
4,989,001
4,973,862
J.P.
Morgan
Chase
Commercial
Mortgage
Securities
Trust
,
2016-JP2,
AS,
3.056%,
8/15/49
.......................
United
States
2,684,000
2,642,960
2016-JP3,
AS,
3.144%,
8/15/49
.......................
United
States
3,990,000
3,869,651
k
2016-JP3,
B,
FRN,
3.397%,
8/15/49
....................
United
States
1,368,000
1,278,054
c,k
JPMBB
Commercial
Mortgage
Securities
Trust
,
2014-C19
,
F
,
144A,
FRN
,
3.75
%
,
4/15/47
..........................
United
States
3,098,225
3,043,645
JPMCC
Commercial
Mortgage
Securities
Trust
,
2016-C4
,
AS
,
3.385
%
,
12/15/49
..................................
United
States
5,571,000
5,360,267
c,k
MAD
Commercial
Mortgage
Trust
,
2025-11MD
,
D
,
144A,
FRN
,
6.571
%
,
10/15/42
..................................
United
States
4,951,000
5,014,492
Morgan
Stanley
Bank
of
America
Merrill
Lynch
Trust
,
k
2013-C10,
B,
FRN,
4.082%,
7/15/46
...................
United
States
3,221,993
3,065,743
k
2013-C10,
C,
FRN,
4.082%,
7/15/46
...................
United
States
4,935,000
4,574,484
k
2013-C9,
B,
FRN,
3.708%,
5/15/46
....................
United
States
2,886,507
2,757,476
k
2013-C9,
C,
FRN,
3.829%,
5/15/46
....................
United
States
3,888,000
3,599,506
k,l
2025-5C1,
XA,
IO,
FRN,
1.377%,
3/15/58
................
United
States
39,340,212
1,522,222
2025-5C2,
AS,
5.384%,
11/15/58
......................
United
States
4,968,000
5,025,397
k
Morgan
Stanley
Capital
I
Trust
,
2018-H3,
AS,
FRN,
4.429%,
7/15/51
...................
United
States
2,265,000
2,232,636
l
2021-L5,
XA,
IO,
FRN,
1.382%,
5/15/54
.................
United
States
32,952,093
1,484,960
c,k
NYC
Commercial
Mortgage
Trust
,
2025-28L
,
A
,
144A,
FRN
,
4.824
%
,
11/05/38
..................................
United
States
4,200,000
4,190,886
c,k
VEGAS
,
2024-GCS
,
D
,
144A,
FRN
,
6.424
%
,
7/10/36
.........
United
States
2,750,000
2,734,996
c,k
VRTX
Trust
,
2025-HQ
,
D
,
144A,
FRN
,
6.815
%
,
8/05/42
.......
United
States
3,960,000
3,960,459
Wells
Fargo
Commercial
Mortgage
Trust
,
c
2016-C33,
D,
144A,
3.123%,
3/15/59
...................
United
States
2,482,514
2,428,209
c,k
2016-C34,
D,
144A,
FRN,
5.294%,
6/15/49
..............
United
States
2,819,995
2,754,761
2018-C46,
AS,
4.382%,
8/15/51
.......................
United
States
2,363,000
2,321,777
k,l
2025-5C3,
XA,
IO,
FRN,
1.044%,
1/15/58
................
United
States
41,712,264
1,143,316
2025-5C4,
AS,
6.093%,
5/15/58
.......................
United
States
3,517,000
3,641,533
k
WFRBS
Commercial
Mortgage
Trust
,
2014-C21,
B,
FRN,
4.213%,
8/15/47
...................
United
States
2,301,088
2,267,601
2014-C23,
B,
FRN,
4.408%,
10/15/57
...................
United
States
1,881,000
1,849,041
168,611,750
a
a
a
a
a
a
Retail
REITs
0.1%
c,k
Fashion
Show
Mall
LLC
,
2024-SHOW
,
A
,
144A,
FRN
,
5.274
%
,
10/10/41
........................................
United
States
2,962,000
2,986,492
Total
Commercial
Mortgage-Backed
Securities
(Cost
$171,321,140)
.............
171,598,242
Mortgage-Backed
Securities
30.7%
m
Federal
Home
Loan
Mortgage
Corp.
(FHLMC)
Adjustable
Rate
0.0%
†
FHLMC,
5.848%,
(1-year
CMT
T-Note
+/-
MBS
Margin),
1/01/33
United
States
6,556
6,680
Federal
Home
Loan
Mortgage
Corp.
(FHLMC)
Fixed
Rate
3.5%
FHLMC
Gold
Pool,
20
Year,
5%,
5/01/27
-
5/01/30
...........
United
States
32,279
32,500
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Mortgage-Backed
Securities
(continued)
Federal
Home
Loan
Mortgage
Corp.
(FHLMC)
Fixed
Rate
(continued)
FHLMC
Gold
Pool,
30
Year,
4.5%,
10/01/40
...............
United
States
28,719
$
28,527
FHLMC
Gold
Pool,
30
Year,
5%,
3/01/34
-
2/01/38
...........
United
States
148,988
150,197
FHLMC
Gold
Pool,
30
Year,
5.5%,
6/01/33
-
6/01/36
.........
United
States
239,553
246,027
FHLMC
Gold
Pool,
30
Year,
6%,
6/01/33
-
6/01/37
...........
United
States
119,619
124,108
FHLMC
Gold
Pool,
30
Year,
6.5%,
6/01/29
-
6/01/36
.........
United
States
24,079
25,455
FHLMC
Gold
Pool,
30
Year,
7%,
8/01/32
..................
United
States
1,074
1,135
FHLMC
Gold
Pool,
30
Year,
7.5%,
1/01/31
................
United
States
862
890
FHLMC
Pool,
30
Year,
2%,
3/01/52
......................
United
States
30,227,648
24,322,475
FHLMC
Pool,
30
Year,
4%,
6/01/52
......................
United
States
31,212,528
29,363,712
FHLMC
Pool,
30
Year,
4.5%,
8/01/52
.....................
United
States
21,188,032
20,459,284
FHLMC
Pool,
30
Year,
5.5%,
11/01/52
....................
United
States
21,191,294
21,425,138
96,179,448
m
Federal
National
Mortgage
Association
(FNMA)
Adjustable
Rate
0.0%
†
FNMA,
6.05%,
(1-year
CMT
T-Note
+/-
MBS
Margin),
12/01/34
.
United
States
24,417
25,068
Federal
National
Mortgage
Association
(FNMA)
Fixed
Rate
18.6%
FNMA,
15
Year,
2.5%,
7/01/27
.........................
United
States
10,989
10,887
FNMA,
20
Year,
4.5%,
3/01/28
.........................
United
States
1,964
1,961
FNMA,
20
Year,
5%,
3/01/28
-
6/01/31
....................
United
States
54,021
54,316
FNMA,
30
Year,
2%,
4/01/52
...........................
United
States
91,977,236
74,002,276
FNMA,
30
Year,
3%,
9/01/48
-
9/01/51
....................
United
States
12,817,309
11,383,038
FNMA,
30
Year,
3.5%,
8/01/52
.........................
United
States
29,816,427
27,380,575
FNMA,
30
Year,
4%,
2/01/49
...........................
United
States
6,373,621
6,101,913
FNMA,
30
Year,
4.5%,
2/01/41
.........................
United
States
93,600
92,862
FNMA,
30
Year,
5%,
10/01/35
..........................
United
States
187,849
190,241
FNMA,
30
Year,
5%,
4/01/53
...........................
United
States
20,426,406
20,235,354
FNMA,
30
Year,
5.5%,
9/01/33
-
12/01/35
.................
United
States
275,432
281,425
FNMA,
30
Year,
6%,
6/01/34
-
5/01/38
....................
United
States
471,619
487,063
FNMA,
30
Year,
6%,
8/01/53
...........................
United
States
16,693,055
17,133,415
FNMA,
30
Year,
6.5%,
3/01/28
-
10/01/37
.................
United
States
76,304
80,308
FNMA,
30
Year,
7.5%,
10/01/29
.........................
United
States
958
980
n
Uniform
Mortgage-Backed
Securities,
1.5%,
TBA,
5/25/56
.....
United
States
15,910,000
12,189,343
n
Uniform
Mortgage-Backed
Securities,
2%,
TBA,
5/25/56
......
United
States
7,099,000
5,681,772
n
Uniform
Mortgage-Backed
Securities,
2.5%,
TBA,
5/25/56
.....
United
States
110,861,000
92,847,788
n
Uniform
Mortgage-Backed
Securities,
3%,
TBA,
5/25/56
......
United
States
51,901,000
45,444,776
n
Uniform
Mortgage-Backed
Securities,
4.5%,
TBA,
5/25/56
.....
United
States
46,500,000
44,734,862
n
Uniform
Mortgage-Backed
Securities,
5%,
TBA,
5/25/56
......
United
States
43,050,000
42,418,225
n
Uniform
Mortgage-Backed
Securities,
5.5%,
TBA,
5/25/56
.....
United
States
79,590,000
79,998,345
n
Uniform
Mortgage-Backed
Securities,
6%,
TBA,
5/25/56
......
United
States
29,040,000
29,649,514
510,401,239
Government
National
Mortgage
Association
(GNMA)
Fixed
Rate
8.6%
GNMA
I,
Single-family,
30
Year,
5%,
6/15/34
-
7/15/34
........
United
States
22,778
22,958
GNMA
I,
Single-family,
30
Year,
5.5%,
2/15/33
-
6/15/36
......
United
States
116,170
117,030
GNMA
I,
Single-family,
30
Year,
6%,
8/15/36
...............
United
States
5,272
5,523
GNMA
I,
Single-family,
30
Year,
7.5%,
5/15/27
..............
United
States
56
57
n
GNMA
II,
Single-family,
30
Year,
2%,
5/15/56
...............
United
States
34,310,000
28,237,765
n
GNMA
II,
Single-family,
30
Year,
2.5%,
5/15/56
.............
United
States
14,570,000
12,482,616
n
GNMA
II,
Single-family,
30
Year,
3.5%,
5/15/56
.............
United
States
19,960,000
18,045,867
n
GNMA
II,
Single-family,
30
Year,
4.5%,
5/15/56
.............
United
States
23,000,000
22,184,219
GNMA
II,
Single-family,
30
Year,
5%,
9/20/33
-
11/20/33
.......
United
States
46,030
46,580
n
GNMA
II,
Single-family,
30
Year,
5%,
5/15/56
...............
United
States
18,439,000
18,281,816
GNMA
II,
Single-family,
30
Year,
5.5%,
6/20/34
.............
United
States
25,006
25,777
n
GNMA
II,
Single-family,
30
Year,
5.5%,
5/15/56
.............
United
States
27,833,000
28,032,938
GNMA
II,
Single-family,
30
Year,
6%,
11/20/34
..............
United
States
28,178
29,510
n
GNMA
II,
Single-family,
30
Year,
6%,
5/15/56
...............
United
States
81,518,000
83,116,894
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Mortgage-Backed
Securities
(continued)
Government
National
Mortgage
Association
(GNMA)
Fixed
Rate
(continued)
GNMA
II,
Single-family,
30
Year,
6.5%,
7/20/28
-
12/20/31
.....
United
States
12,992
$
13,598
n
GNMA
II,
Single-family,
30
Year,
6.5%,
5/15/56
.............
United
States
23,635,000
24,690,741
GNMA
II,
Single-family,
30
Year,
7.5%,
4/20/32
.............
United
States
3,810
3,895
235,337,784
Total
Mortgage-Backed
Securities
(Cost
$842,876,345)
.........................
841,950,219
Residential
Mortgage-Backed
Securities
3.0%
Financial
Services
3.0%
c,i
Bellemeade
Re
Ltd.
,
2021-3A
,
B1
,
144A,
FRN
,
7.495
%
,
(
30-day
SOFR
Average
+
3.85
%
),
9/25/31
.....................
United
States
2,675,000
2,749,788
c
BRAVO
Residential
Funding
Trust
,
k
2019-2,
A3,
144A,
FRN,
3.5%,
10/25/44
.................
United
States
1,663,600
1,598,234
2023-NQM6,
A1,
144A,
6.602%,
9/25/63
................
United
States
820,828
822,961
2024-NQM3,
A1,
144A,
6.191%,
3/25/64
................
United
States
780,395
786,334
c,i
Chase
Home
Lending
Mortgage
Trust
,
2025-3,
A11,
144A,
FRN,
4.945%,
(
30-day
SOFR
Average
+
1.3%),
2/25/56
....................................
United
States
1,788,235
1,786,735
2025-7,
A11,
144A,
FRN,
5.045%,
(30-day
SOFR
Average
+
1.4%),
5/25/56
....................................
United
States
1,577,870
1,583,936
c,k
CIM
Trust
,
2019-INV1,
A1,
144A,
FRN,
4%,
2/25/49
................
United
States
368,820
352,562
2019-INV2,
A3,
144A,
FRN,
4%,
5/25/49
................
United
States
1,085,630
1,029,429
c,i
Citigroup
Mortgage
Loan
Trust
,
2025-4
,
A28
,
144A,
FRN
,
4.945
%
,
(
30-day
SOFR
Average
+
1.3
%
),
10/25/55
...............
United
States
1,426,211
1,431,094
c
Cross
Mortgage
Trust
,
2024-H1
,
A1
,
144A,
6.085
%
,
12/25/68
..
United
States
584,285
587,518
c,i
FHLMC
STACR
REMIC
Trust
,
2023-DNA2,
M1A,
144A,
FRN,
5.745%,
(30-day
SOFR
Average
+
2.1%),
4/25/43
..................................
United
States
1,348,666
1,366,040
2025-DNA1,
A1,
144A,
FRN,
4.595%,
(30-day
SOFR
Average
+
0.95%),
1/25/45
...................................
United
States
1,750,770
1,752,683
2025-DNA3,
M1,
144A,
FRN,
4.745%,
(30-day
SOFR
Average
+
1.1%),
9/25/45
..................................
United
States
2,655,378
2,656,685
c,i
FNMA
Connecticut
Avenue
Securities
Trust
,
2025-R01,
1M1,
144A,
FRN,
4.745%,
(30-day
SOFR
Average
+
1.1%),
1/25/45
....................................
United
States
944,679
945,056
2025-R02,
1A1,
144A,
FRN,
4.645%,
(30-day
SOFR
Average
+
1%),
2/25/45
.....................................
United
States
1,076,263
1,078,382
2025-R03,
2A1,
144A,
FRN,
5.095%,
(30-day
SOFR
Average
+
1.45%),
3/25/45
...................................
United
States
1,398,972
1,407,189
2025-R04,
1A1,
144A,
FRN,
4.645%,
(30-day
SOFR
Average
+
1%),
5/25/45
.....................................
United
States
1,300,303
1,302,503
2026-R01,
2M1,
144A,
FRN,
4.645%,
(30-day
SOFR
Average
+
1%),
1/25/46
.....................................
United
States
3,175,594
3,177,587
2026-R03,
2A1,
144A,
FRN,
4.74%,
(30-day
SOFR
Average
+
1.1%),
4/25/46
....................................
United
States
8,991,000
9,055,721
c,i
GS
Mortgage-Backed
Securities
Trust
,
2025-PJ8
,
A27
,
144A,
FRN
,
4.945
%
,
(
30-day
SOFR
Average
+
1.3
%
),
2/25/56
.....
United
States
719,423
721,376
c,i
Home
Re
Ltd.
,
2026-1
,
M1C
,
144A,
FRN
,
6.245
%
,
(
30-day
SOFR
Average
+
2.6
%
),
1/25/36
............................
United
States
978,000
984,890
c
HOMES
Trust
,
2024-NQM1
,
A1
,
144A,
5.915
%
,
7/25/69
......
United
States
563,192
567,048
c
Imperial
Fund
Mortgage
Trust
,
2023-NQM1
,
A1
,
144A,
5.941
%
,
2/25/68
.........................................
United
States
1,669,896
1,673,082
c
J.P.
Morgan
Mortgage
Trust
,
k
2021-15,
A4,
144A,
FRN,
2.5%,
6/25/52
.................
United
States
3,110,898
2,787,051
2025-VIS2,
A2,
144A,
5.638%,
12/25/55
.................
United
States
2,937,729
2,943,580
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Residential
Mortgage-Backed
Securities
(continued)
Financial
Services
(continued)
c,k
LHOME
Mortgage
Trust
,
2025-RTL2
,
A1
,
144A,
FRN
,
5.612
%
,
4/25/40
.........................................
United
States
897,000
$
901,552
c,k
Mill
City
Mortgage
Loan
Trust
,
2018-4
,
A1B
,
144A,
FRN
,
3.5
%
,
4/25/66
.........................................
United
States
3,156,124
3,106,246
c
Morgan
Stanley
Residential
Mortgage
Loan
Trust
,
2024-NQM1
,
A1
,
144A,
6.152
%
,
12/25/68
..........................
United
States
1,658,416
1,669,296
c
OBX
Trust
,
k
2021-J3,
A4,
144A,
FRN,
2.5%,
10/25/51
................
United
States
881,829
792,841
2023-NQM7,
A1,
144A,
6.844%,
4/25/63
................
United
States
1,504,543
1,512,104
2024-NQM2,
A1,
144A,
5.878%,
12/25/63
...............
United
States
948,739
953,300
2024-NQM3,
A1,
144A,
6.129%,
12/25/63
...............
United
States
1,262,363
1,270,794
2024-NQM8,
A1,
144A,
6.233%,
5/25/64
................
United
States
1,936,039
1,954,879
i
2025-J2,
AF,
144A,
FRN,
4.945%,
(
30-day
SOFR
Average
+
1.3%),
9/25/55
....................................
United
States
3,016,134
3,026,662
c,k
OLIT
,
2025-HB2
,
A
,
144A,
FRN
,
3
%
,
11/25/38
..............
United
States
2,001,781
1,957,411
c,k
Onity
Loan
Investment
Trust
,
2025-HB1
,
A
,
144A,
FRN
,
3
%
,
6/25/38
.........................................
United
States
1,249,794
1,227,347
c,i
PMT
Loan
Trust
,
2025-J2
,
A11
,
144A,
FRN
,
4.995
%
,
(
30-day
SOFR
Average
+
1.35
%
),
8/25/56
.....................
United
States
456,006
458,161
c,k
Provident
Funding
Associates
LLP
,
2021-J1
,
A3
,
144A,
FRN
,
2.5
%
,
2/20/49
....................................
United
States
1,428,306
1,277,022
c,k
Provident
Funding
Mortgage
Trust
,
2019-1
,
A2
,
144A,
FRN
,
3
%
,
12/25/49
........................................
United
States
1,215,806
1,059,082
c
PRPM
LLC
,
2026-1
,
A1
,
144A,
5.185
%
,
2/25/31
............
United
States
3,800,130
3,767,265
c,k
PSMC
Trust
,
2021-3
,
A3
,
144A,
FRN
,
2.5
%
,
8/25/51
.........
United
States
7,790,182
7,044,184
c,i
Radian
Mortgage
Capital
Trust
,
2025-J3
,
A25
,
144A,
FRN
,
5.145
%
,
(
30-day
SOFR
Average
+
1.5
%
),
12/25/55
........
United
States
2,186,648
2,198,380
c,i
Sequoia
Mortgage
Trust
,
2025-8
,
A26F
,
144A,
FRN
,
5.045
%
,
(
30-
day
SOFR
Average
+
1.4
%
),
9/25/55
...................
United
States
1,633,825
1,641,078
c
Verus
Securitization
Trust
,
2023-6,
A1,
144A,
6.665%,
9/25/68
....................
United
States
363,884
365,476
2024-4,
A1,
144A,
6.218%,
6/25/69
....................
United
States
1,259,235
1,273,187
82,603,731
a
a
a
a
a
a
Total
Residential
Mortgage-Backed
Securities
(Cost
$84,420,817)
...............
82,603,731
Agency
Commercial
Mortgage-Backed
Securities
4.5%
Financial
Services
4.5%
l
FHLMC
,
4988,
LI,
IO,
4%,
7/25/50
............................
United
States
25,548,481
5,888,858
5052,
KI,
IO,
4%,
12/25/50
...........................
United
States
19,247,359
3,944,660
5070,
HI,
IO,
3.5%,
2/25/51
..........................
United
States
28,976,200
5,420,949
5124,
YI,
IO,
3%,
7/25/51
............................
United
States
14,700,640
2,543,539
5125,
IL,
IO,
4.5%,
11/15/47
..........................
United
States
22,106,705
4,660,124
5147,
NI,
IO,
3%,
10/25/46
...........................
United
States
66,099,337
9,394,652
5164,
IC,
IO,
4%,
11/25/51
...........................
United
States
22,592,216
4,700,618
5187,
EI,
IO,
4.5%,
1/25/52
..........................
United
States
11,843,493
2,723,019
5206,
IV,
IO,
4%,
1/25/50
............................
United
States
30,592,534
4,991,701
5365,
IO,
2.5%,
7/25/51
.............................
United
States
46,673,093
7,445,586
5457,
IO,
5%,
10/25/54
.............................
United
States
15,440,818
3,260,712
5529,
EI,
IO,
4.5%,
11/25/51
.........................
United
States
18,813,393
4,147,941
FNMA
,
l
2021-12,
MI,
IO,
3%,
3/25/51
.........................
United
States
15,683,918
2,938,327
i
2024-105,
KF,
FRN,
4.645%,
(30-day
SOFR
Average
+
1%),
1/25/55
.........................................
United
States
8,374,242
8,433,253
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Agency
Commercial
Mortgage-Backed
Securities
(continued)
Financial
Services
(continued)
FNMA,
(continued)
i
2024-87,
FB,
FRN,
4.745%,
(30-day
SOFR
Average
+
1.1%),
12/25/54
........................................
United
States
8,364,979
$
8,446,386
GNMA
,
l
2019-137,
PI,
IO,
3.5%,
11/20/49
......................
United
States
28,937,421
5,633,005
l
2020-151,
MI,
IO,
2.5%,
10/20/50
......................
United
States
27,935,517
4,160,825
l
2022-78,
IO,
3%,
8/20/51
............................
United
States
23,102,220
3,864,877
l
2023-168,
IE,
IO,
3%,
11/20/51
.......................
United
States
33,531,376
5,457,768
l
2023-171,
IO,
3%,
2/20/51
...........................
United
States
14,852,389
2,434,700
l
2023-40,
CI,
IO,
2%,
10/20/50
........................
United
States
20,843,062
2,073,949
l
2024-79,
IN,
IO,
3%,
11/20/51
........................
United
States
22,190,257
4,687,618
i
2025-169,
FB,
FRN,
4.64%,
(30-day
SOFR
Average
+
1%),
10/20/55
........................................
United
States
5,898,651
5,938,680
l
2025-173,
DI,
IO,
3%,
8/20/51
........................
United
States
25,450,062
4,414,440
l
2025-25,
IG,
IO,
4.5%,
12/20/52
.......................
United
States
10,921,180
2,182,067
l
2025-5,
IO,
3.5%,
4/20/51
...........................
United
States
26,434,098
4,984,427
124,772,681
a
a
a
a
a
a
Total
Agency
Commercial
Mortgage-Backed
Securities
(Cost
$123,805,800)
......
124,772,681
Municipal
Bonds
0.9%
California
0.4%
California
Health
Facilities
Financing
Authority
,
State
of
California
Personal
Income
Tax
,
Revenue
,
2022
,
4.19
%
,
6/01/37
......
United
States
2,875,000
2,693,267
City
of
Orange
,
Revenue
,
2021
,
Refunding
,
2.65
%
,
6/01/34
....
United
States
1,305,000
1,119,354
City
of
Pomona
,
Revenue
,
2020
BJ
,
3.716
%
,
8/01/40
........
United
States
795,000
683,620
County
of
Fresno
,
Revenue
,
2004
A
,
NATL
Insured
,
4.71
%,
8/15/32
.........................................
United
States
1,710,000
1,280,055
County
of
Tulare
,
Revenue
,
2018
,
4.445
%
,
6/01/37
..........
United
States
2,495,000
2,377,064
State
of
California
,
GO
,
4.35
%
,
11/01/32
..................
United
States
3,575,000
3,570,935
11,724,295
Florida
0.1%
State
Board
of
Administration
Finance
Corp.
,
Florida
Hurricane
Catastrophe
Fund
,
Revenue
,
2024
A
,
5.526
%
,
7/01/34
......
United
States
2,540,000
2,656,664
Georgia
0.0%
†
Georgia
Higher
Education
Facilities
Authority
,
University
System
of
Georgia
,
Revenue
,
2026
A
,
5.273
%
,
1/01/40
...........
United
States
615,000
614,961
Illinois
0.1%
State
of
Illinois
,
GO
,
2026
A
,
4.954
%
,
4/01/33
..............
United
States
2,390,000
2,417,780
New
Jersey
0.0%
†
New
Jersey
Transportation
Trust
Fund
Authority
,
State
of
New
Jersey
,
Revenue
,
2010
B
,
6.561
%
,
12/15/40
.............
United
States
525,000
575,281
New
York
0.1%
New
York
City
Transitional
Finance
Authority
,
Future
Tax
Secured
,
Revenue
,
2026
F-2
,
4.66
%
,
2/01/36
....................
United
States
1,925,000
1,887,291
Ohio
0.0%
†
JobsOhio
Beverage
System
,
Revenue,
Senior
Lien
,
2020
A
,
ETM,
2.833
%
,
1/01/38
...................................
United
States
1,575,000
1,316,401
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Municipal
Bonds
(continued)
Pennsylvania
0.2%
Pennsylvania
Economic
Development
Financing
Authority
,
Revenue
,
2025
,
5.689
%
,
6/01/54
......................
United
States
1,855,000
$
1,862,680
Redevelopment
Authority
of
the
City
of
Philadelphia
,
City
of
Philadelphia
,
Revenue
,
2026
A
,
5.002
%
,
11/01/38
.........
United
States
2,895,000
2,852,990
4,715,670
Total
Municipal
Bonds
(Cost
$26,342,800)
....................................
25,908,343
Shares
a
Escrows
and
Litigation
Trusts
0.0%
†
a,b
All
Day
Electric,
Inc.,
Escrow
Account
....................
United
States
291
—
a,b
K2016470219
South
Africa
Ltd.,
Escrow
Account
............
South
Africa
620,001
9,813
b
Mesquite
Energy,
Inc.,
Escrow
Account
...................
United
States
6,000,000
30,300
Total
Escrows
and
Litigation
Trusts
(Cost
$5,707,489)
.........................
40,113
Total
Long
Term
Investments
(Cost
$3,205,864,279)
...........................
3,119,202,576
a
Number
of
Contracts
Notional
Amount
#
a
a
aa
Options
Purchased
0.1%
Puts
-
Over-the-Counter
Interest
Rate
Swaptions
0.1%
Receive
Floating
1-day
SOFR,
Pay
Fixed
3.88%,
Counterparty
CITI,
Expires
7/10/26
...............................
1
25,374,000
374,491
Receive
Floating
1-day
SOFR,
Pay
Fixed
4.3%,
Counterparty
CITI,
Expires
7/10/26
...............................
1
50,748,000
145,602
Receive
Floating
3-month
EURIBOR,
Pay
Fixed
2.765%,
Counterparty
BOFA,
Expires
3/19/27
...................
1
248,789,000
EUR
1,073,850
1,593,943
Total
Options
Purchased
(Cost
$1,482,034)
...................................
1,593,943
Short
Term
Investments
8.6%
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Money
Market
Funds
8.6%
o,p
Franklin
Institutional
U.S.
Government
Money
Market
Fund,
3.593%
.........................................
United
States
234,995,433
234,995,433
Total
Money
Market
Funds
(Cost
$234,995,433)
...............................
234,995,433
Total
Short
Term
Investments
(Cost
$234,995,433
)
.............................
234,995,433
a
Total
Investments
(Cost
$3,442,341,746)
122.3%
..............................
$3,355,791,952
TBA
Sale
Commitments
(0.8)%
..............................................
(21,469,454)
Options
Written
(0.1)%
.....................................................
(1,611,285)
Other
Assets,
less
Liabilities
(21.4
)%
........................................
(585,391,943)
Net
Assets
100.0%
.........................................................
$2,747,319,270
a
a
a
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
a
Country
Principal
Amount
*
a
Value
q
TBA
Sale
Commitments
(0.8)%
Mortgage-Backed
Securities
(0.8)%
Federal
National
Mortgage
Association
(FNMA)
Fixed
Rate
(0.8)%
Uniform
Mortgage-Backed
Securities
,
3.5%,
TBA,
5/25/56
................................
United
States
(5,811,000)
$
(5,290,164)
4%,
TBA,
5/25/56
..................................
United
States
(17,250,000)
(16,179,290)
(21,469,454)
Total
TBA
Sale
Commitments
(Proceeds
$(21,612,812))
........................
$(21,469,454)
Number
of
Contracts
Notional
Amount
#
r
Options
Written
(0.1)%
Puts
-
Over-the-Counter
Interest
Rate
Swaptions
(0.1)%
Receive
Floating
1-day
SOFR,
Pay
Fixed
4.09%,
Counterparty
CITI,
Expires
7/10/26
...............................
1
(76,122,000)
(509,880)
Receive
Floating
3-month
EURIBOR,
Pay
Fixed
3.165%,
Counterparty
BOFA,
Expires
3/19/27
...................
1
(248,789,000)
EUR
(667,713)
Receive
Floating
3-month
EURIBOR,
Pay
Fixed
3.565%,
Counterparty
BOFA,
Expires
3/19/27
...................
1
(248,789,000)
EUR
(433,692)
(1,611,285)
Total
Options
Written
(Premiums
received
$1,504,514)
.........................
$
(1,611,285)
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
#
Notional
amount
is
the
number
of
contracts
multiplied
by
contract
size,
and
may
be
multiplied
by
the
underlying
price.
May
include
currency
units,
bushels,
shares,
pounds,
barrels
or
other
units.
Currency
units
are
stated
in
U.S.
dollars
unless
otherwise
indicated.
*
The
principal
amount
is
stated
in
U.S.
dollars
unless
otherwise
indicated.
†
Rounds
to
less
than
0.1%
of
net
assets.
a
Fair
valued
using
significant
unobservable
inputs.
See
Note
13
regarding
fair
value
measurements.
b
Non-income
producing.
c
Security
was
purchased
pursuant
to
Rule
144A
or
Regulation
S
under
the
Securities
Act
of
1933.
144A
securities
may
be
sold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers
or
in
a
public
offering
registered
under
the
Securities
Act
of
1933.
Regulation
S
securities
cannot
be
sold
in
the
United
States
without
either
an
effective
registration
statement
filed
pursuant
to
the
Securities
Act
of
1933,
or
pursuant
to
an
exemption
from
registration.
At
April
30,
2026,
the
aggregate
value
of
these
securities
was
$818,189,185,
representing
29.8%
of
net
assets.
d
Defaulted
security
or
security
for
which
income
has
been
deemed
uncollectible.
See
Note
6.
e
Income
may
be
received
in
additional
securities
and/or
cash.
f
A
portion
or
all
of
the
security
purchased
on
a
delayed
delivery
basis.
See
Note
1(c).
g
The
rate
shown
represents
the
yield
at
period
end.
h
See
Note
1(g)
regarding
senior
floating
rate
interests.
i
The
coupon
rate
shown
represents
the
rate
inclusive
of
any
caps
or
floors,
if
applicable,
in
effect
at
period
end.
j
See
Note
1(h)
regarding
Marketplace
Lending.
See
full
breakdown
of
marketplace
loans
holdings
in
the
table
at
the
end
of
this
schedule.
k
Adjustable
rate
security
with
an
interest
rate
that
is
not
based
on
a
published
reference
index
and
spread.
The
rate
is
based
on
the
structure
of
the
agreement
and
current
market
conditions.
The
coupon
rate
shown
represents
the
rate
at
period
end.
l
Investment
in
an
interest-only
security
entitles
holders
to
receive
only
the
interest
payment
on
the
underlying
instruments.
The
principal
amount
shown
is
the
notional
amount
of
the
underlying
instruments.
m
Adjustable
Rate
Mortgage-Backed
Security
(ARM);
the
rate
shown
is
the
effective
rate
at
period
end.
ARM
rates
are
not
based
on
a
published
reference
rate
and
spread;
they
are
based
on
the
weighted
average
rates
of
the
underlying
mortgage
loans,
less
the
applicable
servicing
and
guarantee
fees
(MBS
margin).
n
Security
purchased
on
a
to-be-announced
(TBA)
basis.
See
Note
1(c).
o
See
Note
3(f)
regarding
investments
in
affiliated
management
investment
companies.
p
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
q
Security
sold
on
a
to-be-announced
(TBA)
basis
resulting
in
a
short
position.
As
such,
the
Fund
is
not
subject
to
fees
and
expenses
associated
with
short
sale
transactions.
See
Note
1(c).
r
See
Note
1(d)
regarding
written
options.
Franklin
Strategic
Series
Schedule
of
Investments,
April
30,
2026
Franklin
Core
Plus
Bond
Fund
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
At
April
30,
2026,
the
Fund
had
the
following
marketplace
loans
outstanding.
See
Note
1(h).
Description
Principal
Amount
Value
Marketplace
Loans
-
0.1%
Block,
Inc.
a
8440181.SQ.FTS.B,
5.639%,
6/02/26
....
$
1,263
$
595
a
8439564.SQ.FTS.B,
5.908%,
6/02/26
....
671
420
a,b
8439931.SQ.FTS.B,
6.559%,
6/02/26
....
1,480
40
a
8444430.SQ.FTS.B,
5.666%,
6/03/26
....
386
333
a,b
8445397.SQ.FTS.B,
6.325%,
6/03/26
....
12,637
224
a
8452856.SQ.FTS.B,
4.769%,
6/04/26
....
29
29
a,b
8451575.SQ.FTS.B,
5.409%,
6/04/26
....
20,874
971
a
8449424.SQ.FTS.B,
6.419%,
6/04/26
....
1,146
668
a,b
8458127.SQ.FTS.B,
5.114%,
6/05/26
....
19,354
344
a
8461445.SQ.FTS.B,
4.78%,
6/06/26
.....
3,192
2,911
a
8463921.SQ.FTS.B,
4.948%,
6/06/26
....
582
351
a,b
8463484.SQ.FTS.B,
6.672%,
6/06/26
....
9,869
172
a
8467646.SQ.FTS.B,
6.657%,
6/08/26
....
915
470
a,b
8470542.SQ.FTS.B,
5.114%,
6/09/26
....
9,729
6,556
a,b
8471165.SQ.FTS.B,
5.635%,
6/09/26
....
18,441
491
a,b
8470455.SQ.FTS.B,
6.325%,
6/09/26
....
984
22
a
8476774.SQ.FTS.B,
6.326%,
6/10/26
....
341
191
a
8480113.SQ.FTS.B,
6.533%,
6/11/26
....
309
157
a
8485153.SQ.FTS.B,
4.78%,
6/12/26
.....
786
609
a
8488063.SQ.FTS.B,
4.957%,
6/12/26
....
1,079
459
a,b
8485522.SQ.FTS.B,
6.42%,
6/12/26
.....
13,205
254
a
8490622.SQ.FTS.B,
4.781%,
6/13/26
....
855
783
a
8492444.SQ.FTS.B,
5.11%,
6/14/26
.....
710
652
a
8497694.SQ.FTS.B,
5.11%,
6/16/26
.....
584
567
a
8496689.SQ.FTS.B,
6.15%,
6/16/26
.....
2,010
998
a
8506309.SQ.FTS.B,
4.778%,
6/18/26
....
1,411
1,198
a,b
8503138.SQ.FTS.B,
6.415%,
6/18/26
....
1,828
40
a,b
8512865.SQ.FTS.B,
5.912%,
6/19/26
....
21,196
545
a
8520522.SQ.FTS.B,
6.114%,
6/22/26
....
176
126
a,b
8520316.SQ.FTS.B,
6.442%,
6/22/26
....
2,461
1,093
a
8524499.SQ.FTS.B,
4.707%,
6/23/26
....
594
497
a,b
8523060.SQ.FTS.B,
4.979%,
6/23/26
....
1,036
15
a,b
8523082.SQ.FTS.B,
6.335%,
6/23/26
....
3,415
60
a
8525381.SQ.FTS.B,
4.776%,
6/24/26
....
2,135
1,630
a
8526175.SQ.FTS.B,
4.927%,
6/24/26
....
187
105
a,b
8530595.SQ.FTS.B,
6.289%,
6/25/26
....
11,746
191
a
8533616.SQ.FTS.B,
5.338%,
6/26/26
....
682
558
a
8531192.SQ.FTS.B,
5.914%,
6/26/26
....
2,730
1,667
a,b
8534044.SQ.FTS.B,
6.448%,
6/26/26
....
11,141
226
a,b
8539874.SQ.FTS.B,
5.031%,
6/28/26
....
8,313
101
a,b
8540718.SQ.FTS.B,
5.343%,
6/29/26
....
3,501
89
a
8546597.SQ.FTS.B,
4.717%,
6/30/26
....
593
515
a,b
8557100.SQ.FTS.B,
4.945%,
7/03/26
....
2,142
30
a
8560945.SQ.FTS.B,
5.904%,
7/05/26
....
568
384
a
8586236.SQ.FTS.B,
5.029%,
7/06/26
....
322
315
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
8590354.SQ.FTS.B,
5.348%,
7/06/26
....
$
2,989
$
40
a,b
8592557.SQ.FTS.B,
6.095%,
7/06/26
....
2,028
51
a
8593881.SQ.FTS.B,
4.717%,
7/07/26
....
44
43
a,b
8596048.SQ.FTS.B,
5.598%,
7/07/26
....
15,182
551
a
8598300.SQ.FTS.B,
4.717%,
7/08/26
....
57
57
a
8598520.SQ.FTS.B,
5.031%,
7/08/26
....
2,831
2,578
a
8598846.SQ.FTS.B,
5.596%,
7/08/26
....
2,941
2,505
a,b
8603241.SQ.FTS.B,
5.031%,
7/09/26
....
5,719
117
a,b
8604154.SQ.FTS.B,
5.031%,
7/09/26
....
26,722
17,752
a
8605739.SQ.FTS.B,
5.621%,
7/09/26
....
63
37
a,b
8608202.SQ.FTS.B,
5.66%,
7/10/26
.....
340
4
a,b
8606413.SQ.FTS.B,
6.45%,
7/10/26
.....
5,442
100
a
8609461.SQ.FTS.B,
5.031%,
7/11/26
....
159
148
a
8613403.SQ.FTS.B,
4.717%,
7/13/26
....
1,904
1,832
a
8611635.SQ.FTS.B,
4.722%,
7/13/26
....
1,498
1,067
a
8612102.SQ.FTS.B,
6.099%,
7/13/26
....
903
748
a
8617158.SQ.FTS.B,
6.101%,
7/14/26
....
645
569
a
8618340.SQ.FTS.B,
4.95%,
7/15/26
.....
151
56
a
8621156.SQ.FTS.B,
5.347%,
7/15/26
....
7,890
7,076
a,b
8621035.SQ.FTS.B,
6.443%,
7/15/26
....
1,808
37
a
8627682.SQ.FTS.B,
4.721%,
7/16/26
....
1,343
1,259
a,b
8627433.SQ.FTS.B,
5.603%,
7/16/26
....
2,693
1,580
a
8625165.SQ.FTS.B,
5.64%,
7/16/26
.....
1,051
550
a,b
8625097.SQ.FTS.B,
6.081%,
7/16/26
....
1,551
28
a,b
8625055.SQ.FTS.B,
6.44%,
7/16/26
.....
1,294
21
a,b
8624623.SQ.FTS.B,
6.445%,
7/16/26
....
1,687
951
a,b
8630161.SQ.FTS.B,
4.928%,
7/17/26
....
738
345
a,b
8630113.SQ.FTS.B,
6.11%,
7/17/26
.....
3,058
43
a,b
8632209.SQ.FTS.B,
5.619%,
7/18/26
....
348
5
a
8633413.SQ.FTS.B,
5.028%,
7/20/26
....
860
751
a
8633610.SQ.FTS.B,
5.918%,
7/20/26
....
67
59
a
8633174.SQ.FTS.B,
6.289%,
7/20/26
....
413
203
a
8634408.SQ.FTS.B,
4.715%,
7/21/26
....
2,896
1,876
a
8635256.SQ.FTS.B,
5.031%,
7/21/26
....
16,661
12,113
a
8639095.SQ.FTS.B,
5.031%,
7/22/26
....
18,046
11,279
a
8637462.SQ.FTS.B,
6.1%,
7/22/26
......
4,426
3,781
a
8640249.SQ.FTS.B,
6.448%,
7/22/26
....
2,329
1,417
a
8646055.SQ.FTS.B,
6.094%,
7/23/26
....
790
618
a,b
8652314.SQ.FTS.B,
6.447%,
7/26/26
....
1,492
23
a,b
8659412.SQ.FTS.B,
4.72%,
7/28/26
.....
7,284
3,876
a
8656818.SQ.FTS.B,
5.031%,
7/28/26
....
2,451
1,823
a,b
8661211.SQ.FTS.B,
6.499%,
7/28/26
....
130
3
a
8665558.SQ.FTS.B,
4.719%,
7/29/26
....
2,284
1,996
a
8666384.SQ.FTS.B,
6.1%,
7/29/26
......
15,283
11,241
a,b
8662647.SQ.FTS.B,
6.445%,
7/29/26
....
3,734
80
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a
8673280.SQ.FTS.B,
5.036%,
7/30/26
....
$
2,193
$
1,728
a
8674563.SQ.FTS.B,
5.344%,
7/30/26
....
4,294
3,149
a,b
8671964.SQ.FTS.B,
5.346%,
7/30/26
....
6,031
2,311
a,b
8674744.SQ.FTS.B,
6.472%,
7/30/26
....
879
447
a
8677309.SQ.FTS.B,
4.719%,
7/31/26
....
5,220
4,395
a
8680247.SQ.FTS.B,
5.027%,
8/01/26
....
23
22
a
8680461.SQ.FTS.B,
5.031%,
8/01/26
....
2,569
2,372
a
8684229.SQ.FTS.B,
4.722%,
8/03/26
....
675
605
a
8689297.SQ.FTS.B,
5.031%,
8/04/26
....
1,843
1,755
a
8688026.SQ.FTS.B,
5.912%,
8/04/26
....
291
277
a,b
8692180.SQ.FTS.B,
5.912%,
8/04/26
....
34,128
718
a
8693676.SQ.FTS.B,
5.031%,
8/05/26
....
874
844
a,b
8697792.SQ.FTS.B,
5.343%,
8/05/26
....
5,744
113
a
8704195.SQ.FTS.B,
5.612%,
8/06/26
....
69
65
a
8706579.SQ.FTS.B,
5.597%,
8/07/26
....
7,714
5,191
a
8712364.SQ.FTS.B,
6.447%,
8/09/26
....
662
369
a
8715175.SQ.FTS.B,
5.361%,
8/10/26
....
319
267
a,b
8713665.SQ.FTS.B,
5.6%,
8/10/26
......
951
22
a
8720364.SQ.FTS.B,
5.353%,
8/11/26
....
1,341
939
a
8719381.SQ.FTS.B,
6.102%,
8/11/26
....
1,820
1,660
a,b
8723059.SQ.FTS.B,
4.717%,
8/12/26
....
20,170
550
a,b
8723864.SQ.FTS.B,
5.627%,
8/12/26
....
9,920
231
a,b
8722338.SQ.FTS.B,
5.63%,
8/12/26
.....
1,713
35
a
8734581.SQ.FTS.B,
4.717%,
8/13/26
....
1,610
1,339
a,b
8734472.SQ.FTS.B,
6.444%,
8/13/26
....
3,490
46
a,b
8738312.SQ.FTS.B,
6.45%,
8/14/26
.....
6,129
62
a,b
8739327.SQ.FTS.B,
6.447%,
8/15/26
....
10,390
220
a,b
8740558.SQ.FTS.B,
5.031%,
8/16/26
....
23,179
648
a,b
8740399.SQ.FTS.B,
5.597%,
8/16/26
....
6,482
4,680
a,b
8741215.SQ.FTS.B,
5.595%,
8/17/26
....
5,716
1,826
a
8744200.SQ.FTS.B,
5.342%,
8/18/26
....
2,707
1,787
a
8748954.SQ.FTS.B,
4.719%,
8/19/26
....
2,844
2,747
a
8757818.SQ.FTS.B,
5.348%,
8/21/26
....
3,346
3,146
a
8760036.SQ.FTS.B,
5.598%,
8/21/26
....
664
450
a
8757666.SQ.FTS.B,
6.102%,
8/21/26
....
21
20
a,b
8757027.SQ.FTS.B,
6.105%,
8/21/26
....
3,241
67
a
8763721.SQ.FTS.B,
4.72%,
8/24/26
.....
2,579
1,909
a,b
8764217.SQ.FTS.B,
5.346%,
8/24/26
....
8,186
194
a
8769719.SQ.FTS.B,
6.287%,
8/25/26
....
890
669
a,b
8767996.SQ.FTS.B,
6.447%,
8/25/26
....
7,938
144
a,b
8768460.SQ.FTS.B,
6.451%,
8/25/26
....
4,904
60
a
8775913.SQ.FTS.B,
5.031%,
8/26/26
....
3,961
1,877
a
8772121.SQ.FTS.B,
5.6%,
8/26/26
......
6,091
4,479
a
8775615.SQ.FTS.B,
5.6%,
8/26/26
......
1,993
1,302
a
8773308.SQ.FTS.B,
6.103%,
8/26/26
....
2,766
1,425
a
8783977.SQ.FTS.B,
5.036%,
8/28/26
....
2,718
1,932
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
8784101.SQ.FTS.B,
6.095%,
8/28/26
....
$
1,625
$
25
a
8786222.SQ.FTS.B,
6.453%,
8/28/26
....
701
443
a
8789099.SQ.FTS.B,
6.459%,
9/01/26
....
409
376
a,b
8789983.SQ.FTS.B,
5.031%,
9/02/26
....
9,342
206
a
8794574.SQ.FTS.B,
4.941%,
9/03/26
....
172
79
a
8793937.SQ.FTS.B,
6.439%,
9/03/26
....
180
151
a,b
8798528.SQ.FTS.B,
4.937%,
9/04/26
....
15,404
7,387
a
8797084.SQ.FTS.B,
5.346%,
9/04/26
....
1,553
1,429
a
8797688.SQ.FTS.B,
6.1%,
9/04/26
......
7,998
5,666
a,b
8799251.SQ.FTS.B,
6.293%,
9/04/26
....
2,686
742
a
8797465.SQ.FTS.B,
6.314%,
9/04/26
....
333
153
a
8800909.SQ.FTS.B,
4.717%,
9/05/26
....
1,172
1,111
a,b
8803302.SQ.FTS.B,
5.031%,
9/05/26
....
7,833
175
a
8803453.SQ.FTS.B,
6.289%,
9/05/26
....
2,970
857
a,b
8803185.SQ.FTS.B,
6.448%,
9/05/26
....
6,688
121
a
8810202.SQ.FTS.B,
4.714%,
9/06/26
....
433
419
a,b
8808155.SQ.FTS.B,
4.949%,
9/06/26
....
713
15
a
8814570.SQ.FTS.B,
4.719%,
9/07/26
....
3,206
2,792
a
8813700.SQ.FTS.B,
5.031%,
9/07/26
....
6,146
5,626
a
8811330.SQ.FTS.B,
5.346%,
9/07/26
....
20,477
17,057
a
8810676.SQ.FTS.B,
5.591%,
9/07/26
....
1,694
692
a
8816217.SQ.FTS.B,
4.717%,
9/09/26
....
10,239
8,468
a
8817896.SQ.FTS.B,
4.718%,
9/10/26
....
3,728
3,308
a
8819695.SQ.FTS.B,
5.342%,
9/10/26
....
1,495
1,270
a
8824350.SQ.FTS.B,
4.717%,
9/11/26
....
6,229
5,175
a,b
8824912.SQ.FTS.B,
4.939%,
9/11/26
....
7,671
3,826
a
8823852.SQ.FTS.B,
5.027%,
9/11/26
....
1,602
1,155
a
8822169.SQ.FTS.B,
5.348%,
9/11/26
....
1,927
1,733
a,b
8822671.SQ.FTS.B,
6.099%,
9/11/26
....
2,827
64
a
8825752.SQ.FTS.B,
4.715%,
9/12/26
....
190
189
a
8830042.SQ.FTS.B,
4.721%,
9/12/26
....
597
587
a
8829866.SQ.FTS.B,
6.1%,
9/12/26
......
5,460
4,003
a,b
8836466.SQ.FTS.B,
5.911%,
9/13/26
....
1,364
922
a
8838758.SQ.FTS.B,
5.918%,
9/13/26
....
419
379
a
8841697.SQ.FTS.B,
5.031%,
9/14/26
....
3,170
2,498
a
8842210.SQ.FTS.B,
5.583%,
9/14/26
....
313
294
a
8845787.SQ.FTS.B,
4.946%,
9/15/26
....
1,151
552
a
8844470.SQ.FTS.B,
5.041%,
9/15/26
....
253
245
a,b
8846019.SQ.FTS.B,
6.095%,
9/15/26
....
1,341
27
a
8846996.SQ.FTS.B,
5.6%,
9/16/26
......
1,684
1,475
a
8848129.SQ.FTS.B,
5.597%,
9/17/26
....
7,312
4,656
a,b
8855947.SQ.FTS.B,
5.358%,
9/18/26
....
1,680
39
a,b
8862132.SQ.FTS.B,
6.1%,
9/19/26
......
4,940
110
a,b
8860499.SQ.FTS.B,
6.455%,
9/19/26
....
1,554
35
a
8867824.SQ.FTS.B,
4.719%,
9/20/26
....
5,060
4,147
a
8869520.SQ.FTS.B,
4.719%,
9/20/26
....
1,371
1,339
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a,b
8867817.SQ.FTS.B,
4.953%,
9/20/26
....
$
580
$
12
a
8865647.SQ.FTS.B,
5.031%,
9/20/26
....
163
156
a,b
8865093.SQ.FTS.B,
5.914%,
9/20/26
....
5,963
1,791
a
8866511.SQ.FTS.B,
6.289%,
9/20/26
....
6,099
1,645
a
8869364.SQ.FTS.B,
6.289%,
9/20/26
....
1,157
713
a,b
8866657.SQ.FTS.B,
6.447%,
9/20/26
....
26,140
417
a
8871615.SQ.FTS.B,
4.719%,
9/21/26
....
2,563
2,186
a
8873146.SQ.FTS.B,
4.719%,
9/21/26
....
3,331
3,242
a
8873449.SQ.FTS.B,
5.35%,
9/21/26
.....
2,347
2,054
a,b
8870696.SQ.FTS.B,
5.618%,
9/21/26
....
1,558
27
a
8875640.SQ.FTS.B,
6.102%,
9/22/26
....
1,015
800
a
8876611.SQ.FTS.B,
4.717%,
9/23/26
....
2,825
2,789
a
8876148.SQ.FTS.B,
4.72%,
9/23/26
.....
2,705
1,729
a
8877024.SQ.FTS.B,
6.45%,
9/24/26
.....
948
812
a
8881961.SQ.FTS.B,
4.717%,
9/25/26
....
804
798
a
8881760.SQ.FTS.B,
5.038%,
9/25/26
....
1,663
1,363
a
8882306.SQ.FTS.B,
5.595%,
9/25/26
....
1
1
a
8886794.SQ.FTS.B,
5.346%,
9/26/26
....
8,127
6,770
a
8890340.SQ.FTS.B,
5.597%,
9/26/26
....
3,604
2,067
a
8888248.SQ.FTS.B,
6.436%,
9/26/26
....
774
291
a,b
8886342.SQ.FTS.B,
6.445%,
9/26/26
....
4,893
1,377
a
8888165.SQ.FTS.B,
6.457%,
9/26/26
....
767
527
a
8895373.SQ.FTS.B,
5.026%,
9/27/26
....
1,349
1,235
a,b
8894126.SQ.FTS.B,
6.447%,
9/27/26
....
4,659
92
a
8898889.SQ.FTS.B,
5.031%,
9/28/26
....
746
628
a
8898952.SQ.FTS.B,
5.598%,
9/28/26
....
4,199
3,996
a
8898743.SQ.FTS.B,
6.105%,
9/28/26
....
545
363
a
8903852.SQ.FTS.B,
4.717%,
9/29/26
....
8,267
7,801
a
8908825.SQ.FTS.B,
4.719%,
9/30/26
....
4,528
3,256
a
8904946.SQ.FTS.B,
5.346%,
9/30/26
....
741
719
a,b
8906652.SQ.FTS.B,
6.102%,
9/30/26
....
6,028
107
a
8913761.SQ.FTS.B,
5.342%,
10/01/26
...
894
315
a
8913778.SQ.FTS.B,
5.355%,
10/01/26
...
483
466
a
8914772.SQ.FTS.B,
4.714%,
10/02/26
...
1,449
1,323
a,b
8916787.SQ.FTS.B,
4.717%,
10/02/26
...
5,743
141
a
8918904.SQ.FTS.B,
4.717%,
10/02/26
...
4,173
3,358
a,b
8916567.SQ.FTS.B,
6.316%,
10/02/26
...
645
10
a
8918224.SQ.FTS.B,
6.476%,
10/02/26
...
306
248
a
8922950.SQ.FTS.B,
4.717%,
10/03/26
...
4,496
4,374
a
8923924.SQ.FTS.B,
4.717%,
10/03/26
...
2,706
2,624
a
8925868.SQ.FTS.B,
4.962%,
10/03/26
...
444
214
a
8925982.SQ.FTS.B,
5.031%,
10/03/26
...
1,877
1,673
a,b
8925548.SQ.FTS.B,
6.099%,
10/03/26
...
5,133
115
a,b
8921608.SQ.FTS.B,
6.473%,
10/03/26
...
711
14
a,b
8928016.SQ.FTS.B,
5.6%,
10/04/26
.....
4,939
65
a,b
8927566.SQ.FTS.B,
6.449%,
10/04/26
...
6,399
108
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a
8927942.SQ.FTS.B,
6.452%,
10/04/26
...
$
753
$
453
a
8930299.SQ.FTS.B,
4.717%,
10/05/26
...
2,286
2,271
a
8935811.SQ.FTS.B,
5.031%,
10/07/26
...
7,208
4,984
a
8940929.SQ.FTS.B,
4.717%,
10/08/26
...
2,785
2,653
a
8939540.SQ.FTS.B,
4.719%,
10/08/26
...
3,231
2,680
a
8937064.SQ.FTS.B,
6.447%,
10/08/26
...
925
609
a
8942058.SQ.FTS.B,
5.031%,
10/09/26
...
20,415
15,462
a
8942926.SQ.FTS.B,
5.603%,
10/09/26
...
318
313
a,b
8943220.SQ.FTS.B,
6.447%,
10/09/26
...
9,148
233
a
8942798.SQ.FTS.B,
6.45%,
10/09/26
....
1,355
1,189
a
8948714.SQ.FTS.B,
5.912%,
10/10/26
...
3,433
3,039
a
8955300.SQ.FTS.B,
6.478%,
10/11/26
...
239
203
a
8958970.SQ.FTS.B,
4.717%,
10/13/26
...
2,951
2,903
a
8963717.SQ.FTS.B,
5.034%,
10/14/26
...
3,668
2,567
a,b
8964612.SQ.FTS.B,
6.446%,
10/15/26
...
5,657
1,536
a
8971413.SQ.FTS.B,
5.338%,
10/16/26
...
550
496
a
8977614.SQ.FTS.B,
5.037%,
10/17/26
...
800
692
a
8979331.SQ.FTS.B,
6.1%,
10/17/26
.....
1,533
1,450
a,b
8977675.SQ.FTS.B,
6.277%,
10/17/26
...
971
15
a
8978308.SQ.FTS.B,
6.447%,
10/17/26
...
655
568
a,b
8983195.SQ.FTS.B,
6.11%,
10/18/26
....
1,220
553
a
8985653.SQ.FTS.B,
4.969%,
10/19/26
...
620
284
a
8985454.SQ.FTS.B,
5.029%,
10/19/26
...
293
288
a
8985623.SQ.FTS.B,
5.36%,
10/19/26
....
846
775
a
8986677.SQ.FTS.B,
5.031%,
10/20/26
...
1,852
1,680
a
8995697.SQ.FTS.B,
5.346%,
10/22/26
...
9,400
6,148
a,b
8995610.SQ.FTS.B,
6.1%,
10/22/26
.....
6,434
92
a
8996846.SQ.FTS.B,
4.719%,
10/23/26
...
3,685
3,573
a
8999594.SQ.FTS.B,
5.92%,
10/23/26
....
1,089
744
a
8999514.SQ.FTS.B,
6.441%,
10/23/26
...
1,232
1,038
a
9006035.SQ.FTS.B,
4.722%,
10/24/26
...
818
797
a,b
9006269.SQ.FTS.B,
5.597%,
10/24/26
...
20,237
320
a
9009247.SQ.FTS.B,
4.712%,
10/25/26
...
2,108
1,837
a
9008810.SQ.FTS.B,
4.717%,
10/25/26
...
2,392
2,220
a
9009735.SQ.FTS.B,
6.447%,
10/25/26
...
10,663
7,983
a
9012361.SQ.FTS.B,
4.717%,
10/26/26
...
1,226
1,101
a,b
4578615.SQ.FTS.B,
4.717%,
4/01/33
....
1,525
–
a,b
4583983.SQ.FTS.B,
4.403%,
4/04/33
....
3,383
–
a,b
4585288.SQ.FTS.B,
4.874%,
4/04/33
....
13,554
–
a,b
4587010.SQ.FTS.B,
3.938%,
4/05/33
....
1,755
–
a,b
4590358.SQ.FTS.B,
3.953%,
4/05/33
....
226
–
a,b
4588245.SQ.FTS.B,
4.558%,
4/05/33
....
3,204
–
a,b
4589702.SQ.FTS.B,
4.569%,
4/05/33
....
3,489
–
a,b
4598182.SQ.FTS.B,
4.574%,
4/07/33
....
1,281
–
a,b
4602285.SQ.FTS.B,
4.403%,
4/08/33
....
31,712
–
a,b
4604615.SQ.FTS.B,
4.56%,
4/09/33
.....
13,726
–
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a,b
4604886.SQ.FTS.B,
4.717%,
4/10/33
....
$
2,273
$
–
a,b
4606179.SQ.FTS.B,
3.932%,
4/11/33
....
10,364
–
a,b
4606464.SQ.FTS.B,
4.403%,
4/11/33
....
12,284
1
a,b
4606335.SQ.FTS.B,
4.882%,
4/11/33
....
2,103
–
a,b
4609551.SQ.FTS.B,
4.56%,
4/12/33
.....
5,454
–
a,b
4612920.SQ.FTS.B,
3.314%,
4/13/33
....
2,172
–
a,b
4610443.SQ.FTS.B,
4.403%,
4/13/33
....
10,147
–
a,b
4622639.SQ.FTS.B,
3.928%,
4/15/33
....
3,183
–
a,b
4624869.SQ.FTS.B,
4.554%,
4/17/33
....
1,488
–
a,b
4626298.SQ.FTS.B,
3.934%,
4/18/33
....
10,268
–
a,b
4627586.SQ.FTS.B,
4.403%,
4/18/33
....
4,624
–
a,b
4626514.SQ.FTS.B,
5.031%,
4/18/33
....
2,949
1
a,b
4629149.SQ.FTS.B,
4.403%,
4/19/33
....
6,425
–
a,b
4632596.SQ.FTS.B,
4.705%,
4/20/33
....
848
–
a,b
4635753.SQ.FTS.B,
4.874%,
4/21/33
....
11,156
–
a,b
4642502.SQ.FTS.B,
4.868%,
4/25/33
....
662
–
a,b
4643970.SQ.FTS.B,
4.56%,
4/26/33
.....
2,081
–
a,b
4657373.SQ.FTS.B,
3.296%,
4/30/33
....
3,122
–
a,b
4656958.SQ.FTS.B,
4.717%,
4/30/33
....
3,103
–
a,b
4661015.SQ.FTS.B,
4.566%,
5/01/33
....
2,307
–
a,b
4661890.SQ.FTS.B,
3.931%,
5/02/33
....
2,289
–
a,b
4663096.SQ.FTS.B,
4.403%,
5/02/33
....
27,120
–
a,b
4663916.SQ.FTS.B,
4.403%,
5/02/33
....
24,742
1
a,b
4662184.SQ.FTS.B,
5.031%,
5/02/33
....
2,428
–
a,b
4665676.SQ.FTS.B,
4.564%,
5/03/33
....
4,604
–
a,b
4675799.SQ.FTS.B,
3.306%,
5/05/33
....
3,282
–
a,b
4677893.SQ.FTS.B,
5.031%,
5/06/33
....
2,173
–
a,b
4693423.SQ.FTS.B,
4.403%,
5/09/33
....
7,036
–
a,b
4693941.SQ.FTS.B,
4.561%,
5/09/33
....
8,872
–
a,b
4692191.SQ.FTS.B,
4.562%,
5/09/33
....
9,113
–
a,b
4692982.SQ.FTS.B,
4.591%,
5/09/33
....
430
–
a,b
4691756.SQ.FTS.B,
4.715%,
5/09/33
....
7,269
–
a,b
4706450.SQ.FTS.B,
4.561%,
5/10/33
....
6,009
–
a,b
4706808.SQ.FTS.B,
4.563%,
5/10/33
....
4,870
–
a,b
4701939.SQ.FTS.B,
4.717%,
5/10/33
....
1,446
–
a,b
4707248.SQ.FTS.B,
4.732%,
5/11/33
....
641
–
a,b
4711828.SQ.FTS.B,
5.031%,
5/12/33
....
3,618
–
a,b
4714060.SQ.FTS.B,
5.031%,
5/13/33
....
1,082
–
a,b
4714469.SQ.FTS.B,
3.27%,
5/14/33
.....
828
–
a,b
4738688.SQ.FTS.B,
4.418%,
5/18/33
....
840
–
a,b
4747188.SQ.FTS.B,
3.31%,
5/19/33
.....
553
–
a,b
4750103.SQ.FTS.B,
4.403%,
5/20/33
....
8,831
–
a,b
4750803.SQ.FTS.B,
4.403%,
5/21/33
....
3,382
–
a,b
4764584.SQ.FTS.B,
5.031%,
5/23/33
....
523
–
a,b
4773604.SQ.FTS.B,
4.403%,
5/24/33
....
9,605
–
a,b
4777853.SQ.FTS.B,
4.565%,
5/24/33
....
1,347
–
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
4774144.SQ.FTS.B,
4.57%,
5/24/33
.....
$
1,718
$
–
a,b
4779678.SQ.FTS.B,
3.301%,
5/25/33
....
899
–
a,b
4796651.SQ.FTS.B,
4.564%,
6/01/33
....
3,524
–
a,b
4808500.SQ.FTS.B,
4.403%,
6/02/33
....
7,711
–
a,b
4807880.SQ.FTS.B,
4.56%,
6/02/33
.....
19,691
2
a,b
4815646.SQ.FTS.B,
4.403%,
6/05/33
....
5,300
–
a,b
4820091.SQ.FTS.B,
4.564%,
6/07/33
....
1,630
–
a,b
4820553.SQ.FTS.B,
4.875%,
6/07/33
....
10,164
–
a,b
4821904.SQ.FTS.B,
4.56%,
6/08/33
.....
796
–
a,b
4831001.SQ.FTS.B,
3.774%,
6/10/33
....
847
–
a,b
4831653.SQ.FTS.B,
3.926%,
6/10/33
....
2,099
–
a,b
4830931.SQ.FTS.B,
4.528%,
6/10/33
....
27
–
a,b
4831110.SQ.FTS.B,
4.57%,
6/10/33
.....
962
–
a,b
4834162.SQ.FTS.B,
4.574%,
6/12/33
....
208
–
a,b
4839102.SQ.FTS.B,
3.296%,
6/14/33
....
1,596
–
a,b
4838333.SQ.FTS.B,
3.941%,
6/14/33
....
750
–
a,b
4842631.SQ.FTS.B,
3.302%,
6/15/33
....
5,776
–
a,b
4842605.SQ.FTS.B,
3.937%,
6/15/33
....
4,000
–
a,b
4841116.SQ.FTS.B,
4.562%,
6/15/33
....
11,234
–
a,b
4848622.SQ.FTS.B,
3.302%,
6/16/33
....
2,069
–
a,b
4862341.SQ.FTS.B,
2.982%,
6/18/33
....
522
–
a,b
4862443.SQ.FTS.B,
4.227%,
6/18/33
....
7,578
–
a,b
4863062.SQ.FTS.B,
4.391%,
6/19/33
....
3,882
–
a,b
4863238.SQ.FTS.B,
4.42%,
6/19/33
.....
2,993
–
a,b
4862998.SQ.FTS.B,
4.559%,
6/19/33
....
1,027
–
a,b
4863412.SQ.FTS.B,
4.56%,
6/19/33
.....
11,561
–
a,b
4862938.SQ.FTS.B,
5.031%,
6/19/33
....
691
–
a,b
4867257.SQ.FTS.B,
3.939%,
6/20/33
....
607
–
a,b
4867843.SQ.FTS.B,
3.675%,
6/21/33
....
493
–
a,b
4868757.SQ.FTS.B,
4.406%,
6/21/33
....
3,219
1
a,b
4869815.SQ.FTS.B,
4.56%,
6/21/33
.....
7,257
–
a,b
4873297.SQ.FTS.B,
3.376%,
6/22/33
....
113
–
a,b
4871837.SQ.FTS.B,
3.928%,
6/22/33
....
1,490
–
a,b
4872072.SQ.FTS.B,
4.557%,
6/22/33
....
4,085
–
a,b
4873405.SQ.FTS.B,
4.56%,
6/22/33
.....
5,886
–
a,b
4873313.SQ.FTS.B,
5.031%,
6/22/33
....
1,287
–
a,b
4874535.SQ.FTS.B,
3.306%,
6/23/33
....
977
–
a,b
4875940.SQ.FTS.B,
4.539%,
6/23/33
....
7,944
1
a,b
4874845.SQ.FTS.B,
4.559%,
6/23/33
....
3,811
–
a,b
4874157.SQ.FTS.B,
4.877%,
6/23/33
....
3,873
–
a,b
4877067.SQ.FTS.B,
3.562%,
6/24/33
....
1,174
–
a,b
4877254.SQ.FTS.B,
3.774%,
6/25/33
....
1,462
–
a,b
4877394.SQ.FTS.B,
4.225%,
6/25/33
....
4,239
–
a,b
4877534.SQ.FTS.B,
4.931%,
6/25/33
....
1,841
–
a,b
4879828.SQ.FTS.B,
2.958%,
6/27/33
....
1,403
–
a,b
4879371.SQ.FTS.B,
3.443%,
6/27/33
....
536
–
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a,b
4879124.SQ.FTS.B,
4.073%,
6/27/33
....
$
4,098
$
–
a,b
4878787.SQ.FTS.B,
4.233%,
6/27/33
....
4,067
–
a,b
4880273.SQ.FTS.B,
4.416%,
6/27/33
....
32,499
1
a,b
4879728.SQ.FTS.B,
4.695%,
6/27/33
....
2,694
–
a,b
4878103.SQ.FTS.B,
5.346%,
6/27/33
....
627
–
a,b
4881967.SQ.FTS.B,
2.297%,
6/28/33
....
358
–
a,b
4881632.SQ.FTS.B,
2.333%,
6/28/33
....
5,202
–
a,b
4880881.SQ.FTS.B,
2.411%,
6/28/33
....
274
–
a,b
4882630.SQ.FTS.B,
3.643%,
6/28/33
....
5,042
1
a,b
4881595.SQ.FTS.B,
4.069%,
6/28/33
....
1,106
–
a,b
4881625.SQ.FTS.B,
4.427%,
6/28/33
....
1,074
–
a,b
4881933.SQ.FTS.B,
4.55%,
6/28/33
.....
502
–
a,b
4882127.SQ.FTS.B,
4.561%,
6/28/33
....
35,043
–
a,b
4880840.SQ.FTS.B,
4.719%,
6/28/33
....
1,128
–
a,b
4886903.SQ.FTS.B,
3.296%,
6/30/33
....
2,071
–
a,b
4889268.SQ.FTS.B,
3.31%,
6/30/33
.....
524
–
a,b
4886912.SQ.FTS.B,
4.563%,
6/30/33
....
2,287
–
a,b
4889574.SQ.FTS.B,
4.877%,
7/01/33
....
2,517
–
a,b
4894101.SQ.FTS.B,
4.717%,
7/04/33
....
12,955
1
a,b
4893066.SQ.FTS.B,
5.031%,
7/04/33
....
3,265
–
a,b
4896547.SQ.FTS.B,
5.849%,
7/05/33
....
4,712
–
a,b
4899151.SQ.FTS.B,
4.563%,
7/06/33
....
3,147
–
a,b
4898852.SQ.FTS.B,
4.874%,
7/06/33
....
2,213
–
a,b
4908064.SQ.FTS.B,
4.403%,
7/11/33
....
16,814
1
a,b
4907364.SQ.FTS.B,
5.031%,
7/11/33
....
1,373
–
a,b
4922562.SQ.FTS.B,
4.56%,
7/14/33
.....
6,112
–
a,b
4916400.SQ.FTS.B,
4.569%,
7/14/33
....
955
–
a,b
4916673.SQ.FTS.B,
4.719%,
7/14/33
....
9,163
–
a,b
4923493.SQ.FTS.B,
3.354%,
7/15/33
....
134
–
a,b
4925329.SQ.FTS.B,
4.145%,
7/18/33
....
1,389
–
a,b
4928876.SQ.FTS.B,
3.333%,
7/19/33
....
514
–
a,b
4931020.SQ.FTS.B,
4.56%,
7/20/33
.....
10,152
–
a,b
4935511.SQ.FTS.B,
4.403%,
7/22/33
....
450
–
a,b
4941224.SQ.FTS.B,
5.031%,
7/25/33
....
4,401
–
a,b
4947272.SQ.FTS.B,
4.885%,
7/27/33
....
1,224
–
a,b
4954105.SQ.FTS.B,
4.557%,
7/28/33
....
2,531
–
a,b
4961597.SQ.FTS.B,
3.303%,
7/31/33
....
6,826
–
a,b
4964338.SQ.FTS.B,
4.886%,
8/01/33
....
1,028
–
a,b
4975322.SQ.FTS.B,
4.539%,
8/05/33
....
1,106
–
a,b
4976561.SQ.FTS.B,
4.553%,
8/07/33
....
2,306
–
a,b
4977248.SQ.FTS.B,
4.56%,
8/07/33
.....
23,393
1
a,b
4980976.SQ.FTS.B,
4.557%,
8/08/33
....
3,062
–
a,b
4978982.SQ.FTS.B,
4.561%,
8/08/33
....
8,763
1
a,b
4979694.SQ.FTS.B,
6.253%,
8/08/33
....
7,423
–
a,b
4981159.SQ.FTS.B,
4.717%,
8/09/33
....
3,017
–
a,b
4983108.SQ.FTS.B,
5.031%,
8/09/33
....
419
–
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
4989442.SQ.FTS.B,
6.239%,
8/11/33
....
$
717
$
–
a,b
4990668.SQ.FTS.B,
3.935%,
8/12/33
....
1,655
–
a,b
4995431.SQ.FTS.B,
4.556%,
8/15/33
....
6,247
–
a,b
5004424.SQ.FTS.B,
4.56%,
8/16/33
.....
1,829
–
a,b
5016072.SQ.FTS.B,
5.435%,
8/17/33
....
5,014
–
a,b
5025752.SQ.FTS.B,
2.033%,
8/19/33
....
6,406
–
a,b
5025882.SQ.FTS.B,
4.885%,
8/19/33
....
1,669
–
a,b
5027373.SQ.FTS.B,
4.018%,
8/21/33
....
8,844
–
a,b
5030831.SQ.FTS.B,
4.56%,
8/22/33
.....
5,213
–
a,b
5031471.SQ.FTS.B,
4.563%,
8/22/33
....
5,258
–
a,b
5033148.SQ.FTS.B,
3.906%,
8/23/33
....
471
–
a,b
5035669.SQ.FTS.B,
4.725%,
8/23/33
....
3,399
–
a,b
5044258.SQ.FTS.B,
5.149%,
8/27/33
....
8,147
2
a,b
5045662.SQ.FTS.B,
4.574%,
8/28/33
....
2,040
–
a,b
5047314.SQ.FTS.B,
4.591%,
8/28/33
....
460
–
a,b
5047321.SQ.FTS.B,
4.717%,
8/28/33
....
5,110
–
a,b
5044794.SQ.FTS.B,
4.807%,
8/28/33
....
5,731
–
a,b
5059326.SQ.FTS.B,
4.561%,
9/04/33
....
13,048
–
a,b
5062512.SQ.FTS.B,
2.6%,
9/06/33
......
3,648
–
a,b
5062340.SQ.FTS.B,
4.883%,
9/06/33
....
2,074
–
a,b
5065404.SQ.FTS.B,
4.572%,
9/07/33
....
2,639
–
a,b
5067242.SQ.FTS.B,
4.382%,
9/08/33
....
5,352
–
a,b
5067403.SQ.FTS.B,
5.351%,
9/08/33
....
2,045
–
a,b
5071139.SQ.FTS.B,
3.848%,
9/09/33
....
2,742
1
a,b
5075119.SQ.FTS.B,
3.748%,
9/10/33
....
1,106
–
a,b
5072967.SQ.FTS.B,
4.066%,
9/10/33
....
542
–
a,b
5074442.SQ.FTS.B,
4.861%,
9/10/33
....
1,909
–
a,b
5077583.SQ.FTS.B,
5.031%,
9/11/33
....
3,691
–
a,b
5081612.SQ.FTS.B,
4.666%,
9/14/33
....
1,324
–
a,b
5084934.SQ.FTS.B,
3.774%,
9/16/33
....
33,929
–
a,b
5085858.SQ.FTS.B,
3.936%,
9/16/33
....
884
–
a,b
5090272.SQ.FTS.B,
4.563%,
9/17/33
....
4,187
–
a,b
5093863.SQ.FTS.B,
4.558%,
9/19/33
....
9,864
–
a,b
5094427.SQ.FTS.B,
3.774%,
9/20/33
....
2,121
–
a,b
5096674.SQ.FTS.B,
4.56%,
9/21/33
.....
13,763
1
a,b
5095917.SQ.FTS.B,
5.031%,
9/21/33
....
17,638
–
a,b
5098275.SQ.FTS.B,
6.063%,
9/22/33
....
6,026
–
a,b
5100485.SQ.FTS.B,
5.722%,
9/23/33
....
4,264
–
a,b
5106538.SQ.FTS.B,
4.562%,
9/24/33
....
11,727
–
a,b
5107353.SQ.FTS.B,
5.031%,
9/24/33
....
1,383
–
a,b
5109145.SQ.FTS.B,
5.031%,
9/25/33
....
1,195
–
a,b
5111024.SQ.FTS.B,
4.724%,
9/27/33
....
670
–
a,b
5112445.SQ.FTS.B,
3.774%,
9/28/33
....
344
–
a,b
5114206.SQ.FTS.B,
4.571%,
9/28/33
....
573
–
a,b
5112955.SQ.FTS.B,
5.031%,
9/28/33
....
4,811
–
a,b
5113266.SQ.FTS.B,
5.387%,
9/28/33
....
1,765
–
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a,b
5124518.SQ.FTS.B,
3.351%,
9/30/33
....
$
11,687
$
–
a,b
5119221.SQ.FTS.B,
4.403%,
9/30/33
....
2,448
–
a,b
5119131.SQ.FTS.B,
4.56%,
9/30/33
.....
1,885
–
a,b
5126438.SQ.FTS.B,
3.495%,
10/01/33
...
22,782
1
a,b
5128413.SQ.FTS.B,
3.917%,
10/02/33
...
1,332
–
a,b
5131669.SQ.FTS.B,
4.56%,
10/04/33
....
22,967
–
a,b
5132006.SQ.FTS.B,
5.007%,
10/04/33
...
790
–
a,b
5138072.SQ.FTS.B,
4.672%,
10/06/33
...
4,185
–
a,b
5142028.SQ.FTS.B,
3.927%,
10/07/33
...
612
–
a,b
5142049.SQ.FTS.B,
4.503%,
10/07/33
...
537
–
a,b
5141482.SQ.FTS.B,
4.508%,
10/07/33
...
2,827
–
a,b
5149269.SQ.FTS.B,
4.974%,
10/10/33
...
941
–
a,b
5153369.SQ.FTS.B,
4.559%,
10/11/33
...
12,680
–
a,b
5153956.SQ.FTS.B,
3.94%,
10/12/33
....
2,957
–
a,b
5157152.SQ.FTS.B,
4.407%,
10/12/33
...
4,186
–
a,b
5154314.SQ.FTS.B,
4.567%,
10/12/33
...
2,780
–
a,b
5154612.SQ.FTS.B,
4.57%,
10/12/33
....
1,314
–
a,b
5157821.SQ.FTS.B,
4.557%,
10/13/33
...
4,950
–
a,b
5159643.SQ.FTS.B,
4.886%,
10/13/33
...
1,281
–
a,b
5163000.SQ.FTS.B,
3.303%,
10/14/33
...
6,619
–
a,b
5162509.SQ.FTS.B,
4.561%,
10/14/33
...
55,221
–
a,b
5165754.SQ.FTS.B,
4.566%,
10/14/33
...
1,218
–
a,b
5170843.SQ.FTS.B,
4.403%,
10/15/33
...
14,553
–
a,b
5168750.SQ.FTS.B,
4.558%,
10/15/33
...
2,545
–
a,b
5171656.SQ.FTS.B,
4.053%,
10/16/33
...
875
–
a,b
5172517.SQ.FTS.B,
3.302%,
10/17/33
...
3,231
–
a,b
5173148.SQ.FTS.B,
5.012%,
10/17/33
...
670
–
a,b
5175259.SQ.FTS.B,
3.354%,
10/18/33
...
30
–
a,b
5176617.SQ.FTS.B,
4.294%,
10/18/33
...
935
–
a,b
5175826.SQ.FTS.B,
4.557%,
10/18/33
...
3,657
–
a,b
5176935.SQ.FTS.B,
5.031%,
10/18/33
...
489
–
a,b
5177078.SQ.FTS.B,
5.189%,
10/18/33
...
260
–
a,b
5184366.SQ.FTS.B,
3.774%,
10/19/33
...
3,564
–
a,b
5189604.SQ.FTS.B,
3.774%,
10/20/33
...
4,636
–
a,b
5203735.SQ.FTS.B,
3.298%,
10/21/33
...
6,108
–
a,b
5210519.SQ.FTS.B,
5.535%,
10/24/33
...
11,522
–
a,b
5223636.SQ.FTS.B,
4.563%,
10/27/33
...
2,509
–
a,b
5230601.SQ.FTS.B,
3.301%,
10/28/33
...
5,805
–
a,b
5234006.SQ.FTS.B,
4.403%,
10/28/33
...
25,481
1
a,b
5230330.SQ.FTS.B,
4.717%,
10/28/33
...
1,320
–
a,b
5238828.SQ.FTS.B,
3.774%,
10/29/33
...
19,166
–
a,b
5240546.SQ.FTS.B,
3.953%,
10/30/33
...
1,371
–
a,b
5240481.SQ.FTS.B,
4.563%,
10/30/33
...
1,280
–
a,b
5240561.SQ.FTS.B,
4.95%,
10/30/33
....
993
–
a,b
5240923.SQ.FTS.B,
4.56%,
11/01/33
....
7,658
–
a,b
5245023.SQ.FTS.B,
3.936%,
11/02/33
...
1,235
–
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
5252966.SQ.FTS.B,
4.188%,
11/04/33
...
$
2,234
$
–
a,b
5256925.SQ.FTS.B,
4.403%,
11/04/33
...
12,494
–
a,b
5251953.SQ.FTS.B,
4.553%,
11/04/33
...
1,860
–
a,b
5267302.SQ.FTS.B,
3.354%,
11/06/33
...
212
–
a,b
5267196.SQ.FTS.B,
4.723%,
11/06/33
...
2,396
–
a,b
5270825.SQ.FTS.B,
4.877%,
11/06/33
...
4,533
–
a,b
5273714.SQ.FTS.B,
4.563%,
11/08/33
...
2,002
–
a,b
5276774.SQ.FTS.B,
4.556%,
11/09/33
...
3,264
–
a,b
5280986.SQ.FTS.B,
4.555%,
11/10/33
...
1,327
–
a,b
5284007.SQ.FTS.B,
4.403%,
11/11/33
...
1,049
–
a,b
5289917.SQ.FTS.B,
3.774%,
11/12/33
...
702
–
a,b
5287039.SQ.FTS.B,
4.475%,
11/12/33
...
8,749
–
a,b
5288567.SQ.FTS.B,
6.146%,
11/12/33
...
487
–
a,b
5292026.SQ.FTS.B,
4.719%,
11/13/33
...
5,106
–
a,b
5293955.SQ.FTS.B,
4.721%,
11/14/33
...
5,278
–
a,b
5293907.SQ.FTS.B,
4.874%,
11/14/33
...
2,714
–
a,b
5295255.SQ.FTS.B,
3.303%,
11/16/33
...
1,890
1
a,b
5296246.SQ.FTS.B,
4.26%,
11/16/33
....
1,628
–
a,b
5300323.SQ.FTS.B,
4.569%,
11/17/33
...
1,387
–
a,b
5312373.SQ.FTS.B,
4.56%,
11/18/33
....
721
–
a,b
5317481.SQ.FTS.B,
4.528%,
11/19/33
...
593
–
a,b
5319057.SQ.FTS.B,
5.031%,
11/19/33
...
2,284
–
a,b
5325009.SQ.FTS.B,
3.047%,
11/22/33
...
6,356
–
a,b
5325109.SQ.FTS.B,
4.114%,
11/22/33
...
3,741
–
a,b
5325953.SQ.FTS.B,
3.673%,
11/23/33
...
26,736
1
a,b
5331997.SQ.FTS.B,
3.29%,
11/24/33
....
1,138
–
a,b
5333772.SQ.FTS.B,
3.324%,
11/24/33
...
967
–
a,b
5334010.SQ.FTS.B,
3.33%,
11/24/33
....
435
–
a,b
5332017.SQ.FTS.B,
4.403%,
11/24/33
...
3,457
–
a,b
5334017.SQ.FTS.B,
4.403%,
11/24/33
...
710
–
a,b
5334919.SQ.FTS.B,
4.56%,
11/24/33
....
1,216
–
a,b
5332382.SQ.FTS.B,
4.858%,
11/24/33
...
1,453
–
a,b
5333523.SQ.FTS.B,
4.881%,
11/24/33
...
620
–
a,b
5337318.SQ.FTS.B,
3.962%,
11/25/33
...
1,470
–
a,b
5336258.SQ.FTS.B,
4.558%,
11/25/33
...
4,115
–
a,b
5365379.SQ.FTS.B,
4.56%,
11/26/33
....
768
–
a,b
5364900.SQ.FTS.B,
4.571%,
11/26/33
...
1,391
–
a,b
5377413.SQ.FTS.B,
3.944%,
11/27/33
...
944
–
a,b
5378585.SQ.FTS.B,
3.953%,
11/27/33
...
392
–
a,b
5369148.SQ.FTS.B,
4.354%,
11/27/33
...
969
–
a,b
5377620.SQ.FTS.B,
4.414%,
11/27/33
...
13,408
2
a,b
5397535.SQ.FTS.B,
3.585%,
11/30/33
...
5,543
–
a,b
5393796.SQ.FTS.B,
5.031%,
11/30/33
...
8
–
a,b
5408127.SQ.FTS.B,
3.774%,
12/01/33
...
1,021
–
a,b
5412734.SQ.FTS.B,
3.992%,
12/01/33
...
8,127
–
a,b
5413423.SQ.FTS.B,
4.879%,
12/01/33
...
2,550
–
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a,b
5411388.SQ.FTS.B,
5.031%,
12/01/33
...
$
563
$
–
a,b
5447961.SQ.FTS.B,
4.557%,
12/02/33
...
697
–
a,b
5472760.SQ.FTS.B,
4.479%,
12/04/33
...
3,648
–
a,b
5475686.SQ.FTS.B,
4.56%,
12/06/33
....
2,736
–
a,b
5479438.SQ.FTS.B,
4.866%,
12/06/33
...
631
–
a,b
5480752.SQ.FTS.B,
5.031%,
12/06/33
...
3,098
–
a,b
5505930.SQ.FTS.B,
6.289%,
12/07/33
...
1,048
–
a,b
5518310.SQ.FTS.B,
3.913%,
12/08/33
...
390
–
a,b
5515187.SQ.FTS.B,
4.403%,
12/08/33
...
4,692
–
a,b
5516154.SQ.FTS.B,
4.72%,
12/08/33
....
12,489
–
a,b
5507000.SQ.FTS.B,
4.758%,
12/08/33
...
38,614
1
a,b
5533995.SQ.FTS.B,
3.277%,
12/09/33
...
813
–
a,b
5534121.SQ.FTS.B,
5.031%,
12/09/33
...
5,159
–
a,b
5534689.SQ.FTS.B,
3.346%,
12/10/33
...
3,849
–
a,b
5537817.SQ.FTS.B,
4.193%,
12/10/33
...
798
–
a,b
5537728.SQ.FTS.B,
4.447%,
12/10/33
...
2,668
–
a,b
5535547.SQ.FTS.B,
4.724%,
12/10/33
...
4,404
–
a,b
5537953.SQ.FTS.B,
5.029%,
12/10/33
...
4,030
–
a,b
5539948.SQ.FTS.B,
4.239%,
12/11/33
...
1,314
–
a,b
5541083.SQ.FTS.B,
2.917%,
12/12/33
...
114
–
a,b
5541094.SQ.FTS.B,
4.721%,
12/12/33
...
5,085
–
a,b
5546515.SQ.FTS.B,
4.556%,
12/13/33
...
2,064
–
a,b
5552344.SQ.FTS.B,
3.537%,
12/14/33
...
1,674
–
a,b
5547946.SQ.FTS.B,
5.031%,
12/14/33
...
1,134
–
a,b
5554641.SQ.FTS.B,
3.292%,
12/15/33
...
62,255
–
a,b
5556696.SQ.FTS.B,
5.344%,
12/15/33
...
5,553
1
a,b
5563038.SQ.FTS.B,
4.564%,
12/16/33
...
4,772
–
a,b
5562047.SQ.FTS.B,
4.565%,
12/16/33
...
3,095
–
a,b
5564628.SQ.FTS.B,
3.302%,
12/17/33
...
2,787
–
a,b
5565992.SQ.FTS.B,
4.875%,
12/17/33
...
2,616
–
a,b
5568881.SQ.FTS.B,
3.298%,
12/19/33
...
1,314
–
a,b
5569070.SQ.FTS.B,
4.568%,
12/19/33
...
29,610
–
a,b
5572327.SQ.FTS.B,
4.572%,
12/20/33
...
243
–
a,b
5574351.SQ.FTS.B,
4.403%,
12/21/33
...
10,696
1
a,b
5573406.SQ.FTS.B,
4.546%,
12/21/33
...
363
–
a,b
5575886.SQ.FTS.B,
4.557%,
12/21/33
...
894
–
a,b
5586899.SQ.FTS.B,
3.653%,
12/24/33
...
2,468
–
a,b
5585522.SQ.FTS.B,
4.55%,
12/24/33
....
445
–
a,b
5588173.SQ.FTS.B,
3.774%,
12/25/33
...
2,866
–
a,b
5589322.SQ.FTS.B,
4.564%,
12/26/33
...
4,040
–
a,b
5588832.SQ.FTS.B,
4.719%,
12/26/33
...
7,140
–
a,b
5594180.SQ.FTS.B,
2.869%,
12/28/33
...
732
–
a,b
5595624.SQ.FTS.B,
4.567%,
12/28/33
...
789
–
a,b
5600496.SQ.FTS.B,
2.664%,
12/29/33
...
371
–
a,b
5599728.SQ.FTS.B,
2.797%,
12/29/33
...
4,867
–
a,b
5597497.SQ.FTS.B,
4.56%,
12/29/33
....
1,451
–
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
5600632.SQ.FTS.B,
5.031%,
12/29/33
...
$
3,133
$
–
a,b
5600526.SQ.FTS.B,
5.296%,
12/29/33
...
1,008
–
a,b
5611517.SQ.FTS.B,
4.558%,
12/30/33
...
2,001
–
a,b
5612507.SQ.FTS.B,
4.56%,
12/30/33
....
11,600
1
a,b
5616046.SQ.FTS.B,
2.619%,
1/01/34
....
1,631
–
a,b
5616216.SQ.FTS.B,
3.563%,
1/01/34
....
5,841
1
a,b
5614938.SQ.FTS.B,
4.555%,
1/01/34
....
2,188
–
a,b
5618116.SQ.FTS.B,
4.875%,
1/02/34
....
8,099
1
a,b
5618863.SQ.FTS.B,
3.774%,
1/03/34
....
1,492
–
a,b
5619959.SQ.FTS.B,
4.559%,
1/04/34
....
2,374
–
a,b
5620066.SQ.FTS.B,
4.566%,
1/04/34
....
2,868
–
a,b
5619464.SQ.FTS.B,
4.582%,
1/04/34
....
646
–
a,b
5623363.SQ.FTS.B,
4.559%,
1/05/34
....
10,990
–
a,b
5624299.SQ.FTS.B,
4.712%,
1/05/34
....
6,091
–
a,b
5630151.SQ.FTS.B,
3.936%,
1/06/34
....
506
–
a,b
5647775.SQ.FTS.B,
4.257%,
1/07/34
....
1,305
–
a,b
5654133.SQ.FTS.B,
4.875%,
1/08/34
....
32,774
–
a,b
5655643.SQ.FTS.B,
3.936%,
1/09/34
....
4,363
–
a,b
5656207.SQ.FTS.B,
4.559%,
1/09/34
....
8,733
1
a,b
5663245.SQ.FTS.B,
3.302%,
1/11/34
....
500
–
a,b
5663983.SQ.FTS.B,
3.826%,
1/11/34
....
461
–
a,b
5662691.SQ.FTS.B,
4.56%,
1/11/34
.....
573
–
a,b
5666806.SQ.FTS.B,
3.304%,
1/12/34
....
13,430
–
a,b
5671581.SQ.FTS.B,
4.559%,
1/12/34
....
18,583
–
a,b
5673210.SQ.FTS.B,
3.934%,
1/13/34
....
2,838
–
a,b
5675130.SQ.FTS.B,
4.718%,
1/13/34
....
490
–
a,b
5695450.SQ.FTS.B,
3.323%,
1/14/34
....
26,182
1
a,b
5694816.SQ.FTS.B,
3.38%,
1/14/34
.....
1,074
–
a,b
5689248.SQ.FTS.B,
4.556%,
1/14/34
....
1,934
–
a,b
5700432.SQ.FTS.B,
4.193%,
1/15/34
....
929
–
a,b
5696963.SQ.FTS.B,
4.559%,
1/15/34
....
8,836
–
a,b
5703401.SQ.FTS.B,
5.031%,
1/17/34
....
1,653
–
a,b
5703743.SQ.FTS.B,
5.031%,
1/17/34
....
855
–
a,b
5708905.SQ.FTS.B,
3.906%,
1/18/34
....
553
–
a,b
5709549.SQ.FTS.B,
4.174%,
1/18/34
....
12,160
–
a,b
5708392.SQ.FTS.B,
4.561%,
1/18/34
....
9,171
–
a,b
5706022.SQ.FTS.B,
5.179%,
1/18/34
....
194
–
a,b
5721102.SQ.FTS.B,
4.871%,
1/20/34
....
1,302
–
a,b
5728577.SQ.FTS.B,
4.56%,
1/21/34
.....
3,241
–
a,b
5732624.SQ.FTS.B,
4.56%,
1/22/34
.....
11,619
–
a,b
5731303.SQ.FTS.B,
4.574%,
1/22/34
....
1,418
–
a,b
5735573.SQ.FTS.B,
4.403%,
1/24/34
....
5,816
1
a,b
5737632.SQ.FTS.B,
3.931%,
1/25/34
....
5,796
–
a,b
5741303.SQ.FTS.B,
4.567%,
1/26/34
....
2,044
–
a,b
5751520.SQ.FTS.B,
3.308%,
1/28/34
....
2,991
–
a,b
5754310.SQ.FTS.B,
3.164%,
1/29/34
....
1,070
–
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a,b
5756610.SQ.FTS.B,
3.774%,
1/29/34
....
$
4,556
$
–
a,b
5757607.SQ.FTS.B,
3.929%,
1/31/34
....
9,346
–
a,b
5760954.SQ.FTS.B,
4.102%,
2/01/34
....
2,824
–
a,b
5758291.SQ.FTS.B,
4.565%,
2/01/34
....
5,772
–
a,b
5767488.SQ.FTS.B,
4.566%,
2/03/34
....
1,220
–
a,b
5773116.SQ.FTS.B,
4.87%,
2/04/34
.....
3,729
–
a,b
5777772.SQ.FTS.B,
4.558%,
2/05/34
....
8,178
–
a,b
5778008.SQ.FTS.B,
4.687%,
2/05/34
....
4,729
–
a,b
5781951.SQ.FTS.B,
4.557%,
2/08/34
....
4,019
–
a,b
5784874.SQ.FTS.B,
5.153%,
2/09/34
....
3,818
–
a,b
5792518.SQ.FTS.B,
4.876%,
2/10/34
....
16,456
–
a,b
5802478.SQ.FTS.B,
3.774%,
2/11/34
....
7,637
–
a,b
5812068.SQ.FTS.B,
3.302%,
2/12/34
....
2,493
–
a,b
5809201.SQ.FTS.B,
3.975%,
2/12/34
....
718
–
a,b
5812645.SQ.FTS.B,
4.529%,
2/12/34
....
2,690
–
a,b
5810852.SQ.FTS.B,
4.558%,
2/12/34
....
3,602
–
a,b
5813253.SQ.FTS.B,
4.558%,
2/12/34
....
7,311
–
a,b
5813184.SQ.FTS.B,
4.894%,
2/12/34
....
1,676
–
a,b
5813462.SQ.FTS.B,
4.687%,
2/13/34
....
1,394
–
a,b
5814016.SQ.FTS.B,
4.876%,
2/13/34
....
2,868
–
a,b
5814576.SQ.FTS.B,
3.308%,
2/14/34
....
2,223
–
a,b
5816945.SQ.FTS.B,
4.876%,
2/15/34
....
4,384
–
a,b
5815447.SQ.FTS.B,
5.156%,
2/15/34
....
1,227
–
a,b
5817070.SQ.FTS.B,
5.158%,
2/15/34
....
30,140
–
a,b
5823345.SQ.FTS.B,
3.944%,
2/17/34
....
1,884
–
a,b
5825002.SQ.FTS.B,
4.56%,
2/17/34
.....
35,998
–
a,b
5823283.SQ.FTS.B,
4.633%,
2/17/34
....
18
–
a,b
5824742.SQ.FTS.B,
4.688%,
2/17/34
....
3,322
–
a,b
5825354.SQ.FTS.B,
4.723%,
2/17/34
....
4,905
–
a,b
5827842.SQ.FTS.B,
4.561%,
2/18/34
....
7,668
–
a,b
5830440.SQ.FTS.B,
4.562%,
2/18/34
....
2,577
–
a,b
5828926.SQ.FTS.B,
4.685%,
2/18/34
....
17,907
–
a,b
5832209.SQ.FTS.B,
4.403%,
2/19/34
....
26,120
–
a,b
5832609.SQ.FTS.B,
4.929%,
2/19/34
....
2,194
–
a,b
5834318.SQ.FTS.B,
3.304%,
2/20/34
....
8,185
–
a,b
5834294.SQ.FTS.B,
4.537%,
2/20/34
....
502
–
a,b
5835079.SQ.FTS.B,
5.031%,
2/20/34
....
683
–
a,b
5837211.SQ.FTS.B,
4.56%,
2/22/34
.....
2,901
–
a,b
5837315.SQ.FTS.B,
4.561%,
2/22/34
....
4,547
–
a,b
5837252.SQ.FTS.B,
5.262%,
2/22/34
....
1,427
–
a,b
5840394.SQ.FTS.B,
4.809%,
2/23/34
....
7,735
–
a,b
5839815.SQ.FTS.B,
4.859%,
2/23/34
....
615
–
a,b
5842093.SQ.FTS.B,
4.874%,
2/23/34
....
1,240
–
a,b
5851647.SQ.FTS.B,
4.534%,
2/25/34
....
1,396
–
a,b
5848551.SQ.FTS.B,
4.685%,
2/25/34
....
1,094
–
a,b
5852027.SQ.FTS.B,
4.82%,
2/26/34
.....
497
–
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
5854311.SQ.FTS.B,
5.158%,
2/26/34
....
$
663
$
–
a,b
5853740.SQ.FTS.B,
5.288%,
2/26/34
....
2,104
–
a,b
5855240.SQ.FTS.B,
5.19%,
2/27/34
.....
6,098
–
a,b
5866864.SQ.FTS.B,
4.019%,
2/28/34
....
2,964
–
a,b
5857039.SQ.FTS.B,
4.523%,
2/28/34
....
219
–
a,b
5861134.SQ.FTS.B,
4.529%,
2/28/34
....
14,061
2
a,b
5866568.SQ.FTS.B,
4.617%,
2/28/34
....
2,638
–
a,b
5855911.SQ.FTS.B,
4.687%,
2/28/34
....
2,925
–
a,b
5861125.SQ.FTS.B,
4.772%,
2/28/34
....
619
–
a,b
5862630.SQ.FTS.B,
5.067%,
2/28/34
....
5,065
–
a,b
5873819.SQ.FTS.B,
5.09%,
3/01/34
.....
1,232
–
a,b
5874482.SQ.FTS.B,
4.762%,
3/02/34
....
657
–
a,b
5874329.SQ.FTS.B,
5.179%,
3/02/34
....
422
–
a,b
5877776.SQ.FTS.B,
5.458%,
3/03/34
....
691
–
a,b
5878846.SQ.FTS.B,
5.302%,
3/05/34
....
356
–
a,b
5885192.SQ.FTS.B,
5.384%,
3/07/34
....
2,394
–
a,b
5884477.SQ.FTS.B,
5.518%,
3/07/34
....
988
–
a,b
5883334.SQ.FTS.B,
5.524%,
3/07/34
....
1,109
–
a,b
5889080.SQ.FTS.B,
4.718%,
3/08/34
....
771
–
a,b
5889436.SQ.FTS.B,
4.844%,
3/08/34
....
14,724
–
a,b
5889875.SQ.FTS.B,
5.174%,
3/08/34
....
97
–
a,b
5889597.SQ.FTS.B,
5.287%,
3/08/34
....
1,085
–
a,b
5894091.SQ.FTS.B,
4.599%,
3/09/34
....
2,167
–
a,b
5893929.SQ.FTS.B,
4.751%,
3/09/34
....
788
–
a,b
5893541.SQ.FTS.B,
5.441%,
3/09/34
....
4,112
–
a,b
5893815.SQ.FTS.B,
5.451%,
3/09/34
....
1,195
–
a,b
5898769.SQ.FTS.B,
3.93%,
3/12/34
.....
2,169
–
a,b
5898320.SQ.FTS.B,
5.031%,
3/12/34
....
8,262
–
a,b
5900989.SQ.FTS.B,
3.935%,
3/13/34
....
5,386
–
a,b
5900390.SQ.FTS.B,
4.434%,
3/13/34
....
13,495
–
a,b
5900600.SQ.FTS.B,
5.093%,
3/13/34
....
7,701
–
a,b
5903864.SQ.FTS.B,
5.043%,
3/14/34
....
2,296
–
a,b
5911495.SQ.FTS.B,
4.309%,
3/16/34
....
40,359
3
a,b
5910869.SQ.FTS.B,
5.031%,
3/16/34
....
2,092
–
a,b
5913989.SQ.FTS.B,
5.445%,
3/17/34
....
1,336
–
a,b
5914396.SQ.FTS.B,
5.177%,
3/18/34
....
1,467
–
a,b
5915505.SQ.FTS.B,
5.283%,
3/19/34
....
16,318
1
a,b
5917707.SQ.FTS.B,
5.541%,
3/19/34
....
3,053
–
a,b
5921285.SQ.FTS.B,
4.747%,
3/20/34
....
2,698
–
a,b
5921918.SQ.FTS.B,
5.156%,
3/20/34
....
11,547
–
a,b
5923022.SQ.FTS.B,
5.284%,
3/21/34
....
1,435
–
a,b
5934059.SQ.FTS.B,
5.076%,
3/24/34
....
1,242
–
a,b
5934219.SQ.FTS.B,
5.158%,
3/24/34
....
22,371
–
a,b
5934730.SQ.FTS.B,
4.74%,
3/25/34
.....
2,564
–
a,b
5936923.SQ.FTS.B,
4.526%,
3/26/34
....
9,927
–
a,b
5938584.SQ.FTS.B,
5.097%,
3/26/34
....
6,806
–
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a,b
5937124.SQ.FTS.B,
5.189%,
3/26/34
....
$
181
$
–
a,b
5941367.SQ.FTS.B,
4.717%,
3/27/34
....
4,768
–
a,b
5945082.SQ.FTS.B,
3.927%,
3/28/34
....
2,500
–
a,b
5943947.SQ.FTS.B,
4.74%,
3/28/34
.....
1,308
–
a,b
5945214.SQ.FTS.B,
5.367%,
3/28/34
....
656
–
a,b
5950686.SQ.FTS.B,
4.744%,
3/29/34
....
810
–
a,b
5954440.SQ.FTS.B,
4.843%,
3/30/34
....
7,514
–
a,b
5953097.SQ.FTS.B,
5.031%,
3/30/34
....
885
–
a,b
5956888.SQ.FTS.B,
4.221%,
4/02/34
....
2,980
–
a,b
5956650.SQ.FTS.B,
5.084%,
4/02/34
....
182
–
a,b
5956268.SQ.FTS.B,
5.096%,
4/02/34
....
609
–
a,b
5960434.SQ.FTS.B,
5.182%,
4/03/34
....
375
–
a,b
5959931.SQ.FTS.B,
5.429%,
4/03/34
....
1,644
–
a,b
5959978.SQ.FTS.B,
5.543%,
4/03/34
....
1,182
–
a,b
5966156.SQ.FTS.B,
4.03%,
4/05/34
.....
4,893
–
a,b
5964109.SQ.FTS.B,
5.28%,
4/05/34
.....
3,134
1
a,b
5980129.SQ.FTS.B,
4.947%,
4/10/34
....
695
–
a,b
5981924.SQ.FTS.B,
4.843%,
4/11/34
....
12,026
1
a,b
5983869.SQ.FTS.B,
5.031%,
4/11/34
....
1,723
–
a,b
5983705.SQ.FTS.B,
5.441%,
4/11/34
....
4,402
–
a,b
5986027.SQ.FTS.B,
5.095%,
4/12/34
....
3,601
–
a,b
5991404.SQ.FTS.B,
4.591%,
4/13/34
....
1,408
1
a,b
5995853.SQ.FTS.B,
4.028%,
4/14/34
....
7,553
–
a,b
5995769.SQ.FTS.B,
4.938%,
4/14/34
....
4,698
–
a,b
5996582.SQ.FTS.B,
5.428%,
4/15/34
....
330
–
a,b
6000328.SQ.FTS.B,
5.275%,
4/17/34
....
2,618
–
a,b
6001519.SQ.FTS.B,
4.591%,
4/18/34
....
505
–
a,b
6010572.SQ.FTS.B,
4.216%,
4/20/34
....
6,145
–
a,b
6010705.SQ.FTS.B,
4.906%,
4/20/34
....
4,090
–
a,b
6015748.SQ.FTS.B,
4.756%,
4/21/34
....
3,151
–
a,b
6023977.SQ.FTS.B,
5.196%,
4/25/34
....
871
–
a,b
6024354.SQ.FTS.B,
5.439%,
4/26/34
....
4,215
–
a,b
6037378.SQ.FTS.B,
4.751%,
4/29/34
....
732
–
a,b
6038361.SQ.FTS.B,
4.526%,
4/30/34
....
2,968
–
a,b
6057823.SQ.FTS.B,
4.905%,
5/04/34
....
17,364
–
a,b
6063087.SQ.FTS.B,
4.305%,
5/07/34
....
4,299
–
a,b
6064155.SQ.FTS.B,
5.379%,
5/08/34
....
694
–
a,b
6064464.SQ.FTS.B,
5.542%,
5/08/34
....
3,001
–
a,b
6111911.SQ.FTS.B,
5.379%,
5/09/34
.....
1,257
1
a,b
6120978.SQ.FTS.B,
4.769%,
5/10/34
....
836
–
a,b
6123828.SQ.FTS.B,
4.906%,
5/10/34
....
15,343
–
a,b
6122851.SQ.FTS.B,
5.157%,
5/10/34
....
5,276
–
a,b
6122683.SQ.FTS.B,
5.438%,
5/10/34
....
9,407
–
a,b
6126543.SQ.FTS.B,
5.457%,
5/12/34
....
452
–
a,b
6127052.SQ.FTS.B,
5.539%,
5/13/34
....
2,897
–
a,b
6134462.SQ.FTS.B,
4.527%,
5/15/34
....
5,519
1
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
6143084.SQ.FTS.B,
5.515%,
5/17/34
....
$
140
$
–
a,b
6145383.SQ.FTS.B,
5.158%,
5/18/34
....
25,311
1
a,b
6147718.SQ.FTS.B,
5.373%,
5/20/34
....
3,339
–
a,b
6147775.SQ.FTS.B,
5.453%,
5/20/34
....
1,022
–
a,b
6149657.SQ.FTS.B,
4.748%,
5/21/34
....
8,931
–
a,b
6149268.SQ.FTS.B,
5.031%,
5/21/34
....
3,411
–
a,b
6154074.SQ.FTS.B,
4.534%,
5/22/34
....
4,237
–
a,b
6160262.SQ.FTS.B,
4.751%,
5/23/34
....
4,566
–
a,b
6159444.SQ.FTS.B,
4.901%,
5/23/34
....
605
–
a,b
6161261.SQ.FTS.B,
5.287%,
5/24/34
....
1,545
–
a,b
6164819.SQ.FTS.B,
5.444%,
5/26/34
....
480
–
a,b
6164962.SQ.FTS.B,
5.445%,
5/26/34
....
3,092
–
a,b
6169262.SQ.FTS.B,
5.444%,
5/28/34
....
142
–
a,b
6173109.SQ.FTS.B,
4.311%,
5/29/34
....
732
–
a,b
6173073.SQ.FTS.B,
4.906%,
5/29/34
....
1,600
–
a,b
6185954.SQ.FTS.B,
5.441%,
6/03/34
....
1,742
–
a,b
6185770.SQ.FTS.B,
5.547%,
6/03/34
....
2,564
–
a,b
6190982.SQ.FTS.B,
4.314%,
6/05/34
....
4,546
–
a,b
6191154.SQ.FTS.B,
5.532%,
6/06/34
....
2,148
–
a,b
6209210.SQ.FTS.B,
4.309%,
6/09/34
....
6,712
1
a,b
6209706.SQ.FTS.B,
5.036%,
6/10/34
....
2,323
–
a,b
6211694.SQ.FTS.B,
5.372%,
6/12/34
....
3,075
–
a,b
6217699.SQ.FTS.B,
4.748%,
6/13/34
....
3,192
–
a,b
6217315.SQ.FTS.B,
5.031%,
6/13/34
....
687
–
a,b
6220586.SQ.FTS.B,
5.031%,
6/14/34
....
3,429
–
a,b
6220625.SQ.FTS.B,
5.378%,
6/14/34
....
8,814
–
a,b
6227194.SQ.FTS.B,
5.02%,
6/16/34
.....
1,771
–
a,b
6236255.SQ.FTS.B,
5.436%,
6/18/34
....
2,023
–
a,b
6237088.SQ.FTS.B,
4.742%,
6/19/34
....
1,309
–
a,b
6237213.SQ.FTS.B,
5.438%,
6/19/34
....
994
–
a,b
6243468.SQ.FTS.B,
4.969%,
6/20/34
....
12,676
–
a,b
6243792.SQ.FTS.B,
5.374%,
6/21/34
....
2,999
–
a,b
6245571.SQ.FTS.B,
5.674%,
6/21/34
....
502
–
a,b
6254473.SQ.FTS.B,
5.251%,
6/23/34
....
13,950
–
a,b
6254361.SQ.FTS.B,
5.374%,
6/23/34
....
1,745
–
a,b
6254841.SQ.FTS.B,
5.443%,
6/23/34
....
4,682
–
a,b
6259695.SQ.FTS.B,
5.545%,
6/27/34
....
2,225
–
a,b
6265153.SQ.FTS.B,
5.127%,
6/29/34
....
11,421
–
a,b
6266370.SQ.FTS.B,
5.252%,
6/29/34
....
5,770
–
a,b
6275326.SQ.FTS.B,
5.44%,
7/03/34
.....
2,114
–
a,b
6277033.SQ.FTS.B,
5.25%,
7/04/34
.....
3,011
–
a,b
6278139.SQ.FTS.B,
5.61%,
7/04/34
.....
931
–
a,b
6282812.SQ.FTS.B,
4.969%,
7/06/34
....
15,894
–
a,b
6285291.SQ.FTS.B,
4.969%,
7/06/34
....
21,510
–
a,b
6285821.SQ.FTS.B,
5.609%,
7/07/34
....
1,998
–
a,b
6300866.SQ.FTS.B,
5.66%,
7/13/34
.....
274
–
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a,b
6309341.SQ.FTS.B,
5.767%,
7/18/34
....
$
1,719
$
–
a,b
6314763.SQ.FTS.B,
4.749%,
7/19/34
....
982
–
a,b
6319056.SQ.FTS.B,
4.748%,
7/21/34
....
430
–
a,b
6351823.SQ.FTS.B,
4.966%,
7/24/34
....
1,939
–
a,b
6353581.SQ.FTS.B,
5.118%,
7/24/34
....
916
–
a,b
6351975.SQ.FTS.B,
5.478%,
7/24/34
....
2,638
–
a,b
6359468.SQ.FTS.B,
5.627%,
7/26/34
....
432
–
a,b
6370285.SQ.FTS.B,
5.757%,
7/30/34
....
1,998
–
a,b
6372961.SQ.FTS.B,
5.377%,
7/31/34
....
57,137
–
a,b
6379092.SQ.FTS.B,
5.66%,
8/02/34
.....
954
–
a,b
6382243.SQ.FTS.B,
4.969%,
8/03/34
....
40,502
–
a,b
6386635.SQ.FTS.B,
4.99%,
8/05/34
.....
1,423
–
a,b
6389269.SQ.FTS.B,
5.373%,
8/06/34
....
5,046
–
a,b
6389202.SQ.FTS.B,
5.751%,
8/06/34
....
3,677
–
a,b
6392987.SQ.FTS.B,
4.75%,
8/07/34
.....
7,102
–
a,b
6392793.SQ.FTS.B,
5.48%,
8/07/34
.....
432
–
a,b
6393441.SQ.FTS.B,
4.971%,
8/08/34
....
2,464
–
a,b
6404033.SQ.FTS.B,
4.755%,
8/11/34
....
2,159
–
a,b
6410608.SQ.FTS.B,
5.471%,
8/14/34
....
23,537
–
a,b
6413090.SQ.FTS.B,
5.251%,
8/15/34
....
14,328
–
a,b
6422493.SQ.FTS.B,
4.96%,
8/17/34
.....
96
–
a,b
6424176.SQ.FTS.B,
4.969%,
8/18/34
....
22,930
2
a,b
6427394.SQ.FTS.B,
4.75%,
8/21/34
.....
24,524
–
a,b
6427044.SQ.FTS.B,
5.471%,
8/21/34
....
637
–
a,b
6431015.SQ.FTS.B,
4.969%,
8/22/34
....
2,894
–
a,b
6439616.SQ.FTS.B,
4.969%,
8/23/34
....
2,924
–
a,b
6439850.SQ.FTS.B,
5.472%,
8/23/34
....
7,981
–
a,b
6436390.SQ.FTS.B,
5.597%,
8/23/34
....
3,413
–
a,b
6442480.SQ.FTS.B,
5.383%,
8/24/34
....
1,919
–
a,b
6451818.SQ.FTS.B,
4.528%,
8/28/34
....
32,683
1
a,b
6452723.SQ.FTS.B,
4.75%,
8/28/34
.....
1,840
–
a,b
6454314.SQ.FTS.B,
4.97%,
9/01/34
.....
6,133
–
a,b
6461434.SQ.FTS.B,
5.252%,
9/03/34
....
6,632
1
a,b
6464078.SQ.FTS.B,
5.121%,
9/04/34
....
818
–
a,b
6467555.SQ.FTS.B,
5.377%,
9/06/34
....
3,596
–
a,b
6465421.SQ.FTS.B,
5.451%,
9/06/34
....
1,180
–
a,b
6470092.SQ.FTS.B,
5.469%,
9/07/34
....
3,576
–
a,b
6475454.SQ.FTS.B,
5.126%,
9/08/34
....
2,557
–
a,b
6475554.SQ.FTS.B,
5.597%,
9/08/34
....
8,062
–
a,b
6481328.SQ.FTS.B,
4.748%,
9/09/34
....
6,302
–
a,b
6483513.SQ.FTS.B,
4.528%,
9/10/34
....
7,992
–
a,b
6484336.SQ.FTS.B,
5.253%,
9/10/34
....
22,221
1
a,b
6488356.SQ.FTS.B,
5.66%,
9/13/34
.....
3,633
–
a,b
6496050.SQ.FTS.B,
5.598%,
9/15/34
....
2,621
–
a,b
6503201.SQ.FTS.B,
4.755%,
9/17/34
....
1,828
–
a,b
6508534.SQ.FTS.B,
5.66%,
9/20/34
.....
3,125
–
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
6523267.SQ.FTS.B,
4.84%,
9/24/34
.....
$
5,923
$
–
a,b
6531074.SQ.FTS.B,
5.031%,
9/28/34
....
24,833
–
a,b
6533670.SQ.FTS.B,
5.44%,
9/28/34
.....
2,210
1
a,b
6537472.SQ.FTS.B,
5.437%,
9/29/34
....
2,567
–
a,b
6541353.SQ.FTS.B,
5.597%,
9/30/34
....
727
–
a,b
6547411.SQ.FTS.B,
4.749%,
10/01/34
...
14,177
1
a,b
6552948.SQ.FTS.B,
5.131%,
10/04/34
...
1,758
–
a,b
6553144.SQ.FTS.B,
5.44%,
10/04/34
....
734
–
a,b
6563116.SQ.FTS.B,
5.436%,
10/07/34
...
626
–
a,b
6566625.SQ.FTS.B,
5.189%,
10/08/34
...
10,420
–
a,b
6570679.SQ.FTS.B,
5.44%,
10/10/34
....
15,812
–
a,b
6577981.SQ.FTS.B,
5.251%,
10/12/34
...
10,021
–
a,b
6581786.SQ.FTS.B,
5.755%,
10/13/34
...
584
–
a,b
6582337.SQ.FTS.B,
6.008%,
10/13/34
...
569
–
a,b
6592468.SQ.FTS.B,
5.188%,
10/18/34
...
26,389
–
a,b
6591444.SQ.FTS.B,
6.157%,
10/18/34
...
1,914
–
a,b
6608375.SQ.FTS.B,
6.263%,
10/24/34
...
1,568
–
a,b
6614457.SQ.FTS.B,
5.759%,
10/26/34
...
2,216
–
a,b
6617414.SQ.FTS.B,
6.006%,
10/27/34
...
2,152
–
a,b
6623607.SQ.FTS.B,
6.419%,
10/28/34
...
2,737
–
a,b
6624957.SQ.FTS.B,
6.411%,
10/30/34
...
3,183
–
a,b
6628247.SQ.FTS.B,
4.937%,
11/01/34
...
3,665
–
a,b
6626404.SQ.FTS.B,
6.006%,
11/01/34
...
693
–
a,b
6628104.SQ.FTS.B,
6.162%,
11/01/34
...
8,424
–
a,b
6629787.SQ.FTS.B,
5.57%,
11/02/34
....
7,692
–
a,b
6632388.SQ.FTS.B,
6.413%,
11/02/34
...
6,201
–
a,b
6633231.SQ.FTS.B,
4.745%,
11/03/34
...
238
–
a,b
6639032.SQ.FTS.B,
5.442%,
11/04/34
...
11,342
–
a,b
6644191.SQ.FTS.B,
5.189%,
11/05/34
...
32,363
–
a,b
6641907.SQ.FTS.B,
5.372%,
11/05/34
...
3,766
–
a,b
6641788.SQ.FTS.B,
5.445%,
11/05/34
...
1,794
–
a,b
6651688.SQ.FTS.B,
4.654%,
11/09/34
...
53,478
–
a,b
6649660.SQ.FTS.B,
5.185%,
11/09/34
...
121
–
a,b
6651437.SQ.FTS.B,
5.454%,
11/09/34
...
494
–
a,b
6655130.SQ.FTS.B,
5.442%,
11/10/34
...
888
–
a,b
6663871.SQ.FTS.B,
4.935%,
11/12/34
...
3,838
–
a,b
6662849.SQ.FTS.B,
4.936%,
11/12/34
...
4,461
–
a,b
6662189.SQ.FTS.B,
6.013%,
11/12/34
...
858
–
a,b
6664005.SQ.FTS.B,
6.167%,
11/12/34
...
3,617
–
a,b
6665226.SQ.FTS.B,
6.006%,
11/13/34
...
660
–
a,b
6668780.SQ.FTS.B,
5.566%,
11/15/34
...
9,273
–
a,b
6672424.SQ.FTS.B,
5.377%,
11/16/34
...
4,203
4
a,b
6670037.SQ.FTS.B,
5.571%,
11/16/34
...
6,805
–
a,b
6674961.SQ.FTS.B,
5.44%,
11/17/34
....
5,853
–
a,b
6678696.SQ.FTS.B,
4.936%,
11/18/34
...
19,360
–
a,b
6681578.SQ.FTS.B,
4.937%,
11/18/34
...
10,776
–
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a,b
6679343.SQ.FTS.B,
5.379%,
11/18/34
...
$
3,191
$
–
a,b
6684387.SQ.FTS.B,
4.738%,
11/19/34
...
1,197
–
a,b
6682519.SQ.FTS.B,
5.381%,
11/19/34
...
771
–
a,b
6685009.SQ.FTS.B,
5.752%,
11/20/34
...
2,633
–
a,b
6685907.SQ.FTS.B,
5.568%,
11/21/34
...
5,699
–
a,b
6686639.SQ.FTS.B,
4.937%,
11/22/34
...
1,131
–
a,b
6686940.SQ.FTS.B,
4.937%,
11/22/34
...
2,880
–
a,b
6689856.SQ.FTS.B,
4.659%,
11/23/34
...
4,087
–
a,b
6692529.SQ.FTS.B,
5.186%,
11/23/34
...
6,099
–
a,b
6689979.SQ.FTS.B,
5.377%,
11/23/34
...
12,919
–
a,b
6709316.SQ.FTS.B,
5.767%,
11/29/34
...
108
–
a,b
6719810.SQ.FTS.B,
6.432%,
12/01/34
...
1,571
–
a,b
6724464.SQ.FTS.B,
4.747%,
12/02/34
...
9,907
–
a,b
6729931.SQ.FTS.B,
6.262%,
12/05/34
...
5,140
–
a,b
6731838.SQ.FTS.B,
4.654%,
12/06/34
...
5,855
–
a,b
6731255.SQ.FTS.B,
5.188%,
12/06/34
...
1,286
–
a,b
6730881.SQ.FTS.B,
5.755%,
12/06/34
...
5,559
–
a,b
6737291.SQ.FTS.B,
5.203%,
12/07/34
...
1,511
–
a,b
6742103.SQ.FTS.B,
6.26%,
12/08/34
....
970
–
a,b
6746092.SQ.FTS.B,
4.659%,
12/09/34
...
1,222
–
a,b
6745247.SQ.FTS.B,
4.74%,
12/09/34
....
775
–
a,b
6746977.SQ.FTS.B,
5.188%,
12/10/34
...
15,911
–
a,b
6753247.SQ.FTS.B,
4.655%,
12/13/34
...
9,691
–
a,b
6753008.SQ.FTS.B,
4.749%,
12/13/34
...
6,085
–
a,b
6756294.SQ.FTS.B,
5.751%,
12/14/34
...
756
–
a,b
6764489.SQ.FTS.B,
4.937%,
12/15/34
...
21,402
–
a,b
6770530.SQ.FTS.B,
5.39%,
12/19/34
....
1,058
–
a,b
6771134.SQ.FTS.B,
6.006%,
12/19/34
...
18,256
–
a,b
6774551.SQ.FTS.B,
5.567%,
12/20/34
...
17,810
–
a,b
6781272.SQ.FTS.B,
5.566%,
12/22/34
...
37,439
–
a,b
6783369.SQ.FTS.B,
6.27%,
12/23/34
....
1,854
–
a,b
6792314.SQ.FTS.B,
6.005%,
12/27/34
...
6,421
–
a,b
6795315.SQ.FTS.B,
6.417%,
12/28/34
...
1,229
–
a,b
6800044.SQ.FTS.B,
6.258%,
12/29/34
...
4,752
–
a,b
6804745.SQ.FTS.B,
5.449%,
12/30/34
...
180
–
a,b
6806677.SQ.FTS.B,
5.568%,
12/30/34
...
3,293
–
a,b
6808256.SQ.FTS.B,
5.546%,
1/01/35
....
794
–
a,b
6812850.SQ.FTS.B,
4.652%,
1/03/35
....
1,848
–
a,b
6812517.SQ.FTS.B,
5.566%,
1/03/35
....
14,910
–
a,b
6810642.SQ.FTS.B,
6.009%,
1/03/35
....
5,633
–
a,b
6815367.SQ.FTS.B,
5.371%,
1/05/35
....
1,775
–
a,b
6822097.SQ.FTS.B,
4.751%,
1/06/35
....
1,805
–
a,b
6818955.SQ.FTS.B,
4.938%,
1/06/35
....
7,512
–
a,b
6826532.SQ.FTS.B,
5.749%,
1/08/35
....
3,960
–
a,b
6836269.SQ.FTS.B,
4.747%,
1/12/35
....
758
–
a,b
6833875.SQ.FTS.B,
5.189%,
1/12/35
....
1,457
–
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
6836478.SQ.FTS.B,
5.749%,
1/12/35
....
$
673
$
–
a,b
6841626.SQ.FTS.B,
4.748%,
1/13/35
....
5,625
–
a,b
6838796.SQ.FTS.B,
6.176%,
1/13/35
....
1,173
–
a,b
6839643.SQ.FTS.B,
6.205%,
1/13/35
....
576
–
a,b
6843667.SQ.FTS.B,
6.415%,
1/14/35
....
32,216
–
a,b
6845960.SQ.FTS.B,
4.748%,
1/15/35
....
2,477
–
a,b
6846131.SQ.FTS.B,
5.747%,
1/15/35
....
690
–
a,b
6846797.SQ.FTS.B,
5.191%,
1/16/35
....
623
–
a,b
6846652.SQ.FTS.B,
5.773%,
1/16/35
....
183
–
a,b
6849498.SQ.FTS.B,
4.655%,
1/17/35
....
5,530
–
a,b
6849711.SQ.FTS.B,
4.743%,
1/17/35
....
628
–
a,b
6849119.SQ.FTS.B,
5.563%,
1/17/35
....
196
–
a,b
6848265.SQ.FTS.B,
6.172%,
1/17/35
....
1,144
–
a,b
6852615.SQ.FTS.B,
4.756%,
1/18/35
....
1,041
–
a,b
6855849.SQ.FTS.B,
4.653%,
1/19/35
....
3,144
–
a,b
6862957.SQ.FTS.B,
6.254%,
1/21/35
....
4,171
–
a,b
6871369.SQ.FTS.B,
5.567%,
1/25/35
....
499
–
a,b
6871155.SQ.FTS.B,
6.012%,
1/25/35
....
3,560
–
a,b
6873383.SQ.FTS.B,
6.15%,
1/26/35
.....
334
–
a,b
6880856.SQ.FTS.B,
5.366%,
1/28/35
....
1,568
–
a,b
6884787.SQ.FTS.B,
6.262%,
1/29/35
....
3,067
–
a,b
6889119.SQ.FTS.B,
6.008%,
1/31/35
....
3,513
–
a,b
6889109.SQ.FTS.B,
6.258%,
1/31/35
....
1,082
–
a,b
6891067.SQ.FTS.B,
6.255%,
2/01/35
....
5,566
–
a,b
6895588.SQ.FTS.B,
4.657%,
2/02/35
....
10,603
–
a,b
6893023.SQ.FTS.B,
5.378%,
2/02/35
....
14,273
1
a,b
6899300.SQ.FTS.B,
4.643%,
2/03/35
....
1,221
–
a,b
6899194.SQ.FTS.B,
4.754%,
2/03/35
....
463
–
a,b
6903284.SQ.FTS.B,
4.654%,
2/04/35
....
3,163
–
a,b
6904989.SQ.FTS.B,
5.189%,
2/05/35
....
22,112
–
a,b
6904822.SQ.FTS.B,
5.573%,
2/05/35
....
285
–
a,b
6908001.SQ.FTS.B,
5.565%,
2/07/35
....
23,167
–
a,b
6909141.SQ.FTS.B,
5.379%,
2/08/35
....
19,068
–
a,b
6913052.SQ.FTS.B,
4.942%,
2/09/35
....
2,970
–
a,b
6914678.SQ.FTS.B,
5.758%,
2/09/35
....
3,385
–
a,b
6916173.SQ.FTS.B,
5.577%,
2/10/35
....
512
–
a,b
6920447.SQ.FTS.B,
6.006%,
2/11/35
....
24,973
–
a,b
6923496.SQ.FTS.B,
6.258%,
2/15/35
....
2,278
1
a,b
6934833.SQ.FTS.B,
4.938%,
2/17/35
....
4,744
–
a,b
6934329.SQ.FTS.B,
6.258%,
2/17/35
....
12,367
–
a,b
6936990.SQ.FTS.B,
4.748%,
2/18/35
....
3,340
–
a,b
6937130.SQ.FTS.B,
6.132%,
2/18/35
....
381
–
a,b
6938552.SQ.FTS.B,
6.416%,
2/18/35
....
6,233
–
a,b
6942251.SQ.FTS.B,
4.656%,
2/20/35
....
3,601
–
a,b
6946120.SQ.FTS.B,
6.164%,
2/21/35
....
10,031
–
a,b
6944161.SQ.FTS.B,
6.261%,
2/21/35
....
1,708
–
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a,b
6966531.SQ.FTS.B,
4.749%,
2/28/35
....
$
3,997
$
–
a,b
6978952.SQ.FTS.B,
4.937%,
2/28/35
....
51,353
1
a,b
6967741.SQ.FTS.B,
5.189%,
2/28/35
....
1,401
–
a,b
6966362.SQ.FTS.B,
5.376%,
2/28/35
....
238
–
a,b
6968103.SQ.FTS.B,
5.455%,
2/28/35
....
537
–
a,b
6966621.SQ.FTS.B,
5.569%,
2/28/35
....
1,752
–
a,b
6971755.SQ.FTS.B,
5.975%,
2/28/35
....
353
–
a,b
6970716.SQ.FTS.B,
6.005%,
2/28/35
....
1,583
–
a,b
6966412.SQ.FTS.B,
6.167%,
2/28/35
....
2,449
–
a,b
6978418.SQ.FTS.B,
6.247%,
2/28/35
....
1,258
–
a,b
6966854.SQ.FTS.B,
6.26%,
2/28/35
.....
3,823
–
a,b
6981964.SQ.FTS.B,
5.376%,
3/01/35
....
13,283
–
a,b
6984708.SQ.FTS.B,
5.567%,
3/02/35
....
1,263
–
a,b
6987569.SQ.FTS.B,
5.754%,
3/05/35
....
3,671
–
a,b
6993089.SQ.FTS.B,
4.76%,
3/06/35
.....
594
–
a,b
7009269.SQ.FTS.B,
6.165%,
3/12/35
....
22,063
–
a,b
7014159.SQ.FTS.B,
5.56%,
3/13/35
.....
1,246
–
a,b
7021732.SQ.FTS.B,
5.376%,
3/15/35
....
2,798
1
a,b
7022730.SQ.FTS.B,
6.259%,
3/15/35
....
3,666
–
a,b
7028537.SQ.FTS.B,
5.189%,
3/18/35
....
66,996
1
a,b
7032279.SQ.FTS.B,
5.567%,
3/19/35
....
1,308
–
a,b
7043444.SQ.FTS.B,
5.376%,
3/21/35
....
6,529
–
a,b
7040179.SQ.FTS.B,
5.564%,
3/21/35
....
8,893
–
a,b
7046836.SQ.FTS.B,
6.261%,
3/22/35
....
2,078
–
a,b
7050197.SQ.FTS.B,
4.749%,
3/25/35
....
13,025
–
a,b
7052668.SQ.FTS.B,
4.936%,
3/25/35
....
1,948
–
a,b
7052092.SQ.FTS.B,
5.754%,
3/25/35
....
4,535
–
a,b
7050592.SQ.FTS.B,
6.263%,
3/25/35
....
912
–
a,b
7054612.SQ.FTS.B,
6.006%,
3/26/35
....
5,385
–
a,b
7061323.SQ.FTS.B,
5.189%,
3/28/35
....
34,494
–
a,b
7062421.SQ.FTS.B,
6.006%,
3/28/35
....
896
–
a,b
7062617.SQ.FTS.B,
6.164%,
3/28/35
....
20,347
–
a,b
7067874.SQ.FTS.B,
6.003%,
3/29/35
....
3,096
–
a,b
7065573.SQ.FTS.B,
6.258%,
3/29/35
....
13,691
–
a,b
7071000.SQ.FTS.B,
4.721%,
4/02/35
....
645
–
a,b
7071948.SQ.FTS.B,
6.248%,
4/02/35
....
631
–
a,b
7080510.SQ.FTS.B,
6.274%,
4/04/35
....
1,437
–
a,b
7085620.SQ.FTS.B,
6.007%,
4/05/35
....
8,877
–
a,b
7089901.SQ.FTS.B,
5.375%,
4/06/35
....
7,927
–
a,b
7091540.SQ.FTS.B,
5.756%,
4/06/35
....
10,017
–
a,b
7091737.SQ.FTS.B,
6.421%,
4/06/35
....
949
–
a,b
7095396.SQ.FTS.B,
5.76%,
4/09/35
.....
2,090
–
a,b
7098792.SQ.FTS.B,
4.653%,
4/10/35
....
2,031
–
a,b
7101698.SQ.FTS.B,
5.393%,
4/11/35
....
1,010
–
a,b
7102724.SQ.FTS.B,
5.566%,
4/11/35
....
4,584
1
a,b
7102932.SQ.FTS.B,
6.255%,
4/11/35
....
1,825
–
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
7105121.SQ.FTS.B,
4.938%,
4/12/35
....
$
1,161
$
–
a,b
7106451.SQ.FTS.B,
5.377%,
4/12/35
....
11,899
–
a,b
7108839.SQ.FTS.B,
4.653%,
4/13/35
....
3,313
–
a,b
7109927.SQ.FTS.B,
6.418%,
4/13/35
....
8,573
–
a,b
7112255.SQ.FTS.B,
6.155%,
4/14/35
....
2,323
–
a,b
7115405.SQ.FTS.B,
4.655%,
4/16/35
....
32,107
1
a,b
7115331.SQ.FTS.B,
5.762%,
4/16/35
....
561
–
a,b
7121272.SQ.FTS.B,
6.012%,
4/17/35
....
2,783
–
a,b
7122345.SQ.FTS.B,
4.762%,
4/18/35
....
402
–
a,b
7123668.SQ.FTS.B,
4.936%,
4/18/35
....
2,218
–
a,b
7123343.SQ.FTS.B,
6.006%,
4/18/35
....
2,848
1
a,b
7134939.SQ.FTS.B,
5.756%,
4/19/35
....
9,292
–
a,b
7137611.SQ.FTS.B,
5.189%,
4/20/35
....
10,916
1
a,b
7147597.SQ.FTS.B,
5.364%,
4/23/35
....
1,926
–
a,b
7147279.SQ.FTS.B,
5.38%,
4/23/35
.....
6,849
–
a,b
7154719.SQ.FTS.B,
5.759%,
4/25/35
....
6,577
–
a,b
7163900.SQ.FTS.B,
6.413%,
4/27/35
....
5,443
1
a,b
7164193.SQ.FTS.B,
5.377%,
4/28/35
....
5,624
–
a,b
7165931.SQ.FTS.B,
5.385%,
4/29/35
....
1,875
–
a,b
7168044.SQ.FTS.B,
5.764%,
4/30/35
....
2,062
–
a,b
7176646.SQ.FTS.B,
4.762%,
5/01/35
....
1,231
–
a,b
7176634.SQ.FTS.B,
5.445%,
5/01/35
....
1,458
–
a,b
7173920.SQ.FTS.B,
5.759%,
5/01/35
....
251
–
a,b
7173881.SQ.FTS.B,
6.415%,
5/01/35
....
2,005
–
a,b
7180807.SQ.FTS.B,
4.654%,
5/02/35
....
2,907
–
a,b
7180850.SQ.FTS.B,
4.935%,
5/02/35
....
2,462
–
a,b
7179318.SQ.FTS.B,
5.189%,
5/02/35
....
11,067
–
a,b
7196096.SQ.FTS.B,
6.003%,
5/07/35
....
8,216
–
a,b
7201085.SQ.FTS.B,
6.419%,
5/08/35
....
1,847
–
a,b
7203631.SQ.FTS.B,
4.745%,
5/09/35
....
1,386
–
a,b
7204614.SQ.FTS.B,
5.184%,
5/09/35
....
3,537
–
a,b
7206450.SQ.FTS.B,
5.373%,
5/09/35
....
1,582
–
a,b
7204933.SQ.FTS.B,
5.409%,
5/09/35
....
381
–
a,b
7206160.SQ.FTS.B,
6.258%,
5/09/35
....
11,872
–
a,b
7215803.SQ.FTS.B,
4.932%,
5/13/35
....
3,486
–
a,b
7215930.SQ.FTS.B,
6.257%,
5/13/35
....
13,761
–
a,b
7224254.SQ.FTS.B,
5.757%,
5/15/35
....
2,770
–
a,b
7222451.SQ.FTS.B,
6.258%,
5/15/35
....
1,539
–
a,b
7235145.SQ.FTS.B,
6.008%,
5/18/35
....
20,605
–
a,b
7237806.SQ.FTS.B,
5.384%,
5/20/35
....
768
–
a,b
7243413.SQ.FTS.B,
5.382%,
5/21/35
....
837
6
a,b
7244368.SQ.FTS.B,
6%,
5/21/35
.......
620
–
a,b
7243236.SQ.FTS.B,
6.26%,
5/21/35
.....
8,746
–
a,b
7247605.SQ.FTS.B,
5.185%,
5/22/35
....
1,856
–
a,b
7249679.SQ.FTS.B,
6.422%,
5/22/35
....
245
–
a,b
7249518.SQ.FTS.B,
6.424%,
5/22/35
....
1,960
–
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a,b
7253237.SQ.FTS.B,
6.01%,
5/24/35
.....
$
270
$
–
a,b
7252834.SQ.FTS.B,
6.167%,
5/24/35
....
4,847
–
a,b
7256122.SQ.FTS.B,
5.365%,
5/25/35
....
1,533
–
a,b
7256570.SQ.FTS.B,
4.935%,
5/26/35
....
5,380
4
a,b
7262532.SQ.FTS.B,
4.752%,
5/28/35
....
3,144
–
a,b
7262602.SQ.FTS.B,
5.43%,
5/28/35
.....
462
–
a,b
7264204.SQ.FTS.B,
4.654%,
5/29/35
....
20,052
17
a,b
7275604.SQ.FTS.B,
5.374%,
6/01/35
....
756
–
a,b
7280873.SQ.FTS.B,
5.192%,
6/04/35
....
5,514
1
a,b
7281601.SQ.FTS.B,
5.409%,
6/04/35
....
1,132
–
a,b
7282811.SQ.FTS.B,
6.248%,
6/04/35
....
529
–
a,b
7281210.SQ.FTS.B,
6.261%,
6/04/35
....
901
–
a,b
7287176.SQ.FTS.B,
6.006%,
6/05/35
....
5,152
–
a,b
7284693.SQ.FTS.B,
6.007%,
6/05/35
....
1,055
–
a,b
7287732.SQ.FTS.B,
6.184%,
6/05/35
....
300
–
a,b
7287144.SQ.FTS.B,
6.267%,
6/05/35
....
1,419
–
a,b
7290056.SQ.FTS.B,
5.377%,
6/06/35
....
5,162
1
a,b
7289261.SQ.FTS.B,
5.565%,
6/06/35
....
1,039
–
a,b
7299621.SQ.FTS.B,
4.654%,
6/08/35
....
35,360
40
a,b
7300176.SQ.FTS.B,
6.008%,
6/08/35
....
136
5
a,b
7303540.SQ.FTS.B,
5.565%,
6/10/35
....
1,343
1
a,b
7303522.SQ.FTS.B,
6.265%,
6/10/35
....
335
–
a,b
7314543.SQ.FTS.B,
5.191%,
6/12/35
....
3,475
–
a,b
7316842.SQ.FTS.B,
4.743%,
6/13/35
....
1,433
15
a,b
7317981.SQ.FTS.B,
5.434%,
6/13/35
....
1,348
1
a,b
7314697.SQ.FTS.B,
5.559%,
6/13/35
....
3,748
62
a,b
7318018.SQ.FTS.B,
5.564%,
6/13/35
....
6,392
2
a,b
7323718.SQ.FTS.B,
6.006%,
6/14/35
....
3,869
–
a,b
7327791.SQ.FTS.B,
4.748%,
6/15/35
....
8,988
4
a,b
7324925.SQ.FTS.B,
5.182%,
6/15/35
....
1,333
2
a,b
7328914.SQ.FTS.B,
5.566%,
6/16/35
....
10,484
–
a,b
7329210.SQ.FTS.B,
6.42%,
6/17/35
.....
3,315
1
a,b
7334014.SQ.FTS.B,
5.459%,
6/18/35
....
1,044
1
a,b
7330422.SQ.FTS.B,
6.162%,
6/18/35
....
625
1
a,b
7336581.SQ.FTS.B,
4.937%,
6/19/35
....
49,530
18
a,b
7335932.SQ.FTS.B,
5.566%,
6/19/35
....
8,474
–
a,b
7334863.SQ.FTS.B,
5.763%,
6/19/35
....
1,344
1
a,b
7339897.SQ.FTS.B,
4.653%,
6/20/35
....
3,395
5
a,b
7340806.SQ.FTS.B,
6.008%,
6/20/35
....
3,592
3
a,b
7344575.SQ.FTS.B,
6.009%,
6/21/35
....
4,098
3
a,b
7346393.SQ.FTS.B,
6.164%,
6/21/35
....
62,612
36
a,b
7348505.SQ.FTS.B,
6.038%,
6/22/35
....
564
1
a,b
7351981.SQ.FTS.B,
4.654%,
6/23/35
....
17,215
6
a,b
7352490.SQ.FTS.B,
4.752%,
6/23/35
....
1,987
1
a,b
7352850.SQ.FTS.B,
6.257%,
6/24/35
....
12,690
15
a,b
7353901.SQ.FTS.B,
6.167%,
6/25/35
....
4,755
4
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
7359006.SQ.FTS.B,
5.439%,
6/27/35
....
$
2,767
$
2
a,b
7371685.SQ.FTS.B,
5.752%,
6/30/35
....
3,456
2
a,b
7370367.SQ.FTS.B,
5.764%,
6/30/35
....
1,662
1
a,b
7370851.SQ.FTS.B,
6.02%,
6/30/35
.....
664
1
a,b
7375076.SQ.FTS.B,
5.374%,
7/02/35
....
6,359
3
a,b
7377813.SQ.FTS.B,
5.76%,
7/03/35
.....
5,830
2
a,b
7387529.SQ.FTS.B,
5.372%,
7/06/35
....
631
1
a,b
7389966.SQ.FTS.B,
4.756%,
7/08/35
....
1,331
1
a,b
7389892.SQ.FTS.B,
5.193%,
7/08/35
....
2,172
1
a,b
7402047.SQ.FTS.B,
5.75%,
7/11/35
.....
5,039
4
a,b
7401076.SQ.FTS.B,
6.161%,
7/11/35
....
4,234
4
a,b
7411525.SQ.FTS.B,
6.169%,
7/16/35
....
946
1
a,b
7412344.SQ.FTS.B,
4.707%,
7/17/35
....
212
–
a,b
7412972.SQ.FTS.B,
5.377%,
7/17/35
....
6,512
7
a,b
7416105.SQ.FTS.B,
4.939%,
7/18/35
....
2,940
3
a,b
7417924.SQ.FTS.B,
5.566%,
7/18/35
....
5,269
11
a,b
7423387.SQ.FTS.B,
5.574%,
7/21/35
....
1,914
3
a,b
7426750.SQ.FTS.B,
4.758%,
7/22/35
....
1,835
2
a,b
7430504.SQ.FTS.B,
4.654%,
7/24/35
....
68,115
41
a,b
7438053.SQ.FTS.B,
5.566%,
7/25/35
....
9,004
17
a,b
7441625.SQ.FTS.B,
4.937%,
7/26/35
....
27,213
1,989
a,b
7443079.SQ.FTS.B,
6.271%,
7/28/35
....
415
1
a,b
7447048.SQ.FTS.B,
4.749%,
7/29/35
....
43,825
14
a,b
7446590.SQ.FTS.B,
5.377%,
7/29/35
....
8,070
51
a,b
7461359.SQ.FTS.B,
6.162%,
8/02/35
....
10,885
7
a,b
7468484.SQ.FTS.B,
4.653%,
8/06/35
....
27,792
25
a,b
7473943.SQ.FTS.B,
5.377%,
8/07/35
....
2,381
2
a,b
7483714.SQ.FTS.B,
5.453%,
8/10/35
....
442
–
a,b
7484428.SQ.FTS.B,
5.189%,
8/11/35
....
4,409
12
a,b
7483959.SQ.FTS.B,
5.756%,
8/11/35
....
2,817
3
a,b
7488673.SQ.FTS.B,
5.581%,
8/13/35
....
805
1
a,b
7489102.SQ.FTS.B,
5.757%,
8/13/35
....
1,307
3
a,b
7490203.SQ.FTS.B,
6.424%,
8/13/35
....
509
1
a,b
7500824.SQ.FTS.B,
6.258%,
8/15/35
....
27,055
15
a,b
7508686.SQ.FTS.B,
4.934%,
8/16/35
....
2,765
6
a,b
7508856.SQ.FTS.B,
4.932%,
8/17/35
....
3,854
7
a,b
7511303.SQ.FTS.B,
4.939%,
8/19/35
....
5,973
11
a,b
7511680.SQ.FTS.B,
5.381%,
8/19/35
....
5,184
7
a,b
7511795.SQ.FTS.B,
5.761%,
8/19/35
....
2,165
5
a,b
7514863.SQ.FTS.B,
4.654%,
8/20/35
....
9,340
13
a,b
7519968.SQ.FTS.B,
6.415%,
8/21/35
....
10,143
27
a,b
7533921.SQ.FTS.B,
5.566%,
8/26/35
....
9,844
32
a,b
7535779.SQ.FTS.B,
4.653%,
8/27/35
....
3,761
8
a,b
7537580.SQ.FTS.B,
4.937%,
8/27/35
....
25,953
71
a,b
7539738.SQ.FTS.B,
5.566%,
8/27/35
....
8,562
1,079
a,b
7542074.SQ.FTS.B,
4.654%,
8/28/35
....
5,237
12
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a,b
7549987.SQ.FTS.B,
5.732%,
8/29/35
....
$
653
$
1
a,b
7552166.SQ.FTS.B,
5.418%,
9/01/35
....
717
1
a,b
7560015.SQ.FTS.B,
6.262%,
9/04/35
....
1,773
5
a,b
7573684.SQ.FTS.B,
4.764%,
9/07/35
....
481
1
a,b
7573640.SQ.FTS.B,
4.937%,
9/07/35
....
3,544
6
a,b
7573480.SQ.FTS.B,
5.571%,
9/07/35
....
3,736
14
a,b
7573972.SQ.FTS.B,
6.003%,
9/07/35
....
4,128
254
a,b
7571507.SQ.FTS.B,
6.169%,
9/07/35
....
2,659
6
a,b
7578877.SQ.FTS.B,
4.78%,
9/09/35
.....
61
–
a,b
7580830.SQ.FTS.B,
5.189%,
9/11/35
....
4,100
13
a,b
7581869.SQ.FTS.B,
6.01%,
9/11/35
.....
1,493
3
a,b
7581762.SQ.FTS.B,
6.253%,
9/11/35
....
384
2
a,b
7586278.SQ.FTS.B,
4.654%,
9/12/35
....
8,025
16
a,b
7586914.SQ.FTS.B,
5.375%,
9/12/35
....
9,130
18
a,b
7590230.SQ.FTS.B,
5.196%,
9/13/35
....
855
3
a,b
7596084.SQ.FTS.B,
4.94%,
9/14/35
.....
7,889
1,304
a,b
7599917.SQ.FTS.B,
6.447%,
9/15/35
....
492
1
a,b
7600486.SQ.FTS.B,
4.769%,
9/16/35
....
645
1
a,b
7600104.SQ.FTS.B,
5.752%,
9/16/35
....
3,186
9
a,b
7601096.SQ.FTS.B,
5.377%,
9/17/35
....
12,879
17
a,b
7603430.SQ.FTS.B,
5.38%,
9/18/35
.....
4,283
9
a,b
7602494.SQ.FTS.B,
6.255%,
9/18/35
....
2,210
3
a,b
7608442.SQ.FTS.B,
5.565%,
9/19/35
....
5,862
66
a,b
7617942.SQ.FTS.B,
5.758%,
9/21/35
....
2,823
8
a,b
7621404.SQ.FTS.B,
6.413%,
9/23/35
....
3,184
7
a,b
7623850.SQ.FTS.B,
5.19%,
9/25/35
.....
482
52
a,b
7623781.SQ.FTS.B,
5.379%,
9/25/35
....
1,952
7
a,b
7624159.SQ.FTS.B,
6.261%,
9/25/35
....
668
2
a,b
7629674.SQ.FTS.B,
5.189%,
9/26/35
....
7,987
20
a,b
7626558.SQ.FTS.B,
5.564%,
9/26/35
....
970
3
a,b
7629259.SQ.FTS.B,
5.565%,
9/26/35
....
2,930
7
a,b
7629134.SQ.FTS.B,
6.413%,
9/26/35
....
4,696
7
a,b
7630481.SQ.FTS.B,
5.189%,
9/27/35
....
11,930
25
a,b
7643054.SQ.FTS.B,
6.165%,
9/29/35
....
373
2
a,b
7639746.SQ.FTS.B,
6.415%,
9/29/35
....
63,645
129
a,b
7643615.SQ.FTS.B,
6.134%,
9/30/35
....
212
1
a,b
7648077.SQ.FTS.B,
4.75%,
10/01/35
....
6,098
19
a,b
7647696.SQ.FTS.B,
5.441%,
10/01/35
...
11,385
35
a,b
7654130.SQ.FTS.B,
6.264%,
10/03/35
...
247
16
a,b
7669547.SQ.FTS.B,
5.432%,
10/07/35
...
1,096
177
a,b
7674523.SQ.FTS.B,
6.289%,
10/09/35
...
6,179
18
a,b
7675618.SQ.FTS.B,
6.415%,
10/09/35
...
38,440
79
a,b
7679612.SQ.FTS.B,
5.562%,
10/10/35
...
2,603
6
a,b
7682366.SQ.FTS.B,
5.376%,
10/11/35
...
4,325
10
a,b
7684952.SQ.FTS.B,
5.567%,
10/11/35
...
741
188
a,b
7685699.SQ.FTS.B,
6.305%,
10/11/35
...
968
3
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
7686665.SQ.FTS.B,
5.569%,
10/12/35
...
$
2,104
$
12
a,b
7694250.SQ.FTS.B,
4.749%,
10/15/35
...
606
2
a,b
7693783.SQ.FTS.B,
5.378%,
10/15/35
...
11,907
32
a,b
7696123.SQ.FTS.B,
5.912%,
10/16/35
...
1,117
5
a,b
7696300.SQ.FTS.B,
5.912%,
10/16/35
...
5,166
20
a,b
7695636.SQ.FTS.B,
6.27%,
10/16/35
....
276
1
a,b
7703086.SQ.FTS.B,
5.093%,
10/18/35
...
1,487
6
a,b
7714659.SQ.FTS.B,
5.193%,
10/24/35
...
5,959
38
a,b
7723470.SQ.FTS.B,
4.78%,
10/25/35
....
302
3
a,b
7725398.SQ.FTS.B,
5.907%,
10/26/35
...
3,637
10
a,b
7725775.SQ.FTS.B,
6.163%,
10/26/35
...
3,004
9
a,b
7729059.SQ.FTS.B,
6.165%,
10/26/35
...
13,362
38
a,b
7726167.SQ.FTS.B,
6.289%,
10/26/35
...
224
46
a,b
7735985.SQ.FTS.B,
6.479%,
10/29/35
...
2,176
8
a,b
7740921.SQ.FTS.B,
4.779%,
10/30/35
...
11,985
92
a,b
7738357.SQ.FTS.B,
5.723%,
10/30/35
...
36,237
166
a,b
7742677.SQ.FTS.B,
5.094%,
11/01/35
...
5,339
45
a,b
7751779.SQ.FTS.B,
5.105%,
11/02/35
...
894
4
a,b
7755332.SQ.FTS.B,
5.357%,
11/03/35
...
124
37
a,b
7755761.SQ.FTS.B,
5.723%,
11/03/35
...
8,935
34
a,b
7756617.SQ.FTS.B,
5.725%,
11/03/35
...
590
3
a,b
7763863.SQ.FTS.B,
4.783%,
11/06/35
...
361
1
a,b
7764093.SQ.FTS.B,
4.767%,
11/07/35
...
1,341
5
a,b
7765591.SQ.FTS.B,
6.162%,
11/07/35
...
3,020
886
a,b
7769643.SQ.FTS.B,
6.178%,
11/08/35
...
1,249
7
a,b
7768040.SQ.FTS.B,
6.293%,
11/08/35
...
1,043
6
a,b
7781183.SQ.FTS.B,
6.289%,
11/10/35
...
4,278
1,329
a,b
7779968.SQ.FTS.B,
6.479%,
11/10/35
...
604
4
a,b
7781843.SQ.FTS.B,
6.164%,
11/11/35
...
675
3
a,b
7782479.SQ.FTS.B,
6.272%,
11/11/35
...
955
274
a,b
7782836.SQ.FTS.B,
6.302%,
11/12/35
...
1,154
4
a,b
7786042.SQ.FTS.B,
6.167%,
11/13/35
...
7,212
30
a,b
7791025.SQ.FTS.B,
4.783%,
11/14/35
...
6,835
40
a,b
7790524.SQ.FTS.B,
6.16%,
11/14/35
....
2,565
10
a,b
7794575.SQ.FTS.B,
4.78%,
11/15/35
....
17,650
170
a,b
7791568.SQ.FTS.B,
5.537%,
11/15/35
...
2,384
16
a,b
7791405.SQ.FTS.B,
6.16%,
11/15/35
....
6,235
27
a,b
7794434.SQ.FTS.B,
6.169%,
11/15/35
...
6,526
22
a,b
7794291.SQ.FTS.B,
6.173%,
11/15/35
...
1,915
15
a,b
7805584.SQ.FTS.B,
5.536%,
11/19/35
...
750
240
a,b
7808746.SQ.FTS.B,
5.346%,
11/20/35
...
13,544
137
a,b
7812943.SQ.FTS.B,
4.765%,
11/21/35
...
1,044
4
a,b
7811957.SQ.FTS.B,
6.287%,
11/21/35
...
4,258
28
a,b
7812879.SQ.FTS.B,
6.48%,
11/21/35
....
2,192
14
a,b
7816821.SQ.FTS.B,
4.749%,
11/22/35
...
3,477
14
a,b
7815015.SQ.FTS.B,
5.719%,
11/22/35
...
3,550
23
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a,b
7813617.SQ.FTS.B,
5.91%,
11/22/35
....
$
9,140
$
42
a,b
7822474.SQ.FTS.B,
4.781%,
11/23/35
...
937
357
a,b
7826745.SQ.FTS.B,
5.094%,
11/24/35
...
2,952
360
a,b
7829173.SQ.FTS.B,
5.912%,
11/24/35
...
5,086
47
a,b
7830023.SQ.FTS.B,
4.78%,
11/25/35
....
11,398
3,778
a,b
7831708.SQ.FTS.B,
5.535%,
11/27/35
...
2,942
15
a,b
7835424.SQ.FTS.B,
4.749%,
11/28/35
...
17,516
66
a,b
7836267.SQ.FTS.B,
6.475%,
11/28/35
...
590
5
a,b
7840090.SQ.FTS.B,
4.75%,
11/29/35
....
1,654
9
a,b
7836996.SQ.FTS.B,
5.912%,
11/29/35
...
961
313
a,b
7846633.SQ.FTS.B,
4.75%,
11/30/35
....
5,174
33
a,b
7848953.SQ.FTS.B,
5.723%,
11/30/35
...
16,191
125
a,b
7851585.SQ.FTS.B,
5.915%,
12/02/35
...
221
58
a,b
7856432.SQ.FTS.B,
4.776%,
12/03/35
...
2,066
268
a,b
7854215.SQ.FTS.B,
6.167%,
12/03/35
...
1,540
9
a,b
7858606.SQ.FTS.B,
5.094%,
12/04/35
...
11,300
79
a,b
7858486.SQ.FTS.B,
5.954%,
12/04/35
...
814
4
a,b
7869186.SQ.FTS.B,
4.772%,
12/06/35
...
226
81
a,b
7867381.SQ.FTS.B,
6.163%,
12/06/35
...
10,339
83
a,b
7869657.SQ.FTS.B,
6.168%,
12/06/35
...
1,298
13
a,b
7872677.SQ.FTS.B,
5.094%,
12/07/35
...
10,160
108
a,b
7874634.SQ.FTS.B,
5.103%,
12/08/35
...
972
10
a,b
7874816.SQ.FTS.B,
5.921%,
12/08/35
...
1,135
12
a,b
7875298.SQ.FTS.B,
6.287%,
12/09/35
...
1,516
188
a,b
7876499.SQ.FTS.B,
4.762%,
12/10/35
...
600
7
a,b
7883146.SQ.FTS.B,
4.747%,
12/11/35
...
7,837
44
a,b
7880155.SQ.FTS.B,
6.164%,
12/11/35
...
1,351
9
a,b
7886840.SQ.FTS.B,
4.747%,
12/12/35
...
511
3
a,b
7885173.SQ.FTS.B,
5.433%,
12/12/35
...
636
7
a,b
7886251.SQ.FTS.B,
5.912%,
12/12/35
...
10,832
112
a,b
7885639.SQ.FTS.B,
6.163%,
12/12/35
...
3,984
44
a,b
7889998.SQ.FTS.B,
4.78%,
12/13/35
....
4,101
36
a,b
7895307.SQ.FTS.B,
6.289%,
12/14/35
...
20,016
115
a,b
7898689.SQ.FTS.B,
5.346%,
12/15/35
...
7,135
2,778
a,b
7899279.SQ.FTS.B,
6.156%,
12/15/35
...
1,617
16
a,b
7900211.SQ.FTS.B,
4.745%,
12/16/35
...
1,260
8
a,b
7901651.SQ.FTS.B,
4.78%,
12/17/35
....
769
320
a,b
7910537.SQ.FTS.B,
5.346%,
12/19/35
...
16,066
183
a,b
7914153.SQ.FTS.B,
5.348%,
12/20/35
...
5,956
36
a,b
7913994.SQ.FTS.B,
6.177%,
12/20/35
...
1,646
10
a,b
7915978.SQ.FTS.B,
5.094%,
12/21/35
...
36,680
341
a,b
7919163.SQ.FTS.B,
5.102%,
12/22/35
...
282
96
a,b
7919471.SQ.FTS.B,
5.912%,
12/22/35
...
5,680
58
a,b
7923129.SQ.FTS.B,
4.781%,
12/24/35
...
6,985
86
a,b
7926597.SQ.FTS.B,
5.911%,
12/25/35
...
3,105
34
a,b
7931961.SQ.FTS.B,
5.439%,
12/26/35
...
3,056
892
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
7929420.SQ.FTS.B,
6.281%,
12/26/35
...
$
2,513
$
26
a,b
7935066.SQ.FTS.B,
4.725%,
12/27/35
...
208
2
a,b
7935729.SQ.FTS.B,
6.153%,
12/27/35
...
1,923
11
a,b
7939914.SQ.FTS.B,
5.534%,
12/28/35
...
7,671
106
a,b
7942180.SQ.FTS.B,
4.757%,
12/29/35
...
2,229
15
a,b
7942057.SQ.FTS.B,
5.904%,
12/29/35
...
3,066
30
a,b
7944955.SQ.FTS.B,
5.093%,
1/01/36
....
24,782
242
a,b
7950936.SQ.FTS.B,
5.347%,
1/02/36
....
1,955
885
a,b
7951446.SQ.FTS.B,
5.719%,
1/02/36
....
3,188
36
a,b
7950515.SQ.FTS.B,
5.911%,
1/02/36
....
1,304
8
a,b
7960559.SQ.FTS.B,
5.912%,
1/05/36
....
22
9
a,b
7962505.SQ.FTS.B,
6.163%,
1/05/36
....
20,002
135
a,b
7964764.SQ.FTS.B,
4.759%,
1/07/36
....
1,606
17
a,b
7968350.SQ.FTS.B,
4.746%,
1/08/36
....
1,919
15
a,b
7969237.SQ.FTS.B,
5.097%,
1/09/36
....
667
83
a,b
7970839.SQ.FTS.B,
5.718%,
1/09/36
....
2,510
1,120
a,b
7978500.SQ.FTS.B,
4.766%,
1/11/36
....
771
10
a,b
7977115.SQ.FTS.B,
5.436%,
1/11/36
....
1,089
9
a,b
7983953.SQ.FTS.B,
5.723%,
1/12/36
....
5,877
2,717
a,b
7984842.SQ.FTS.B,
4.741%,
1/13/36
....
3,159
17
a,b
7984169.SQ.FTS.B,
6.164%,
1/13/36
....
24,072
270
a,b
7986712.SQ.FTS.B,
6.165%,
1/15/36
....
1,216
490
a,b
7990281.SQ.FTS.B,
6.165%,
1/16/36
....
9,974
90
a,b
7993294.SQ.FTS.B,
6.151%,
1/17/36
....
1,119
10
a,b
8000517.SQ.FTS.B,
6.284%,
1/17/36
....
1,021
13
a,b
7997671.SQ.FTS.B,
6.289%,
1/17/36
....
580
99
a,b
8004096.SQ.FTS.B,
6.163%,
1/18/36
....
67,437
529
a,b
8008266.SQ.FTS.B,
4.722%,
1/19/36
....
232
4
a,b
8008601.SQ.FTS.B,
4.78%,
1/19/36
.....
6,115
93
a,b
8010295.SQ.FTS.B,
5.911%,
1/20/36
....
13,906
85
a,b
8010866.SQ.FTS.B,
5.547%,
1/21/36
....
528
8
a,b
8012825.SQ.FTS.B,
5.906%,
1/22/36
....
779
83
a,b
8015166.SQ.FTS.B,
6.158%,
1/22/36
....
740
98
a,b
8016257.SQ.FTS.B,
5.095%,
1/23/36
....
238
109
a,b
8016541.SQ.FTS.B,
6.477%,
1/23/36
....
4,399
57
a,b
8021419.SQ.FTS.B,
4.759%,
1/24/36
....
1,975
18
a,b
8021596.SQ.FTS.B,
5.093%,
1/24/36
....
2,023
34
a,b
8020710.SQ.FTS.B,
6.162%,
1/24/36
....
5,242
46
a,b
8021730.SQ.FTS.B,
6.478%,
1/24/36
....
10,299
123
a,b
8025995.SQ.FTS.B,
5.422%,
1/25/36
....
943
13
a,b
8031599.SQ.FTS.B,
5.346%,
1/27/36
....
872
157
a,b
8031473.SQ.FTS.B,
5.445%,
1/27/36
....
3,422
45
a,b
8040547.SQ.FTS.B,
5.351%,
1/30/36
....
1,219
652
a,b
8037317.SQ.FTS.B,
6.165%,
1/30/36
....
205
93
a,b
8048220.SQ.FTS.B,
4.78%,
2/01/36
.....
618
11
a,b
8050429.SQ.FTS.B,
4.78%,
2/01/36
.....
527
282
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a,b
8051888.SQ.FTS.B,
4.744%,
2/02/36
....
$
1,531
$
14
a,b
8052271.SQ.FTS.B,
6.163%,
2/02/36
....
669
9
a,b
8050565.SQ.FTS.B,
6.164%,
2/02/36
....
6,532
59
a,b
8056576.SQ.FTS.B,
6.477%,
2/05/36
....
669
9
a,b
8070315.SQ.FTS.B,
5.902%,
2/08/36
....
121
57
a,b
8074535.SQ.FTS.B,
4.78%,
2/09/36
.....
17,750
2,666
a,b
8073409.SQ.FTS.B,
6.296%,
2/09/36
....
1,109
10
a,b
8076636.SQ.FTS.B,
4.776%,
2/10/36
....
547
4
a,b
8076650.SQ.FTS.B,
5.094%,
2/10/36
....
2,948
1,396
a,b
8083196.SQ.FTS.B,
5.347%,
2/13/36
....
3,791
1,887
a,b
8085032.SQ.FTS.B,
6.48%,
2/14/36
.....
9,808
155
a,b
8097211.SQ.FTS.B,
5.909%,
2/17/36
....
1,063
509
a,b
8098527.SQ.FTS.B,
5.72%,
2/18/36
.....
1,559
220
a,b
8099364.SQ.FTS.B,
5.917%,
2/19/36
....
855
126
a,b
8104579.SQ.FTS.B,
6.474%,
2/20/36
....
2,671
26
a,b
8113190.SQ.FTS.B,
6.543%,
2/22/36
....
2,143
69
a,b
8117156.SQ.FTS.B,
6.152%,
2/23/36
....
10,731
5,801
a,b
8119065.SQ.FTS.B,
6.155%,
2/24/36
....
3,355
34
a,b
8122481.SQ.FTS.B,
4.78%,
2/26/36
.....
12,947
2,245
a,b
8125247.SQ.FTS.B,
4.749%,
2/27/36
....
2,612
41
a,b
8124817.SQ.FTS.B,
5.644%,
2/27/36
....
1,528
24
a,b
8137603.SQ.FTS.B,
4.782%,
2/28/36
....
3,443
2,100
a,b
8139332.SQ.FTS.B,
6.318%,
2/28/36
....
107
47
a,b
8139400.SQ.FTS.B,
6.423%,
2/28/36
....
564
10
a,b
8155930.SQ.FTS.B,
5.114%,
3/05/36
....
651
368
a
8158885.SQ.FTS.B,
5.92%,
3/05/36
.....
347
176
a,b
8162440.SQ.FTS.B,
6.421%,
3/07/36
....
6,964
127
a,b
8163826.SQ.FTS.B,
6.4%,
3/08/36
......
676
13
a,b
8165084.SQ.FTS.B,
5.41%,
3/09/36
.....
11,638
218
a,b
8164934.SQ.FTS.B,
6.159%,
3/09/36
....
802
415
a,b
8165043.SQ.FTS.B,
6.348%,
3/09/36
....
1,227
503
a,b
8177398.SQ.FTS.B,
4.779%,
3/12/36
....
7,486
163
a,b
8178539.SQ.FTS.B,
4.78%,
3/12/36
.....
9,322
178
a,b
8181148.SQ.FTS.B,
5.628%,
3/13/36
....
3,453
491
a
8180916.SQ.FTS.B,
6.346%,
3/13/36
....
232
120
a
8185295.SQ.FTS.B,
5.101%,
3/15/36
....
160
102
a,b
8185861.SQ.FTS.B,
6.336%,
3/15/36
....
900
18
a,b
8187056.SQ.FTS.B,
4.779%,
3/16/36
....
28,286
7,451
a
8190366.SQ.FTS.B,
5.119%,
3/17/36
....
400
90
a,b
8193726.SQ.FTS.B,
5.114%,
3/18/36
....
14,703
290
a
8203270.SQ.FTS.B,
5.413%,
3/20/36
....
1,696
1,103
a
8205825.SQ.FTS.B,
5.614%,
3/20/36
....
290
160
a,b
8205976.SQ.FTS.B,
5.912%,
3/20/36
....
3,822
986
a,b
8205369.SQ.FTS.B,
6.329%,
3/20/36
....
1,746
12
a,b
8204610.SQ.FTS.B,
6.682%,
3/20/36
....
2,461
45
a
8206989.SQ.FTS.B,
6.551%,
3/21/36
....
1,589
847
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
8209177.SQ.FTS.B,
6.148%,
3/23/36
....
$
4,860
$
96
a
8213268.SQ.FTS.B,
4.958%,
3/24/36
....
1,115
608
a
8215602.SQ.FTS.B,
4.784%,
3/25/36
....
535
367
a
8216882.SQ.FTS.B,
5.66%,
3/25/36
.....
3,816
2,212
a,b
8216590.SQ.FTS.B,
6.314%,
3/25/36
....
1,287
25
a,b
8221997.SQ.FTS.B,
6.536%,
3/26/36
....
342
7
a
8226398.SQ.FTS.B,
5.627%,
3/27/36
....
348
209
a
8227883.SQ.FTS.B,
5.913%,
3/27/36
....
2,327
1,472
a
8228042.SQ.FTS.B,
4.779%,
3/28/36
....
8,824
5,097
a
8237680.SQ.FTS.B,
4.956%,
4/01/36
....
9,120
5,208
a,b
8247535.SQ.FTS.B,
6.552%,
4/03/36
....
1,830
46
a
8248806.SQ.FTS.B,
6.675%,
4/03/36
....
8,029
4,532
a
8250977.SQ.FTS.B,
4.778%,
4/04/36
....
1,943
1,365
a
8250191.SQ.FTS.B,
6.334%,
4/04/36
....
267
128
a,b
8255354.SQ.FTS.B,
4.958%,
4/07/36
....
655
10
a,b
8255421.SQ.FTS.B,
5.41%,
4/07/36
.....
7,188
2,437
a
8277202.SQ.FTS.B,
5.113%,
4/11/36
....
1,713
1,015
a
8276869.SQ.FTS.B,
5.114%,
4/11/36
....
4,242
2,947
a,b
8283179.SQ.FTS.B,
5.117%,
4/15/36
....
6,353
157
a,b
8281860.SQ.FTS.B,
5.408%,
4/15/36
....
3,357
148
a
8284751.SQ.FTS.B,
5.63%,
4/15/36
.....
86
51
a
8284791.SQ.FTS.B,
5.66%,
4/15/36
.....
403
242
a
8283828.SQ.FTS.B,
6.324%,
4/15/36
....
1,079
618
a,b
8287641.SQ.FTS.B,
5.112%,
4/16/36
....
4,543
205
a,b
8287420.SQ.FTS.B,
5.909%,
4/16/36
....
2,138
57
a,b
8288479.SQ.FTS.B,
6.326%,
4/16/36
....
5,431
84
a,b
8286845.SQ.FTS.B,
6.411%,
4/16/36
....
1,221
29
a,b
8287565.SQ.FTS.B,
6.414%,
4/16/36
....
553
345
a,b
8286690.SQ.FTS.B,
6.534%,
4/16/36
....
1,636
39
a
8298827.SQ.FTS.B,
5.41%,
4/19/36
.....
3,744
2,682
a
8299881.SQ.FTS.B,
4.782%,
4/20/36
....
1,524
1,135
a
8304334.SQ.FTS.B,
5.409%,
4/21/36
....
2,178
1,315
a,b
8301755.SQ.FTS.B,
6.326%,
4/21/36
....
4,584
93
a,b
8304151.SQ.FTS.B,
6.673%,
4/21/36
....
2,265
60
a,b
8304649.SQ.FTS.B,
6.325%,
4/22/36
....
2,215
46
a
8308031.SQ.FTS.B,
4.776%,
4/23/36
....
406
305
a
8318235.SQ.FTS.B,
5.646%,
4/25/36
....
1,382
766
a,b
8319657.SQ.FTS.B,
5.66%,
4/25/36
.....
16,364
8,055
a
8322385.SQ.FTS.B,
4.78%,
4/27/36
.....
1,082
803
a,b
8322107.SQ.FTS.B,
6.54%,
4/27/36
.....
1,115
485
a
8329865.SQ.FTS.B,
5.114%,
4/29/36
....
1,179
899
a
8327713.SQ.FTS.B,
5.413%,
4/29/36
....
782
594
a
8333158.SQ.FTS.B,
5.115%,
4/30/36
....
418
297
a
8334093.SQ.FTS.B,
5.635%,
4/30/36
....
2,627
1,518
a,b
8339247.SQ.FTS.B,
6.673%,
4/30/36
....
8,515
149
a
8340531.SQ.FTS.B,
5.409%,
5/01/36
....
21,358
12,388
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Block,
Inc.
(continued)
a,b
8344345.SQ.FTS.B,
6.329%,
5/02/36
....
$
2,204
$
1,302
a
8344398.SQ.FTS.B,
6.359%,
5/02/36
....
109
51
a,b
8345584.SQ.FTS.B,
6.415%,
5/03/36
....
1,848
40
a,b
8348402.SQ.FTS.B,
4.952%,
5/04/36
....
328
197
a
8347538.SQ.FTS.B,
5.115%,
5/04/36
....
1,605
965
a,b
8347967.SQ.FTS.B,
5.117%,
5/04/36
....
2,187
1,523
a
8348640.SQ.FTS.B,
5.66%,
5/04/36
.....
675
506
a,b
8349157.SQ.FTS.B,
6.327%,
5/04/36
....
5,772
114
a
8352758.SQ.FTS.B,
4.78%,
5/05/36
.....
44,359
32,601
a
8351752.SQ.FTS.B,
6.422%,
5/05/36
....
4,250
2,009
a
8362642.SQ.FTS.B,
5.113%,
5/07/36
....
4,698
2,537
a
8360828.SQ.FTS.B,
5.66%,
5/07/36
.....
8,464
4,997
a
8361678.SQ.FTS.B,
6.141%,
5/07/36
....
234
142
a,b
8367859.SQ.FTS.B,
4.78%,
5/08/36
.....
2,964
146
a
8367817.SQ.FTS.B,
4.954%,
5/08/36
....
1,251
582
a,b
8368633.SQ.FTS.B,
5.675%,
5/09/36
....
512
260
a,b
8370594.SQ.FTS.B,
5.615%,
5/11/36
....
252
120
a
8370406.SQ.FTS.B,
6.154%,
5/11/36
....
135
97
a,b
8370392.SQ.FTS.B,
6.301%,
5/11/36
....
311
7
a,b
8370612.SQ.FTS.B,
6.42%,
5/11/36
.....
4,659
98
a,b
8373458.SQ.FTS.B,
5.912%,
5/12/36
....
2,677
1,747
a,b
8373052.SQ.FTS.B,
6.141%,
5/12/36
....
2,470
64
a
8372657.SQ.FTS.B,
6.154%,
5/12/36
....
4,702
2,788
a,b
8373371.SQ.FTS.B,
6.321%,
5/12/36
....
3,913
100
a
8374700.SQ.FTS.B,
6.424%,
5/12/36
....
3,675
2,161
a,b
8376661.SQ.FTS.B,
4.956%,
5/13/36
....
1,560
38
a,b
8376230.SQ.FTS.B,
5.66%,
5/13/36
.....
4,232
61
a,b
8381919.SQ.FTS.B,
4.965%,
5/14/36
....
1,506
26
a
8383275.SQ.FTS.B,
5.404%,
5/14/36
....
938
723
a,b
8382098.SQ.FTS.B,
6.149%,
5/14/36
....
8,174
229
a,b
8383353.SQ.FTS.B,
6.15%,
5/14/36
.....
37,881
1,009
a,b
8382493.SQ.FTS.B,
6.55%,
5/14/36
.....
10,128
144
a
8385298.SQ.FTS.B,
5.66%,
5/15/36
.....
208
174
a
8387911.SQ.FTS.B,
4.781%,
5/16/36
....
2,323
1,181
a
8388466.SQ.FTS.B,
5.125%,
5/16/36
....
624
388
a
8388312.SQ.FTS.B,
5.427%,
5/16/36
....
618
434
a,b
8392372.SQ.FTS.B,
4.78%,
5/18/36
.....
3,862
195
a,b
8391986.SQ.FTS.B,
5.112%,
5/18/36
....
5,055
242
a
8390042.SQ.FTS.B,
5.66%,
5/18/36
.....
916
482
a
8390639.SQ.FTS.B,
6.427%,
5/18/36
....
7
4
a,b
8396180.SQ.FTS.B,
4.959%,
5/19/36
....
1,271
29
a,b
8395941.SQ.FTS.B,
6.146%,
5/19/36
....
2,108
1,099
a
8396223.SQ.FTS.B,
6.152%,
5/19/36
....
3,884
2,151
a,b
8398764.SQ.FTS.B,
5.66%,
5/20/36
.....
21,029
572
a
8406914.SQ.FTS.B,
6.547%,
5/21/36
....
4,280
2,722
a
8412573.SQ.FTS.B,
4.784%,
5/22/36
....
3,263
2,213
Description
Principal
Amount
Value
Block,
Inc.
(continued)
a,b
8408339.SQ.FTS.B,
6.551%,
5/22/36
....
$
5,451
$
52
a
8414495.SQ.FTS.B,
4.781%,
5/24/36
....
2,543
1,971
a,b
8418827.SQ.FTS.B,
5.409%,
5/25/36
....
63,980
1,305
a
8422169.SQ.FTS.B,
5.663%,
5/26/36
....
4,809
3,358
a
8424605.SQ.FTS.B,
5.911%,
5/26/36
....
3,964
2,424
a
8423665.SQ.FTS.B,
6.152%,
5/26/36
....
3,025
2,455
a
8431678.SQ.FTS.B,
6.153%,
5/28/36
....
991
710
a,b
8435782.SQ.FTS.B,
4.943%,
5/29/36
....
1,958
38
a
8436467.SQ.FTS.B,
4.962%,
5/29/36
....
783
446
a,b
8435257.SQ.FTS.B,
5.917%,
5/29/36
....
1,285
55
615,067
Freedom
Financial
Asset
Management
LLC
APP-15053612.FP.FTS.B,
13.99%,
7/26/26
515
517
APP-15053337.FP.FTS.B,
17.99%,
7/26/26
841
855
APP-16719236.FP.FTS.B,
10.49%,
9/04/26
1,801
1,809
APP-16630984.FP.FTS.B,
14.49%,
9/12/26
1,714
1,727
APP-16335651.FP.FTS.B,
14.49%,
9/15/26
1,959
1,971
APP-17464221.FP.FTS.B,
16.74%,
9/15/26
1,169
1,182
APP-16710569.FP.FTS.B,
15.49%,
9/16/26
2,922
2,941
APP-17279512.FP.FTS.B,
16.74%,
9/22/26
1,754
1,785
APP-16676602.FP.FTS.B,
11.24%,
11/05/26
1,440
1,442
APP-11381442.FP.FTS.B,
20.49%,
11/26/26
4,117
4,235
APP-11579549.FP.FTS.B,
13.49%,
12/15/26
..........................
5,002
5,028
APP-11022370.FP.FTS.B,
16.49%,
12/20/26
..........................
1,411
1,422
APP-11740523.FP.FTS.B,
10.99%,
12/21/26
..........................
4,097
4,133
APP-11723942.FP.FTS.B,
19.49%,
12/21/26
..........................
10,986
11,340
APP-12116526.FP.FTS.B,
18.99%,
1/05/27
2,908
2,961
APP-11410185.FP.FTS.B,
22.49%,
1/10/27
6,718
6,948
APP-12032875.FP.FTS.B,
11.24%,
1/16/27
4,648
4,695
APP-11694985.FP.FTS.B,
12.99%,
1/21/27
3,002
3,036
APP-12169743.FP.FTS.B,
24.24%,
1/22/27
6,973
7,245
APP-12186510.FP.FTS.B,
9.74%,
1/23/27
.
7,297
7,364
APP-11595106.FP.FTS.B,
13.49%,
1/26/27
2,519
2,547
APP-11595260.FP.FTS.B,
18.99%,
1/30/27
796
803
APP-11709701.FP.FTS.B,
16.49%,
2/04/27
2,636
2,659
APP-11725393.FP.FTS.B,
17.99%,
2/04/27
11,267
11,522
APP-11694359.FP.FTS.B,
19.99%,
2/04/27
141
140
APP-11660434.FP.FTS.B,
20.49%,
2/04/27
7,372
7,634
APP-11694079.FP.FTS.B,
10.99%,
2/05/27
4,130
4,162
APP-11722179.FP.FTS.B,
11.99%,
2/05/27
5,541
5,587
APP-11742867.FP.FTS.B,
23.24%,
2/05/27
5,087
5,265
APP-12337990.FP.FTS.B,
16.49%,
2/07/27
1,831
1,848
APP-11738196.FP.FTS.B,
21.99%,
2/15/27
2,861
2,950
APP-12029572.FP.FTS.B,
16.99%,
2/24/27
1,207
1,217
APP-12050224.FP.FTS.B,
11.74%,
3/01/27
9,017
9,087
APP-12168636.FP.FTS.B,
13.24%,
3/01/27
4,318
4,356
APP-12158633.FP.FTS.B,
23.24%,
3/02/27
5,367
5,540
APP-12050159.FP.FTS.B,
13.24%,
3/07/27
7,592
7,672
APP-12105970.FP.FTS.B,
10.99%,
3/08/27
4,763
4,805
APP-12155604.FP.FTS.B,
11.24%,
3/08/27
1,389
1,392
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Freedom
Financial
Asset
Management
LLC
(continued)
APP-12106008.FP.FTS.B,
13.49%,
3/08/27
$
3,553
$
3,591
APP-12432804.FP.FTS.B,
13.24%,
3/09/27
7,909
7,986
APP-11508449.FP.FTS.B,
8.49%,
3/10/27
.
6,142
6,194
APP-12203395.FP.FTS.B,
22.49%,
3/10/27
3,750
1,412
APP-12210087.FP.FTS.B,
18.74%,
3/11/27
11,317
11,601
APP-12071137.FP.FTS.B,
19.99%,
3/11/27
7,040
7,253
APP-12460903.FP.FTS.B,
10.99%,
3/15/27
8,368
8,446
APP-12467297.FP.FTS.B,
13.24%,
3/15/27
6,798
6,876
APP-12418630.FP.FTS.B,
17.99%,
3/18/27
4,877
5,018
APP-12463831.FP.FTS.B,
19.99%,
3/18/27
2,189
2,245
APP-12380981.FP.FTS.B,
13.74%,
3/20/27
2,084
2,103
APP-12230901.FP.FTS.B,
20.24%,
3/20/27
11,183
11,524
APP-12424835.FP.FTS.B,
23.99%,
3/20/27
9,053
9,452
APP-12459776.FP.FTS.B,
10.99%,
3/21/27
7,178
7,253
APP-12287335.FP.FTS.B,
13.24%,
3/21/27
5,222
5,292
APP-12270745.FP.FTS.B,
17.74%,
3/23/27
7,597
7,816
APP-12429877.FP.FTS.B,
19.74%,
3/23/27
8,621
8,922
APP-12107351.FP.FTS.B,
16.49%,
3/24/27
5,829
6,016
APP-12468743.FP.FTS.B,
18.24%,
3/24/27
793
795
APP-11397497.FP.FTS.B,
11.99%,
4/19/27
6,131
6,204
APP-12033253.FP.FTS.B,
17.99%,
4/24/27
4,091
4,261
APP-12133804.FP.FTS.B,
10.99%,
4/30/27
5,989
6,051
APP-12097459.FP.FTS.B,
13.24%,
5/08/27
6,658
6,737
APP-12345892.FP.FTS.B,
13.49%,
5/22/27
2,986
3,017
APP-12468566.FP.FTS.B,
19.74%,
6/25/27
13,331
13,910
APP-15007182.FP.FTS.B,
16.99%,
7/11/27
3,584
3,637
APP-15105817.FP.FTS.B,
11.74%,
7/15/27
6,356
6,427
APP-16662334.FP.FTS.B,
15.24%,
7/26/27
8,338
8,458
APP-15116487.FP.FTS.B,
21.49%,
7/28/27
6,075
6,364
APP-16465567.FP.FTS.B,
15.49%,
7/30/27
5,165
5,247
APP-16640475.FP.FTS.B,
12.74%,
8/02/27
5,926
5,988
APP-12159801.FP.FTS.B,
16.99%,
8/15/27
8,933
9,203
APP-15106325.FP.FTS.B,
23.24%,
8/28/27
539
541
APP-16632155.FP.FTS.B,
11.49%,
9/01/27
5,681
5,741
APP-16448250.FP.FTS.B,
13.49%,
9/01/27
2,345
2,374
APP-16676570.FP.FTS.B,
15.24%,
9/01/27
7,132
7,303
APP-12175594.FP.FTS.B,
18.99%,
9/01/27
2,016
2,034
APP-16852920.FP.FTS.B,
10.99%,
9/04/27
12,540
12,679
APP-16640455.FP.FTS.B,
10.99%,
9/05/27
7,274
7,353
APP-15052242.FP.FTS.B,
11.74%,
9/13/27
16,801
17,088
APP-17458875.FP.FTS.B,
16.49%,
9/13/27
1,749
1,769
APP-16687847.FP.FTS.B,
9.49%,
9/15/27
.
6,388
6,470
APP-17490395.FP.FTS.B,
15.24%,
9/26/27
11,640
11,832
APP-17504832.FP.FTS.B,
13.74%,
9/27/27
1,818
1,826
APP-12176796.FP.FTS.B,
8.99%,
10/25/27
3,415
3,438
APP-16627732.FP.FTS.B,
12.99%,
10/25/27
..........................
9,998
10,158
b
APP-16800634.FP.FTS.B,
15.99%,
10/28/27
..........................
22,740
2,805
APP-11872544.FP.FTS.B,
19.99%,
11/25/27
1,828
1,867
APP-12199831.FP.FTS.B,
16.99%,
5/22/36
682
688
453,087
LendingClub
Corp.
-
LCX
162966512.LC.FTS.B,
11.02%,
4/12/35
...
1,591
–
Description
Principal
Amount
Value
LendingClub
Corp.
-
LCX
PM
172665217.LC.FTS.B,
15.4%,
12/04/35
...
$
531
$
531
Prosper
Funding
LLC
1592846.PS.FTS.B,
15.9%,
7/23/26
.....
575
581
1599440.PS.FTS.B,
26.4%,
8/05/26
.....
275
278
1600466.PS.FTS.B,
18.73%,
8/06/26
....
1,499
1,509
1603759.PS.FTS.B,
20.59%,
8/06/26
....
1,036
1,042
1611384.PS.FTS.B,
13.88%,
8/09/26
....
906
905
1611810.PS.FTS.B,
13%,
8/10/26
.......
223
222
1606042.PS.FTS.B,
14.74%,
8/10/26
....
2,574
1,821
1611807.PS.FTS.B,
19.33%,
8/10/26
....
1,545
1,558
1612149.PS.FTS.B,
20.7%,
8/10/26
.....
660
667
1612140.PS.FTS.B,
23.74%,
8/10/26
....
715
721
1603532.PS.FTS.B,
20.5%,
8/12/26
.....
1,156
1,168
1611322.PS.FTS.B,
12.5%,
8/19/26
.....
3,081
3,084
1618149.PS.FTS.B,
13.7%,
8/19/26
.....
878
879
1615738.PS.FTS.B,
13.3%,
8/27/26
.....
358
359
1611798.PS.FTS.B,
25.74%,
9/01/26
....
1,719
1,751
1625300.PS.FTS.B,
11.79%,
9/23/26
....
752
755
1631647.PS.FTS.B,
12.7%,
9/28/26
.....
1,786
1,793
1638105.PS.FTS.B,
13.4%,
9/28/26
.....
861
865
1648282.PS.FTS.B,
14%,
10/26/26
......
2,016
2,047
1645223.PS.FTS.B,
10.5%,
10/27/26
....
1,127
1,131
1648588.PS.FTS.B,
14.39%,
10/27/26
...
2,031
2,063
1646309.PS.FTS.B,
9.62%,
10/28/26
....
2,219
2,227
1646072.PS.FTS.B,
28.23%,
10/28/26
...
1,987
2,045
1646819.PS.FTS.B,
11.2%,
10/29/26
....
590
598
1650901.PS.FTS.B,
11.2%,
10/29/26
....
2,285
2,316
1489833.PS.FTS.B,
16.99%,
10/30/26
...
1,375
1,383
1649809.PS.FTS.B,
11.1%,
10/31/26
....
1,272
1,276
1656183.PS.FTS.B,
14.38%,
10/31/26
...
1,190
1,194
1650023.PS.FTS.B,
14.79%,
11/04/26
....
1,735
1,737
1649791.PS.FTS.B,
15.1%,
11/05/26
....
4,017
4,085
1651754.PS.FTS.B,
10.5%,
11/08/26
....
2,905
2,905
1658080.PS.FTS.B,
14.63%,
11/08/26
....
2,006
2,024
1666449.PS.FTS.B,
14.6%,
11/09/26
....
1,807
1,830
1658839.PS.FTS.B,
14.68%,
11/09/26
....
2,361
2,362
1658842.PS.FTS.B,
17%,
11/09/26
......
2,088
2,113
1667757.PS.FTS.B,
18.25%,
11/12/26
....
2,185
2,219
1661797.PS.FTS.B,
21%,
11/15/26
......
437
450
1664327.PS.FTS.B,
13.5%,
11/30/26
....
813
830
1687146.PS.FTS.B,
11.43%,
12/16/26
....
2,022
2,023
1680241.PS.FTS.B,
14.38%,
12/16/26
...
4,445
4,453
1680301.PS.FTS.B,
18.5%,
12/16/26
....
960
975
1675265.PS.FTS.B,
10.5%,
12/20/26
....
3,805
3,811
b
1688964.PS.FTS.B,
13.93%,
12/21/26
...
4,186
–
1689036.PS.FTS.B,
14.6%,
12/21/26
....
3,783
3,840
1676819.PS.FTS.B,
14.68%,
12/22/26
...
6,409
5,680
1680116.PS.FTS.B,
14%,
12/29/26
......
5,340
5,497
1690116.PS.FTS.B,
23.11%,
12/31/26
....
3,542
3,665
1694572.PS.FTS.B,
11.6%,
1/13/27
.....
4,119
4,124
b
1694593.PS.FTS.B,
23.4%,
1/13/27
.....
5,579
–
1702152.PS.FTS.B,
12.87%,
1/14/27
....
1,161
1,162
1688534.PS.FTS.B,
12.9%,
1/16/27
.....
761
759
1704984.PS.FTS.B,
10.29%,
1/19/27
....
2,397
2,403
1698709.PS.FTS.B,
15.2%,
1/20/27
.....
3,026
3,074
1674146.PS.FTS.B,
18.78%,
1/20/27
....
2,417
2,458
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Prosper
Funding
LLC
(continued)
1721439.PS.FTS.B,
12%,
2/15/27
.......
$
566
$
566
1708901.PS.FTS.B,
18.33%,
2/15/27
....
4,689
4,778
1720974.PS.FTS.B,
18.4%,
2/15/27
.....
4,657
4,735
1709498.PS.FTS.B,
25.9%,
2/16/27
.....
2,641
2,666
1708466.PS.FTS.B,
18.6%,
2/22/27
.....
1,544
1,569
1709507.PS.FTS.B,
13.5%,
3/15/27
.....
929
932
1749006.PS.FTS.B,
19.53%,
3/31/27
....
3,134
3,163
1749429.PS.FTS.B,
25.9%,
4/01/27
.....
1,895
1,944
b
1603750.PS.FTS.B,
15.9%,
5/20/27
.....
3,120
417
1722171.PS.FTS.B,
18.78%,
6/14/27
....
2,574
1,372
b
1682455.PS.FTS.B,
11.43%,
11/21/27
....
16,126
992
1739157.PS.FTS.B,
11.5%,
12/18/27
....
12,327
6,872
1708907.PS.FTS.B,
18.13%,
2/20/28
....
9,391
9,278
b
1689368.PS.FTS.B,
16.2%,
1/14/35
.....
354
–
140,001
Upgrade,
Inc.
-
Card
991762816.UG.FTS.B,
29.49%,
6/20/26
..
35
3
991545568.UG.FTS.B,
29.49%,
8/16/26
..
477
498
991721350.UG.FTS.B,
29.49%,
8/16/26
..
516
468
991573331.UG.FTS.B,
29.49%,
9/17/26
..
94
98
991658250.UG.FTS.B,
16.99%,
1/20/27
..
100
101
991645022.UG.FTS.B,
29.49%,
1/21/27
..
37
32
991721939.UG.FTS.B,
16.99%,
2/02/27
..
325
334
991894965.UG.FTS.B,
16.99%,
2/03/27
..
1,363
1,397
991579043.UG.FTS.B,
19.99%,
4/17/27
..
1,291
1,032
991663324.UG.FTS.B,
22.36%,
5/29/27
..
26
27
b
991727635.UG.FTS.B,
28.98%,
6/07/27
..
173
–
991579317.UG.FTS.B,
29.49%,
6/16/27
..
87
91
b
991693097.UG.FTS.B,
26.94%,
9/20/27
..
317
22
991716805.UG.FTS.B,
22.97%,
11/08/27
.
285
291
991664785.UG.FTS.B,
18.98%,
12/26/27
.
161
111
991735384.UG.FTS.B,
29.49%,
6/06/29
..
360
373
991587677.UG.FTS.B,
29.49%,
1/17/30
..
438
464
991719643.UG.FTS.B,
29.49%,
8/22/30
..
150
92
991883200.UG.FTS.B,
29.49%,
1/07/31
..
27
27
991758368.UG.FTS.B,
29.49%,
1/20/31
..
9
9
991754815.UG.FTS.B,
29.49%,
2/24/31
..
9
9
991695320.UG.FTS.B,
29.49%,
3/05/31
..
2
–
5,479
Upstart
Network,
Inc.
L1711804.UP.FTS.B,
9.08%,
9/14/26
.....
1,015
1,000
L1709773.UP.FTS.B,
9.1%,
9/14/26
.....
83
82
L1710250.UP.FTS.B,
9.72%,
9/14/26
....
823
812
L1711112.UP.FTS.B,
12.03%,
9/14/26
....
573
567
L1711626.UP.FTS.B,
13.98%,
9/14/26
....
2,242
2,213
L1707201.UP.FTS.B,
16.24%,
9/14/26
....
1,757
1,737
L1711610.UP.FTS.B,
17.32%,
9/14/26
....
2,981
2,940
L1708807.UP.FTS.B,
17.72%,
9/14/26
....
1,202
1,189
L1710981.UP.FTS.B,
17.81%,
9/14/26
....
1,300
1,282
L1709643.UP.FTS.B,
20.04%,
9/14/26
....
499
493
L1708429.UP.FTS.B,
20.63%,
9/14/26
....
381
375
b
L1709924.UP.FTS.B,
24.74%,
9/14/26
....
420
30
L1710379.UP.FTS.B,
24.83%,
9/14/26
....
6
6
L1710592.UP.FTS.B,
25.03%,
9/14/26
....
212
182
Description
Principal
Amount
Value
Upstart
Network,
Inc.
(continued)
L1712014.UP.FTS.B,
25.46%,
9/14/26
....
$
236
$
232
L1710375.UP.FTS.B,
25.49%,
9/14/26
....
272
268
L1711582.UP.FTS.B,
25.87%,
9/14/26
....
4,270
4,207
L1709668.UP.FTS.B,
25.91%,
9/14/26
....
209
206
FW1708283.UP.FTS.B,
30.95%,
9/14/26
..
698
605
b
FW1709045.UP.FTS.B,
31.04%,
9/14/26
..
686
146
FW1709237.UP.FTS.B,
31.24%,
9/14/26
..
760
749
FW1712567.UP.FTS.B,
31.44%,
9/14/26
..
447
441
L1709686.UP.FTS.B,
14.5%,
9/16/26
....
2,280
2,250
FW1711817.UP.FTS.B,
20.95%,
9/20/26
..
617
608
b
L1873953.UP.FTS.B,
6.89%,
10/18/26
....
9,434
796
L1873001.UP.FTS.B,
11.14%,
10/18/26
...
1,123
942
L1872155.UP.FTS.B,
11.36%,
10/18/26
...
169
167
L1873842.UP.FTS.B,
11.7%,
10/18/26
....
2,149
2,120
L1873090.UP.FTS.B,
11.9%,
10/18/26
....
193
191
FW1873975.UP.FTS.B,
13.55%,
10/18/26
.
863
852
L1874369.UP.FTS.B,
14.32%,
10/18/26
...
1,088
1,076
FW1874328.UP.FTS.B,
14.8%,
10/18/26
..
1,363
1,348
L1860167.UP.FTS.B,
14.86%,
10/18/26
...
269
224
L1873835.UP.FTS.B,
15.93%,
10/18/26
...
1,407
1,228
L1872814.UP.FTS.B,
16.38%,
10/18/26
...
1,897
1,877
L1873320.UP.FTS.B,
16.64%,
10/18/26
...
282
279
L1873707.UP.FTS.B,
17.21%,
10/18/26
...
913
903
FW1869707.UP.FTS.B,
17.52%,
10/18/26
.
2,150
2,123
L1874163.UP.FTS.B,
17.64%,
10/18/26
...
975
962
L1873356.UP.FTS.B,
19.63%,
10/18/26
...
211
208
L1872983.UP.FTS.B,
19.88%,
10/18/26
...
548
514
FW1873856.UP.FTS.B,
20.15%,
10/18/26
.
904
893
L1873825.UP.FTS.B,
20.43%,
10/18/26
...
7,565
7,460
L1873221.UP.FTS.B,
20.79%,
10/18/26
...
307
303
L1873820.UP.FTS.B,
21.93%,
10/18/26
...
426
420
L1874034.UP.FTS.B,
22.67%,
10/18/26
...
283
280
L1873180.UP.FTS.B,
24.02%,
10/18/26
...
161
159
L1873408.UP.FTS.B,
24.34%,
10/18/26
...
487
481
L1870381.UP.FTS.B,
24.72%,
10/18/26
...
1,009
995
L1868887.UP.FTS.B,
24.97%,
10/18/26
...
2,779
1,140
L1872784.UP.FTS.B,
25.04%,
10/18/26
...
1,073
1,058
L1873304.UP.FTS.B,
25.15%,
10/18/26
...
174
172
FW1873077.UP.FTS.B,
25.29%,
10/18/26
.
494
488
L1872764.UP.FTS.B,
25.4%,
10/18/26
....
248
245
L1874416.UP.FTS.B,
25.46%,
10/18/26
...
4,047
3,993
L1874151.UP.FTS.B,
25.48%,
10/18/26
...
181
179
L1870887.UP.FTS.B,
26.18%,
10/18/26
...
284
281
FW1874429.UP.FTS.B,
27.19%,
10/18/26
.
650
641
FW1873344.UP.FTS.B,
27.72%,
10/18/26
.
2,403
2,372
FW1872622.UP.FTS.B,
28.59%,
10/18/26
.
553
546
FW1874208.UP.FTS.B,
29.47%,
10/18/26
.
619
611
FW1873268.UP.FTS.B,
30.52%,
10/18/26
.
324
320
FW1872558.UP.FTS.B,
30.55%,
10/18/26
.
234
231
FW1874112.UP.FTS.B,
31.18%,
10/18/26
.
895
883
L1874280.UP.FTS.B,
15.62%,
11/01/26
...
4,694
4,645
L2010047.UP.FTS.B,
7.23%,
11/09/26
....
1,343
1,321
L1982018.UP.FTS.B,
9.85%,
11/09/26
....
716
704
L2008329.UP.FTS.B,
10.3%,
11/09/26
....
867
853
L2009188.UP.FTS.B,
10.68%,
11/09/26
...
3,071
3,028
L2009665.UP.FTS.B,
10.88%,
11/09/26
...
1,242
1,223
L2006518.UP.FTS.B,
11.38%,
11/09/26
...
394
388
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Upstart
Network,
Inc.
(continued)
L2005066.UP.FTS.B,
12.51%,
11/09/26
...
$
2,293
$
2,259
FW2004957.UP.FTS.B,
13.66%,
11/09/26
.
385
380
L2006397.UP.FTS.B,
13.66%,
11/09/26
...
1,545
1,522
L2008524.UP.FTS.B,
14.03%,
11/09/26
...
2,988
2,944
L2009234.UP.FTS.B,
14.43%,
11/09/26
...
1,091
1,077
L2008618.UP.FTS.B,
14.73%,
11/09/26
...
943
929
L2009287.UP.FTS.B,
14.91%,
11/09/26
...
915
902
L2008691.UP.FTS.B,
15.38%,
11/09/26
...
740
730
L2008772.UP.FTS.B,
15.55%,
11/09/26
...
1,596
1,576
L2009243.UP.FTS.B,
15.94%,
11/09/26
...
1,609
1,589
FW2010280.UP.FTS.B,
16.52%,
11/09/26
.
2,603
2,571
FW2009372.UP.FTS.B,
16.77%,
11/09/26
.
2,448
2,418
L2008272.UP.FTS.B,
17.06%,
11/09/26
...
3,282
3,241
L2006918.UP.FTS.B,
18.03%,
11/09/26
...
5,207
5,126
FW2005908.UP.FTS.B,
18.71%,
11/09/26
.
760
749
FW2009511.UP.FTS.B,
18.82%,
11/09/26
.
1,010
994
L2007966.UP.FTS.B,
18.98%,
11/09/26
...
340
334
L2007377.UP.FTS.B,
19.06%,
11/09/26
...
2,883
2,847
L2007099.UP.FTS.B,
20.26%,
11/09/26
...
5,547
5,450
L2008551.UP.FTS.B,
20.27%,
11/09/26
...
3,780
3,713
FW2004995.UP.FTS.B,
21%,
11/09/26
...
1,021
1,005
FW2006513.UP.FTS.B,
21.09%,
11/09/26
.
288
283
L2006375.UP.FTS.B,
21.38%,
11/09/26
...
316
311
FW2009886.UP.FTS.B,
22.16%,
11/09/26
.
722
711
L2009468.UP.FTS.B,
22.18%,
11/09/26
...
2,331
2,291
L2009034.UP.FTS.B,
22.22%,
11/09/26
...
473
464
L2007056.UP.FTS.B,
24.37%,
11/09/26
...
475
467
FW2006718.UP.FTS.B,
24.97%,
11/09/26
.
946
930
L2007001.UP.FTS.B,
25.04%,
11/09/26
...
283
278
L2009837.UP.FTS.B,
25.1%,
11/09/26
....
286
281
L2005357.UP.FTS.B,
25.2%,
11/09/26
....
944
928
L2006252.UP.FTS.B,
25.33%,
11/09/26
...
399
392
L2007046.UP.FTS.B,
25.34%,
11/09/26
...
341
336
FW2009941.UP.FTS.B,
25.35%,
11/09/26
.
1,499
1,473
L2009460.UP.FTS.B,
25.35%,
11/09/26
...
586
577
L2007026.UP.FTS.B,
25.44%,
11/09/26
...
342
336
L1976857.UP.FTS.B,
25.45%,
11/09/26
...
1,516
1,491
L2008185.UP.FTS.B,
25.45%,
11/09/26
...
767
754
FW2007576.UP.FTS.B,
26.1%,
11/09/26
..
969
952
L2009167.UP.FTS.B,
26.14%,
11/09/26
...
1,918
1,885
FW2006658.UP.FTS.B,
26.38%,
11/09/26
.
1,155
1,137
FW2008080.UP.FTS.B,
27.3%,
11/09/26
..
293
288
FW2009450.UP.FTS.B,
27.39%,
11/09/26
.
1,516
1,490
FW2005859.UP.FTS.B,
28.42%,
11/09/26
.
2,752
2,706
FW2005194.UP.FTS.B,
29.14%,
11/09/26
.
1,306
1,285
FW2005025.UP.FTS.B,
31.15%,
11/09/26
.
1,558
1,532
FW2008400.UP.FTS.B,
31.31%,
11/09/26
.
704
695
FW2009323.UP.FTS.B,
31.47%,
11/09/26
.
1,265
1,244
FW2009221.UP.FTS.B,
30.79%,
11/12/26
.
3,104
2,344
L2005604.UP.FTS.B,
7.24%,
11/15/26
....
3,725
2,985
L2009697.UP.FTS.B,
20.69%,
11/15/26
...
890
876
L2077278.UP.FTS.B,
10.24%,
11/19/26
...
237
234
L2079683.UP.FTS.B,
10.46%,
11/19/26
...
616
607
L2077229.UP.FTS.B,
11.22%,
11/19/26
...
2,940
2,900
L2079790.UP.FTS.B,
11.54%,
11/19/26
...
1,271
1,253
L2069545.UP.FTS.B,
12.88%,
11/19/26
...
911
899
L2080759.UP.FTS.B,
14.39%,
11/19/26
...
2,192
2,163
Description
Principal
Amount
Value
Upstart
Network,
Inc.
(continued)
L2077934.UP.FTS.B,
15.05%,
11/19/26
...
$
1,187
$
1,171
b
L2077136.UP.FTS.B,
16.73%,
11/19/26
...
2,286
420
FW2080998.UP.FTS.B,
16.87%,
11/19/26
.
117
116
FW2078513.UP.FTS.B,
16.88%,
11/19/26
.
2,947
2,918
L2079147.UP.FTS.B,
16.93%,
11/19/26
...
2,655
2,629
L2073789.UP.FTS.B,
17.39%,
11/19/26
...
654
242
L2079089.UP.FTS.B,
19.11%,
11/19/26
...
1,001
991
L2079136.UP.FTS.B,
19.7%,
11/19/26
....
2,838
2,801
FW2076082.UP.FTS.B,
20.04%,
11/19/26
.
2,431
2,401
L2077767.UP.FTS.B,
20.73%,
11/19/26
...
1,752
1,729
FW2080860.UP.FTS.B,
21.93%,
11/19/26
.
3,142
3,100
L2080597.UP.FTS.B,
22.59%,
11/19/26
...
398
393
L2079001.UP.FTS.B,
24.08%,
11/19/26
...
1,399
1,380
b
FW2076263.UP.FTS.B,
24.18%,
11/19/26
.
944
66
FW2080275.UP.FTS.B,
26.15%,
11/19/26
.
670
662
L2075827.UP.FTS.B,
27%,
11/19/26
.....
1,808
1,786
L2078364.UP.FTS.B,
15.16%,
11/20/26
...
954
944
FW2009687.UP.FTS.B,
29.61%,
11/21/26
.
1,038
1,021
L2008677.UP.FTS.B,
10.77%,
11/23/26
...
1,466
1,444
L2010117.UP.FTS.B,
24.96%,
11/23/26
...
764
751
FW2007433.UP.FTS.B,
21.02%,
11/24/26
.
1,305
1,283
L2079956.UP.FTS.B,
14.89%,
12/01/26
...
1,268
1,255
FW2080677.UP.FTS.B,
18.72%,
12/04/26
.
3,678
2,601
L2196810.UP.FTS.B,
7.42%,
12/07/26
....
934
917
L2198501.UP.FTS.B,
8.94%,
12/07/26
....
640
629
L2195995.UP.FTS.B,
9.12%,
12/07/26
....
692
680
L2197856.UP.FTS.B,
11.23%,
12/07/26
...
906
892
FW2199260.UP.FTS.B,
12.51%,
12/07/26
.
4,204
4,138
L2200250.UP.FTS.B,
13.28%,
12/07/26
...
872
858
L2197658.UP.FTS.B,
13.72%,
12/07/26
...
895
655
b
FW2198593.UP.FTS.B,
14.12%,
12/07/26
.
1,695
122
L2199997.UP.FTS.B,
14.15%,
12/07/26
...
655
644
L2198350.UP.FTS.B,
15.19%,
12/07/26
...
139
137
L2199879.UP.FTS.B,
16.31%,
12/07/26
...
2,346
961
L2198446.UP.FTS.B,
16.58%,
12/07/26
...
8,555
8,443
b
L2198345.UP.FTS.B,
17.18%,
12/07/26
...
5,774
1,153
L2198376.UP.FTS.B,
17.42%,
12/07/26
...
4,226
4,154
L2199726.UP.FTS.B,
18.1%,
12/07/26
....
1,141
1,126
L2196412.UP.FTS.B,
18.83%,
12/07/26
...
346
342
L2199248.UP.FTS.B,
19.04%,
12/07/26
...
2,961
2,922
L2199129.UP.FTS.B,
20.12%,
12/07/26
...
434
428
L2197655.UP.FTS.B,
20.75%,
12/07/26
...
999
980
L2196680.UP.FTS.B,
21.47%,
12/07/26
...
1,199
1,179
L2199874.UP.FTS.B,
22.34%,
12/07/26
...
1,683
1,651
L2192706.UP.FTS.B,
22.47%,
12/07/26
...
2,043
2,006
FW2196522.UP.FTS.B,
23.26%,
12/07/26
.
761
55
b
L2200210.UP.FTS.B,
24.56%,
12/07/26
...
6,477
461
L2198546.UP.FTS.B,
25.32%,
12/07/26
...
322
317
L2197183.UP.FTS.B,
25.46%,
12/07/26
...
367
361
L2197844.UP.FTS.B,
25.47%,
12/07/26
...
601
589
L2199814.UP.FTS.B,
25.68%,
12/07/26
...
1,297
1,273
FW2199793.UP.FTS.B,
25.9%,
12/07/26
..
1,735
1,704
FW2200069.UP.FTS.B,
28.54%,
12/07/26
.
774
617
FW2198176.UP.FTS.B,
29.22%,
12/07/26
.
610
598
FW2199632.UP.FTS.B,
32.42%,
12/07/26
.
1,179
1,158
L2201100.UP.FTS.B,
5.82%,
12/08/26
....
1,508
1,478
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Upstart
Network,
Inc.
(continued)
L2203382.UP.FTS.B,
6.5%,
12/08/26
....
$
1,527
$
1,498
L2206413.UP.FTS.B,
7.44%,
12/08/26
....
1,024
1,008
L2201126.UP.FTS.B,
7.87%,
12/08/26
....
1,493
1,473
L2200918.UP.FTS.B,
8.74%,
12/08/26
....
687
676
FW2202215.UP.FTS.B,
9.76%,
12/08/26
..
4,165
4,106
L2205258.UP.FTS.B,
10.97%,
12/08/26
...
504
496
L2202707.UP.FTS.B,
11.01%,
12/08/26
...
677
668
L2200873.UP.FTS.B,
11.09%,
12/08/26
...
1,504
1,481
L2205661.UP.FTS.B,
11.13%,
12/08/26
...
2,006
1,975
FW2202691.UP.FTS.B,
11.21%,
12/08/26
.
502
494
FW2201210.UP.FTS.B,
12.48%,
12/08/26
.
342
337
b
L2202867.UP.FTS.B,
13.27%,
12/08/26
...
694
158
L2202534.UP.FTS.B,
13.68%,
12/08/26
...
2,634
2,593
L2200884.UP.FTS.B,
13.99%,
12/08/26
...
1,307
1,286
L2201701.UP.FTS.B,
14.19%,
12/08/26
...
1,240
1,221
L2200543.UP.FTS.B,
14.23%,
12/08/26
...
979
964
FW2206534.UP.FTS.B,
14.38%,
12/08/26
.
567
558
FW2201365.UP.FTS.B,
14.41%,
12/08/26
.
2,578
2,539
L2205970.UP.FTS.B,
14.78%,
12/08/26
...
471
464
L2203172.UP.FTS.B,
14.86%,
12/08/26
...
1,795
1,767
L2203888.UP.FTS.B,
15.35%,
12/08/26
...
543
534
L2205432.UP.FTS.B,
15.94%,
12/08/26
...
4,228
4,174
L2195672.UP.FTS.B,
16.2%,
12/08/26
....
2,371
2,341
L2203269.UP.FTS.B,
16.66%,
12/08/26
...
835
824
L2200406.UP.FTS.B,
17.28%,
12/08/26
...
825
815
L2203876.UP.FTS.B,
17.53%,
12/08/26
...
4,698
3,363
L2202653.UP.FTS.B,
17.59%,
12/08/26
...
2,339
2,309
L2200437.UP.FTS.B,
17.72%,
12/08/26
...
472
464
L2206114.UP.FTS.B,
17.92%,
12/08/26
...
385
380
L2201870.UP.FTS.B,
17.98%,
12/08/26
...
570
561
L2202316.UP.FTS.B,
18.78%,
12/08/26
...
579
211
L2171699.UP.FTS.B,
19.26%,
12/08/26
...
1,692
1,661
FW2201480.UP.FTS.B,
19.28%,
12/08/26
.
1,363
1,345
L2201833.UP.FTS.B,
19.78%,
12/08/26
...
972
957
L2203346.UP.FTS.B,
19.86%,
12/08/26
...
1,257
1,241
L2200528.UP.FTS.B,
20.47%,
12/08/26
...
694
683
L2201790.UP.FTS.B,
20.6%,
12/08/26
....
557
548
L2203266.UP.FTS.B,
21.37%,
12/08/26
...
1,058
1,039
L2203685.UP.FTS.B,
21.52%,
12/08/26
...
707
694
L2206634.UP.FTS.B,
21.58%,
12/08/26
...
444
436
FW2202543.UP.FTS.B,
22.46%,
12/08/26
.
241
237
L2200624.UP.FTS.B,
22.5%,
12/08/26
....
410
404
L2203293.UP.FTS.B,
22.93%,
12/08/26
...
351
345
L2203557.UP.FTS.B,
23.55%,
12/08/26
...
132
130
b
L2197277.UP.FTS.B,
23.68%,
12/08/26
...
1,999
155
FW2200085.UP.FTS.B,
23.88%,
12/08/26
.
477
35
L2204440.UP.FTS.B,
24.51%,
12/08/26
...
254
250
L2200752.UP.FTS.B,
24.63%,
12/08/26
...
213
209
FW2200668.UP.FTS.B,
24.66%,
12/08/26
.
1,550
1,521
L2201876.UP.FTS.B,
24.84%,
12/08/26
...
236
232
L2200418.UP.FTS.B,
24.91%,
12/08/26
...
1,407
1,384
L2204236.UP.FTS.B,
25.3%,
12/08/26
....
353
346
L2204385.UP.FTS.B,
25.38%,
12/08/26
...
262
257
L2204272.UP.FTS.B,
25.42%,
12/08/26
...
188
185
L2200539.UP.FTS.B,
25.48%,
12/08/26
...
1,183
1,162
L2202382.UP.FTS.B,
25.5%,
12/08/26
....
388
381
L2206619.UP.FTS.B,
25.63%,
12/08/26
...
1,621
1,593
Description
Principal
Amount
Value
Upstart
Network,
Inc.
(continued)
L2205529.UP.FTS.B,
25.96%,
12/08/26
...
$
1,520
$
1,493
FW2200840.UP.FTS.B,
27.39%,
12/08/26
.
1,868
1,836
FW2200263.UP.FTS.B,
28.29%,
12/08/26
.
4,301
4,227
FW2203128.UP.FTS.B,
28.72%,
12/08/26
.
225
221
FW2201641.UP.FTS.B,
29.67%,
12/08/26
.
1,887
1,855
FW2206862.UP.FTS.B,
29.87%,
12/08/26
.
265
261
FW2202866.UP.FTS.B,
30.6%,
12/08/26
..
329
229
FW2203290.UP.FTS.B,
31.07%,
12/08/26
.
329
324
FW2205002.UP.FTS.B,
31.08%,
12/08/26
.
744
731
FW2200524.UP.FTS.B,
31.14%,
12/08/26
.
784
770
FW2199311.UP.FTS.B,
31.18%,
12/08/26
.
330
325
FW2199186.UP.FTS.B,
25.95%,
12/09/26
.
460
452
FW2200076.UP.FTS.B,
28.24%,
12/13/26
.
11,318
11,117
L2202911.UP.FTS.B,
21.13%,
12/14/26
...
1,255
1,234
FW2203667.UP.FTS.B,
23.01%,
12/14/26
.
3,066
3,012
L2196899.UP.FTS.B,
24.65%,
12/15/26
...
1,241
1,219
FW2199126.UP.FTS.B,
31.54%,
12/15/26
.
1,480
1,456
L2200110.UP.FTS.B,
25.93%,
12/16/26
...
1,768
1,446
L2203117.UP.FTS.B,
13.79%,
12/17/26
...
1,519
1,495
b
L2201499.UP.FTS.B,
21.34%,
12/17/26
...
3,493
255
FW2205704.UP.FTS.B,
28.05%,
12/18/26
.
1,127
1,108
L2206448.UP.FTS.B,
16%,
12/19/26
.....
1,778
1,752
L2196775.UP.FTS.B,
22.04%,
12/19/26
...
205
202
b
FW2197646.UP.FTS.B,
16.34%,
1/01/27
..
2,680
193
L2411009.UP.FTS.B,
5.26%,
1/11/27
.....
5,848
5,726
L2402399.UP.FTS.B,
6.09%,
1/11/27
.....
4,602
4,507
L2413519.UP.FTS.B,
6.19%,
1/11/27
.....
3,805
3,730
FW2406810.UP.FTS.B,
7.3%,
1/11/27
....
761
748
L2408660.UP.FTS.B,
7.61%,
1/11/27
.....
1,208
1,186
L2412785.UP.FTS.B,
7.81%,
1/11/27
.....
351
345
L2413727.UP.FTS.B,
8.61%,
1/11/27
.....
871
304
L2407187.UP.FTS.B,
8.85%,
1/11/27
.....
891
875
FW2411415.UP.FTS.B,
9.04%,
1/11/27
...
1,113
1,094
L2410685.UP.FTS.B,
9.48%,
1/11/27
.....
1,914
1,249
FW2406985.UP.FTS.B,
9.83%,
1/11/27
...
547
537
L2411458.UP.FTS.B,
10.12%,
1/11/27
....
404
397
L2413945.UP.FTS.B,
10.53%,
1/11/27
....
4,069
4,005
L2413044.UP.FTS.B,
11.78%,
1/11/27
....
1,565
1,540
L2412100.UP.FTS.B,
13.07%,
1/11/27
....
1,274
1,254
L2411596.UP.FTS.B,
13.42%,
1/11/27
....
969
954
FW2412839.UP.FTS.B,
13.8%,
1/11/27
...
2,141
2,107
FW2407206.UP.FTS.B,
13.82%,
1/11/27
..
1,178
1,160
L2409821.UP.FTS.B,
14.42%,
1/11/27
....
1,073
1,056
L2410324.UP.FTS.B,
14.46%,
1/11/27
....
3,988
3,925
L2408774.UP.FTS.B,
14.55%,
1/11/27
....
796
787
L2408843.UP.FTS.B,
14.84%,
1/11/27
....
427
421
L2406986.UP.FTS.B,
16.62%,
1/11/27
....
1,033
1,020
L2412621.UP.FTS.B,
16.62%,
1/11/27
....
826
816
FW2411635.UP.FTS.B,
17.05%,
1/11/27
..
1,061
1,044
L2411840.UP.FTS.B,
17.48%,
1/11/27
....
6,377
4,384
L2406982.UP.FTS.B,
17.53%,
1/11/27
....
2,170
1,501
FW2411466.UP.FTS.B,
17.75%,
1/11/27
..
422
416
L2407285.UP.FTS.B,
17.96%,
1/11/27
....
1,233
431
L2410765.UP.FTS.B,
18.19%,
1/11/27
....
1,512
1,493
L2412345.UP.FTS.B,
18.51%,
1/11/27
....
628
618
FW2406958.UP.FTS.B,
18.83%,
1/11/27
..
328
323
L2407160.UP.FTS.B,
18.83%,
1/11/27
....
3,753
3,708
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Upstart
Network,
Inc.
(continued)
L2412374.UP.FTS.B,
19.25%,
1/11/27
....
$
2,657
$
2,610
FW2410395.UP.FTS.B,
20.34%,
1/11/27
..
1,100
1,083
FW2412890.UP.FTS.B,
20.68%,
1/11/27
..
2,300
2,260
L2407644.UP.FTS.B,
21.08%,
1/11/27
....
890
875
L2410907.UP.FTS.B,
21.6%,
1/11/27
.....
808
794
L2410622.UP.FTS.B,
23.11%,
1/11/27
....
1,105
1,087
FW2412083.UP.FTS.B,
23.34%,
1/11/27
..
1,061
1,043
FW2412786.UP.FTS.B,
24.26%,
1/11/27
..
1,744
1,715
FW2407461.UP.FTS.B,
25.01%,
1/11/27
..
1,187
1,167
L2407824.UP.FTS.B,
25.08%,
1/11/27
....
975
958
L2406959.UP.FTS.B,
25.22%,
1/11/27
....
416
409
L2413560.UP.FTS.B,
25.29%,
1/11/27
....
871
856
b
FW2411982.UP.FTS.B,
25.34%,
1/11/27
..
1,780
128
b
L2411780.UP.FTS.B,
25.37%,
1/11/27
....
142
52
L2409900.UP.FTS.B,
25.4%,
1/11/27
.....
208
205
L2411491.UP.FTS.B,
25.4%,
1/11/27
.....
131
129
L2411973.UP.FTS.B,
25.47%,
1/11/27
....
310
305
FW2412928.UP.FTS.B,
25.61%,
1/11/27
..
480
472
FW2411046.UP.FTS.B,
26.47%,
1/11/27
..
2,397
1,690
b
L2409231.UP.FTS.B,
26.66%,
1/11/27
....
1,381
251
FW2406988.UP.FTS.B,
27.86%,
1/11/27
..
1,241
1,220
FW2410159.UP.FTS.B,
27.94%,
1/11/27
..
1,008
991
FW2411293.UP.FTS.B,
29.42%,
1/11/27
..
407
400
FW2407567.UP.FTS.B,
29.43%,
1/11/27
..
1,132
809
FW2408568.UP.FTS.B,
29.5%,
1/11/27
...
1,141
1,123
FW2412942.UP.FTS.B,
30.18%,
1/11/27
..
1,061
1,044
FW2413390.UP.FTS.B,
30.33%,
1/11/27
..
1,054
1,037
FW2413147.UP.FTS.B,
30.55%,
1/11/27
..
1,318
896
FW2412502.UP.FTS.B,
30.76%,
1/11/27
..
3,873
3,811
FW2411299.UP.FTS.B,
30.92%,
1/11/27
..
430
423
FW2392367.UP.FTS.B,
30.94%,
1/11/27
..
537
528
FW2411010.UP.FTS.B,
31.02%,
1/11/27
..
1,172
1,153
FW2407947.UP.FTS.B,
31.05%,
1/11/27
..
963
707
FW2411738.UP.FTS.B,
31.08%,
1/11/27
..
439
432
FW2410751.UP.FTS.B,
34.47%,
1/11/27
..
1,335
1,322
L2414801.UP.FTS.B,
6.11%,
1/12/27
.....
1,851
1,813
L2419361.UP.FTS.B,
6.41%,
1/12/27
....
256
251
L2402757.UP.FTS.B,
6.51%,
1/12/27
....
1,055
1,035
L2416784.UP.FTS.B,
6.53%,
1/12/27
....
343
336
L2418799.UP.FTS.B,
6.56%,
1/12/27
....
2,073
2,030
FW2414856.UP.FTS.B,
6.64%,
1/12/27
...
172
168
L2416695.UP.FTS.B,
6.86%,
1/12/27
....
777
761
L2414595.UP.FTS.B,
7.05%,
1/12/27
....
1,299
1,275
L2410292.UP.FTS.B,
7.3%,
1/12/27
.....
642
631
L2417990.UP.FTS.B,
7.34%,
1/12/27
....
8,704
8,549
L2417199.UP.FTS.B,
7.43%,
1/12/27
....
6,731
6,618
FW2419541.UP.FTS.B,
7.5%,
1/12/27
....
2,300
2,261
L2414153.UP.FTS.B,
7.51%,
1/12/27
....
436
427
L2417691.UP.FTS.B,
7.69%,
1/12/27
....
3,918
3,838
L2418009.UP.FTS.B,
9.08%,
1/12/27
....
2,159
2,121
L2414926.UP.FTS.B,
9.43%,
1/12/27
....
5,739
5,636
L2413887.UP.FTS.B,
9.49%,
1/12/27
....
1,090
1,073
FW2415990.UP.FTS.B,
9.9%,
1/12/27
....
6,212
4,193
L2414275.UP.FTS.B,
9.91%,
1/12/27
....
6,394
6,286
L2417012.UP.FTS.B,
10.17%,
1/12/27
....
322
316
FW2417548.UP.FTS.B,
10.24%,
1/12/27
..
2,759
2,710
FW2417403.UP.FTS.B,
10.31%,
1/12/27
..
1,292
1,272
Description
Principal
Amount
Value
Upstart
Network,
Inc.
(continued)
L2414718.UP.FTS.B,
10.85%,
1/12/27
....
$
744
$
732
L2414779.UP.FTS.B,
11.77%,
1/12/27
....
757
746
L2419353.UP.FTS.B,
12.95%,
1/12/27
....
6,312
6,215
L2414553.UP.FTS.B,
14.38%,
1/12/27
....
4,409
2,994
L2418960.UP.FTS.B,
15.54%,
1/12/27
....
4,052
4,005
L2414253.UP.FTS.B,
16.15%,
1/12/27
....
1,650
1,630
L2414473.UP.FTS.B,
16.4%,
1/12/27
....
178
176
L2420474.UP.FTS.B,
16.75%,
1/12/27
....
3,126
3,079
L2417581.UP.FTS.B,
17.27%,
1/12/27
....
919
909
FW2415024.UP.FTS.B,
19.94%,
1/12/27
..
1,903
1,872
L2418100.UP.FTS.B,
20.74%,
1/12/27
....
4,011
3,951
L2389418.UP.FTS.B,
22.12%,
1/12/27
....
1,658
564
FW2416362.UP.FTS.B,
23.42%,
1/12/27
..
989
973
L2409743.UP.FTS.B,
23.49%,
1/12/27
....
3,098
1,993
L2415306.UP.FTS.B,
24.21%,
1/12/27
....
2,529
2,488
L2411740.UP.FTS.B,
25.36%,
1/12/27
....
382
376
L2414777.UP.FTS.B,
25.43%,
1/12/27
....
312
307
L2418684.UP.FTS.B,
25.49%,
1/12/27
....
722
710
FW2418174.UP.FTS.B,
25.89%,
1/12/27
..
2,280
2,244
FW2419574.UP.FTS.B,
26.43%,
1/12/27
..
4,267
4,198
b
FW2418008.UP.FTS.B,
28.88%,
1/12/27
..
555
103
FW2418392.UP.FTS.B,
30.87%,
1/12/27
..
523
515
FW2416140.UP.FTS.B,
30.99%,
1/12/27
..
572
563
FW2419527.UP.FTS.B,
33.12%,
1/12/27
..
271
266
L2418737.UP.FTS.B,
5.93%,
1/16/27
....
678
664
L2410494.UP.FTS.B,
17.56%,
1/16/27
....
4,230
4,178
L2413379.UP.FTS.B,
24.03%,
1/18/27
....
4,723
4,644
FW2415348.UP.FTS.B,
30.45%,
1/19/27
..
5,146
5,063
L2419563.UP.FTS.B,
14.64%,
1/27/27
....
5,683
5,596
L2417088.UP.FTS.B,
15.78%,
2/12/27
....
1,756
1,736
L1708544.UP.FTS.B,
12.57%,
2/14/27
....
761
749
FW1708581.UP.FTS.B,
23.53%,
2/14/27
..
876
863
L1709217.UP.FTS.B,
25.78%,
2/14/27
....
8,173
6,384
L2632551.UP.FTS.B,
5.37%,
2/15/27
....
2,228
2,179
L2632779.UP.FTS.B,
5.63%,
2/15/27
....
1,305
1,276
L2630774.UP.FTS.B,
8.69%,
2/15/27
....
791
773
L2635638.UP.FTS.B,
9.41%,
2/15/27
....
1,297
1,276
FW2633029.UP.FTS.B,
9.57%,
2/15/27
...
301
295
FW2635247.UP.FTS.B,
10.37%,
2/15/27
..
1,712
1,684
L2633836.UP.FTS.B,
12%,
2/15/27
......
2,281
2,244
L2630147.UP.FTS.B,
12.15%,
2/15/27
....
8,435
8,302
L2635861.UP.FTS.B,
12.41%,
2/15/27
....
1,796
1,768
L2637042.UP.FTS.B,
13.14%,
2/15/27
....
1,715
1,688
L2631332.UP.FTS.B,
13.22%,
2/15/27
....
1,073
1,056
FW2633237.UP.FTS.B,
13.24%,
2/15/27
..
762
750
b
L2632724.UP.FTS.B,
14.48%,
2/15/27
....
1,485
246
L2637603.UP.FTS.B,
14.83%,
2/15/27
....
1,402
1,380
FW2631558.UP.FTS.B,
15.18%,
2/15/27
..
3,327
3,275
L2635221.UP.FTS.B,
15.45%,
2/15/27
....
1,285
1,266
FW2631951.UP.FTS.B,
15.91%,
2/15/27
..
2,252
1,721
L2635424.UP.FTS.B,
16.37%,
2/15/27
....
9,059
8,958
FW2635945.UP.FTS.B,
17.32%,
2/15/27
..
1,265
1,246
FW2635531.UP.FTS.B,
18.53%,
2/15/27
..
2,769
2,738
L2633648.UP.FTS.B,
20.29%,
2/15/27
....
2,347
2,320
L2632212.UP.FTS.B,
21.09%,
2/15/27
....
950
936
FW2631142.UP.FTS.B,
21.84%,
2/15/27
..
744
732
L2636740.UP.FTS.B,
22.15%,
2/15/27
....
251
247
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Upstart
Network,
Inc.
(continued)
L2633500.UP.FTS.B,
22.28%,
2/15/27
....
$
1,281
$
1,261
L2629665.UP.FTS.B,
24.47%,
2/15/27
....
1,972
1,548
L2634268.UP.FTS.B,
25.05%,
2/15/27
....
584
575
L2632154.UP.FTS.B,
25.31%,
2/15/27
....
6,139
6,047
L2631893.UP.FTS.B,
25.41%,
2/15/27
....
892
879
L2634591.UP.FTS.B,
25.45%,
2/15/27
....
288
283
FW2631141.UP.FTS.B,
25.72%,
2/15/27
..
3,470
3,418
L2634677.UP.FTS.B,
25.78%,
2/15/27
....
1,053
1,037
L2636195.UP.FTS.B,
25.92%,
2/15/27
....
3,952
3,893
L2635199.UP.FTS.B,
26.23%,
2/15/27
....
1,667
1,642
FW2634760.UP.FTS.B,
26.38%,
2/15/27
..
1,564
1,540
FW2637086.UP.FTS.B,
26.68%,
2/15/27
..
880
866
FW2632183.UP.FTS.B,
27.72%,
2/15/27
..
1,916
1,888
FW2629864.UP.FTS.B,
30.9%,
2/15/27
...
732
576
FW2631968.UP.FTS.B,
30.98%,
2/15/27
..
802
790
FW2633604.UP.FTS.B,
31.13%,
2/15/27
..
751
740
L2641249.UP.FTS.B,
9.09%,
2/16/27
....
2,927
2,873
FW2640044.UP.FTS.B,
9.77%,
2/16/27
...
1,117
1,097
L2628258.UP.FTS.B,
10.4%,
2/16/27
....
3,320
3,268
L2639939.UP.FTS.B,
10.73%,
2/16/27
....
2,943
2,897
L2640107.UP.FTS.B,
11.57%,
2/16/27
....
2,229
2,195
L2642580.UP.FTS.B,
11.66%,
2/16/27
....
730
719
L2642829.UP.FTS.B,
11.96%,
2/16/27
....
4,489
4,420
L2637999.UP.FTS.B,
12.45%,
2/16/27
....
2,367
2,331
L2639543.UP.FTS.B,
14.06%,
2/16/27
....
2,178
2,145
L2637807.UP.FTS.B,
14.59%,
2/16/27
....
3,183
3,135
L2643572.UP.FTS.B,
14.72%,
2/16/27
....
440
434
FW2640160.UP.FTS.B,
14.88%,
2/16/27
..
5,079
5,001
FW2643607.UP.FTS.B,
16.31%,
2/16/27
..
11,304
11,183
FW2638305.UP.FTS.B,
16.48%,
2/16/27
..
2,484
2,457
L2639711.UP.FTS.B,
16.7%,
2/16/27
.....
364
360
L2641429.UP.FTS.B,
17.81%,
2/16/27
....
3,015
2,983
L2638277.UP.FTS.B,
18.32%,
2/16/27
....
1,177
1,164
FW2640938.UP.FTS.B,
20.16%,
2/16/27
..
2,637
2,597
L2643431.UP.FTS.B,
20.38%,
2/16/27
....
4,039
3,098
FW2639130.UP.FTS.B,
21.01%,
2/16/27
..
977
963
L2631819.UP.FTS.B,
22.11%,
2/16/27
....
4,432
4,365
L2637903.UP.FTS.B,
22.13%,
2/16/27
....
2,857
2,817
FW2643737.UP.FTS.B,
23.79%,
2/16/27
..
4,481
1,528
L2644184.UP.FTS.B,
24.14%,
2/16/27
....
2,556
2,530
L2638887.UP.FTS.B,
24.84%,
2/16/27
....
519
511
L2642235.UP.FTS.B,
24.97%,
2/16/27
....
392
386
L2644251.UP.FTS.B,
25.49%,
2/16/27
....
325
321
L2643938.UP.FTS.B,
25.5%,
2/16/27
....
415
409
L2638678.UP.FTS.B,
25.84%,
2/16/27
....
1,770
1,744
FW2638017.UP.FTS.B,
27.09%,
2/16/27
..
2,306
2,274
FW2636711.UP.FTS.B,
27.4%,
2/16/27
...
2,704
2,666
FW2644630.UP.FTS.B,
28.55%,
2/16/27
..
2,916
2,876
FW2639696.UP.FTS.B,
30.14%,
2/16/27
..
280
276
FW2639361.UP.FTS.B,
31.17%,
2/16/27
..
397
392
FW2638060.UP.FTS.B,
31.21%,
2/16/27
..
742
732
FW2645630.UP.FTS.B,
12.87%,
2/17/27
..
1,906
1,879
L2644980.UP.FTS.B,
12.95%,
2/17/27
....
347
342
FW2645588.UP.FTS.B,
15.61%,
2/17/27
..
875
750
b
L2645010.UP.FTS.B,
20.52%,
2/17/27
....
3,456
592
FW2642053.UP.FTS.B,
21.61%,
2/17/27
..
1,026
1,011
L2645131.UP.FTS.B,
25.45%,
2/17/27
....
329
325
Description
Principal
Amount
Value
Upstart
Network,
Inc.
(continued)
FW2645571.UP.FTS.B,
26.48%,
2/17/27
..
$
1,063
$
1,049
FW2645842.UP.FTS.B,
30.86%,
2/17/27
..
773
762
FW2639867.UP.FTS.B,
26.3%,
2/19/27
...
558
550
L2633374.UP.FTS.B,
7.21%,
2/22/27
....
3,665
3,583
FW2636201.UP.FTS.B,
12.12%,
2/28/27
..
1,483
1,459
FW2645675.UP.FTS.B,
15.8%,
2/28/27
...
6,143
6,080
L2643974.UP.FTS.B,
25.5%,
2/28/27
....
963
950
FW2644598.UP.FTS.B,
29.38%,
3/01/27
..
3,239
3,194
L1874284.UP.FTS.B,
13.39%,
3/18/27
....
1,599
1,575
L1874238.UP.FTS.B,
17.32%,
3/18/27
....
1,703
1,302
b
L1873877.UP.FTS.B,
25.05%,
3/18/27
....
2,038
148
FW1873866.UP.FTS.B,
28.25%,
3/18/27
..
283
20
b
FW1872975.UP.FTS.B,
32.03%,
3/18/27
..
1,693
121
L1874548.UP.FTS.B,
26.04%,
3/26/27
....
2,004
1,978
b
L1873528.UP.FTS.B,
25.71%,
3/28/27
....
3,114
224
FW2204427.UP.FTS.B,
30.34%,
4/08/27
..
2,842
1,832
L1947969.UP.FTS.B,
8.25%,
4/09/27
....
695
428
L2004674.UP.FTS.B,
22.44%,
4/09/27
....
3,420
3,365
L2006933.UP.FTS.B,
23.7%,
4/09/27
....
1,801
1,771
L2006560.UP.FTS.B,
24.67%,
4/09/27
....
2,395
2,354
L2004971.UP.FTS.B,
25.6%,
4/09/27
....
2,937
2,882
FW2007255.UP.FTS.B,
28.65%,
4/09/27
..
1,565
1,539
FW2009107.UP.FTS.B,
29.81%,
4/09/27
..
1,191
1,170
FW2008461.UP.FTS.B,
31.23%,
4/09/27
..
457
450
L2079526.UP.FTS.B,
17.98%,
4/19/27
....
1,024
771
L2078541.UP.FTS.B,
18.53%,
4/19/27
....
891
878
L2076557.UP.FTS.B,
21.86%,
4/19/27
....
7,337
7,248
L2078089.UP.FTS.B,
22.76%,
4/19/27
....
6,295
6,211
FW2077484.UP.FTS.B,
23.29%,
4/19/27
..
6,043
1,915
FW2076494.UP.FTS.B,
27.89%,
4/19/27
..
1,461
1,444
L2005313.UP.FTS.B,
17.04%,
4/20/27
....
11,268
11,132
FW2009466.UP.FTS.B,
29.96%,
4/24/27
..
224
221
L2412142.UP.FTS.B,
8.74%,
4/26/27
....
4,937
4,838
L2196542.UP.FTS.B,
14.21%,
5/07/27
....
2,903
1,711
FW2198673.UP.FTS.B,
15.71%,
5/07/27
..
7,453
4,443
L2197891.UP.FTS.B,
23.8%,
5/07/27
....
940
923
FW2198564.UP.FTS.B,
27.96%,
5/07/27
..
1,776
1,111
FW2197220.UP.FTS.B,
29.81%,
5/07/27
..
932
916
b
L2203856.UP.FTS.B,
13.82%,
5/08/27
....
12,256
883
b
L2205436.UP.FTS.B,
16.02%,
5/08/27
....
13,386
2,061
L2201272.UP.FTS.B,
16.5%,
5/08/27
....
1,407
1,381
L2205691.UP.FTS.B,
16.93%,
5/08/27
....
9,261
670
L2203740.UP.FTS.B,
19.62%,
5/08/27
....
710
698
b
FW2202220.UP.FTS.B,
20.45%,
5/08/27
..
10,488
824
L2204624.UP.FTS.B,
23.54%,
5/08/27
....
8,815
5,509
L2204118.UP.FTS.B,
23.56%,
5/08/27
....
6,251
6,140
FW2202542.UP.FTS.B,
24.64%,
5/08/27
..
1,665
1,638
L2203217.UP.FTS.B,
25.16%,
5/08/27
....
391
385
FW2201944.UP.FTS.B,
25.52%,
5/08/27
..
2,347
1,433
L2195192.UP.FTS.B,
17.22%,
5/15/27
....
1,129
1,115
b
L2197038.UP.FTS.B,
12.26%,
5/16/27
....
1,395
101
FW2198942.UP.FTS.B,
24.77%,
5/18/27
..
6,397
4,819
FW2645832.UP.FTS.B,
18.88%,
5/21/27
..
5,156
5,103
L2194879.UP.FTS.B,
17.51%,
5/22/27
....
5,980
5,906
L2195912.UP.FTS.B,
25.21%,
5/22/27
....
2,414
2,368
FW2195399.UP.FTS.B,
29.81%,
5/22/27
..
1,048
1,032
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Description
Principal
Amount
Value
Marketplace
Loans
(continued)
Upstart
Network,
Inc.
(continued)
L2203741.UP.FTS.B,
7.33%,
5/23/27
....
$
4,128
$
4,043
FW2199867.UP.FTS.B,
13.82%,
5/23/27
..
5,400
5,307
L2203381.UP.FTS.B,
18.04%,
5/23/27
....
1,994
1,969
L2204897.UP.FTS.B,
23.87%,
5/23/27
....
11,416
8,380
L2206744.UP.FTS.B,
13.51%,
5/28/27
....
7,052
6,933
FW2185665.UP.FTS.B,
20.17%,
6/08/27
..
2,760
198
L2412468.UP.FTS.B,
7.67%,
6/11/27
.....
13,688
7,649
L2412874.UP.FTS.B,
8.03%,
6/11/27
.....
1,994
580
L2412901.UP.FTS.B,
8.44%,
6/11/27
.....
4,199
2,370
L2408318.UP.FTS.B,
10.27%,
6/11/27
....
1,184
1,162
L2413229.UP.FTS.B,
11.26%,
6/11/27
....
7,138
7,009
FW2407472.UP.FTS.B,
18.08%,
6/11/27
..
9,110
8,951
b
L2413373.UP.FTS.B,
23.72%,
6/11/27
....
16,202
1,174
FW2409812.UP.FTS.B,
24.81%,
6/11/27
..
1,188
1,168
FW2411228.UP.FTS.B,
26.37%,
6/11/27
..
1,770
1,744
FW2413018.UP.FTS.B,
30.69%,
6/11/27
..
309
303
b
L2415490.UP.FTS.B,
12.71%,
6/12/27
....
6,033
436
b
L2418697.UP.FTS.B,
22.86%,
6/12/27
....
1,820
288
L2416737.UP.FTS.B,
23.4%,
6/12/27
....
750
511
FW2418092.UP.FTS.B,
30.98%,
6/12/27
..
582
573
FW2411936.UP.FTS.B,
13.61%,
6/26/27
..
2,237
2,197
b
L2198053.UP.FTS.B,
20.47%,
7/08/27
....
1,817
283
FW1711888.UP.FTS.B,
15.29%,
7/14/27
..
2,103
2,079
L2637476.UP.FTS.B,
21.48%,
7/15/27
....
4,389
315
L2633167.UP.FTS.B,
24.54%,
7/15/27
....
2,466
2,429
FW2634310.UP.FTS.B,
27.59%,
7/15/27
..
3,560
2,592
FW2634423.UP.FTS.B,
28.99%,
7/15/27
..
10,120
9,985
FW2637881.UP.FTS.B,
14.54%,
7/16/27
..
1,860
1,826
L2639355.UP.FTS.B,
21.49%,
7/16/27
....
1,351
1,331
FW2639691.UP.FTS.B,
23.69%,
7/16/27
..
6,238
6,135
L2645113.UP.FTS.B,
10.21%,
7/17/27
....
2,420
2,376
FW2645472.UP.FTS.B,
26.31%,
7/17/27
..
6,533
6,440
FW2632915.UP.FTS.B,
24.46%,
7/20/27
..
5,573
5,481
FW2644628.UP.FTS.B,
30.88%,
7/24/27
..
690
682
L2642277.UP.FTS.B,
22.82%,
7/28/27
....
2,706
2,666
L2407955.UP.FTS.B,
27%,
8/11/27
......
2,542
182
L2009631.UP.FTS.B,
16.91%,
9/09/27
....
2,838
2,803
FW2007802.UP.FTS.B,
23.93%,
9/09/27
..
13,669
13,378
L2004302.UP.FTS.B,
21.93%,
9/24/27
....
1,023
1,004
FW2005949.UP.FTS.B,
25.57%,
9/24/27
..
2,979
2,925
FW2192438.UP.FTS.B,
23.66%,
10/07/27
.
3,578
3,509
L2202159.UP.FTS.B,
13.54%,
10/08/27
...
8,409
8,213
L2203340.UP.FTS.B,
21.11%,
10/08/27
...
882
64
L2206615.UP.FTS.B,
25.87%,
10/08/27
...
8,166
4,428
b
FW2202975.UP.FTS.B,
30.2%,
10/08/27
..
2,397
161
L2641861.UP.FTS.B,
16.53%,
10/17/27
...
4,451
322
L2200600.UP.FTS.B,
11.71%,
10/23/27
...
1,677
1,156
L2201626.UP.FTS.B,
25.65%,
11/08/27
...
1,425
103
FW2410081.UP.FTS.B,
8.78%,
11/11/27
..
2,977
216
FW2415964.UP.FTS.B,
31.16%,
11/12/27
.
496
312
FW2410499.UP.FTS.B,
31.67%,
11/16/27
.
753
741
b
L2645397.UP.FTS.B,
26.19%,
11/19/27
...
1,295
203
FW2406392.UP.FTS.B,
23.41%,
12/11/27
.
3,126
226
L2644100.UP.FTS.B,
5.16%,
12/16/27
....
987
967
FW2643411.UP.FTS.B,
29.58%,
12/16/27
.
2,727
2,686
L1710242.UP.FTS.B,
16.42%,
9/14/28
....
1,399
1,377
Description
Principal
Amount
Value
Upstart
Network,
Inc.
(continued)
L1973640.UP.FTS.B,
20.1%,
11/09/28
....
$
5,691
$
405
L2009558.UP.FTS.B,
26.34%,
11/09/28
...
9,332
9,288
L2195991.UP.FTS.B,
26.01%,
12/07/28
...
5,404
5,389
L2204377.UP.FTS.B,
25.94%,
12/08/28
...
2,614
2,582
L2635238.UP.FTS.B,
13.81%,
2/15/29
....
7,786
7,735
L2631621.UP.FTS.B,
15.64%,
2/15/29
....
11,526
11,331
L2633434.UP.FTS.B,
17.36%,
2/15/29
....
2,529
2,517
L2413593.UP.FTS.B,
23.06%,
4/11/29
....
4,860
352
1,017,861
Total
Marketplace
Loans
(Cost
$9,189,510
)
.......................
$2,232,026
a
The
rate
shown
represents
the
yield
at
period
end.
b
Defaulted
security
or
security
for
which
income
has
been
deemed
uncollectible.
See
Note
6.
Franklin
Strategic
Series
Schedule
of
Investments,
April
30,
2026
Franklin
Core
Plus
Bond
Fund
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
At
April
30,
2026
,
the
Fund
had
the
following futures
contracts
outstanding.
See
Note
1
(
d
).
At
April
30,
2026
,
the
Fund
had
the
following
forward
exchange
contracts
outstanding.
See
Note
1
(
d
).
At
April
30,
2026
,
the
Fund
had
the
following credit
default
swap
contracts outstanding.
See
Note
1(d)
.
Futures
Contracts
Description
Type
Number
of
Contracts
Notional
Amount
*
Expiration
Date
Value/
Unrealized
Appreciation
(Depreciation)
Interest
rate
contracts
Euro-Bobl
..................................
Short
26
$
3,522,945
6/08/26
$
49,656
Euro-Bund
.................................
Short
28
4,119,605
6/08/26
82,185
U.S.
Treasury
10
Year
Notes
....................
Short
366
40,477,312
6/18/26
518,655
U.S.
Treasury
10
Year
Ultra
Notes
................
Long
206
23,249,031
6/18/26
(
193,405
)
U.S.
Treasury
2
Year
Notes
.....................
Long
314
65,037,250
6/30/26
(
108,202
)
U.S.
Treasury
5
Year
Notes
.....................
Long
214
23,076,891
6/30/26
(
93,910
)
U.S.
Treasury
Long
Bonds
.....................
Long
791
89,259,406
6/18/26
(
2,858,180
)
U.S.
Treasury
Ultra
Bonds
......................
Long
276
31,748,625
6/18/26
(
1,175,415
)
Total
Futures
Contracts
......................................................................
$(3,778,616)
*
As
of
period
end.
Forward
Exchange
Contracts
Currency
Counter-
party
a
Type
Quantity
Contract
Amount
*
Settlement
Date
Unrealized
Appreciation
Unrealized
Depreciation
a
a
a
a
a
a
a
a
OTC
Forward
Exchange
Contracts
Euro
.............
JPHQ
Sell
3,974,000
4,614,963
5/26/26
$
—
$
(
54,085
)
Euro
.............
JPHQ
Sell
2,600,000
3,085,770
6/22/26
27,212
—
Euro
.............
JPHQ
Buy
846,000
996,657
7/13/26
—
(
553
)
Euro
.............
JPHQ
Sell
2,381,000
2,805,012
7/13/26
1,556
—
Total
Forward
Exchange
Contracts
...................................................
$28,768
$(54,638)
Net
unrealized
appreciation
(depreciation)
............................................
$(25,870)
*
In
U.S.
dollars
unless
otherwise
indicated.
a
May
be
comprised
of
multiple
contracts
with
the
same
counterparty,
currency
and
settlement
date.
Credit
Default
Swap
Contracts
Description
Periodic
Payment
Rate
Received
(Paid)
Payment
Frequency
Counter-
party
Maturity
Date
Notional
Amount
a
Value
Upfront
Payments
(Receipts)
Unrealized
Appreciation
(Depreciation)
Rating
b
Centrally
Cleared
Swap
Contracts
Contracts
to
Buy
Protection
c
Traded
Index
iTraxx
Europe
Main
45
....
(1.00)%
Quarterly
6/20/31
69,880,000
EUR
$
(
1,683,607
)
$
(
990,819
)
$
(
692,788
)
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Core
Plus
Bond
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
See
Note 9 regarding
other
derivative
information.
See
Abbreviations
on
page
158.
Credit
Default
Swap
Contracts
(continued)
Description
Periodic
Payment
Rate
Received
(Paid)
Payment
Frequency
Counter-
party
Maturity
Date
Notional
Amount
a
Value
Upfront
Payments
(Receipts)
Unrealized
Appreciation
(Depreciation)
Rating
b
Centrally
Cleared
Swap
Contracts
(continued)
Contracts
to
Sell
Protection
c,d
Traded
Index
CDX.NA.HY.45
.
5.00%
Quarterly
12/20/30
10,230,000
$
797,704
$
732,056
$
65,648
Non-
Investment
Grade
CDX.NA.HY.46
.
5.00%
Quarterly
6/20/31
18,400,000
1,418,605
951,748
466,857
Non-
Investment
Grade
CDX.NA.IG.46
..
1.00%
Quarterly
6/20/31
80,470,000
1,784,139
1,232,845
551,294
Investment
Grade
Total
Centrally
Cleared
Swap
Contracts
.....................................
$2,316,841
$1,925,830
$391,011
OTC
Swap
Contracts
Contracts
to
Buy
Protection
c
Traded
Index
CDX.NA.HY.45
.
(5.00)%
Quarterly
CITI
12/20/30
9,300,000
(
1,414,531
)
(
1,291,228
)
(
123,303
)
Total
OTC
Swap
Contracts
..............................................
$(1,414,531)
$(1,291,228)
$(123,303)
Total
Credit
Default
Swap
Contracts
....................................
$902,310
$
634,602
$267,708
a
In
U.S.
dollars
unless
otherwise
indicated.
For
contracts
to
sell
protection,
the
notional
amount
is
equal
to
the
maximum
potential
amount
of
the
future
payments
and
no
recourse
provisions
have
been
entered
into
in
association
with
the
contracts.
b
Based
on
Standard
and
Poor's
(S&P)
Rating
for
single
name
swaps
and
internal
ratings
for
index
swaps.
Internal
ratings
based
on
mapping
into
equivalent
ratings
from
external
vendors.
c
Performance
triggers
for
settlement
of
contract
include
default,
bankruptcy
or
restructuring
for
single
name
swaps,
and
failure
to
pay
or
bankruptcy
of
the
underlying
securities
for
traded
index
swaps.
d
The
fund
enters
contracts
to
sell
protection
to
create
a
long
credit
position.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Growth
Opportunities
Fund
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$44.86
$45.99
$39.15
$43.14
$56.25
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.25)
(0.16)
(0.20)
(0.12)
(0.28)
Net
realized
and
unrealized
gains
(losses)
...........
9.34
4.24
12.81
(2.19)
(7.76)
Total
from
investment
operations
....................
9.09
4.08
12.61
(2.31)
(8.04)
Less
distributions
from:
Net
realized
gains
.............................
(8.65)
(5.21)
(5.77)
(1.68)
(5.07)
Net
asset
value,
end
of
year
.......................
$45.30
$44.86
$45.99
$39.15
$43.14
Total
return
c
...................................
20.74%
7.85%
33.49%
(4.98)%
(16.57)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.89%
0.89%
0.91%
0.95%
0.90%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.88%
0.89%
d
0.91%
d,e
0.94%
e
0.89%
e
Net
investment
(loss)
............................
(0.53)%
(0.32)%
(0.45)%
(0.30)%
(0.49)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$3,569,378
$3,383,277
$3,453,647
$2,765,017
$3,215,834
Portfolio
turnover
rate
............................
39.14%
f
27.59%
27.49%
16.52%
f
17.20%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
11
for
current
year
information.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Growth
Opportunities
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$29.51
$31.99
$28.86
$32.55
$43.87
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.39)
(0.36)
(0.38)
(0.30)
(0.54)
Net
realized
and
unrealized
gains
(losses)
...........
6.05
3.09
9.28
(1.71)
(5.71)
Total
from
investment
operations
....................
5.66
2.73
8.90
(2.01)
(6.25)
Less
distributions
from:
Net
realized
gains
.............................
(8.65)
(5.21)
(5.77)
(1.68)
(5.07)
Net
asset
value,
end
of
year
.......................
$26.52
$29.51
$31.99
$28.86
$32.55
Total
return
c
...................................
19.82%
7.03%
32.52%
(5.69)%
(17.20)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.64%
1.64%
1.66%
1.70%
1.65%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
1.64%
d
1.64%
d
1.66%
d,e
1.69%
e
1.64%
e
Net
investment
(loss)
............................
(1.28)%
(1.07)%
(1.18)%
(1.05)%
(1.23)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$67,999
$75,994
$87,686
$119,070
$158,895
Portfolio
turnover
rate
............................
39.14%
f
27.59%
27.49%
16.52%
f
17.20%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
11
for
current
year
information.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Growth
Opportunities
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
R
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$40.28
$41.85
$36.13
$40.06
$52.69
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.33)
(0.26)
(0.29)
(0.20)
(0.39)
Net
realized
and
unrealized
gains
(losses)
...........
8.35
3.90
11.78
(2.05)
(7.17)
Total
from
investment
operations
....................
8.02
3.64
11.49
(2.25)
(7.56)
Less
distributions
from:
Net
realized
gains
.............................
(8.65)
(5.21)
(5.77)
(1.68)
(5.07)
Net
asset
value,
end
of
year
.......................
$39.65
$40.28
$41.85
$36.13
$40.06
Total
return
....................................
20.42%
7.57%
33.18%
(5.21)%
(16.79)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.14%
1.14%
1.16%
1.20%
1.15%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
1.14%
c
1.14%
c
1.16%
c,d
1.19%
d
1.14%
d
Net
investment
(loss)
............................
(0.78)%
(0.57)%
(0.70)%
(0.55)%
(0.73)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$25,148
$25,260
$28,933
$22,664
$27,009
Portfolio
turnover
rate
............................
39.14%
e
27.59%
27.49%
16.52%
e
17.20%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
e
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
11
for
current
year
information.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Growth
Opportunities
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$53.48
$53.82
$44.87
$48.98
$63.06
Income
from
investment
operations
a
:
Net
investment
income
(loss)
b
....................
(0.12)
(—)
c
(0.05)
0.02
(0.10)
Net
realized
and
unrealized
gains
(losses)
...........
11.19
4.87
14.77
(2.45)
(8.91)
Total
from
investment
operations
....................
11.07
4.87
14.72
(2.43)
(9.01)
Less
distributions
from:
Net
realized
gains
.............................
(8.65)
(5.21)
(5.77)
(1.68)
(5.07)
Net
asset
value,
end
of
year
.......................
$55.90
$53.48
$53.82
$44.87
$48.98
Total
return
....................................
21.11%
8.19%
33.94%
(4.62)%
(16.32)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.57%
0.57%
0.58%
0.59%
0.57%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.57%
d
0.57%
d
0.58%
d,e
0.58%
e
0.57%
d,e
Net
investment
income
(loss)
......................
(0.21)%
(—)%
f
(0.11)%
0.05%
(0.16)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$408,527
$371,773
$375,777
$449,119
$461,475
Portfolio
turnover
rate
............................
39.14%
g
27.59%
27.49%
16.52%
g
17.20%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Amount
rounds
to
less
than
$0.01
per
share.
d
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Rounds
to
less
than
0.01%.
g
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
11
for
current
year
information.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Growth
Opportunities
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$52.06
$52.54
$43.96
$48.07
$62.01
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.16)
(0.04)
(0.10)
(0.02)
(0.15)
Net
realized
and
unrealized
gains
(losses)
...........
10.89
4.77
14.45
(2.41)
(8.72)
Total
from
investment
operations
....................
10.73
4.73
14.35
(2.43)
(8.87)
Less
distributions
from:
Net
realized
gains
.............................
(8.65)
(5.21)
(5.77)
(1.68)
(5.07)
Net
asset
value,
end
of
year
.......................
$54.14
$52.06
$52.54
$43.96
$48.07
Total
return
....................................
21.04%
8.12%
33.80%
(4.71)%
(16.37)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.64%
0.64%
0.66%
0.69%
0.65%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.63%
0.64%
c
0.66%
c,d
0.68%
d
0.64%
d
Net
investment
(loss)
............................
(0.28)%
(0.08)%
(0.19)%
(0.05)%
(0.24)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$323,349
$304,150
$291,914
$325,234
$636,524
Portfolio
turnover
rate
............................
39.14%
e
27.59%
27.49%
16.52%
e
17.20%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
e
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
11
for
current
year
information.
Franklin
Strategic
Series
Schedule
of
Investments,
April
30,
2026
Franklin
Growth
Opportunities
Fund
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
96.2%
Aerospace
&
Defense
5.8%
a,b,c
Anduril
Industries,
Inc.
,
B
.............................
United
States
117,526
$
8,103,418
a,b,c
Anduril
Industries,
Inc.
,
C
.............................
United
States
55
3,792
b
Axon
Enterprise,
Inc.
.................................
United
States
80,066
32,167,316
BWX
Technologies,
Inc.
..............................
United
States
168,598
36,482,921
Curtiss-Wright
Corp.
.................................
United
States
83,386
60,054,597
Howmet
Aerospace,
Inc.
..............................
United
States
183,253
44,537,809
a,b,c
Space
Exploration
Technologies
Corp.
,
A
..................
United
States
142,857
75,227,068
256,576,921
Automobiles
1.9%
b
Tesla,
Inc.
.........................................
United
States
223,200
85,179,816
Beverages
0.6%
Coca-Cola
Co.
(The)
.................................
United
States
326,610
25,723,803
Biotechnology
1.6%
b
Insmed,
Inc.
.......................................
United
States
227,635
31,033,479
b
Natera,
Inc.
........................................
United
States
193,955
39,985,763
71,019,242
Broadline
Retail
5.3%
b
Amazon.com,
Inc.
...................................
United
States
873,802
231,609,958
Building
Products
1.2%
Trane
Technologies
plc
...............................
United
States
110,655
54,502,014
Capital
Markets
0.7%
S&P
Global,
Inc.
....................................
United
States
72,600
31,307,298
Chemicals
0.9%
Linde
plc
..........................................
United
States
80,837
40,510,654
Commercial
Services
&
Supplies
1.1%
a,b,c
Celonis
SE
........................................
Germany
4,619
416,631
a,b,c
Celonis
SE
,
D
......................................
Germany
25,571
2,306,491
a,b
Optoro,
Inc.
........................................
United
States
556,026
—
Republic
Services,
Inc.
,
A
.............................
United
States
209,953
43,926,367
46,649,489
Communications
Equipment
1.7%
b
Arista
Networks,
Inc.
.................................
United
States
284,115
49,069,502
b
Ciena
Corp.
.......................................
United
States
46,431
24,496,067
73,565,569
Construction
&
Engineering
0.5%
Comfort
Systems
USA,
Inc.
............................
United
States
12,815
23,582,804
Construction
Materials
0.8%
Martin
Marietta
Materials,
Inc.
..........................
United
States
53,572
33,164,818
Consumer
Staples
Distribution
&
Retail
2.2%
Casey's
General
Stores,
Inc.
...........................
United
States
115,652
95,083,292
Electric
Utilities
0.7%
Entergy
Corp.
......................................
United
States
251,944
29,706,717
Electrical
Equipment
2.3%
b
Forgent
Power
Solutions,
Inc.
,
A
........................
United
States
332,179
12,496,574
GE
Vernova,
Inc.
....................................
United
States
59,727
64,711,815
nVent
Electric
plc
...................................
United
States
158,665
22,673,229
99,881,618
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Growth
Opportunities
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Electronic
Equipment,
Instruments
&
Components
3.3%
Amphenol
Corp.
,
A
..................................
United
States
640,449
$
94,318,924
b
Celestica,
Inc.
......................................
Canada
70,419
28,842,918
b
Coherent
Corp.
.....................................
United
States
72,133
23,061,642
146,223,484
Entertainment
2.1%
b
Netflix,
Inc.
........................................
United
States
757,944
70,951,138
b
ROBLOX
Corp.
,
A
...................................
United
States
402,009
22,215,017
93,166,155
Financial
Services
1.5%
Mastercard,
Inc.
,
A
..................................
United
States
126,585
63,662,128
Ground
Transportation
0.8%
Old
Dominion
Freight
Line,
Inc.
.........................
United
States
170,767
36,276,034
Health
Care
Equipment
&
Supplies
0.9%
b
Dexcom,
Inc.
.......................................
United
States
359,238
21,392,623
b
Intuitive
Surgical,
Inc.
................................
United
States
41,520
18,999,967
40,392,590
Health
Care
Providers
&
Services
1.6%
McKesson
Corp.
....................................
United
States
85,928
70,048,506
Hotels,
Restaurants
&
Leisure
0.7%
b
DoorDash,
Inc.
,
A
...................................
United
States
183,223
30,900,559
Interactive
Media
&
Services
11.2%
Alphabet,
Inc.
,
C
....................................
United
States
864,803
330,302,858
Meta
Platforms,
Inc.
,
A
...............................
United
States
261,427
159,969,795
490,272,653
IT
Services
1.7%
a,b,c
Canva
Australia
Holdings
Pty.
Ltd.
,
A
.....................
Australia
3,094
5,093,157
a,b,c
Canva
Australia
Holdings
Pty.
Ltd.
,
B
.....................
Australia
11,829
19,472,190
b
Cloudflare,
Inc.
,
A
...................................
United
States
126,315
25,890,786
b
Shopify,
Inc.
,
A
.....................................
Canada
217,662
26,365,398
76,821,531
Life
Sciences
Tools
&
Services
0.5%
b
Repligen
Corp.
.....................................
United
States
88,804
10,506,401
b,d
Tempus
AI,
Inc.
,
A
...................................
United
States
186,393
10,341,084
20,847,485
Machinery
1.0%
Parker-Hannifin
Corp.
................................
United
States
47,348
43,059,218
Pharmaceuticals
3.2%
Eli
Lilly
&
Co.
......................................
United
States
107,712
100,667,635
b
Jazz
Pharmaceuticals
plc
.............................
United
States
192,521
39,085,614
139,753,249
Semiconductors
&
Semiconductor
Equipment
24.7%
b
Advanced
Micro
Devices,
Inc.
..........................
United
States
105,207
37,294,829
Analog
Devices,
Inc.
.................................
United
States
100,531
40,439,600
Broadcom,
Inc.
.....................................
United
States
510,415
213,062,534
KLA
Corp.
.........................................
United
States
17,181
30,072,763
Lam
Research
Corp.
.................................
United
States
191,021
49,256,675
b
Lattice
Semiconductor
Corp.
...........................
United
States
437,397
53,484,905
b
MACOM
Technology
Solutions
Holdings,
Inc.
..............
United
States
78,346
22,063,017
Micron
Technology,
Inc.
...............................
United
States
50,525
26,129,509
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Growth
Opportunities
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Semiconductors
&
Semiconductor
Equipment
(continued)
Monolithic
Power
Systems,
Inc.
.........................
United
States
54,601
$
88,148,400
NVIDIA
Corp.
......................................
United
States
2,144,801
428,037,936
Taiwan
Semiconductor
Manufacturing
Co.
Ltd.
,
ADR
.........
Taiwan
160,443
63,545,055
Teradyne,
Inc.
......................................
United
States
98,639
33,879,537
1,085,414,760
Software
6.5%
b
AppLovin
Corp.
,
A
...................................
United
States
36,621
16,345,783
a,b,c
ClearMotion,
Inc.
....................................
United
States
6,309,366
650,899
b
Crowdstrike
Holdings,
Inc.
,
A
...........................
United
States
57,593
25,672,080
Microsoft
Corp.
.....................................
United
States
443,757
180,955,230
a,b,c
OpenAI
Foundation
..................................
United
States
8,668
5,960,897
a,b,c
Plaid,
Inc.
,
A
.......................................
United
States
56,433
13,666,978
a,b,c
Stripe,
Inc.
,
B
......................................
United
States
260,482
16,635,683
b
Synopsys,
Inc.
.....................................
United
States
53,327
25,735,610
285,623,160
Specialty
Retail
1.0%
b
AutoZone,
Inc.
.....................................
United
States
8,320
30,817,530
b
Carvana
Co.
,
A
.....................................
United
States
32,968
13,048,734
43,866,264
Technology
Hardware,
Storage
&
Peripherals
7.8%
Apple,
Inc.
........................................
United
States
1,138,591
308,956,668
Dell
Technologies,
Inc.
,
C
.............................
United
States
107,581
22,479,050
b
Everpure,
Inc.
,
A
....................................
United
States
162,855
11,635,989
343,071,707
Trading
Companies
&
Distributors
0.4%
b,d
QXO,
Inc.
.........................................
United
States
931,611
18,697,433
Total
Common
Stocks
(Cost
$
1,980,982,888
)
..................................
4,226,160,929
Convertible
Preferred
Stocks
2.4%
Aerospace
&
Defense
0.3%
a,b,c
Anduril
Industries,
Inc.
,
G
.............................
United
States
180,222
12,426,307
Automobile
Components
0.3%
a,b,c
Flock
Group,
Inc.
,
B
.................................
United
States
750,387
11,729,975
a,b,c
Flock
Group,
Inc.
,
C
.................................
United
States
80,684
1,261,244
a,b,c
Flock
Group,
Inc.
,
F-1
................................
United
States
21,303
333,006
13,324,225
Software
1.8%
a,b,c
Anthropic
PBC
,
G-1
.................................
United
States
38,589
9,999,815
a,b,c
Databricks,
Inc.
,
G
..................................
United
States
338,280
64,623,462
a,b,c
OneTrust
LLC
,
C
....................................
United
States
517,056
4,805,902
79,429,179
Total
Convertible
Preferred
Stocks
(Cost
$
60,096,304
)
.........................
105,179,711
Preferred
Stocks
0.3%
Software
0.3%
a,b,c
Anthropic
PBC
,
F-1
..................................
United
States
49,656
12,867,677
a,b,c
ClearMotion,
Inc.
,
A-3
................................
United
States
417,667
60,170
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Growth
Opportunities
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Preferred
Stocks
(continued)
Software
(continued)
a,b,c
ClearMotion,
Inc.
,
A-4
................................
United
States
2,606,463
$
341,496
13,269,343
Total
Preferred
Stocks
(Cost
$
7,251,387
)
.....................................
13,269,343
Escrows
and
Litigation
Trusts
0.0%
a,b
Fortinet,
Inc.,
Escrow
Account
..........................
United
States
810,440
—
a,b
Wheels
Up
Experience,
Inc.,
Escrow
Account
..............
United
States
514
—
Total
Escrows
and
Litigation
Trusts
(Cost
$
–
)
.................................
—
Total
Long
Term
Investments
(Cost
$
2,048,330,579
)
...........................
4,344,609,983
a
Short
Term
Investments
1.5%
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Money
Market
Funds
1.1%
e,f
Franklin
Institutional
U.S.
Government
Money
Market
Fund
,
3.593
%
.........................................
United
States
47,555,504
47,555,504
Total
Money
Market
Funds
(Cost
$
47,555,504
)
................................
47,555,504
g
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
0.4%
Money
Market
Funds
0.4%
e,f
Franklin
Institutional
U.S.
Government
Money
Market
Fund
,
3.593
%
.........................................
United
States
19,950,750
19,950,750
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$
19,950,750
)
.........................................................
19,950,750
Total
Short
Term
Investments
(Cost
$
67,506,254
)
..............................
67,506,254
a
Total
Investments
(Cost
$
2,115,836,833
)
100.4
%
...............................
$4,412,116,237
Other
Assets,
less
Liabilities
(
0.4
)
%
.........................................
(17,715,424)
Net
Assets
100.0%
.........................................................
$4,394,400,813
a
a
a
See
Abbreviations
on
page
158
.
a
Fair
valued
using
significant
unobservable
inputs.
See
Note
13
regarding
fair
value
measurements.
b
Non-income
producing.
c
See
Note
7
regarding
restricted
securities.
d
A
portion
or
all
of
the
security
is
on
loan
at
April
30,
2026.
See
Note
1(e).
e
See
Note
3(f)
regarding
investments
in
affiliated
management
investment
companies.
f
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
g
See
Note
1(e)
regarding
securities
on
loan.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Natural
Resources
Fund
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$28.15
$30.98
$28.10
$27.01
$20.02
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.51
0.52
0.55
0.68
0.50
Net
realized
and
unrealized
gains
(losses)
...........
17.56
(2.67)
2.90
1.09
6.77
Total
from
investment
operations
....................
18.07
(2.15)
3.45
1.77
7.27
Less
distributions
from:
Net
investment
income
..........................
(0.62)
(0.68)
(0.57)
(0.68)
(0.28)
Net
asset
value,
end
of
year
.......................
$45.60
$28.15
$30.98
$28.10
$27.01
Total
return
c
...................................
64.73%
(6.87)%
12.41%
6.56%
36.63%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.97%
1.00%
1.02%
0.97%
1.10%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.96%
d
0.99%
1.01%
e
0.96%
e
1.10%
d
Net
investment
income
...........................
1.40%
1.72%
1.90%
2.45%
2.17%
Supplemental
data
Net
assets
,
end
of
year
(000’s)
.....................
$389,699
$221,768
$272,081
$301,153
$289,403
Portfolio
turnover
rate
............................
27.09%
19.72%
11.86%
23.76%
27.45%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Natural
Resources
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$27.48
$30.12
$27.43
$26.45
$19.58
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.24
0.29
0.33
0.46
0.32
Net
realized
and
unrealized
gains
(losses)
...........
17.12
(2.58)
2.82
1.06
6.63
Total
from
investment
operations
....................
17.36
(2.29)
3.15
1.52
6.95
Less
distributions
from:
Net
investment
income
..........................
(0.38)
(0.35)
(0.46)
(0.54)
(0.08)
Net
asset
value,
end
of
year
.......................
$44.46
$27.48
$30.12
$27.43
$26.45
Total
return
c
...................................
63.49%
(7.58)%
11.60%
5.75%
35.59%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.72%
1.75%
1.77%
1.72%
1.86%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
1.71%
d
1.74%
1.76%
e
1.71%
e
1.86%
d
Net
investment
income
...........................
0.67%
0.99%
1.16%
1.72%
1.41%
Supplemental
data
Net
assets
,
end
of
year
(000’s)
.....................
$18,182
$13,076
$17,371
$25,090
$30,427
Portfolio
turnover
rate
............................
27.09%
19.72%
11.86%
23.76%
27.45%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Natural
Resources
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$30.67
$33.71
$30.45
$29.17
$21.58
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.68
0.69
0.73
0.79
0.64
Net
realized
and
unrealized
gains
(losses)
...........
19.18
(2.91)
3.15
1.24
7.31
Total
from
investment
operations
....................
19.86
(2.22)
3.88
2.03
7.95
Less
distributions
from:
Net
investment
income
..........................
(0.73)
(0.82)
(0.62)
(0.75)
(0.36)
Net
asset
value,
end
of
year
.......................
$49.80
$30.67
$33.71
$30.45
$29.17
Total
return
....................................
65.36%
(6.56)%
12.90%
6.99%
37.24%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.64%
0.67%
0.67%
0.65%
0.80%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.59%
c
0.62%
0.61%
d
0.56%
d
0.65%
Net
investment
income
...........................
1.70%
2.09%
2.34%
2.65%
2.53%
Supplemental
data
Net
assets
,
end
of
year
(000’s)
.....................
$19,396
$6,894
$7,995
$12,387
$4,943
Portfolio
turnover
rate
............................
27.09%
19.72%
11.86%
23.76%
27.45%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Natural
Resources
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$30.43
$33.43
$30.23
$28.97
$21.44
Income
from
investment
operations
a
:
Net
investment
income
b
.........................
0.64
0.65
0.67
0.80
0.60
Net
realized
and
unrealized
gains
(losses)
...........
19.02
(2.89)
3.13
1.18
7.24
Total
from
investment
operations
....................
19.66
(2.24)
3.80
1.98
7.84
Less
distributions
from:
Net
investment
income
..........................
(0.69)
(0.76)
(0.60)
(0.72)
(0.31)
Net
asset
value,
end
of
year
.......................
$49.40
$30.43
$33.43
$30.23
$28.97
Total
return
....................................
65.18%
(6.68)%
12.72%
6.86%
36.93%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.71%
0.75%
0.77%
0.72%
0.85%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.70%
c
0.74%
0.76%
d
0.71%
d
0.85%
c
Net
investment
income
...........................
1.62%
1.97%
2.15%
2.71%
2.39%
Supplemental
data
Net
assets
,
end
of
year
(000’s)
.....................
$111,640
$52,147
$76,028
$82,840
$87,707
Portfolio
turnover
rate
............................
27.09%
19.72%
11.86%
23.76%
27.45%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchases
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
Franklin
Strategic
Series
Schedule
of
Investments,
April
30,
2026
Franklin
Natural
Resources
Fund
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Shares
a
Value
a
Common
Stocks
97.5%
Agricultural
Products
&
Services
0.8%
Bunge
Global
SA
.....................................
United
States
34,700
$
4,409,329
Coal
&
Consumable
Fuels
0.8%
Cameco
Corp.
.......................................
Canada
36,100
4,441,744
Construction
&
Engineering
0.5%
a,b
Cadeler
A/S
,
ADR
.....................................
Denmark
100,624
2,785,272
a
Construction
Materials
2.0%
Martin
Marietta
Materials,
Inc.
............................
United
States
17,100
10,586,097
Copper
4.4%
Antofagasta
plc
.......................................
Chile
88,600
4,296,899
a
Capstone
Copper
Corp.
................................
Canada
185,600
1,546,724
a
ERO
Copper
Corp.
....................................
Brazil
50,300
1,300,131
Freeport-McMoRan,
Inc.
................................
United
States
222,500
12,856,050
Lundin
Mining
Corp.
...................................
Chile
156,800
4,024,035
24,023,839
Diversified
Metals
&
Mining
9.4%
a
Aclara
Resources,
Inc.
.................................
United
Kingdom
549,700
1,966,755
a,c
Aclara
Resources,
Inc.
,
144A
............................
United
Kingdom
455,354
1,629,198
Anglo
American
plc
....................................
South
Africa
57,316
2,836,281
b
BHP
Group
Ltd.
,
ADR
..................................
Australia
159,900
12,680,070
a
Brazilian
Rare
Earths
Ltd.
...............................
Australia
630,000
2,258,771
Glencore
plc
.........................................
Australia
546,900
4,250,418
Hudbay
Minerals,
Inc.
..................................
Canada
67,600
1,563,656
a
IperionX
Ltd.
.........................................
Australia
933,700
2,848,064
a
Ivanhoe
Electric,
Inc.
...................................
United
States
99,000
1,270,170
a
Ivanhoe
Mines
Ltd.
,
A
..................................
Congo
306,600
2,482,865
a
Lindian
Resources
Ltd.
.................................
Australia
5,058,152
2,981,523
a,b
MP
Materials
Corp.
....................................
United
States
68,700
4,536,948
Rio
Tinto
plc
,
ADR
.....................................
Australia
43,600
4,380,928
South32
Ltd.
.........................................
Australia
685,800
2,032,402
Teck
Resources
Ltd.
,
B
.................................
Canada
52,200
3,050,046
50,768,095
Electrical
Components
&
Equipment
0.9%
a
Otovo
ASA
..........................................
Norway
1,518,096
1,751,734
a
T1
Energy,
Inc.
.......................................
Norway
704,800
3,383,040
5,134,774
Electronic
Equipment
&
Instruments
0.5%
Badger
Meter,
Inc.
.....................................
United
States
23,700
2,865,567
Fertilizers
&
Agricultural
Chemicals
3.8%
Corteva,
Inc.
.........................................
United
States
115,200
9,332,352
Nutrien
Ltd.
..........................................
Canada
147,500
11,210,000
20,542,352
Gold
10.7%
Agnico
Eagle
Mines
Ltd.
................................
Canada
66,300
12,467,338
Alamos
Gold,
Inc.
,
A
...................................
Canada
130,100
5,191,166
Barrick
Mining
Corp.
...................................
Canada
326,900
12,860,246
a
Coeur
Mining,
Inc.
.....................................
United
States
132,900
2,388,213
Equinox
Gold
Corp.
....................................
Canada
509,400
7,111,224
Newmont
Corp.
.......................................
United
States
159,700
17,741,073
57,759,260
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Natural
Resources
Fund
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Shares
a
Value
a
Common
Stocks
(continued)
Heavy
Electrical
Equipment
1.1%
a
Forgent
Power
Solutions,
Inc.
,
A
..........................
United
States
56,700
$
2,133,054
GE
Vernova,
Inc.
......................................
United
States
3,400
3,683,764
5,816,818
Industrial
Gases
4.1%
Air
Products
and
Chemicals,
Inc.
..........................
United
States
33,100
9,931,655
Linde
plc
............................................
United
States
24,000
12,027,360
21,959,015
Industrial
Machinery
&
Supplies
&
Components
0.5%
Xylem,
Inc.
..........................................
United
States
21,800
2,575,888
Integrated
Oil
&
Gas
15.3%
BP
plc
,
ADR
.........................................
United
States
274,500
13,005,810
Chevron
Corp.
.......................................
United
States
76,140
14,718,624
Exxon
Mobil
Corp.
.....................................
United
States
135,806
20,958,940
Occidental
Petroleum
Corp.
.............................
United
States
102,200
6,191,276
Shell
plc
,
ADR
........................................
United
States
96,600
8,758,722
Suncor
Energy,
Inc.
....................................
Canada
131,800
9,031,504
TotalEnergies
SE
.....................................
France
111,800
10,364,978
83,029,854
Metal,
Glass
&
Plastic
Containers
1.0%
Ball
Corp.
...........................................
United
States
42,000
2,565,360
Crown
Holdings,
Inc.
...................................
United
States
25,700
2,526,567
5,091,927
Oil
&
Gas
Drilling
0.8%
Patterson-UTI
Energy,
Inc.
..............................
United
States
210,300
2,569,866
a
Precision
Drilling
Corp.
.................................
Canada
17,200
1,605,276
4,175,142
Oil
&
Gas
Equipment
&
Services
7.7%
Baker
Hughes
Co.
,
A
...................................
United
States
65,100
4,535,517
Cactus,
Inc.
,
A
........................................
United
States
51,800
2,886,296
Flowco
Holdings,
Inc.
,
A
................................
United
States
77,000
1,911,910
Halliburton
Co.
.......................................
United
States
65,400
2,766,420
Liberty
Energy,
Inc.
,
A
..................................
United
States
134,600
4,548,134
a
Oceaneering
International,
Inc.
...........................
United
States
34,700
1,302,638
Ranger
Energy
Services,
Inc.
,
A
..........................
United
States
77,000
1,344,420
Select
Water
Solutions,
Inc.
,
A
............................
United
States
147,718
2,471,322
SLB
Ltd.
............................................
United
States
126,400
7,189,632
Solaris
Energy
Infrastructure,
Inc.
,
A
.......................
United
States
28,300
2,089,672
Technip
Energies
NV
...................................
France
58,099
2,748,523
TechnipFMC
plc
......................................
United
Kingdom
86,500
6,536,805
Trican
Well
Service
Ltd.
.................................
Canada
249,600
1,324,854
41,656,143
Oil
&
Gas
Exploration
&
Production
17.8%
Aker
BP
ASA
.........................................
Norway
186,100
7,275,081
Canadian
Natural
Resources
Ltd.
.........................
Canada
212,600
10,148,330
ConocoPhillips
.......................................
United
States
149,100
18,753,798
Coterra
Energy,
Inc.
...................................
United
States
316,400
11,361,924
EOG
Resources,
Inc.
..................................
United
States
94,000
13,213,580
EQT
Corp.
..........................................
United
States
115,700
6,951,256
a
Infinity
Natural
Resources,
Inc.
,
A
.........................
United
States
283,800
4,623,102
Matador
Resources
Co.
................................
United
States
93,300
5,918,952
Ovintiv,
Inc.
..........................................
United
States
125,900
7,749,145
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Natural
Resources
Fund
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Shares
a
Value
a
Common
Stocks
(continued)
Oil
&
Gas
Exploration
&
Production
(continued)
Permian
Resources
Corp.
,
A
.............................
United
States
195,700
$
4,231,034
a
Tamboran
Resources
Corp.
..............................
Australia
65,400
2,360,940
Tourmaline
Oil
Corp.
...................................
Canada
57,200
2,770,832
95,357,974
Oil
&
Gas
Refining
&
Marketing
4.2%
Marathon
Petroleum
Corp.
..............................
United
States
26,500
6,579,685
Phillips
66
...........................................
United
States
55,600
9,960,740
Valero
Energy
Corp.
...................................
United
States
25,000
6,314,500
22,854,925
Oil
&
Gas
Storage
&
Transportation
8.5%
Cheniere
Energy,
Inc.
..................................
United
States
10,300
2,831,985
Enbridge,
Inc.
........................................
Canada
76,900
4,261,798
Kinder
Morgan,
Inc.
....................................
United
States
276,200
9,078,694
ONEOK,
Inc.
.........................................
United
States
20,800
1,923,168
Targa
Resources
Corp.
.................................
United
States
33,000
8,582,640
TC
Energy
Corp.
......................................
Canada
114,900
7,690,257
Williams
Cos.,
Inc.
(The)
................................
United
States
145,800
11,125,998
45,494,540
Paper
&
Plastic
Packaging
Products
&
Materials
0.6%
Packaging
Corp.
of
America
.............................
United
States
16,700
3,564,615
Precious
Metals
&
Minerals
0.1%
Valterra
Platinum
Ltd.
..................................
South
Africa
5,648
458,862
Specialty
Chemicals
0.6%
Albemarle
Corp.
......................................
United
States
800
157,360
Neo
Performance
Materials,
Inc.
..........................
Canada
74,300
1,383,877
c
Neo
Performance
Materials,
Inc.
,
144A
.....................
Canada
85,000
1,583,171
3,124,408
Steel
1.4%
Reliance,
Inc.
........................................
United
States
11,400
4,132,500
Vale
SA
,
ADR
,
B
......................................
Brazil
186,500
3,051,140
7,183,640
Total
Common
Stocks
(Cost
$
276,440,161
)
.....................................
525,660,080
a
Convertible
Preferred
Stocks
0.8%
Environmental
&
Facilities
Services
0.4%
a,d,e
Redwood
Materials,
Inc.
,
E
..............................
United
States
39,802
1,899,983
a
Specialty
Chemicals
0.4%
Albemarle
Corp.
,
7.25
%
................................
United
States
30,800
2,400,552
Total
Convertible
Preferred
Stocks
(Cost
$
3,439,983
)
............................
4,300,535
Warrants
a
a
a
a
a
Warrants
0.1%
Integrated
Oil
&
Gas
0.1%
a
Occidental
Petroleum
Corp.
,
8/03/27
.......................
United
States
17,900
690,045
Total
Warrants
(Cost
$
88,605
)
.................................................
690,045
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Natural
Resources
Fund
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
a
Convertible
Bonds
0.3%
Gold
0.3%
c
B2Gold
Corp.
,
Senior
Note
,
144A,
2.75
%
,
2/01/30
.............
Canada
933,000
$
1,500,497
Total
Convertible
Bonds
(Cost
$
933,000
)
.......................................
1,500,497
Total
Long
Term
Investments
(Cost
$
280,901,749
)
...............................
532,151,157
a
Short
Term
Investments
3.8%
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Money
Market
Funds
1.4%
f,g
Franklin
Institutional
U.S.
Government
Money
Market
Fund
,
3.593
%
United
States
7,586,679
7,586,679
Total
Money
Market
Funds
(Cost
$
7,586,679
)
...................................
7,586,679
h
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
2.4%
Money
Market
Funds
2.4%
f,g
Franklin
Institutional
U.S.
Government
Money
Market
Fund
,
3.593
%
United
States
12,868,615
12,868,615
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$
12,868,615
)
................................................................
12,868,615
Total
Short
Term
Investments
(Cost
$
20,455,294
)
................................
20,455,294
a
Total
Investments
(Cost
$
301,357,043
)
102.5
%
..................................
$552,606,451
Other
Assets,
less
Liabilities
(
2.5
)
%
...........................................
(13,690,469)
Net
Assets
100.0%
...........................................................
$538,915,982
See
Abbreviations
on
page
158
.
*
The
principal
amount
is
stated
in
U.S.
dollars
unless
otherwise
indicated.
a
Non-income
producing.
b
A
portion
or
all
of
the
security
is
on
loan
at
April
30,
2026.
See
Note
1(e).
c
Security
was
purchased
pursuant
to
Rule
144A
or
Regulation
S
under
the
Securities
Act
of
1933.
144A
securities
may
be
sold
in
transactions
exempt
from
registration
only
to
qualified
institutional
buyers
or
in
a
public
offering
registered
under
the
Securities
Act
of
1933.
Regulation
S
securities
cannot
be
sold
in
the
United
States
without
either
an
effective
registration
statement
filed
pursuant
to
the
Securities
Act
of
1933,
or
pursuant
to
an
exemption
from
registration.
At
April
30,
2026,
the
aggregate
value
of
these
securities
was
$4,712,866,
representing
0.9%
of
net
assets.
d
Fair
valued
using
significant
unobservable
inputs.
See
Note
13
regarding
fair
value
measurements.
e
See
Note
7
regarding
restricted
securities.
f
See
Note
3(f)
regarding
investments
in
affiliated
management
investment
companies.
g
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
h
See
Note
1(e)
regarding
securities
on
loan.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small
Cap
Growth
Fund
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$20.25
$20.93
$17.19
$17.78
$30.08
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.15)
(0.14)
(0.09)
(0.09)
(0.14)
Net
realized
and
unrealized
gains
(losses)
...........
6.20
(0.54)
3.83
(0.40)
(7.89)
Total
from
investment
operations
....................
6.05
(0.68)
3.74
(0.49)
(8.03)
Less
distributions
from:
Net
realized
gains
.............................
(2.04)
—
—
(0.10)
(4.27)
Net
asset
value,
end
of
year
.......................
$24.26
$20.25
$20.93
$17.19
$17.78
Total
return
c
...................................
30.13%
(3.25)%
21.76%
(2.73)%
(29.53)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.07%
1.04%
1.08%
1.11%
1.03%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
1.07%
d
1.04%
d
1.07%
e
1.10%
e
1.03%
d,e
Net
investment
(loss)
............................
(0.67)%
(0.64)%
(0.48)%
(0.54)%
(0.54)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$873,630
$778,491
$881,445
$763,871
$860,536
Portfolio
turnover
rate
............................
48.01%
16.31%
f
15.99%
16.86%
30.88%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
11
for
prior
year
information.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small
Cap
Growth
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$13.75
$14.32
$11.84
$12.37
$22.57
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.22)
(0.21)
(0.16)
(0.15)
(0.25)
Net
realized
and
unrealized
gains
(losses)
...........
4.19
(0.36)
2.64
(0.28)
(5.68)
Total
from
investment
operations
....................
3.97
(0.57)
2.48
(0.43)
(5.93)
Less
distributions
from:
Net
realized
gains
.............................
(2.04)
—
—
(0.10)
(4.27)
Net
asset
value,
end
of
year
.......................
$15.68
$13.75
$14.32
$11.84
$12.37
Total
return
c
...................................
29.21%
(3.98)%
20.95%
(3.44)%
(30.07)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.82%
1.79%
1.83%
1.86%
1.78%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
1.82%
d
1.79%
d
1.82%
e
1.84%
e
1.78%
d,e
Net
investment
(loss)
............................
(1.41)%
(1.39)%
(1.23)%
(1.28)%
(1.31)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$17,343
$19,333
$22,351
$20,551
$32,755
Portfolio
turnover
rate
............................
48.01%
16.31%
f
15.99%
16.86%
30.88%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
11
for
prior
year
information.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small
Cap
Growth
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
R
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$18.18
$18.85
$15.52
$16.10
$27.76
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.19)
(0.18)
(0.12)
(0.12)
(0.19)
Net
realized
and
unrealized
gains
(losses)
...........
5.57
(0.49)
3.45
(0.36)
(7.20)
Total
from
investment
operations
....................
5.38
(0.67)
3.33
(0.48)
(7.39)
Less
distributions
from:
Net
realized
gains
.............................
(2.04)
—
—
(0.10)
(4.27)
Net
asset
value,
end
of
year
.......................
$21.52
$18.18
$18.85
$15.52
$16.10
Total
return
....................................
29.79%
(3.50)%
21.46%
(2.95)%
(29.71)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.32%
1.29%
1.33%
1.36%
1.28%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
1.32%
c
1.29%
c
1.32%
d
1.35%
d
1.28%
c,d
Net
investment
(loss)
............................
(0.92)%
(0.89)%
(0.73)%
(0.79)%
(0.79)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$48,833
$40,535
$39,963
$39,777
$50,324
Portfolio
turnover
rate
............................
48.01%
16.31%
e
15.99%
16.86%
30.88%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
e
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
11
for
prior
year
information.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small
Cap
Growth
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$23.92
$24.63
$20.15
$20.73
$34.14
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.07)
(0.07)
(0.02)
(0.02)
(0.04)
Net
realized
and
unrealized
gains
(losses)
...........
7.35
(0.64)
4.50
(0.46)
(9.10)
Total
from
investment
operations
....................
7.28
(0.71)
4.48
(0.48)
(9.14)
Less
distributions
from:
Net
realized
gains
.............................
(2.04)
—
—
(0.10)
(4.27)
Net
asset
value,
end
of
year
.......................
$29.16
$23.92
$24.63
$20.15
$20.73
Total
return
....................................
30.66%
(2.88)%
22.23%
(2.29)%
(29.26)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.67%
0.66%
0.67%
0.68%
0.65%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.66%
0.65%
0.66%
c
0.66%
c
0.64%
c
Net
investment
(loss)
............................
(0.26)%
(0.25)%
(0.07)%
(0.10)%
(0.15)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$1,151,092
$1,113,133
$1,458,516
$1,345,064
$1,529,170
Portfolio
turnover
rate
............................
48.01%
16.31%
d
15.99%
16.86%
30.88%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
d
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
11
for
prior
year
information.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small
Cap
Growth
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$23.19
$23.91
$19.59
$20.19
$33.43
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.11)
(0.10)
(0.05)
(0.05)
(0.08)
Net
realized
and
unrealized
gains
(losses)
...........
7.13
(0.62)
4.37
(0.45)
(8.89)
Total
from
investment
operations
....................
7.02
(0.72)
4.32
(0.50)
(8.97)
Less
distributions
from:
Net
realized
gains
.............................
(2.04)
—
—
(0.10)
(4.27)
Net
asset
value,
end
of
year
.......................
$28.17
$23.19
$23.91
$19.59
$20.19
Total
return
....................................
30.50%
(3.05)%
22.10%
(2.50)%
(29.34)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.82%
0.79%
0.83%
0.86%
0.78%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.82%
c
0.79%
c
0.82%
d
0.85%
d
0.77%
d
Net
investment
(loss)
............................
(0.42)%
(0.38)%
(0.23)%
(0.29)%
(0.29)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$344,389
$326,857
$390,099
$341,973
$433,191
Portfolio
turnover
rate
............................
48.01%
16.31%
e
15.99%
16.86%
30.88%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
e
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
11
for
prior
year
information.
Franklin
Strategic
Series
Schedule
of
Investments,
April
30,
2026
Franklin
Small
Cap
Growth
Fund
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
96.8%
Aerospace
&
Defense
6.2%
a
AAR
Corp.
........................................
United
States
426,041
$
47,022,145
a,b
Aevex
Corp.
,
A
.....................................
United
States
465,304
14,075,446
BWX
Technologies,
Inc.
..............................
United
States
301,978
65,345,019
a
Kratos
Defense
&
Security
Solutions,
Inc.
.................
United
States
389,378
24,550,283
150,992,893
Banks
2.1%
FB
Financial
Corp.
..................................
United
States
442,703
23,936,951
Western
Alliance
Bancorp
.............................
United
States
337,723
27,537,934
51,474,885
Biotechnology
11.2%
a
Alkermes
plc
.......................................
United
States
317,039
10,687,385
a
Apogee
Therapeutics,
Inc.
.............................
United
States
68,595
5,685,839
a
Arcutis
Biotherapeutics,
Inc.
...........................
United
States
398,931
9,263,178
a,b
Ascendis
Pharma
A/S
................................
Denmark
131,118
30,075,847
a
Benitec
Biopharma,
Inc.
..............................
Australia
357,531
4,308,249
a
Bicara
Therapeutics,
Inc.
..............................
United
States
505,080
10,899,626
a
Bridgebio
Pharma,
Inc.
...............................
United
States
429,950
30,573,744
a
CG
oncology,
Inc.
...................................
United
States
202,961
13,545,617
a
Cytokinetics,
Inc.
....................................
United
States
214,074
13,694,314
a
Dianthus
Therapeutics,
Inc.
............................
United
States
208,194
18,279,433
a
Dyne
Therapeutics,
Inc.
..............................
United
States
505,324
8,868,436
a
Mirum
Pharmaceuticals,
Inc.
...........................
United
States
162,759
15,838,078
a,b
Newamsterdam
Pharma
Co.
NV
........................
Netherlands
296,852
8,478,093
a,b
Olema
Pharmaceuticals,
Inc.
...........................
United
States
382,477
5,511,494
a
Oruka
Therapeutics,
Inc.
..............................
United
States
213,110
14,578,855
a
Praxis
Precision
Medicines,
Inc.
........................
United
States
25,376
8,090,630
a
PTC
Therapeutics,
Inc.
...............................
United
States
185,128
12,044,428
a
Relay
Therapeutics,
Inc.
..............................
United
States
460,495
5,968,015
a
Revolution
Medicines,
Inc.
.............................
United
States
84,606
12,193,417
a
Spyre
Therapeutics,
Inc.
..............................
United
States
155,799
11,599,236
a
Syndax
Pharmaceuticals,
Inc.
..........................
United
States
563,259
12,070,640
a
Xenon
Pharmaceuticals,
Inc.
...........................
Canada
200,051
11,210,858
273,465,412
Building
Products
3.3%
AAON,
Inc.
........................................
United
States
474,302
44,257,120
a
Modine
Manufacturing
Co.
............................
United
States
143,981
36,661,882
80,919,002
Capital
Markets
3.7%
Evercore,
Inc.
,
A
....................................
United
States
76,714
24,647,441
Hamilton
Lane,
Inc.
,
A
................................
United
States
166,979
15,360,398
Houlihan
Lokey,
Inc.
,
A
...............................
United
States
169,911
26,293,727
a
Miami
International
Holdings,
Inc.
.......................
United
States
505,985
23,523,243
89,824,809
Commercial
Services
&
Supplies
0.0%
a,c
Optoro,
Inc.
........................................
United
States
554,878
—
Communications
Equipment
1.8%
a
Lumentum
Holdings,
Inc.
..............................
United
States
48,526
43,785,980
Construction
&
Engineering
6.3%
Arcosa,
Inc.
.......................................
United
States
543,335
68,715,577
Granite
Construction,
Inc.
.............................
United
States
441,767
60,553,003
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Small
Cap
Growth
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Construction
&
Engineering
(continued)
a,b
Solv
Energy,
Inc.
,
A
..................................
United
States
620,471
$
24,719,565
153,988,145
Construction
Materials
0.3%
b
Titan
America
SA
...................................
Belgium
465,636
7,678,338
Consumer
Staples
Distribution
&
Retail
1.5%
a
Performance
Food
Group
Co.
..........................
United
States
391,733
35,475,340
Diversified
Consumer
Services
0.1%
a,b
Nerdy,
Inc.
........................................
United
States
1,988,031
1,777,697
Electrical
Equipment
1.3%
a
Forgent
Power
Solutions,
Inc.
,
A
........................
United
States
836,032
31,451,524
Electronic
Equipment,
Instruments
&
Components
4.6%
Badger
Meter,
Inc.
...................................
United
States
151,859
18,361,272
a
Fabrinet
..........................................
Thailand
61,026
41,709,440
a
Mirion
Technologies,
Inc.
,
A
............................
United
States
770,242
15,212,279
Vontier
Corp.
.......................................
United
States
1,037,534
37,226,720
112,509,711
Energy
Equipment
&
Services
2.6%
Cactus,
Inc.
,
A
......................................
United
States
421,346
23,477,399
Liberty
Energy,
Inc.
,
A
................................
United
States
1,155,269
39,036,540
62,513,939
Financial
Services
1.9%
a
Flywire
Corp.
......................................
United
States
1,029,716
13,911,463
a
Paymentus
Holdings,
Inc.
,
A
...........................
United
States
1,136,062
31,866,539
45,778,002
Food
Products
0.8%
a
Freshpet,
Inc.
......................................
United
States
285,124
19,211,655
Health
Care
Equipment
&
Supplies
3.1%
a
Ceribell,
Inc.
.......................................
United
States
767,437
15,471,530
a
Haemonetics
Corp.
..................................
United
States
315,365
18,950,283
a
Integer
Holdings
Corp.
...............................
United
States
282,278
24,984,426
a
Kestra
Medical
Technologies
Ltd.
.......................
United
States
792,087
16,412,042
75,818,281
Health
Care
Providers
&
Services
5.5%
Ensign
Group,
Inc.
(The)
..............................
United
States
124,880
23,313,847
a
GeneDx
Holdings
Corp.
,
A
.............................
United
States
201,666
12,682,775
a
Guardant
Health,
Inc.
................................
United
States
304,272
26,496,006
a
HealthEquity,
Inc.
...................................
United
States
292,152
23,965,229
a
Hinge
Health,
Inc.
,
A
.................................
United
States
348,510
15,543,546
a
Privia
Health
Group,
Inc.
..............................
United
States
1,272,198
31,614,120
133,615,523
Health
Care
REITs
0.0%
†
a
Janus
Living,
Inc.
,
A-1
................................
United
States
22,515
590,794
Hotel
&
Resort
REITs
0.7%
Pebblebrook
Hotel
Trust
..............................
United
States
1,142,568
16,053,080
Hotels,
Restaurants
&
Leisure
3.4%
a
Cava
Group,
Inc.
....................................
United
States
315,564
29,476,833
a
Navan,
Inc.
,
A
......................................
United
States
560,849
9,809,249
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Small
Cap
Growth
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Hotels,
Restaurants
&
Leisure
(continued)
Texas
Roadhouse,
Inc.
,
A
.............................
United
States
156,627
$
25,215,381
Wingstop,
Inc.
......................................
United
States
115,426
18,936,790
83,438,253
Household
Durables
1.0%
a
M/I
Homes,
Inc.
.....................................
United
States
195,570
25,715,499
IT
Services
0.6%
a
DigitalOcean
Holdings,
Inc.
............................
United
States
143,861
13,872,516
Life
Sciences
Tools
&
Services
1.8%
Bio-Techne
Corp.
...................................
United
States
300,718
16,635,720
a
Repligen
Corp.
.....................................
United
States
234,118
27,698,500
44,334,220
Machinery
3.0%
a
Alliance
Laundry
Holdings,
Inc.
.........................
United
States
787,743
19,985,040
a
RBC
Bearings,
Inc.
..................................
United
States
87,266
52,280,188
72,265,228
Media
1.6%
New
York
Times
Co.
(The)
,
A
...........................
United
States
502,038
39,676,063
Oil,
Gas
&
Consumable
Fuels
2.4%
a
Infinity
Natural
Resources,
Inc.
,
A
.......................
United
States
1,176,185
19,160,054
Matador
Resources
Co.
..............................
United
States
611,064
38,765,900
57,925,954
Passenger
Airlines
1.6%
a
Alaska
Air
Group,
Inc.
................................
United
States
491,479
19,221,744
a
Allegiant
Travel
Co.
..................................
United
States
251,350
19,012,114
38,233,858
Personal
Care
Products
0.6%
a
BellRing
Brands,
Inc.
.................................
United
States
870,171
15,489,044
Pharmaceuticals
3.5%
a
Amylyx
Pharmaceuticals,
Inc.
..........................
United
States
751,245
12,019,920
a
EyePoint,
Inc.
......................................
United
States
1,506,751
19,889,113
a
Jazz
Pharmaceuticals
plc
.............................
United
States
188,758
38,321,649
a,b
LENZ
Therapeutics,
Inc.
..............................
United
States
147,282
1,322,593
a
Phathom
Pharmaceuticals,
Inc.
.........................
United
States
565,898
6,338,058
a
Structure
Therapeutics,
Inc.
,
ADR
.......................
United
States
185,223
7,677,493
85,568,826
Professional
Services
1.9%
a,b
Andersen
Group,
Inc.
,
A
..............................
United
States
952,087
33,684,838
a
Legalzoom.com,
Inc.
.................................
United
States
1,914,759
12,350,196
46,035,034
Semiconductors
&
Semiconductor
Equipment
8.5%
a
Credo
Technology
Group
Holding
Ltd.
....................
United
States
263,118
45,785,163
a
Lattice
Semiconductor
Corp.
...........................
United
States
443,407
54,219,808
a
Onto
Innovation,
Inc.
.................................
United
States
187,795
55,410,793
a
SiTime
Corp.
.......................................
United
States
90,474
50,859,959
206,275,723
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Small
Cap
Growth
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Software
6.7%
a,c,d
ClearMotion,
Inc.
....................................
United
States
3,698,772
$
381,580
a
Freshworks,
Inc.
,
A
..................................
United
States
1,001,040
8,168,486
a
Gitlab,
Inc.
,
A
......................................
United
States
637,482
14,113,852
a
Intapp,
Inc.
........................................
United
States
499,138
11,205,648
a
JFrog
Ltd.
.........................................
United
States
332,466
15,439,721
a
Klaviyo,
Inc.
,
A
.....................................
United
States
941,201
18,908,728
a
LiveRamp
Holdings,
Inc.
..............................
United
States
532,998
15,579,532
a
nCino,
Inc.
........................................
United
States
1,045,050
18,267,474
a
Netskope,
Inc.
,
A
....................................
United
States
1,070,518
10,662,359
a
Procore
Technologies,
Inc.
............................
United
States
468,167
26,488,889
a
ServiceTitan,
Inc.
,
A
.................................
United
States
395,472
23,514,765
162,731,034
Specialty
Retail
1.5%
a
Boot
Barn
Holdings,
Inc.
..............................
United
States
122,754
21,046,173
Lithia
Motors,
Inc.
,
A
.................................
United
States
57,385
16,648,536
37,694,709
Textiles,
Apparel
&
Luxury
Goods
0.6%
Steven
Madden
Ltd.
.................................
United
States
410,498
15,418,305
Trading
Companies
&
Distributors
1.1%
Herc
Holdings,
Inc.
..................................
United
States
204,177
25,914,145
Total
Common
Stocks
(Cost
$
1,616,015,433
)
..................................
2,357,513,421
Convertible
Preferred
Stocks
2.8%
Automobile
Components
0.6%
a,c,d
Flock
Group,
Inc.
,
G
.................................
United
States
987,540
15,437,126
Communications
Equipment
0.2%
a,c,d
Astranis
Space
Technologies
Corp.
,
E
....................
United
States
311,952
5,999,994
Diversified
Consumer
Services
0.5%
a,c,d
Newsela,
Inc.
,
D
....................................
United
States
709,046
12,707,441
Software
1.3%
a,c,d
Benchling,
Inc.
,
F
...................................
United
States
382,306
1,803,489
a,c,d
Checkr,
Inc.
,
E
.....................................
United
States
1,388,889
21,170,063
a,c,d
OneTrust
LLC
,
A
....................................
United
States
625,361
5,812,569
a,c,d
OneTrust
LLC
,
A-1
..................................
United
States
56,457
524,753
a,c,d
Smule,
Inc.
,
J
......................................
United
States
162,712
1,603,972
30,914,846
Specialty
Retail
0.2%
a,c,d
1661,
Inc.
,
F
.......................................
United
States
3,436,485
3,786,378
Total
Convertible
Preferred
Stocks
(Cost
$
96,764,288
)
.........................
68,845,785
Preferred
Stocks
0.2%
Automobile
Components
0.2%
a,c,d
Tula
eTechnology,
Inc.
................................
United
States
361,111
—
a,c,d
Tula
eTechnology,
Inc.
,
E
.............................
United
States
3,611,111
3,872,916
3,872,916
Software
0.0%
†
a,c,d
ClearMotion,
Inc.
,
A-3
................................
United
States
1,037,942
149,527
a,c,d
ClearMotion,
Inc.
,
A-4
................................
United
States
6,477,294
848,649
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Small
Cap
Growth
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Preferred
Stocks
(continued)
Software
(continued)
a,c,d
Smule,
Inc.
,
144A
,
G
.................................
United
States
1,542,673
$
177,103
a,c,d
Smule,
Inc.
,
144A
,
H
.................................
United
States
352,675
47,866
1,223,145
Total
Preferred
Stocks
(Cost
$
21,224,989
)
....................................
5,096,061
Rights
Rights
0.0%
Biotechnology
0.0%
a,c,d
Chinook
Therapeutics,
Inc.,
CVR
,
6/30/30
.................
United
States
410,500
—
Total
Rights
(Cost
$
–
)
......................................................
—
Shares
Escrows
and
Litigation
Trusts
0.0%
a,c
Wheels
Up
Experience,
Inc.,
Escrow
Account
..............
United
States
440
—
Total
Escrows
and
Litigation
Trusts
(Cost
$
–
)
.................................
—
Total
Long
Term
Investments
(Cost
$
1,734,004,710
)
...........................
2,431,455,267
a
Short
Term
Investments
2.6%
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Money
Market
Funds
0.5%
e,f
Franklin
Institutional
U.S.
Government
Money
Market
Fund
,
3.593
%
.........................................
United
States
11,427,550
11,427,550
Total
Money
Market
Funds
(Cost
$
11,427,550
)
................................
11,427,550
g
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
2.1%
Money
Market
Funds
2.1%
e,f
Franklin
Institutional
U.S.
Government
Money
Market
Fund
,
3.593
%
.........................................
United
States
51,918,825
51,918,825
Total
Investments
from
Cash
Collateral
Received
for
Loaned
Securities
(Cost
$
51,918,825
)
.........................................................
51,918,825
Total
Short
Term
Investments
(Cost
$
63,346,375
)
..............................
63,346,375
a
Total
Investments
(Cost
$
1,797,351,085
)
102.4
%
..............................
$2,494,801,642
Other
Assets,
less
Liabilities
(
2.4
)
%
.........................................
(59,514,243)
Net
Assets
100.0%
.........................................................
$2,435,287,399
a
a
a
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Small
Cap
Growth
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
See
Abbreviations
on
page
158
.
†
Rounds
to
less
than
0.1%
of
net
assets.
a
Non-income
producing.
b
A
portion
or
all
of
the
security
is
on
loan
at
April
30,
2026.
See
Note
1(e).
c
Fair
valued
using
significant
unobservable
inputs.
See
Note
13
regarding
fair
value
measurements.
d
See
Note
7
regarding
restricted
securities.
e
See
Note
3(f)
regarding
investments
in
affiliated
management
investment
companies.
f
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
g
See
Note
1(e)
regarding
securities
on
loan.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small-Mid
Cap
Growth
Fund
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
A
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$36.02
$35.22
$29.75
$33.07
$49.66
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.12)
(0.08)
(0.01)
(0.05)
(0.25)
Net
realized
and
unrealized
gains
(losses)
...........
5.29
0.88
5.48
(1.39)
(9.42)
Total
from
investment
operations
....................
5.17
0.80
5.47
(1.44)
(9.67)
Less
distributions
from:
Net
realized
gains
.............................
(3.04)
—
—
(1.88)
(6.92)
Net
asset
value,
end
of
year
.......................
$38.15
$36.02
$35.22
$29.75
$33.07
Total
return
c
...................................
14.38%
2.27%
18.39%
(4.07)%
(22.83)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.85%
0.84%
0.87%
0.90%
0.85%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.84%
0.84%
d
0.85%
e
0.88%
e
0.84%
e
Net
investment
(loss)
............................
(0.29)%
(0.20)%
(0.02)%
(0.17)%
(0.54)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$2,595,224
$2,596,499
$2,822,866
$2,578,199
$3,019,703
Portfolio
turnover
rate
............................
32.96%
33.86%
f
37.02%
27.75%
48.89%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
11
for
prior
year
information.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
C
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$16.04
$15.80
$13.45
$16.20
$27.98
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.18)
(0.16)
(0.11)
(0.13)
(0.32)
Net
realized
and
unrealized
gains
(losses)
...........
2.35
0.40
2.46
(0.74)
(4.54)
Total
from
investment
operations
....................
2.17
0.24
2.35
(0.87)
(4.86)
Less
distributions
from:
Net
realized
gains
.............................
(3.04)
—
—
(1.88)
(6.92)
Net
asset
value,
end
of
year
.......................
$15.17
$16.04
$15.80
$13.45
$16.20
Total
return
c
...................................
13.55%
1.52%
17.47%
(4.76)%
(23.43)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.60%
1.59%
1.62%
1.65%
1.60%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
1.59%
1.59%
d
1.60%
e
1.63%
e
1.59%
e
Net
investment
(loss)
............................
(1.04)%
(0.95)%
(0.77)%
(0.92)%
(1.29)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$41,625
$48,685
$60,281
$82,982
$110,596
Portfolio
turnover
rate
............................
32.96%
33.86%
f
37.02%
27.75%
48.89%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Total
return
does
not
reflect
sales
commissions
or
contingent
deferred
sales
charges,
if
applicable.
d
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
11
for
prior
year
information.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
R
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$30.04
$29.44
$24.93
$28.11
$43.32
Income
from
investment
operations
a
:
Net
investment
(loss)
b
..........................
(0.18)
(0.14)
(0.07)
(0.11)
(0.32)
Net
realized
and
unrealized
gains
(losses)
...........
4.40
0.74
4.58
(1.19)
(7.97)
Total
from
investment
operations
....................
4.22
0.60
4.51
(1.30)
(8.29)
Less
distributions
from:
Net
realized
gains
.............................
(3.04)
—
—
(1.88)
(6.92)
Net
asset
value,
end
of
year
.......................
$31.22
$30.04
$29.44
$24.93
$28.11
Total
return
....................................
14.07%
2.04%
18.09%
(4.30)%
(23.00)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
1.10%
1.09%
1.12%
1.15%
1.10%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
1.09%
1.09%
c
1.10%
d
1.13%
d
1.09%
d
Net
investment
(loss)
............................
(0.54)%
(0.45)%
(0.27)%
(0.42)%
(0.79)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$34,130
$33,211
$37,276
$34,371
$38,761
Portfolio
turnover
rate
............................
32.96%
33.86%
e
37.02%
27.75%
48.89%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
d
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
e
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
11
for
prior
year
information.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Class
R6
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$44.32
$43.23
$36.39
$39.84
$58.24
Income
from
investment
operations
a
:
Net
investment
income
(loss)
b
....................
0.02
0.07
0.14
0.08
(0.10)
Net
realized
and
unrealized
gains
(losses)
...........
6.52
1.07
6.70
(1.65)
(11.38)
Total
from
investment
operations
....................
6.54
1.14
6.84
(1.57)
(11.48)
Less
distributions
from:
Net
investment
income
..........................
—
(0.05)
—
—
—
Net
realized
gains
.............................
(3.04)
—
—
(1.88)
(6.92)
Total
distributions
...............................
(3.04)
(0.05)
—
(1.88)
(6.92)
Net
asset
value,
end
of
year
.......................
$47.82
$44.32
$43.23
$36.39
$39.84
Total
return
....................................
14.79%
2.61%
18.82%
(3.70)%
(22.57)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.51%
0.51%
0.51%
0.53%
0.51%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.50%
0.50%
0.49%
c
0.49%
c
0.50%
c
Net
investment
income
(loss)
......................
0.05%
0.14%
0.34%
0.23%
(0.19)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$437,861
$437,087
$539,962
$451,447
$540,509
Portfolio
turnover
rate
............................
32.96%
33.86%
d
37.02%
27.75%
48.89%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
d
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
11
for
prior
year
information.
Franklin
Strategic
Series
Financial
Highlights
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
Year
Ended
April
30,
2026
2025
2024
2023
2022
Advisor
Class
Per
share
operating
performance
(for
a
share
outstanding
throughout
the
year)
Net
asset
value,
beginning
of
year
...................
$42.85
$41.79
$35.22
$38.68
$56.79
Income
from
investment
operations
a
:
Net
investment
income
(loss)
b
....................
(0.02)
0.02
0.09
0.03
(0.15)
Net
realized
and
unrealized
gains
(losses)
...........
6.30
1.04
6.48
(1.61)
(11.04)
Total
from
investment
operations
....................
6.28
1.06
6.57
(1.58)
(11.19)
Less
distributions
from:
Net
investment
income
..........................
—
(—)
c
—
—
—
Net
realized
gains
.............................
(3.04)
—
—
(1.88)
(6.92)
Net
asset
value,
end
of
year
.......................
$46.09
$42.85
$41.79
$35.22
$38.68
Total
return
....................................
14.69%
2.52%
18.68%
(3.81)%
(22.65)%
Ratios
to
average
net
assets
Expenses
before
waiver
and
payments
by
affiliates
......
0.60%
0.59%
0.62%
0.65%
0.60%
Expenses
net
of
waiver
and
payments
by
affiliates
.......
0.59%
0.59%
d
0.60%
e
0.63%
e
0.59%
e
Net
investment
income
(loss)
......................
(0.04)%
0.05%
0.23%
0.08%
(0.28)%
Supplemental
data
Net
assets,
end
of
year
(000’s)
.....................
$423,911
$416,492
$435,671
$469,050
$532,573
Portfolio
turnover
rate
............................
32.96%
33.86%
f
37.02%
27.75%
48.89%
a
The
amount
shown
for
a
share
outstanding
throughout
the
period
may
not
correlate
with
the
Statement
of
Operations
for
the
period
due
to
the
timing
of
sales
and
repurchas-
es
of
the
Fund’s
shares
in
relation
to
income
earned
and/or
fluctuating
fair
value
of
the
investments
of
the
Fund.
b
Based
on
average
daily
shares
outstanding.
c
Amount
rounds
to
less
than
$0.01
per
share.
d
Benefit
of
waiver
and
payments
by
affiliates
rounds
to
less
than
0.01%.
e
Benefit
of
expense
reduction
rounds
to
less
than
0.01%.
f
Excludes
the
value
of
portfolio
activity
as
a
result
of
in-kind
transactions.
See
Note
11
for
prior
year
information.
Franklin
Strategic
Series
Schedule
of
Investments,
April
30,
2026
Franklin
Small-Mid
Cap
Growth
Fund
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
94.1%
Aerospace
&
Defense
7.5%
a
Arxis,
Inc.
,
A
.......................................
United
States
222,303
$
7,780,605
a
Axon
Enterprise,
Inc.
.................................
United
States
172,026
69,113,166
BWX
Technologies,
Inc.
..............................
United
States
250,270
54,155,925
Howmet
Aerospace,
Inc.
..............................
United
States
551,035
133,923,546
264,973,242
Banks
1.2%
Fifth
Third
Bancorp
..................................
United
States
851,600
43,227,216
Biotechnology
5.4%
a
Alnylam
Pharmaceuticals,
Inc.
..........................
United
States
158,320
48,998,457
a
Ascendis
Pharma
A/S
................................
Denmark
72,761
16,689,918
a
CG
oncology,
Inc.
...................................
United
States
200,480
13,380,035
a
Insmed,
Inc.
.......................................
United
States
235,515
32,107,760
a
Ionis
Pharmaceuticals,
Inc.
............................
United
States
167,060
12,489,406
a
Natera,
Inc.
........................................
United
States
324,800
66,960,768
190,626,344
Building
Products
1.6%
AAON,
Inc.
........................................
United
States
597,073
55,712,882
Capital
Markets
7.1%
Ares
Management
Corp.
,
A
............................
United
States
411,312
48,288,029
LPL
Financial
Holdings,
Inc.
...........................
United
States
139,948
46,760,825
MSCI,
Inc.
,
A
.......................................
United
States
109,440
64,723,910
Nasdaq,
Inc.
.......................................
United
States
443,736
40,783,776
a
Robinhood
Markets,
Inc.
,
A
............................
United
States
220,553
16,076,108
Tradeweb
Markets,
Inc.
,
A
.............................
United
States
296,376
33,564,582
250,197,230
Construction
&
Engineering
3.2%
Comfort
Systems
USA,
Inc.
............................
United
States
61,667
113,482,697
Consumer
Staples
Distribution
&
Retail
1.8%
Casey's
General
Stores,
Inc.
...........................
United
States
60,400
49,657,860
a
Performance
Food
Group
Co.
..........................
United
States
136,395
12,351,931
62,009,791
Electrical
Equipment
6.8%
AMETEK,
Inc.
......................................
United
States
265,345
62,488,747
Vertiv
Holdings
Co.
,
A
................................
United
States
537,785
176,656,995
239,145,742
Entertainment
2.1%
a
ROBLOX
Corp.
,
A
...................................
United
States
1,338,959
73,990,874
Financial
Services
0.8%
a
Paymentus
Holdings,
Inc.
,
A
...........................
United
States
954,396
26,770,808
Ground
Transportation
1.5%
Old
Dominion
Freight
Line,
Inc.
.........................
United
States
244,488
51,936,586
Health
Care
Equipment
&
Supplies
2.9%
a
Dexcom,
Inc.
.......................................
United
States
1,035,580
61,668,789
a
IDEXX
Laboratories,
Inc.
..............................
United
States
75,336
42,248,429
103,917,218
Health
Care
Providers
&
Services
2.0%
Cencora,
Inc.
......................................
United
States
231,186
71,207,600
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Health
Care
Technology
0.7%
a
Veeva
Systems,
Inc.
,
A
...............................
United
States
166,734
$
26,005,502
Hotels,
Restaurants
&
Leisure
11.6%
a
Cava
Group,
Inc.
....................................
United
States
461,336
43,093,396
a
DoorDash,
Inc.
,
A
...................................
United
States
269,209
45,402,098
Hilton
Worldwide
Holdings,
Inc.
.........................
United
States
266,715
86,434,330
Marriott
International,
Inc.
,
A
...........................
United
States
151,450
54,777,950
Royal
Caribbean
Cruises
Ltd.
..........................
United
States
410,701
108,326,496
Texas
Roadhouse,
Inc.
,
A
.............................
United
States
278,884
44,897,535
Wingstop,
Inc.
......................................
United
States
167,672
27,508,268
410,440,073
Household
Durables
0.8%
a
NVR,
Inc.
.........................................
United
States
4,717
29,791,959
Independent
Power
and
Renewable
Electricity
Producers
2.1%
Vistra
Corp.
........................................
United
States
475,201
75,005,726
Interactive
Media
&
Services
0.3%
a
Pinterest,
Inc.
,
A
....................................
United
States
437,741
8,605,988
IT
Services
2.2%
a
Cloudflare,
Inc.
,
A
...................................
United
States
370,301
75,900,596
Life
Sciences
Tools
&
Services
1.0%
a
Repligen
Corp.
.....................................
United
States
296,425
35,070,042
Machinery
0.9%
Xylem,
Inc.
........................................
United
States
275,637
32,569,268
Media
1.3%
New
York
Times
Co.
(The)
,
A
...........................
United
States
585,501
46,272,144
Oil,
Gas
&
Consumable
Fuels
3.3%
Cheniere
Energy,
Inc.
................................
United
States
88,393
24,303,655
Targa
Resources
Corp.
...............................
United
States
358,980
93,363,519
117,667,174
Professional
Services
1.5%
Verisk
Analytics,
Inc.
,
A
...............................
United
States
291,117
53,708,175
Real
Estate
Management
&
Development
0.6%
a
Jones
Lang
LaSalle,
Inc.
..............................
United
States
62,023
19,731,377
Residential
REITs
0.4%
Equity
LifeStyle
Properties,
Inc.
.........................
United
States
197,734
12,514,585
Semiconductors
&
Semiconductor
Equipment
6.2%
a
Credo
Technology
Group
Holding
Ltd.
....................
United
States
166,730
29,012,687
a
Lattice
Semiconductor
Corp.
...........................
United
States
435,091
53,202,928
Monolithic
Power
Systems,
Inc.
.........................
United
States
74,528
120,318,748
a
Onto
Innovation,
Inc.
.................................
United
States
57,063
16,837,009
219,371,372
Software
7.5%
a
Arteris,
Inc.
........................................
United
States
1,456,454
42,178,908
a
Datadog,
Inc.
,
A
....................................
United
States
519,477
68,669,664
a
Fair
Isaac
Corp.
....................................
United
States
33,957
34,805,925
a
Guidewire
Software,
Inc.
..............................
United
States
237,365
32,848,942
a
Manhattan
Associates,
Inc.
............................
United
States
102,085
14,076,501
a,b,c
Plaid,
Inc.
,
A
.......................................
United
States
30,940
7,493,068
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Common
Stocks
(continued)
Software
(continued)
a
Procore
Technologies,
Inc.
............................
United
States
552,941
$
31,285,402
a
Tyler
Technologies,
Inc.
...............................
United
States
98,554
33,620,711
264,979,121
Specialty
Retail
6.8%
a
AutoZone,
Inc.
.....................................
United
States
15,400
57,042,062
a
Burlington
Stores,
Inc.
................................
United
States
178,660
57,172,987
a
Carvana
Co.
,
A
.....................................
United
States
200,070
79,187,706
Tractor
Supply
Co.
..................................
United
States
1,377,833
48,361,938
241,764,693
Technology
Hardware,
Storage
&
Peripherals
1.0%
a
Everpure,
Inc.
,
A
....................................
United
States
504,541
36,049,454
Trading
Companies
&
Distributors
2.0%
Fastenal
Co.
.......................................
United
States
417,357
18,751,850
United
Rentals,
Inc.
..................................
United
States
54,446
52,259,449
71,011,299
Total
Common
Stocks
(Cost
$
2,246,150,861
)
..................................
3,323,656,778
Convertible
Preferred
Stocks
2.7%
Aerospace
&
Defense
0.8%
a,b,c
Anduril
Industries,
Inc.
,
F
..............................
United
States
414,483
28,578,603
Diversified
Consumer
Services
0.2%
a,b,c
Newsela,
Inc.
,
D
....................................
United
States
423,782
7,594,972
Semiconductors
&
Semiconductor
Equipment
0.2%
a,b,c
Phononic
Devices,
Inc.
,
F-S
...........................
United
States
2,970,061
6,046,293
Software
1.5%
a,b,c
Benchling,
Inc.
,
F
...................................
United
States
347,106
1,637,436
a,b,c
Databricks,
Inc.
,
G
..................................
United
States
227,829
43,523,409
a,b,c
OneTrust
LLC
,
C
....................................
United
States
767,526
7,133,956
52,294,801
Total
Convertible
Preferred
Stocks
(Cost
$
65,344,990
)
.........................
94,514,669
Preferred
Stocks
0.0%
†
Semiconductors
&
Semiconductor
Equipment
0.0%
†
a,b,c
Phononic
Devices,
Inc.
,
G-2-S
..........................
United
States
513,050
1,824,398
a,b,c
Phononic,
Inc.
,
H-S
..................................
United
States
117,763
584,839
2,409,237
Total
Preferred
Stocks
(Cost
$
460,692
)
.......................................
2,409,237
Warrants
Warrants
0.0%
†
Semiconductors
&
Semiconductor
Equipment
0.0%
†
a,b,c
Phononic,
Inc.
,
H-S
,
12/31/29
..........................
United
States
23,970
32,191
a,b,c
Phononic,
Inc.
,
H-S-X
,
12/31/29
........................
United
States
47,104
63,259
95,450
Total
Warrants
(Cost
$
44,031
)
...............................................
95,450
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
a
a
Country
Principal
Amount
*
a
Value
a
a
a
a
a
Convertible
Bonds
0.0%
†
Semiconductors
&
Semiconductor
Equipment
0.0%
†
b,c
Phononic,
Inc.
,
5.31
%
,
11/30/27
........................
United
States
66,235
$
79,754
b,c
Phononic,
Inc.
,
H-S
,
5.31
%
,
11/30/27
....................
United
States
66,235
81,015
b,c
Phononic,
Inc.
,
H-S
,
5.31
%
,
11/30/27
....................
United
States
66,235
82,304
243,073
Total
Convertible
Bonds
(Cost
$
198,704
)
.....................................
243,073
d
Senior
Floating
Rate
Interests
0.1%
Semiconductors
&
Semiconductor
Equipment
0.1%
b,e
Phononic,
Inc.,
First
Lien,
Term
Loan,
B
,
PIK,
12
%
,
12/31/27
...
United
States
1,174,043
1,010,160
Total
Senior
Floating
Rate
Interests
(Cost
$
1,127,742
)
.........................
1,010,160
Shares
a
Escrows
and
Litigation
Trusts
0.0%
a,b
Blaize
Events
&
Media,
Inc.,
Escrow
Account
...............
United
States
343,168
—
a,b
Blaize
Holdings,
Inc.,
Escrow
Account
....................
United
States
114,150
—
Total
Escrows
and
Litigation
Trusts
(Cost
$
–
)
.................................
—
Total
Long
Term
Investments
(Cost
$
2,313,327,020
)
...........................
3,421,929,367
a
Short
Term
Investments
2.1%
a
a
Country
Shares
a
Value
a
a
a
a
a
a
Money
Market
Funds
2.1%
f,g
Franklin
Institutional
U.S.
Government
Money
Market
Fund
,
3.593
%
.........................................
United
States
74,959,605
74,959,605
Total
Money
Market
Funds
(Cost
$
74,959,605
)
................................
74,959,605
Total
Short
Term
Investments
(Cost
$
74,959,605
)
..............................
74,959,605
a
Total
Investments
(Cost
$
2,388,286,625
)
99.0
%
................................
$3,496,888,972
Other
Assets,
less
Liabilities
1.0
%
...........................................
35,863,907
Net
Assets
100.0%
.........................................................
$3,532,752,879
a
a
a
Franklin
Strategic
Series
Schedule
of
Investments
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
See
Abbreviations
on
page
158
.
*
The
principal
amount
is
stated
in
U.S.
dollars
unless
otherwise
indicated.
†
Rounds
to
less
than
0.1%
of
net
assets.
a
Non-income
producing.
b
Fair
valued
using
significant
unobservable
inputs.
See
Note
13
regarding
fair
value
measurements.
c
See
Note
7
regarding
restricted
securities.
d
See
Note
1(g)
regarding
senior
floating
rate
interests.
e
Income
may
be
received
in
additional
securities
and/or
cash.
f
See
Note
3(f)
regarding
investments
in
affiliated
management
investment
companies.
g
The
rate
shown
is
the
annualized
seven-day
effective
yield
at
period
end.
Franklin
Strategic
Series
Financial
Statements
Statements
of
Assets
and
Liabilities
April
30,
2026
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Franklin
Growth
Opportunities
Fund
Assets:
Investments
in
securities:
Cost
-
Unaffiliated
issuers
.................................
$494,620,655
$3,207,346,313
$2,048,330,579
Cost
-
Non-controlled
affiliates
(Note
3
f
)
......................
57,612,300
234,995,433
67,506,254
Value
-
Unaffiliated
issuers
(Includes
securities
loaned
of
$31,272,989,
$—
and
$19,958,958,
respectively)
..........................
$1,014,410,785
$3,120,796,519
$4,344,609,983
Value
-
Non-controlled
affiliates
(Note
3
f
)
......................
57,612,300
234,995,433
67,506,254
Cash
..................................................
93,044
—
35,681
Foreign
currency,
at
value
(cost
$113,
$167,265
and
$–,
respectively)
..
116
169,148
—
Receivables:
Investment
securities
sold
.................................
313,172
1,844,303
105,530,395
Receivable
for
sales
of
TBA
securities
(Note
1
c
)
................
–
21,612,812
–
Capital
shares
sold
......................................
450,599
2,714,380
1,230,540
Dividends
and
interest
...................................
229,019
27,901,807
223,896
Deposits
with
brokers
for:
OTC
derivative
contracts
................................
—
1,040,000
—
TBA
transactions
(Note
1c)
..............................
—
2,003,000
—
Futures
contracts
......................................
—
5,198,156
—
Centrally
cleared
swap
contracts
..........................
—
237,200
—
Variation
margin
on
centrally
cleared
swap
contracts
.............
—
145,230
—
Unrealized
appreciation
on
OTC
forward
exchange
contracts
........
—
28,768
—
Unrealized
appreciation
on
unfunded
commitments
(Note
1
c
)
........
311,468
—
—
Total
assets
........................................
1,073,420,503
3,418,686,756
4,519,136,749
Liabilities:
Payables:
Investment
securities
purchased
............................
2,798,212
52,335,774
11,844,549
Payable
for
purchases
of
TBA
securities
(Note
1
c
)
...............
—
590,170,941
—
Capital
shares
redeemed
.................................
656,925
1,461,089
89,323,250
Management
fees
.......................................
510,798
852,087
1,881,512
Distribution
fees
........................................
135,819
460,215
770,434
Transfer
agent
fees
......................................
261,242
704,098
826,168
Trustees'
fees
and
expenses
...............................
247
190
54
Variation
margin
on
futures
contracts
.........................
—
37,617
—
Funds
advanced
by
custodian
...............................
—
411,174
—
OTC
swap
contracts
(upfront
receipts
$–,
$1,419,283
and
$–,
respectively)
............................................
—
1,291,228
—
Unrealized
depreciation
on
OTC
swap
contracts
..................
—
123,303
—
Options
written,
at
value
(premiums
received
$–,
$1,504,514
and
$–,
respectively)
............................................
—
1,611,285
—
Unrealized
depreciation
on
OTC
forward
exchange
contracts
........
—
54,638
—
TBA
sale
commitments,
at
value
(proceeds
$–,
$21,612,812
and
$–)
(Note
1c)
...............................................
—
21,469,454
—
Payable
upon
return
of
securities
loaned
(Note
1
e
)
................
31,626,763
—
19,950,750
Unrealized
depreciation
on
unfunded
loan
commitments
(Note
8
)
.....
—
92
—
Accrued
expenses
and
other
liabilities
.........................
70,227
384,301
139,219
Total
liabilities
.......................................
36,060,233
671,367,486
124,735,936
Net
assets,
at
value
...............................
$1,037,360,270
$2,747,319,270
$4,394,400,813
Net
assets
consist
of:
Paid-in
capital
...........................................
$455,619,045
$3,901,923,879
$1,889,321,150
Total
distributable
earnings
(losses)
...........................
581,741,225
(1,154,604,609)
2,505,079,663
Net
assets,
at
value
...............................
$1,037,360,270
$2,747,319,270
$4,394,400,813
Franklin
Strategic
Series
Financial
Statements
Statements
of
Assets
and
Liabilities
(continued)
April
30,
2026
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Franklin
Growth
Opportunities
Fund
Class
A:
Net
assets,
at
value
.....................................
$861,885,514
$2,044,094,482
$3,569,378,187
Shares
outstanding
......................................
4,963,881
246,238,308
78,797,446
Net
asset
value
per
share
a,b
................................
$173.63
$8.30
$45.30
Maximum
offering
price
per
share
(net
asset
value
per
share
÷
94.50%,
96.25%
and
94.50%,
respectively)
b
..........................
$183.74
$8.62
$47.94
Class
C:
Net
assets,
at
value
.....................................
$22,571,899
$45,167,848
$67,998,689
Shares
outstanding
......................................
146,448
5,433,207
2,563,799
Net
asset
value
and
maximum
offering
price
per
share
a,b
..........
$154.13
$8.31
$26.52
Class
R:
Net
assets,
at
value
.....................................
$—
$33,525,075
$25,147,654
Shares
outstanding
......................................
—
4,060,396
634,251
Net
asset
value
and
maximum
offering
price
per
share
b
...........
$—
$8.26
$39.65
Class
R6:
Net
assets,
at
value
.....................................
$13,158,425
$282,963,666
$408,527,105
Shares
outstanding
......................................
69,918
34,022,747
7,307,798
Net
asset
value
and
maximum
offering
price
per
share
b
...........
$188.20
$8.32
$55.90
Advisor
Class:
Net
assets,
at
value
.....................................
$139,744,432
$341,568,199
$323,349,178
Shares
outstanding
......................................
758,068
41,079,666
5,972,224
Net
asset
value
and
maximum
offering
price
per
share
b
...........
$184.34
$8.31
$54.14
a
Redemption
price
is
equal
to
net
asset
value
less
contingent
deferred
sales
charges,
if
applicable.
b
Net
asset
value
per
share
may
not
recalculate
due
to
rounding.
Franklin
Strategic
Series
Financial
Statements
Statements
of
Assets
and
Liabilities
(continued)
April
30,
2026
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Franklin
Natural
Resources
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Assets:
Investments
in
securities:
Cost
-
Unaffiliated
issuers
.................................
$280,901,749
$1,734,004,710
$2,313,327,020
Cost
-
Non-controlled
affiliates
(Note
3
f
)
......................
20,455,294
63,346,375
74,959,605
Value
-
Unaffiliated
issuers
(Includes
securities
loaned
of
$12,988,816,
$52,624,457
and
$—,
respectively)
..........................
$532,151,157
$2,431,455,267
$3,421,929,367
Value
-
Non-controlled
affiliates
(Note
3
f
)
......................
20,455,294
63,346,375
74,959,605
Cash
..................................................
106,660
—
6,840
Foreign
currency,
at
value
(cost
$81,082,
$–
and
$166,
respectively)
..
81,170
—
171
Receivables:
Investment
securities
sold
(Includes
securities
loaned
$–,
$659,884
and
$–
respectively)
.....................................
13,633
8,024,054
39,684,882
Capital
shares
sold
......................................
475,050
532,160
646,247
Dividends
and
interest
...................................
265,462
173,340
725,732
European
Union
tax
reclaims
(Note
1
i
)
.......................
65,052
—
—
Due
from
custodian
......................................
—
1,198,750
—
Total
assets
........................................
553,613,478
2,504,729,946
3,537,952,844
Liabilities:
Payables:
Investment
securities
purchased
............................
947,270
1,064,280
—
Capital
shares
redeemed
.................................
414,660
12,960,156
2,185,246
Management
fees
.......................................
212,261
1,220,464
1,290,045
Distribution
fees
........................................
93,950
210,207
568,976
Transfer
agent
fees
......................................
117,327
532,122
986,223
Trustees'
fees
and
expenses
...............................
99
134
216
Funds
advanced
by
custodian
...............................
—
198,324
—
Payable
upon
return
of
securities
loaned
(Note
1
e
)
................
12,868,615
53,117,575
—
Accrued
expenses
and
other
liabilities
.........................
43,314
139,285
169,259
Total
liabilities
.......................................
14,697,496
69,442,547
5,199,965
Net
assets,
at
value
...............................
$538,915,982
$2,435,287,399
$3,532,752,879
Net
assets
consist
of:
Paid-in
capital
...........................................
$413,537,403
$1,422,126,677
$2,353,006,343
Total
distributable
earnings
(losses)
...........................
125,378,579
1,013,160,722
1,179,746,536
Net
assets,
at
value
...............................
$538,915,982
$2,435,287,399
$3,532,752,879
Franklin
Strategic
Series
Financial
Statements
Statements
of
Assets
and
Liabilities
(continued)
April
30,
2026
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Franklin
Natural
Resources
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Class
A:
Net
assets,
at
value
.....................................
$389,698,549
$873,630,329
$2,595,224,470
Shares
outstanding
......................................
8,546,118
36,008,822
68,026,218
Net
asset
value
per
share
a,b
................................
$45.60
$24.26
$38.15
Maximum
offering
price
per
share
(net
asset
value
per
share
÷
94.50%)
b
..............................................
$48.25
$25.67
$40.37
Class
C:
Net
assets,
at
value
.....................................
$18,181,552
$17,343,081
$41,625,312
Shares
outstanding
......................................
408,925
1,106,148
2,743,939
Net
asset
value
and
maximum
offering
price
per
share
a,b
..........
$44.46
$15.68
$15.17
Class
R:
Net
assets,
at
value
.....................................
$—
$48,833,074
$34,130,448
Shares
outstanding
......................................
—
2,269,284
1,093,125
Net
asset
value
and
maximum
offering
price
per
share
b
...........
$—
$21.52
$31.22
Class
R6:
Net
assets,
at
value
.....................................
$19,396,026
$1,151,091,967
$437,861,376
Shares
outstanding
......................................
389,460
39,474,981
9,157,059
Net
asset
value
and
maximum
offering
price
per
share
b
...........
$49.80
$29.16
$47.82
Advisor
Class:
Net
assets,
at
value
.....................................
$111,639,855
$344,388,948
$423,911,273
Shares
outstanding
......................................
2,259,931
12,227,193
9,198,420
Net
asset
value
and
maximum
offering
price
per
share
b
...........
$49.40
$28.17
$46.09
a
Redemption
price
is
equal
to
net
asset
value
less
contingent
deferred
sales
charges,
if
applicable.
b
Net
asset
value
per
share
may
not
recalculate
due
to
rounding.
Franklin
Strategic
Series
Financial
Statements
Statements
of
Operations
for
the
year
ended
April
30,
2026
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Franklin
Growth
Opportunities
Fund
Investment
income:
Dividends:
(net
of
foreign
taxes
of
$2,384,
$–
and
$58,437,
respectively)
Unaffiliated
issuers
......................................
$3,565,905
$114,279
$14,836,331
Non-controlled
affiliates
(Note
3
f
)
...........................
728,255
4,256,023
1,104,970
Interest:
Unaffiliated
issuers
......................................
—
127,813,171
—
Income
from
securities
loaned:
Unaffiliated
entities
(net
of
fees
and
rebates)
...................
(517,768)
12,459
(697,248)
Non-controlled
affiliates
(Note
3
f
)
...........................
1,177,751
4,804
759,446
Total
investment
income
.................................
4,954,143
132,200,736
16,003,499
Expenses:
Management
fees
(Note
3
a
)
.................................
5,380,598
9,035,652
24,268,214
Distribution
fees:
(Note
3c
)
Class
A
..............................................
1,834,630
5,057,427
9,150,742
Class
C
..............................................
202,109
305,467
762,908
Class
R
..............................................
—
171,023
130,470
Transfer
agent
fees:
(Note
3e
)
Class
A
..............................................
896,470
2,825,585
3,072,065
Class
C
..............................................
24,857
65,466
64,243
Class
R
..............................................
—
47,724
21,932
Class
R6
.............................................
14,443
63,726
72,616
Advisor
Class
..........................................
144,189
420,845
279,522
Custodian
fees
..........................................
4,447
17,900
24,954
Reports
to
shareholders
fees
................................
79,251
282,439
213,823
Registration
and
filing
fees
..................................
88,876
119,636
91,715
Professional
fees
.........................................
107,254
288,620
138,980
Trustees'
fees
and
expenses
................................
9,894
27,991
48,949
Marketplace
lending
fees
(Note
1
h
)
...........................
—
546,604
—
Other
..................................................
29,668
180,249
118,357
Total
expenses
.......................................
8,816,686
19,456,354
38,459,490
Expenses
waived/paid
by
affiliates
(Note
3
f
and
3
g
)
............
(91,716)
(2,187,640)
(86,905)
Net
expenses
.......................................
8,724,970
17,268,714
38,372,585
Net
investment
income
(loss)
..........................
(3,770,827)
114,932,022
(22,369,086)
Franklin
Strategic
Series
Financial
Statements
Statements
of
Operations
(continued)
for
the
year
ended
April
30,
2026
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Franklin
Growth
Opportunities
Fund
Realized
and
unrealized
gains
(losses):
Net
realized
gain
(loss)
from:
Investments:
*
Unaffiliated
issuers
....................................
132,431,714
(16,231,490)
719,356,046
Non-controlled
affiliates
(Note
3
f
)
..........................
—
338,565
—
Written
options
.........................................
—
1,771,572
—
Foreign
currency
transactions
..............................
1,922
11,840
—
Forward
exchange
contracts
...............................
—
(339,383)
—
Futures
contracts
.......................................
—
(2,182,585)
—
TBA
sale
commitments
...................................
—
3,064,225
—
Swap
contracts
.........................................
—
(2,182,807)
—
Net
realized
gain
(loss)
................................
132,433,636
(15,750,063)
719,356,046
Net
change
in
unrealized
appreciation
(depreciation)
on:
Investments:
Unaffiliated
issuers
....................................
301,996,177
23,149,775
137,236,875
Non-controlled
affiliates
(Note
3
f
)
..........................
—
(1,061,917)
—
Translation
of
other
assets
and
liabilities
denominated
in
foreign
currencies
...........................................
(5)
(1,721)
—
Unfunded
commitments
(Note
1
c
)
...........................
311,468
—
—
Unfunded
loan
commitments
(Note
8
)
........................
—
(24)
—
Written
options
.........................................
—
(106,771)
—
Forward
exchange
contracts
...............................
—
144,902
—
Futures
contracts
.......................................
—
(2,216,598)
—
TBA
sale
commitments
...................................
—
143,358
—
Swap
contracts
.........................................
—
(252,763)
—
Change
in
deferred
tax
benefit
.............................
—
(287,971)
—
Net
change
in
unrealized
appreciation
(depreciation)
..........
302,307,640
19,510,270
137,236,875
Net
realized
and
unrealized
gain
(loss)
..........................
434,741,276
3,760,207
856,592,921
Net
increase
(decrease)
in
net
assets
resulting
from
operations
........
$430,970,449
$118,692,229
$834,223,835
Franklin
Strategic
Series
Financial
Statements
Statements
of
Operations
(continued)
for
the
year
ended
April
30,
2026
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Franklin
Natural
Resources
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Investment
income:
Dividends:
(net
of
foreign
taxes
of
$404,047,
$–
and
$–,
respectively)
Unaffiliated
issuers
......................................
$8,508,739
$7,808,790
$17,622,223
Non-controlled
affiliates
(Note
3
f
)
...........................
372,469
1,668,928
2,630,648
Interest:
Unaffiliated
issuers
......................................
77,907
—
103,876
Income
from
securities
loaned:
Unaffiliated
entities
(net
of
fees
and
rebates)
...................
(375,984)
(1,569,913)
(273,403)
Non-controlled
affiliates
(Note
3
f
)
...........................
459,264
1,928,892
373,347
Other
income
(Note
1i)
.....................................
63,005
—
—
Total
investment
income
.................................
9,105,400
9,836,697
20,456,691
Expenses:
Management
fees
(Note
3
a
)
.................................
1,993,550
15,248,855
17,048,347
Distribution
fees:
(Note
3c
)
Class
A
..............................................
715,888
2,129,580
6,850,563
Class
C
..............................................
154,305
188,919
477,203
Class
R
..............................................
—
226,686
176,179
Transfer
agent
fees:
(Note
3e
)
Class
A
..............................................
406,877
1,552,754
3,361,698
Class
C
..............................................
22,096
34,519
58,772
Class
R
..............................................
—
82,586
43,191
Class
R6
.............................................
8,143
351,158
176,088
Advisor
Class
..........................................
104,662
630,027
550,080
Custodian
fees
..........................................
5,009
13,779
28,126
Reports
to
shareholders
fees
................................
39,138
177,980
269,042
Registration
and
filing
fees
..................................
45,900
94,571
71,909
Professional
fees
.........................................
89,132
120,188
127,925
Trustees'
fees
and
expenses
................................
4,395
27,021
41,028
Other
..................................................
47,453
58,197
85,375
Total
expenses
.......................................
3,636,548
20,936,820
29,365,526
Expenses
waived/paid
by
affiliates
(Note
3
f
and
3
g
)
............
(44,498)
(163,897)
(185,250)
Net
expenses
.......................................
3,592,050
20,772,923
29,180,276
Net
investment
income
(loss)
..........................
5,513,350
(10,936,226)
(8,723,585)
Realized
and
unrealized
gains
(losses):
Net
realized
gain
(loss)
from:
Investments:
Unaffiliated
issuers
....................................
25,796,403
384,753,801
264,955,392
Foreign
currency
transactions
..............................
15,489
—
—
Net
realized
gain
(loss)
................................
25,811,892
384,753,801
264,955,392
Net
change
in
unrealized
appreciation
(depreciation)
on:
Investments:
Unaffiliated
issuers
....................................
162,285,186
270,177,712
245,936,725
Translation
of
other
assets
and
liabilities
denominated
in
foreign
currencies
...........................................
(1,700)
—
4
Net
change
in
unrealized
appreciation
(depreciation)
..........
162,283,486
270,177,712
245,936,729
Net
realized
and
unrealized
gain
(loss)
..........................
188,095,378
654,931,513
510,892,121
Net
increase
(decrease)
in
net
assets
resulting
from
operations
........
$193,608,728
$643,995,287
$502,168,536
*
Includes
gains
from
redemption
in-kind.
See
Note
11.
Franklin
Strategic
Series
Financial
Statements
Statements
of
Changes
in
Net
Assets
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Year
Ended
April
30,
2026
Year
Ended
April
30,
2025
Year
Ended
April
30,
2026
Year
Ended
April
30,
2025
Increase
(decrease)
in
net
assets:
Operations:
Net
investment
income
(loss)
.......
$(3,770,827)
$(2,590,143)
$114,932,022
$119,294,173
Net
realized
gain
(loss)
............
132,433,636
73,170,652
(15,750,063)
(38,648,459)
Net
change
in
unrealized
appreciation
(depreciation)
.................
302,307,640
(94,432,247)
19,510,270
93,676,023
Net
increase
(decrease)
in
net
assets
resulting
from
operations
.
430,970,449
(23,851,738)
118,692,229
174,321,737
Distributions
to
shareholders:
Class
A
........................
(83,604,188)
(58,160,749)
(86,978,395)
(95,594,345)
Class
C
........................
(2,442,259)
(2,094,936)
(1,820,476)
(2,412,060)
Class
R
........................
—
—
(1,393,969)
(1,613,364)
Class
R6
.......................
(1,454,759)
(718,012)
(7,647,352)
(6,689,754)
Advisor
Class
...................
(13,121,806)
(10,336,804)
(13,660,378)
(13,313,957)
Total
distributions
to
shareholders
.....
(100,623,012)
(71,310,501)
(111,500,570)
(119,623,480)
Capital
share
transactions:
(Note
2
)
Class
A
........................
(2,040,920)
(38,843,761)
47,867,343
(133,993,404)
Class
C
........................
(1,895,840)
(7,618,126)
(4,826,778)
(16,499,318)
Class
R
........................
—
—
(1,542,895)
(1,822,597)
Class
R6
.......................
2,873,926
(2,735,688)
152,958,148
(5,214,894)
Advisor
Class
...................
659,401
(22,539,823)
77,426,224
(14,309,594)
Total
capital
share
transactions
.......
(403,433)
(71,737,398)
271,882,042
(171,839,807)
Net
increase
(decrease)
in
net
assets
.....................
329,944,004
(166,899,637)
279,073,701
(117,141,550)
Net
assets:
Beginning
of
year
..................
707,416,266
874,315,903
2,468,245,569
2,585,387,119
End
of
year
......................
$1,037,360,270
$707,416,266
$2,747,319,270
$2,468,245,569
Franklin
Strategic
Series
Financial
Statements
Statements
of
Changes
in
Net
Assets
(continued)
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Annual
Report
Franklin
Growth
Opportunities
Fund
Franklin
Natural
Resources
Fund
Year
Ended
April
30,
2026
Year
Ended
April
30,
2025
Year
Ended
April
30,
2026
Year
Ended
April
30,
2025
Increase
(decrease)
in
net
assets:
Operations:
Net
investment
income
(loss)
.......
$(22,369,086)
$(13,326,269)
$5,513,350
$5,936,093
Net
realized
gain
(loss)
............
719,356,046
635,930,982
25,811,892
40,252,844
Net
change
in
unrealized
appreciation
(depreciation)
.................
137,236,875
(271,511,394)
162,283,486
(69,393,925)
Net
increase
(decrease)
in
net
assets
resulting
from
operations
.
834,223,835
351,093,319
193,608,728
(23,204,988)
Distributions
to
shareholders:
Class
A
........................
(612,663,084)
(369,084,244)
(4,817,152)
(5,502,509)
Class
C
........................
(19,015,638)
(12,622,834)
(160,066)
(182,237)
Class
R
........................
(4,900,231)
(3,415,709)
—
—
Class
R6
.......................
(56,931,350)
(34,745,269)
(219,156)
(189,377)
Advisor
Class
...................
(48,211,191)
(28,758,057)
(1,265,420)
(1,473,063)
Total
distributions
to
shareholders
.....
(741,721,494)
(448,626,113)
(6,461,794)
(7,347,186)
Capital
share
transactions:
(Note
2
)
Class
A
........................
122,601,424
13,326,108
29,895,817
(27,661,206)
Class
C
........................
(2,901,437)
(6,183,112)
(2,366,776)
(2,902,346)
Class
R
........................
(123,716)
(2,540,912)
—
—
Class
R6
.......................
16,732,533
(1,469,348)
7,011,085
(408,268)
Advisor
Class
...................
5,135,808
16,896,851
23,343,521
(18,065,354)
Total
capital
share
transactions
.......
141,444,612
20,029,587
57,883,647
(49,037,174)
Net
increase
(decrease)
in
net
assets
.....................
233,946,953
(77,503,207)
245,030,581
(79,589,348)
Net
assets:
Beginning
of
year
..................
4,160,453,860
4,237,957,067
293,885,401
373,474,749
End
of
year
......................
$4,394,400,813
$4,160,453,860
$538,915,982
$293,885,401
Franklin
Strategic
Series
Financial
Statements
Statements
of
Changes
in
Net
Assets
(continued)
Annual
Report
The
accompanying
notes
are
an
integral
part
of
these
financial
statements.
Franklin
Small
Cap
Growth
Fund
Franklin
Small-Mid
Cap
Growth
Fund
Year
Ended
April
30,
2026
Year
Ended
April
30,
2025
Year
Ended
April
30,
2026
Year
Ended
April
30,
2025
Increase
(decrease)
in
net
assets:
Operations:
Net
investment
income
(loss)
.......
$(10,936,226)
$(11,377,359)
$(8,723,585)
$(5,524,130)
Net
realized
gain
(loss)
............
384,753,801
144,656,230
264,955,392
307,720,259
Net
change
in
unrealized
appreciation
(depreciation)
.................
270,177,712
(178,380,414)
245,936,729
(192,741,089)
Net
increase
(decrease)
in
net
assets
resulting
from
operations
.
643,995,287
(45,101,543)
502,168,536
109,455,040
Distributions
to
shareholders:
Class
A
........................
(72,040,761)
—
(202,149,326)
—
Class
C
........................
(2,329,693)
—
(7,705,668)
—
Class
R
........................
(4,258,273)
—
(3,099,620)
—
Class
R6
.......................
(82,542,335)
—
(27,526,306)
(584,008)
Advisor
Class
...................
(24,999,071)
—
(27,635,120)
(36,409)
Total
distributions
to
shareholders
.....
(186,170,133)
—
(268,116,040)
(620,417)
Capital
share
transactions:
(Note
2
)
Class
A
........................
(55,079,343)
(82,255,977)
(165,615,063)
(300,799,425)
Class
C
........................
(4,584,322)
(2,290,623)
(5,737,002)
(13,148,119)
Class
R
........................
933,597
3,114,250
(603,930)
(5,075,773)
Class
R6
.......................
(193,227,775)
(332,174,220)
(35,047,398)
(122,929,048)
Advisor
Class
...................
(48,928,040)
(55,318,476)
(26,269,429)
(30,964,132)
Total
capital
share
transactions
.......
(300,885,883)
(468,925,046)
(233,272,822)
(472,916,497)
Net
increase
(decrease)
in
net
assets
.....................
156,939,271
(514,026,589)
779,674
(364,081,874)
Net
assets:
Beginning
of
year
..................
2,278,348,128
2,792,374,717
3,531,973,205
3,896,055,079
End
of
year
......................
$2,435,287,399
$2,278,348,128
$3,532,752,879
$3,531,973,205
Franklin
Strategic
Series
Notes
to
Financial
Statements
1.
Organization
and
Significant
Accounting
Policies
Franklin
Strategic
Series
(Trust)
is
registered
under
the
Investment
Company
Act
of
1940
(1940
Act)
as
an
open-end
management
investment
company,
consisting
of t
welve
separate
funds,
six
of
which
are
included
in
this
report (Funds).
The
Funds
follow
the
accounting
and
reporting
guidance
in
Financial
Accounting
Standards
Board
(FASB)
Accounting
Standards
Codification
Topic
946,
Financial
Services
–
Investment
Companies
(ASC
946)
and
apply
the
specialized
accounting
and
reporting
guidance
in
U.S.
Generally
Accepted
Accounting
Principles
(U.S.
GAAP),
including,
but
not
limited
to,
ASC
946.
The
classes
of
shares
offered
within
each
of
the
Funds
are
indicated
below.
Class
C
shares
automatically
convert
to
Class
A
shares
on
a
monthly
basis,
after
they
have
been
held
for
8
years.
Each
class
of
shares
may
differ
by
its initial
sales
load,
contingent
deferred
sales
charges,
voting
rights
on
matters
affecting
a
single
class,
its
exchange
privilege
and
fees
due
to
differing
arrangements
for
distribution
and
transfer
agent
fees.
Class
A,
Class
C,
Class
R6
&
Advisor
Class
Franklin
Biotechnology
Discovery
Fund
Franklin
Natural
Resources
Fund
Class
A,
Class
C,
Class
R,
Class
R6
&
Advisor
Class
Franklin
Core
Plus
Bond
Fund
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-Mid
Cap
Growth
Fund
The
following
summarizes
the Funds'
significant
accounting
policies
.
a.
Financial
Instrument
Valuation
The Funds'
investments
in
financial
instruments
are
carried
at
fair
value
daily.
Fair
value
is
the
price
that
would
be
received
to
sell
an
asset
or
paid
to
transfer
a
liability
in
an
orderly
transaction
between
market
participants
on
the
measurement
date.
The Funds calculate the
net
asset
value
(NAV)
per
share
each
business
day
as
of
4
p.m.
Eastern
time
or
the
regularly
scheduled
close
of
the
New
York
Stock
Exchange
(NYSE),
whichever
is
earlier. Under
compliance
policies
and
procedures
approved
by
the
Trust’s
Board
of
Trustees
(the
Board),
the
Board
has
designated
the
Funds’
investment
manager
as
the
valuation
designee
and
has
responsibility
for
oversight
of
valuation.
The
investment
manager
is
assisted
by
the
Funds'
administrator
in
performing
this
responsibility,
including
leading
the
cross-
functional
Valuation
Committee
(VC).
The
Funds
may
utilize
independent
pricing
services,
quotations
from
securities
and
financial
instrument
dealers,
and
other
market
sources
to
determine
fair
value.
Equity
securities
and
derivative
financial instruments listed
on
an
exchange
or
on
the
NASDAQ
National
Market
System
are
valued
at
the
last
quoted
sale
price
or
the
official
closing
price of
the
day,
respectively. Foreign
equity
securities
are
valued
as
of
the
close
of
trading
on
the
foreign
stock
exchange
on
which
the
security
is
primarily
traded,
or
as
of
4
p.m.
Eastern
time.
The
value
is
then
converted
into
its
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m.
Eastern
time
on
the
day
that
the
value
of
the
security
is
determined.
Over-the-counter
(OTC)
securities
are
valued
within
the
range
of
the
most
recent
quoted
bid
and
ask
prices.
Securities
that
trade
in
multiple
markets
or
on
multiple
exchanges
are
valued
according
to
the
broadest
and
most
representative
market.
Certain
equity
securities
are
valued
based
upon
fundamental
characteristics
or
relationships
to
similar
securities.
Debt
securities
generally
trade
in
the
OTC
market rather
than
on
a
securities
exchange.
The
Funds'
pricing
services
use
multiple
valuation
techniques
to
determine
fair
value.
In
instances
where
sufficient
market
activity
exists,
the
pricing
services
may
utilize
a
market-based
approach
through
which
quotes
from
market
makers
are
used
to
determine
fair
value.
In
instances
where
sufficient
market
activity
may
not
exist
or
is
limited,
the
pricing
services
also
utilize
proprietary
valuation
models
which
may
consider
market
characteristics
such
as
benchmark
yield
curves,
credit
spreads,
estimated
default
rates,
anticipated
market
interest
rate
volatility,
coupon
rates,
anticipated
timing
of
principal
repayments,
underlying
collateral,
and
other
unique
security
features
in
order
to
estimate
the
relevant
cash
flows,
which
are
then
discounted
to
calculate
the
fair
value.
Securities
denominated
in
a
foreign
currency
are
converted
into
their
U.S.
dollar
equivalent
at
the
foreign
exchange
rate
in
effect
at
4
p.m.
Eastern
time
on
the
date
that
the
values
of
the
foreign
debt
securities
are
determined.
Investments
in open-end mutual
funds
are
valued
at
the
closing
NAV.
Certain
derivative
financial
instruments
are
centrally
cleared
or
trade
in
the
OTC
market.
The
Funds' pricing
services
use
various
techniques
including
industry
standard
option
pricing
models
and
proprietary
discounted
cash
flow
models
to
determine
the
fair
value
of
those
instruments.
The
Funds' net
Franklin
Strategic
Series
Notes
to
Financial
Statements
benefit
or
obligation
under
the
derivative
contract,
as
measured
by
the
fair
value
of
the
contract,
is
included
in
net
assets.
The
Funds
have
procedures
to
determine
the
fair
value
of
financial
instruments
for
which
market
prices
are
not
reliable
or
readily
available.
Under
these
procedures,
the
Funds
primarily
employ
a
market-based
approach
which
may
use
related
or
comparable
assets
or
liabilities,
recent
transactions,
market
multiples,
and
other
relevant
information
for
the
investment
to
determine
the
fair
value
of
the
investment.
An
income-based
valuation
approach
may
also
be
used
in
which
the
anticipated
future
cash
flows
of
the
investment
are
discounted
to
calculate
fair
value.
Discounts
may
also
be
applied
due
to
the
nature
or
duration
of
any
restrictions
on
the
disposition
of
the
investments.
Due
to
the
inherent
uncertainty
of
valuations
of
such
investments,
the
fair
values
may
differ
significantly
from
the
values
that
would
have
been
used
had
an
active
market
existed.
Trading
in
securities
on
foreign
securities
stock
exchanges
and
OTC
markets
may
be
completed
before
4
p.m.
Eastern
time.
In
addition,
trading
in
certain
foreign
markets
may
not
take
place
on
every
Funds'
business
day.
Events
can occur
between
the
time
at
which
trading
in
a
foreign
security
is
completed
and
4
p.m.
Eastern
time
that
might
call
into
question
the
reliability
of
the
value
of
a
portfolio
security
held
by
the
Fund.
As
a
result,
differences
may
arise
between
the
value
of
the
Funds'
portfolio
securities
as
determined
at
the
foreign
market
close
and
the
latest
indications
of
value
at
4
p.m.
Eastern
time.
In
order
to
minimize
the
potential
for
these
differences,
an
independent
pricing
service
may
be
used
to
adjust
the
value
of
the
Funds'
portfolio
securities
to
the
latest
indications
of
fair
value
at
4
p.m.
Eastern
time.
At
April
30,
2026,
certain
securities
may
have
been
fair
valued
using
these
procedures,
in
which
case
the
securities
were
categorized
as
Level
2
within
the
fair
value
hierarchy
(referred
to
as
“market
level
fair
value”).
See
the
Fair
Value
Measurements
note
for
more
information.
When
the
last
day
of
the
reporting
period
is
a
non-business
day,
certain
foreign
markets
may
be
open
on
those
days
that
the
Funds'
NAV
is
not
calculated,
which
could
result
in
differences
between
the
value
of
the
Funds'
portfolio
securities
on
the
last
business
day
and
the
last
calendar
day
of
the
reporting
period.
Any
security
valuation
changes
due
to
an
open
foreign
market
are
adjusted
and
reflected
by
the
Funds
for
financial
reporting
purposes.
b.
Foreign
Currency
Translation
Portfolio
securities
and
other
assets
and
liabilities
denominated
in
foreign
currencies
are
translated
into
U.S.
dollars
based
on
the
exchange
rate
of
such
currencies
against
U.S.
dollars
on
the
date
of
valuation.
The
Funds
may
enter
into
foreign
currency
exchange
contracts
to
facilitate
transactions
denominated
in
a
foreign
currency.
Purchases
and
sales
of
securities,
income
and
expense
items
denominated
in
foreign
currencies
are
translated
into
U.S.
dollars
at
the
exchange
rate
in
effect
on
the
transaction
date.
Portfolio
securities
and
assets
and
liabilities
denominated
in
foreign
currencies
contain
risks
that
those
currencies
will
decline
in
value
relative
to
the
U.S.
dollar.
Occasionally,
events
may
impact
the
availability
or
reliability
of
foreign
exchange
rates
used
to
convert
the
U.S.
dollar
equivalent
value.
If
such
an
event
occurs,
the
foreign
exchange
rate
will
be
valued
at
fair
value
using
procedures
established
and
approved
by
the
Board.
The
Funds
do
not
separately
report
the
effect
of
changes
in
foreign
exchange
rates
from
changes
in
market
prices
on
securities
held.
Such
changes
are
included
in
net
realized
and
unrealized
gain
or
loss
from
investments
in
the
Statements
of
Operations.
Realized
foreign
exchange
gains
or
losses
arise
from
sales
of
foreign
currencies,
currency
gains
or
losses
realized
between
the
trade
and
settlement
dates
on
securities
transactions
and
the
difference
between
the
recorded
amounts
of
dividends,
interest,
and
foreign
withholding
taxes
and
the
U.S.
dollar
equivalent
of
the
amounts
actually
received
or
paid.
Net
unrealized
foreign
exchange
gains
and
losses
arise
from
changes
in
foreign
exchange
rates
on
foreign
denominated
assets
and
liabilities
other
than
investments
in
securities
held
at
the
end
of
the
reporting
period.
c.
Securities
Purchased
on
a
When-Issued,
Forward Commitment or
Delayed
Delivery
Basis
and
TBA
Basis
Certain
or
all
Funds
may
purchase
securities
on
a
when-
issued,
forward
commitment
or
delayed
delivery and to-
be-announced
(TBA)
basis,
with
payment
and
delivery
scheduled
for
a
future
date.
These
transactions
are
subject
1.
Organization
and
Significant
Accounting
Policies
(continued)
a.
Financial
Instrument
Valuation
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
to
market
fluctuations
and
are
subject
to
the
risk
that
the
value
at
delivery
may
be
more
or
less
than
the
trade
date
purchase
price.
Although
the
Funds
will
generally
purchase
these
securities
with
the
intention
of
holding
the
securities, they
may
sell
the
securities
before
the
settlement
date.
Collateral
has
been
pledged
and/or
received
for
open
TBA
trades.
These
types
of
securities
may
be
considered
unfunded
and
the
Fund
may
be
obligated
to
perform
on
such
agreements
at
a
future
date.
Unfunded
commitments
are
marked
to
market
daily
and
any
unrealized
appreciation
or
depreciation
is
included
in
the
Statement
of
Assets
and
Liabilities
and
the
Statement
of
Operations.
At
April
30,
2026,
unfunded
commitments
were
as
follows:
d.
Derivative
Financial
Instruments
Certain
or
all
Funds
invested
in
derivative
financial
instruments
in
order
to
manage
risk
or
gain
exposure
to
various
other
investments
or
markets.
Derivatives
are
financial
contracts
based
on
an
underlying
or
notional
amount,
require
no
initial
investment
or
an
initial
net
investment
that
is
smaller
than
would
normally
be
required
to
have
a
similar
response
to
changes
in
market
factors,
and
require
or
permit
net
settlement.
Derivatives
contain
various
risks
including
the
potential
inability
of
the
counterparty
to
fulfill
their
obligations
under
the
terms
of
the
contract,
the
potential
for
an
illiquid
secondary
market,
and/or
the
potential
for
market
movements
which
expose
the
Fund
to
gains
or
losses
in
excess
of
the
amounts
shown
in
the
Statements
of
Assets
and
Liabilities.
Realized
gain
and
loss
and
unrealized
appreciation
and
depreciation
on
these
contracts
for
the
period
are
included
in
the
Statements
of
Operations.
Derivative
counterparty
credit
risk
is
managed
through
a
formal
evaluation
of
the
creditworthiness
of
all
potential
counterparties.
Certain
or
all
Funds
attempt
to
reduce
their
exposure
to
counterparty
credit
risk
on
OTC
derivatives,
whenever
possible,
by
entering
into
International
Swaps
and
Derivatives
Association
(ISDA)
master
agreements
with
certain
counterparties.
These
agreements
contain
various
provisions,
including
but
not
limited
to
collateral
requirements,
events
of
default,
or
early
termination.
Termination
events
applicable
to
the
counterparty
include
certain
deteriorations
in
the
credit
quality
of
the
counterparty.
Termination
events
applicable
to
the
Funds
include
failure
of
the
Funds
to
maintain
certain
net
asset
levels
and/or
limit
the
decline
in
net
assets
over
various
periods
of
time.
In
the
event
of
default
or
early
termination,
the
ISDA
master
agreement
gives
the
non-defaulting
party
the
right
to
net
and
close-out
all
transactions
traded,
whether
or
not
arising
under
the
ISDA
agreement,
to
one
net
amount
payable
by
one
counterparty
to
the
other.
However,
absent
an
event
of
default
or
early
termination,
OTC
derivative
assets
and
liabilities
are
presented
gross
and
not
offset
in
the
Statements
of
Assets
and
Liabilities.
Early
termination
by
the
counterparty
may
result
in
an
immediate
payment
by
the
Funds
of
any
net
liability
owed
to
that
counterparty
under
the
ISDA
agreement.
At
April
30,
2026,
certain
or
all
Funds
had
OTC
derivatives
in
a
net
liability
position
by
counterparty
and
the
aggregate
value
of
collateral
pledged
for
such
contracts
was
as
follows:
Collateral
requirements
differ
by
type
of
derivative.
Collateral
or
initial
margin
requirements
are
set
by
the
broker
or
exchange
clearing
house
for
exchange
traded
and
centrally
cleared
derivatives.
Initial
margin
deposited
is
held
at
the
exchange
or
at
the
broker and
can
be
in
the
form
of
cash
and/or
securities.
For
OTC
derivatives
traded
under
an
ISDA
master
agreement,
posting
of
collateral
is
required
by
either
the
Fund
or
the
applicable
counterparty
if
the
total
net
exposure
of
all
OTC
derivatives
with
the
applicable
counterparty
exceeds
the
minimum
transfer
amount,
which
typically
ranges
from
$100,000
to
$250,000,
and
can
vary
depending
on
the
counterparty
and
the
type
of
agreement.
Generally,
collateral
is
determined
at
the
close
of
Fund
business
each
day
and
any
additional
collateral
required
due
to
changes
in
derivative
values
may
be
delivered
by
the
Fund
or
the
counterparty
the
next
business
day,
or
within
a
few
business
days.
Collateral
pledged
and/or
received
by
the
Fund
for
OTC
derivatives,
if
any,
is
held
in
segregated
accounts
with
the
Fund's
custodian/counterparty
broker
and
can
be
in
the
form
of
cash
and/or
securities.
Unrestricted
Investment
Unfunded
Commitment
Franklin
Biotechnology
Discovery
Fund
Candid
Therapeutics,
Inc.,
$3,046,668
Obsidian
Therapeutics,
Inc.,
C
$3,667,504
$6,714,172
Net
Liability
Position
Aggregate
Value
of
Collateral
Pledged
Franklin
Core
Plus
Bond
Fund
$1,457,743
$1,300,000
1.
Organization
and
Significant
Accounting
Policies
(continued)
c.
Securities
Purchased
on
a
When-Issued,
Forward Commitment or
Delayed
Delivery
Basis
and
TBA
Basis
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
cash
may
be
invested
according
to
the
Funds'
investment
objectives.
To
the
extent
that
the
amounts
due
to
the
Fund
from
its
counterparties
are
not
subject
to
collateralization
or
are
not
fully
collateralized,
the
Fund
bears
the
risk
of
loss
from
counterparty
non-performance.
Certain
or
all
Funds
entered
into
exchange
traded
futures
contracts
primarily
to
manage
and/or
gain
exposure
to
interest
rate
risk. A
futures
contract
is
an
agreement
between
the
Fund
and
a
counterparty
to
buy
or
sell
an
asset
at
a
specified
price
on
a
future
date.
Required
initial
margins
are
pledged
by
the
Fund,
and
the
daily
change
in
fair
value
is
accounted
for
as
a
variation
margin
payable
or
receivable
in
the
Statements
of
Assets
and
Liabilities.
Futures
contracts
outstanding
at
period
end,
if
any,
are
listed
in
the
Funds'
Schedules
of
Investments.
Certain
or
all
Funds
entered
into
OTC
forward
exchange
contracts
primarily
to
manage
and/or
gain
exposure
to
certain
foreign
currencies.
A
forward
exchange
contract
is
an
agreement
between
the
Fund
and
a
counterparty
to
buy
or
sell
a
foreign
currency at
a
specific
exchange
rate
on
a
future
date. Forward
exchange
contracts
outstanding
at
period
end,
if
any,
are
listed
in
the
Funds'
Schedules
of
Investments.
Certain
or
all
Funds
entered
into
credit
default
swap
contracts
primarily
to
manage
and/or
gain
exposure
to
credit
risk.
A
credit
default
swap
is
an
agreement
between
the
Fund
and
a
counterparty
whereby
the
buyer
of
the
contract
receives
credit
protection
and
the
seller
of
the
contract
guarantees
the
credit
worthiness
of
a
referenced
debt
obligation.
These
agreements
may
be
privately
negotiated
in
the
over-the-counter
market
(OTC
credit
default
swaps)
or
may
be
executed
in
a
multilateral
trade
facility
platform,
such
as
a
registered
exchange
(centrally
cleared
credit
default
swaps).
The
underlying
referenced
debt
obligation
may
be
a
single
issuer
of
corporate
or
sovereign
debt,
a
credit
index,
a
basket
of
issuers
or
indices,
or
a
tranche
of
a
credit
index
or
basket
of
issuers
or
indices.
In
the
event
of
a
default
of
the
underlying
referenced
debt
obligation,
the
buyer
is
entitled
to
receive
the
notional
amount
of
the
credit
default
swap
contract
from
the
seller
in
exchange
for
the
referenced
debt
obligation,
a
net
settlement
amount
equal
to
the
notional
amount
of
the
credit
default
swap
less
the
recovery
value
of
the
referenced
debt
obligation,
or
other
agreed
upon
amount.
For
centrally
cleared
credit
default
swaps,
required
initial
margins
are
pledged
by
the
Fund,
and
the
daily
change
in
fair
value
is
accounted
for
as
a
variation
margin
payable
or
receivable
in
the
Consolidated
Statements
of
Assets
and
Liabilities.
Over
the
term
of
the
contract,
the
buyer
pays
the
seller
a
periodic
stream
of
payments,
provided
that
no
event
of
default
has
occurred.
Such
periodic
payments
are
accrued
daily
as
an
unrealized
appreciation or
depreciation
until
the
payments
are
made,
at
which
time
they
are
realized.
Upfront
payments
and
receipts
are
reflected
in
the Statements
of
Assets
and
Liabilities
and
represent
compensating
factors
between
stated
terms
of
the
credit
default
swap
agreement
and
prevailing
market
conditions
(credit
spreads
and
other
relevant
factors).
These
upfront
payments
and
receipts
are
amortized
over
the
term
of
the
contract
as
a
realized
gain
or
loss
in
the
Statements
of
Operations.
Credit
default
swap
contracts
outstanding
at
period
end,
if
any,
are
listed
in
the
Funds'
Schedules
of
Investments.
Certain
or
all
Funds
purchased
or
wrote
exchange
traded and/or
OTC option
contracts
primarily
to
manage
and/
or
gain
exposure
to
equity
volatility
and
credit risk.
An
option
is
a
contract
entitling
the
holder
to
purchase
or
sell
a
specific
amount
of
shares
or
units
of
an
asset
or
notional
amount
of
a
swap
(swaption),
at
a
specified
price.
When
an
option
is
purchased
or
written,
an
amount
equal
to
the
premium
paid
or
received
is
recorded
as
an
asset
or
liability,
respectively.
Upon
exercise
of
an
option,
the
acquisition
cost
or
sales
proceeds
of
the
underlying
investment
is
adjusted
by
any
premium
received
or
paid.
Upon
expiration
of
an
option,
any
premium
received
or
paid
is
recorded
as
a
realized
gain
or
loss.
Upon
closing
an
option
other
than
through
expiration
or
exercise,
the
difference
between
the
premium
received
or
paid
and
the
cost
to
close
the
position
is
recorded
as
a
realized
gain
or
loss.
Option
contracts
outstanding
at
period
end,
if
any,
are
listed
in
the
Funds'
Schedules
of
Investments.
See
Note
9
regarding
other
derivative
information.
e.
Securities
Lending
Certain
or
all
Funds
participate
in
an
agency
based
securities
lending
program
to
earn
additional
income.
The
Fund
receives
collateral
in
the
form
of
cash
and/or
U.S.
Government
and
Agency
securities
against
the
loaned
securities
in
an
amount
equal
to
at
least
102%
of
the
fair
value
of
the
loaned
securities.
Collateral
is
maintained
over
the
life
of
the
loan
in
an
amount
not
less
than
100%
of
the
fair
value
of
loaned
securities,
as
determined
at
the
close
of
Fund
business
each
day;
any
additional
collateral
required
1.
Organization
and
Significant
Accounting
Policies
(continued)
d.
Derivative
Financial
Instruments
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
due
to
changes
in
security
values
is
delivered
to
the
Fund
on
the
next
business
day.
Any
cash
collateral
received
is
deposited
into
a
joint
cash
account
with
other
funds
and
is
used
to
invest
in
a
money
market
fund
managed
by
Franklin
Advisers,
Inc.,
an
affiliate
of
the
Funds,
and/or
uninvested
cash
as
included
in
due
from
custodian
in
the
Statements
of
Assets
and
Liabilities. The
Fund
may
receive
income
from
the
investment
of
cash
collateral,
in
addition
to
lending
fees
paid
by
the
borrower.
Income
from
securities
loaned,
net
of
fees
paid
to
the
securities
lending
agent
and/or
third-
party
vendor,
is
reported
separately
in
the Statements of
Operations.
The
Fund
bears
the
market
risk
with
respect
to
any
cash
collateral
investment,
securities
loaned,
and
the
risk
that
the
agent
may
default
on
its
obligations
to
the
Fund.
If
the
borrower
defaults
on
its
obligation
to
return
the
securities
loaned,
the
Fund
has
the
right
to
repurchase
the
securities
in
the
open
market
using
the
collateral
received.
The
securities
lending
agent
has
agreed
to
indemnify
the
Fund
in
the
event
of
default
by
a
third
party
borrower.
Securities
on
loan
outstanding
at
period
end,
if
any,
are
listed
in
the
Funds'
Schedules
of
Investments.
f.
Mortgage
Dollar
Rolls
Certain
or
all
Funds
enter
into
mortgage
dollar
rolls,
typically
on
a
TBA
basis.
Mortgage
dollar
rolls
are
agreements
between
the
Fund
and
a
financial
institution
where
the
Fund
sells
(or
buys)
mortgage-backed
securities
for
delivery
on
a
specified
date
and
simultaneously
contracts
to
repurchase
(or
sell)
substantially
similar
(same
type,
coupon,
and
maturity)
securities
at
a
future
date
and
at
a
predetermined
price.
Gains
or
losses
are
realized
on
the
initial
sale,
and
the
difference
between
the
repurchase
price
and
the
sale
price
is
recorded
as
an
unrealized
gain
or
loss
to
the
Fund
upon
entering
into
the
mortgage
dollar
roll.
In
addition,
the
Fund
may
invest
the
cash
proceeds
that
are
received
from
the
initial
sale.
During
the
period
between
the
sale
and
repurchase,
the
Fund
is
not
entitled
to
principal
and
interest
paid
on
the
mortgage
backed
securities.
Transactions
in
mortgage
dollar
rolls
are
accounted
for
as
purchases
and
sales
and
may
result
in
an
increase
to
the
Fund's
portfolio
turnover
rate.
The
risks
of
mortgage
dollar
roll
transactions
include
the
potential
inability
of
the
counterparty
to
fulfill
its
obligations.
g.
Senior
Floating
Rate
Interests
Certain
or
all
Funds
invest
in
senior
secured
corporate
loans
that
pay
interest
at
rates
which
are
periodically
reset
by
reference
to
a
base
lending
rate
plus
a
spread.
These
base
lending
rates
are
generally
the
prime
rate
offered
by
a
designated
U.S.
bank
or
the
Secured
Overnight
Financing
Rate
(SOFR).
Senior
secured
corporate
loans
often
require
prepayment
of
principal
from
excess
cash
flows
or
at
the
discretion
of
the
borrower.
As
a
result,
actual
maturity
may
be
substantially
less
than
the
stated
maturity.
Senior
secured
corporate
loans
in
which
the
Funds
invest
are
generally
readily
marketable,
but
may
be
subject
to
certain
restrictions
on
resale.
h.
Marketplace
Lending
Certain
or
all
Funds
invest in
loans
obtained
through
marketplace
lending.
Marketplace
lending,
sometimes
referred
to
as
peer-to-peer
lending,
is
a
method
of
financing
in
which
a
platform
facilitates
the
borrowing
and
lending
of
money.
It
is
considered
an
alternative
to
more
traditional
forms
of
debt
financing.
Prospective
borrowers
are
required
to
provide
certain
financial
information
to
the
platform,
including,
but
not
limited
to,
the
intended
purpose
of
the
loan,
income,
employment
information,
credit
score,
debt-
to-income
ratio,
credit
history
(including
defaults
and
delinquencies)
and
home
ownership
status.
Based
on
this
and
other
information,
the
platform
assigns
its
own
credit
rating
to
the
borrower
and
sets
the
interest
rate
for
the
requested
loan.
The
platform
then
posts
the
borrowing
requests
online,
giving
investors
the
opportunity
to
purchase
the
loans
based
on
factors
such
as
the
interest
rates
and
expected
yields
of
the
loans,
the
borrower
background
data,
and
the
credit
rating
assigned
by
the
platform.
When
the
Funds
invest
in
these
loans,
they
usually
purchase
all
rights,
title
and
interest
in
the
loans
pursuant
to
a
loan
purchase
agreement
directly
from
the
platform.
The
platform
or
a
third-party
servicer
typically
continues
to
service
the
loans,
collecting
payments
and
distributing
them
to
the
Funds,
less
any
servicing
fees
assessed.
The
servicer
is
typically
responsible
for
taking
actions
against
a
borrower
in
the
event
of
a
default
on
the
loan.
Servicing
fees,
along
with
other
administration
fees,
are
included
in
marketplace
lending
fees
in
the
Statements
of
Operations.
The
Funds,
as
investors
in
a
loan,
would
be
entitled
to
receive
payment
only
from
the
borrower
and
would
not
be
able
to
recover
1.
Organization
and
Significant
Accounting
Policies
(continued)
e.
Securities
Lending
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
any
deficiency
from
the
platform,
except
under
very
narrow
circumstances.
The
loans
in
which
the
Funds
may
invest
are
unsecured.
i.
Income
and
Deferred
Taxes
It
is each
Fund's
policy
to
qualify
as
a
regulated
investment
company
under
the
Internal
Revenue
Code. Each
Fund
intends
to
distribute
to
shareholders
substantially
all
of
its
taxable
income
and
net
realized
gains
to
relieve
it
from
federal
income
and excise
taxes.
As
a
result,
no
provision
for
U.S.
federal
income
taxes
is
required.
The
Funds
may
be
subject
to
foreign
taxation
related
to
income
received,
capital
gains
on
the
sale
of
securities
and
certain
foreign
currency
transactions
in
the
foreign
jurisdictions
in
which the
Funds invest.
Foreign
taxes,
if
any,
are
recorded
based
on
the
tax
regulations
and
rates
that
exist
in
the
foreign
markets
in
which
the
Funds
invest.
In
some
cases,
the
Funds
may
be
entitled
to
reclaim
all
or
a
portion
of
such
taxes,
and
such
reclaim
amounts,
if
any,
are
reflected
as
a
dividend
receivable
in
the
Statements
of
Assets
and
Liabilities
and
dividend
income
in
the
Statements
of
Operations.
In
many
cases,
however,
the
Funds
may
not
receive
such
amounts
for
an
extended
period
of
time,
depending
on
the
country
of
investment.
When
a
capital
gain
tax
is
determined
to
apply, certain
or all Funds record
an
estimated
deferred
tax
liability
in
an
amount
that
would
be
payable
if
the
securities
were
disposed
of
on
the
valuation
date.
As
a
result
of
several
court
cases,
in
certain
countries
across
the
European
Union, certain
or
all Funds
filed
additional
tax
reclaims
for
previously
withheld
taxes
on
dividends
earned
in
those
countries
(EU
reclaims). Income
recognized,
if
any,
for
EU
reclaims
is
reflected
as
other
income
in
the
Statements
of
Operations
and
any
related
receivable,
if
any,
is
reflected
as
European
Union
tax
reclaims
in
the
Statements
of
Assets
and
Liabilities.
Any
fees
associated
with
these
filings
are
reflected
in
other
expenses in
the
Statements
of
Operations.
When
uncertainty
exists
as
to
the
ultimate
resolution
of
these
proceedings,
the
likelihood
of
receipt
of
these
EU
reclaims,
and
the
potential
timing
of
payment,
no
amounts
are
reflected
in
the
financial
statements.
For
U.S.
income
tax
purposes,
EU
reclaims
received
by
the
Funds,
if
any,
reduce
the
amount
of
foreign
taxes
Fund
shareholders
can
use
as
tax
deductions
or credits
on
their
income
tax
returns.
Each
Fund
may
recognize
an
income
tax
liability
related
to
its
uncertain
tax
positions
under
U.S.
GAAP
when
the
uncertain
tax
position
has
a
less
than
50%
probability
that
it
will
be
sustained
upon
examination
by
the
tax
authorities
based
on
its
technical
merits.
As
of
April
30,
2026, each
Fund
has
determined
that
no
tax
liability
is
required
in
its
financial
statements
related
to
uncertain
tax
positions
for
any
open
tax
years
(or
expected
to
be
taken
in
future
tax
years).
The
Funds'
federal
and
state
income
and
federal
excise
tax
returns
for
the
prior
three
fiscal
years
are
subject
to
examination
by
the
Internal
Revenue
Service
and
state
departments
of
revenue.
j.
Security
Transactions,
Investment
Income,
Expenses
and
Distributions
Security
transactions
are
accounted
for
on
trade
date.
Realized
gains
and
losses
on
security
transactions
are
determined
on
a
specific
identification
basis.
Interest
income
(including
interest
income
from
payment-in-kind
securities,
if
any)
and
estimated
expenses
are
accrued
daily.
Amortization
of
premium
and
accretion
of
discount
on
debt
securities
are
included
in
interest
income.
Paydown
gains
and
losses
are
recorded
as
an
adjustment
to
interest
income.
Certain
or
all
Funds
may
receive
other
income
from
investments
in
senior
secured
corporate
loans
or
unfunded
commitments,
including
amendment
fees,
consent
fees
or
commitment
fees.
These
fees
are
recorded
as
income
when
received
by
the
Funds.
Facility
fees
are
recognized
as
income
over
the
expected
term
of
the
loan.
Dividend
income
is
recorded
on
the
ex-dividend
date
except
for
certain
dividends
from
securities
where
the
dividend
rate
is
not
available.
In
such
cases,
the
dividend
is
recorded
as
soon
as
the
information
is
received
by
the
Funds.
Distributions
to
shareholders
are
recorded
on
the
ex-dividend
date.
Distributable
earnings
are
determined
according
to
income
tax
regulations
(tax
basis)
and
may
differ
from
earnings
recorded
in
accordance
with
U.S.
GAAP.
These
differences
may
be
permanent
or
temporary.
Permanent
differences
are
reclassified
among
capital
accounts
to
reflect
their
tax
character.
These
reclassifications
have
no
impact
on
net
assets
or
the
results
of
operations.
Temporary
differences
are
not
reclassified,
as
they
may
reverse
in
subsequent
periods.
1.
Organization
and
Significant
Accounting
Policies
(continued)
h.
Marketplace
Lending
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Common
expenses
incurred
by
the
Trust
are
allocated
among
the
Funds
based
on
the
ratio
of
net
assets
of
each
Fund
to
the
combined
net
assets
of
the
Trust
or
based
on
the
ratio
of
number
of
shareholders
of
each
Fund
to
the
combined
number
of
shareholders
of
the
Trust.
Fund
specific
expenses
are
charged
directly
to
the
Fund
that
incurred
the
expense.
Realized
and
unrealized gains
and
losses
and
net
investment
income,
excluding
class
specific
expenses,
are
allocated
daily
to
each
class
of
shares
based
upon
the
relative
proportion
of
net
assets
of
each
class.
Differences
in
per
share
distributions
by
class
are
generally
due
to
differences
in
class
specific
expenses.
Inflation-indexed
bonds
are
adjusted
for
inflation
through
periodic
increases
or
decreases
in
the
security's
interest
accruals,
face
amount,
or
principal
redemption
value,
by
amounts
corresponding
to
the
rate
of
inflation
as
measured
by
an
index.
Any
increase
or
decrease
in
the
face
amount
or
principal
redemption
value
will
be
included
as
interest
income in
the
Statements of
Operations.
k.
Accounting
Estimates
The
preparation
of
financial
statements
in
accordance
with
U.S.
GAAP
requires
management
to
make
estimates
and
assumptions
that
affect
the
reported
amounts
of
assets
and
liabilities
at
the
date
of
the
financial
statements
and
the
amounts
of
income
and
expenses
during
the
reporting
period.
Actual
results
could
differ
from
those
estimates.
l.
Guarantees
and
Indemnifications
Under
the Trust's
organizational
documents,
its
officers
and trustees
are
indemnified
by
the Trust against
certain
liabilities
arising
out
of
the
performance
of
their
duties
to
the
Trust.
Additionally,
in
the
normal
course
of
business,
the Trust,
on
behalf
of
the
Funds, enters
into
contracts
with
service
providers
that
contain
general
indemnification
clauses.
The Trust's
maximum
exposure
under
these
arrangements
is
unknown
as
this
would
involve
future
claims
that
may
be
made
against
the Trust
that
have
not
yet
occurred.
Currently,
the Trust
expects
the
risk
of
loss
to
be
remote.
2.
Shares
of
Beneficial
Interest
At
April
30,
2026,
there
were
an
unlimited
number
of
shares
authorized
(without
par value).
Transactions
in
the
Funds'
shares
were
as
follows:
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Shares
Amount
Shares
Amount
Class
A
Class
A
Shares:
Year
ended
April
30,
2026
Shares
sold
a
...................................
452,826
$71,581,297
39,993,641
$335,013,734
Shares
issued
in
reinvestment
of
distributions
..........
471,712
79,384,475
9,897,465
82,552,750
Shares
redeemed
...............................
(1,027,573)
(153,006,692)
(44,244,021)
(369,699,141)
Net
increase
(decrease)
..........................
(103,035)
$(2,040,920)
5,647,085
$47,867,343
Year
ended
April
30,
2025
Shares
sold
a
...................................
332,355
$44,053,974
22,481,003
$186,387,121
Shares
issued
in
reinvestment
of
distributions
..........
458,575
55,359,208
10,959,008
90,763,522
Shares
redeemed
...............................
(1,051,742)
(138,256,943)
(49,596,623)
(411,144,047)
Net
increase
(decrease)
..........................
(260,812)
$(38,843,761)
(16,156,612)
$(133,993,404)
Class
C
1.
Organization
and
Significant
Accounting
Policies
(continued)
j.
Security
Transactions,
Investment
Income,
Expenses
and
Distributions
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Shares
Amount
Shares
Amount
Class
C
Shares:
Year
ended
April
30,
2026
Shares
sold
...................................
26,661
$3,563,880
1,562,595
$13,103,380
Shares
issued
in
reinvestment
of
distributions
..........
16,176
2,422,884
211,384
1,764,984
Shares
redeemed
a
..............................
(60,742)
(7,882,604)
(2,356,029)
(19,695,142)
Net
increase
(decrease)
..........................
(17,905)
$(1,895,840)
(582,050)
$(4,826,778)
Year
ended
April
30,
2025
Shares
sold
...................................
19,046
$2,353,553
753,774
$6,257,260
Shares
issued
in
reinvestment
of
distributions
..........
19,065
2,077,266
281,445
2,334,099
Shares
redeemed
a
..............................
(99,243)
(12,048,945)
(3,024,923)
(25,090,677)
Net
increase
(decrease)
..........................
(61,132)
$(7,618,126)
(1,989,704)
$(16,499,318)
Class
R
Class
R
Shares:
Year
ended
April
30,
2026
Shares
sold
...................................
—
$—
1,260,218
$10,482,036
Shares
issued
in
reinvestment
of
distributions
..........
—
—
167,768
1,392,158
Shares
redeemed
...............................
—
—
(1,616,566)
(13,417,089)
Net
increase
(decrease)
..........................
—
$—
(188,580)
$(1,542,895)
Year
ended
April
30,
2025
Shares
sold
...................................
—
$—
1,024,893
$8,467,666
Shares
issued
in
reinvestment
of
distributions
..........
—
—
195,600
1,611,622
Shares
redeemed
...............................
—
—
(1,443,030)
(11,901,885)
Net
increase
(decrease)
..........................
—
$—
(222,537)
$(1,822,597)
Class
R6
Class
R6
Shares:
Year
ended
April
30,
2026
Shares
sold
...................................
62,072
$10,713,579
22,290,109
$186,905,014
Shares
issued
in
reinvestment
of
distributions
..........
7,740
1,410,180
776,337
6,488,881
Shares
redeemed
...............................
(53,986)
(9,249,833)
(4,827,510)
(40,435,747)
Net
increase
(decrease)
..........................
15,826
$2,873,926
18,238,936
$152,958,148
Year
ended
April
30,
2025
Shares
sold
...................................
16,934
$2,422,327
2,929,164
$24,331,763
Shares
issued
in
reinvestment
of
distributions
..........
5,289
685,392
691,054
5,733,962
Shares
redeemed
...............................
(41,454)
(5,843,407)
(4,242,650)
(35,280,619)
Net
increase
(decrease)
..........................
(19,231)
$(2,735,688)
(622,432)
$(5,214,894)
Advisor
Class
2.
Shares
of
Beneficial
Interest
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Shares
Amount
Shares
Amount
Advisor
Class
Shares:
Year
ended
April
30,
2026
Shares
sold
...................................
203,282
$34,026,257
17,131,235
$143,549,189
Shares
issued
in
reinvestment
of
distributions
..........
72,286
12,903,771
1,200,545
10,031,756
Shares
redeemed
...............................
(288,166)
(46,270,627)
(9,102,941)
(76,154,721)
Net
increase
(decrease)
..........................
(12,598)
$659,401
9,228,839
$77,426,224
Year
ended
April
30,
2025
Shares
sold
...................................
220,200
$30,743,369
6,280,226
$52,139,748
Shares
issued
in
reinvestment
of
distributions
..........
80,296
10,216,149
1,138,066
9,442,088
Shares
redeemed
...............................
(477,052)
(63,499,341)
(9,142,865)
(75,891,430)
Net
increase
(decrease)
..........................
(176,556)
$(22,539,823)
(1,724,573)
$(14,309,594)
Franklin
Growth
Opportunities
Fund
Franklin
Natural
Resources
Fund
Shares
Amount
Shares
Amount
Class
A
Class
A
Shares:
Year
ended
April
30,
2026
Shares
sold
a
...................................
4,683,801
$223,489,392
2,541,925
$100,691,102
Shares
issued
in
reinvestment
of
distributions
..........
13,485,705
596,472,754
129,315
4,725,177
Shares
redeemed
...............................
(14,790,752)
(697,360,722)
(2,004,183)
(75,520,462)
Net
increase
(decrease)
..........................
3,378,754
$122,601,424
667,057
$29,895,817
Year
ended
April
30,
2025
Shares
sold
a
...................................
5,031,942
$250,874,920
925,041
$27,838,462
Shares
issued
in
reinvestment
of
distributions
..........
7,302,641
359,874,058
194,399
5,414,009
Shares
redeemed
...............................
(12,005,894)
(597,422,870)
(2,024,155)
(60,913,677)
Net
increase
(decrease)
..........................
328,689
$13,326,108
(904,715)
$(27,661,206)
Class
C
Class
C
Shares:
Year
ended
April
30,
2026
Shares
sold
...................................
291,912
$8,795,031
86,187
$3,223,767
Shares
issued
in
reinvestment
of
distributions
..........
729,395
18,942,404
4,463
159,430
Shares
redeemed
a
..............................
(1,032,731)
(30,638,872)
(157,628)
(5,749,973)
Net
increase
(decrease)
..........................
(11,424)
$(2,901,437)
(66,978)
$(2,366,776)
Year
ended
April
30,
2025
Shares
sold
...................................
356,759
$12,096,577
94,231
$2,813,600
Shares
issued
in
reinvestment
of
distributions
..........
387,090
12,580,477
6,634
180,856
Shares
redeemed
a
..............................
(910,033)
(30,860,166)
(201,667)
(5,896,802)
Net
increase
(decrease)
..........................
(166,184)
$(6,183,112)
(100,802)
$(2,902,346)
Class
R
2.
Shares
of
Beneficial
Interest
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Franklin
Growth
Opportunities
Fund
Franklin
Natural
Resources
Fund
Shares
Amount
Shares
Amount
Class
R
Shares:
Year
ended
April
30,
2026
Shares
sold
...................................
74,393
$3,207,758
—
$—
Shares
issued
in
reinvestment
of
distributions
..........
126,458
4,900,231
—
—
Shares
redeemed
...............................
(193,793)
(8,231,705)
—
—
Net
increase
(decrease)
..........................
7,058
$(123,716)
—
$—
Year
ended
April
30,
2025
Shares
sold
...................................
93,018
$4,125,976
—
$—
Shares
issued
in
reinvestment
of
distributions
..........
77,139
3,415,709
—
—
Shares
redeemed
...............................
(234,362)
(10,082,597)
—
—
Net
increase
(decrease)
..........................
(64,205)
$(2,540,912)
—
$—
Class
R6
Class
R6
Shares:
Year
ended
April
30,
2026
Shares
sold
...................................
1,978,710
$110,802,413
235,117
$9,847,873
Shares
issued
in
reinvestment
of
distributions
..........
1,043,128
56,881,762
5,498
219,156
Shares
redeemed
in-kind
(Not
e
11)
..................
(1,529,052)
(85,474,006)
—
—
Shares
redeemed
...............................
(1,136,364)
(65,477,636)
(75,943)
(3,055,944)
Net
increase
(decrease)
..........................
356,422
$16,732,533
164,672
$7,011,085
Year
ended
April
30,
2025
Shares
sold
...................................
455,037
$26,879,630
60,752
$1,999,816
Shares
issued
in
reinvestment
of
distributions
..........
591,573
34,713,486
6,248
189,377
Shares
redeemed
...............................
(1,077,443)
(63,062,464)
(79,392)
(2,597,461)
Net
increase
(decrease)
..........................
(30,833)
$(1,469,348)
(12,392)
$(408,268)
Advisor
Class
Advisor
Class
Shares:
Year
ended
April
30,
2026
Shares
sold
...................................
570,840
$32,104,980
831,085
$34,993,830
Shares
issued
in
reinvestment
of
distributions
..........
890,650
47,044,169
31,875
1,260,631
Shares
redeemed
...............................
(1,331,401)
(74,013,341)
(316,660)
(12,910,940)
Net
increase
(decrease)
..........................
130,089
$5,135,808
546,300
$23,343,521
Year
ended
April
30,
2025
Shares
sold
...................................
841,794
$48,289,642
299,136
$9,817,889
Shares
issued
in
reinvestment
of
distributions
..........
487,232
27,840,441
48,788
1,467,544
Shares
redeemed
...............................
(1,042,578)
(59,233,232)
(908,746)
(29,350,787)
Net
increase
(decrease)
..........................
286,448
$16,896,851
(560,822)
$(18,065,354)
2.
Shares
of
Beneficial
Interest
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Franklin
Small
Cap
Growth
Fund
Franklin
Small-Mid
Cap
Growth
Fund
Shares
Amount
Shares
Amount
Class
A
Class
A
Shares:
Year
ended
April
30,
2026
Shares
sold
a
...................................
3,101,248
$71,345,735
4,205,625
$165,499,049
Shares
issued
in
reinvestment
of
distributions
..........
2,972,039
70,229,288
5,216,816
198,030,341
Shares
redeemed
...............................
(8,512,645)
(196,654,366)
(13,485,096)
(529,144,453)
Net
increase
(decrease)
..........................
(2,439,358)
$(55,079,343)
(4,062,655)
$(165,615,063)
Year
ended
April
30,
2025
Shares
sold
a
...................................
4,955,470
$109,647,310
5,367,190
$203,572,054
Shares
redeemed
...............................
(8,615,492)
(191,903,287)
(13,437,841)
(504,371,479)
Net
increase
(decrease)
..........................
(3,660,022)
$(82,255,977)
(8,070,651)
$(300,799,425)
Class
C
Class
C
Shares:
Year
ended
April
30,
2026
Shares
sold
...................................
181,432
$2,778,167
326,799
$5,525,953
Shares
issued
in
reinvestment
of
distributions
..........
151,481
2,319,174
505,294
7,645,105
Shares
redeemed
a
..............................
(632,578)
(9,681,663)
(1,122,915)
(18,908,060)
Net
increase
(decrease)
..........................
(299,665)
$(4,584,322)
(290,822)
$(5,737,002)
Year
ended
April
30,
2025
Shares
sold
...................................
223,183
$3,388,766
364,289
$6,156,727
Shares
redeemed
a
..............................
(377,681)
(5,679,389)
(1,144,009)
(19,304,846)
Net
increase
(decrease)
..........................
(154,498)
$(2,290,623)
(779,720)
$(13,148,119)
Class
R
Class
R
Shares:
Year
ended
April
30,
2026
Shares
sold
...................................
401,464
$8,291,387
157,905
$5,097,476
Shares
issued
in
reinvestment
of
distributions
..........
202,968
4,258,273
99,567
3,095,521
Shares
redeemed
...............................
(564,298)
(11,616,063)
(270,081)
(8,796,927)
Net
increase
(decrease)
..........................
40,134
$933,597
(12,609)
$(603,930)
Year
ended
April
30,
2025
Shares
sold
...................................
798,778
$16,855,590
194,991
$6,053,095
Shares
redeemed
...............................
(690,039)
(13,741,340)
(355,454)
(11,128,868)
Net
increase
(decrease)
..........................
108,739
$3,114,250
(160,463)
$(5,075,773)
Class
R6
2.
Shares
of
Beneficial
Interest
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
3.
Transactions
with
Affiliates
Franklin
Resources,
Inc.
is
the
holding
company
for
various
subsidiaries
that
together
are
referred
to
as
Franklin
Templeton.
Certain
officers
and
trustees
of
the Trust are
also
officers
and/or
directors
of
the
following
subsidiaries:
Franklin
Small
Cap
Growth
Fund
Franklin
Small-Mid
Cap
Growth
Fund
Shares
Amount
Shares
Amount
Class
R6
Shares:
Year
ended
April
30,
2026
Shares
sold
...................................
8,190,921
$222,960,058
1,934,449
$93,878,361
Shares
issued
in
reinvestment
of
distributions
..........
2,551,955
72,373,453
505,819
24,036,539
Shares
redeemed
...............................
(17,808,329)
(488,561,286)
(3,145,268)
(152,962,298)
Net
increase
(decrease)
..........................
(7,065,453)
$(193,227,775)
(705,000)
$(35,047,398)
Year
ended
April
30,
2025
Shares
sold
...................................
8,186,126
$213,802,927
2,024,595
$92,994,472
Shares
issued
in
reinvestment
of
distributions
..........
—
—
10,403
510,275
Shares
redeemed
in-kind
(Not
e
11)
..................
(2,046,951)
(51,319,956)
(530,869)
(23,798,846)
Shares
redeemed
...............................
(18,809,271)
(494,657,191)
(4,131,407)
(192,634,949)
Net
increase
(decrease)
..........................
(12,670,096)
$(332,174,220)
(2,627,278)
$(122,929,048)
Advisor
Class
Advisor
Class
Shares:
Year
ended
April
30,
2026
Shares
sold
...................................
1,669,576
$44,082,030
1,384,638
$64,724,024
Shares
issued
in
reinvestment
of
distributions
..........
818,641
22,438,962
581,876
26,655,751
Shares
redeemed
...............................
(4,355,250)
(115,449,032)
(2,487,808)
(117,649,204)
Net
increase
(decrease)
..........................
(1,867,033)
$(48,928,040)
(521,294)
$(26,269,429)
Year
ended
April
30,
2025
Shares
sold
...................................
2,433,680
$61,722,891
1,568,765
$70,783,754
Shares
issued
in
reinvestment
of
distributions
..........
—
—
743
35,253
Shares
redeemed
...............................
(4,651,378)
(117,041,367)
(2,274,042)
(101,783,139)
Net
increase
(decrease)
..........................
(2,217,698)
$(55,318,476)
(704,534)
$(30,964,132)
a
May
include
a
portion
of
Class
C
shares
that
were
automatically
converted
to
Class
A.
Subsidiary
Affiliation
Franklin
Advisers,
Inc.
(Advisers)
Investment
manager
Franklin
Templeton
Services,
LLC
(FT
Services)
Administrative
manager
Franklin
Distributors,
LLC
(Distributors)
Principal
underwriter
Franklin
Templeton
Investor
Services,
LLC
(Investor
Services)
Transfer
agent
2.
Shares
of
Beneficial
Interest
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
a.
Management
Fees
Franklin
Biotechnology
Discovery
Fund pays
an
investment
management fee,
calculated
daily
and
paid
monthly,
to Advisers based
on the
average
daily
net
assets
of
the
Fund
as
follows:
Prior
to
May
8,
2025,
Franklin
Core
Plus
Bond
Fund
paid
fees,
calculated
daily
and
paid
monthly,
to
Advisers
based
on
the
average
daily
net
assets
of
the
Fund
as
follows:
Effective
May
8,
2025,
Franklin
Core
Plus
Bond
Fund
pays
an
investment
management
fee,
calculated
daily
and
paid
monthly,
to
Advisers
based
on
the
average
daily
net
assets
of
the
Fund
as
follows:
Annualized
Fee
Rate
Net
Assets
0.775%
Up
to
and
including
$100
million
0.650%
Over
$100
million,
up
to
and
including
$200
million
0.635%
Over
$200
million,
up
to
and
including
$250
million
0.585%
Over
$250
million,
up
to
and
including
$700
million
0.550%
Over
$700
million,
up
to
and
including
$1.2
billion
0.525%
Over
$1.2
billion,
up
to
and
including
$7.5
billion
0.515%
Over
$7.5
billion,
up
to
and
including
$10
billion
0.505%
Over
$10
billion,
up
to
and
including
$12.5
billion
0.495%
Over
$12.5
billion,
up
to
and
including
$15
billion
0.475%
In
excess
of
$15
billion
Annualized
Fee
Rate
Net
Assets
0.625%
Up
to
and
including
$100
million
0.500%
Over
$100
million,
up
to
and
including
$250
million
0.450%
Over
$250
million,
up
to
and
including
$7.5
billion
0.440%
Over
$7.5
billion,
up
to
and
including
$10
billion
0.430%
Over
$10
billion,
up
to
and
including
$12.5
billion
0.420%
Over
$12.5
billion,
up
to
and
including
$15
billion
0.400%
Over
$15
billion,
up
to
and
including
$17.5
billion
0.380%
Over
$17.5
billion,
up
to
and
including
$20
billion
0.360%
Over
$20
billion,
up
to
and
including
$35
billion
0.355%
Over
$35
billion,
up
to
and
including
$50
billion
0.350%
In
excess
of
$50
billion
Annualized
Fee
Rate
Net
Assets
0.350%
Up
to
and
including
$5
billion
0.330%
Over
$5
billion,
up
to
and
including
$10
billion
0.310%
Over
$10
billion,
up
to
and
including
$20
billion
0.290%
In
excess
of
$20
billion
3.
Transactions
with
Affiliates
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Franklin
Growth
Opportunities
Fund pays
an
investment
management fee,
calculated
daily
and
paid
monthly,
to Advisers based
on the
average
daily
net
assets
of
the
Fund
as
follows:
Franklin
Natural
Resources
Fund
and
Franklin
Small-Mid
Cap
Growth
Fund pay
an
investment
management fee,
calculated
daily and
paid
monthly,
to Advisers based
on the
average
daily
net
assets
of
each
of
the
Funds
as
follows:
Franklin
Small
Cap
Growth
Fund pays
an
investment
management fee,
calculated
daily
and
paid
monthly,
to Advisers based
on the
average
daily
net
assets
of
the
Fund
as
follows:
Annualized
Fee
Rate
Net
Assets
0.700%
Up
to
and
including
$500
million
0.600%
Over
$500
million,
up
to
and
including
$1
billion
0.550%
Over
$1
billion,
up
to
and
including
$1.5
billion
0.500%
Over
$1.5
billion,
up
to
and
including
$6.5
billion
0.475%
Over
$6.5
billion,
up
to
and
including
$11.5
billion
0.450%
Over
$11.5
billion,
up
to
and
including
$16.5
billion
0.440%
Over
$16.5
billion,
up
to
and
including
$19
billion
0.430%
Over
$19
billion,
up
to
and
including
$21.5
billion
0.420%
In
excess
of
$21.5
billion
Annualized
Fee
Rate
Net
Assets
0.625%
Up
to
and
including
$100
million
0.500%
Over
$100
million,
up
to
and
including
$250
million
0.450%
Over
$250
million,
up
to
and
including
$7.5
billion
0.440%
Over
$7.5
billion,
up
to
and
including
$10
billion
0.430%
Over
$10
billion,
up
to
and
including
$12.5
billion
0.420%
Over
$12.5
billion,
up
to
and
including
$15
billion
0.400%
In
excess
of
$15
billion
Annualized
Fee
Rate
Net
Assets
0.750%
Up
to
and
including
$500
million
0.650%
Over
$500
million,
up
to
and
including
$1
billion
0.600%
Over
$1
billion,
up
to
and
including
$1.5
billion
0.550%
Over
$1.5
billion,
up
to
and
including
$6.5
billion
0.525%
Over
$6.5
billion,
up
to
and
including
$11.5
billion
0.500%
Over
$11.5
billion,
up
to
and
including
$16.5
billion
0.490%
Over
$16.5
billion,
up
to
and
including
$19
billion
0.480%
Over
$19
billion,
up
to
and
including
$21.5
billion
0.470%
In
excess
of
$21.5
billion
3.
Transactions
with
Affiliates
(continued)
a.
Management
Fees
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
For
the
year
ended
April
30,
2026,
each
Fund's
gross
effective
investment
management
fee
rate
based
on
average
daily
net
assets
was
as
follows:
b.
Administrative
Fees
Under
an
agreement
with
Advisers,
FT
Services
provides
administrative
services
to
the
Funds.
The
fee
is
paid
by
Advisers
based
on
each
of the
Funds'
average
daily
net
assets,
and
is
not
an
additional
expense
of
the
Funds.
c.
Distribution
Fees
The
Board
has
adopted
distribution
plans
for
each
share
class,
with
the
exception
of
Class
R6
and
Advisor
Class
shares,
pursuant
to
Rule
12b-1
under
the
1940
Act.
Under
the
Funds'
Class
A
reimbursement
distribution
plans,
the
Funds
reimburse
Distributors
for
costs
incurred
in
connection
with
the
servicing,
sale
and
distribution
of each
Fund's
shares
up
to
the
maximum
annual
plan
rate.
Under
the
Class
A
reimbursement
distribution
plans,
costs
exceeding
the
maximum
for
the
current
plan
year
cannot
be
reimbursed
in
subsequent
periods.
In
addition,
under
the
Funds'
Class
C
and
R compensation
distribution
plans,
the
Funds
pay
Distributors
for
costs
incurred
in
connection
with
the
servicing,
sale
and
distribution
of each
Fund's
shares
up
to
the
maximum
annual
plan
rate
for
each
class.
The
plan
year,
for
purposes
of
monitoring
compliance
with
the
maximum
annual
plan
rates,
is
February
1
through
January
31
for
each
Fund.
The
maximum
annual
plan
rates,
based
on
the
average
daily
net
assets,
for
each
class,
are
as
follows:
For
Franklin
Biotechnology
Discovery
Fund,
Franklin
Growth
Opportunities
Fund,
Franklin
Natural
Resources
Fund
and
Franklin
Small
Cap
Growth
Fund,
the
Board
has
set
the
current
rate
at
0.25%
per
year
for
Class
A
shares
until
further
notice
and
approval
by
the
Board.
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Franklin
Growth
Opportunities
Fund
Gross
effective
investment
management
fee
rate
...................
0.609%
0.352%
0.539%
Franklin
Natural
Resources
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Gross
effective
investment
management
fee
rate
...................
0.515%
0.621%
0.457%
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Franklin
Growth
Opportunities
Fund
Class
A
................................................
0.35%
0.25%
0.35%
Class
C
................................................
1.00%
0.65%
1.00%
Class
R
................................................
—%
0.50%
0.50%
Franklin
Natural
Resources
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Class
A
................................................
0.35%
0.35%
0.25%
Class
C
................................................
1.00%
1.00%
1.00%
Class
R
................................................
—%
0.50%
0.50%
3.
Transactions
with
Affiliates
(continued)
a.
Management
Fees
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
d.
Sales
Charges/Underwriting
Agreements
Front-end
sales
charges
and
contingent
deferred
sales
charges
(CDSC)
do
not
represent
expenses
of
the
Funds.
These
charges
are
deducted
from
the
proceeds
of
sales
of
fund
shares
prior
to
investment
or
from
redemption
proceeds
prior
to
remittance,
as
applicable.
Distributors
has
advised
the
Funds
of
the
following
commission
transactions
related
to
the
sales
and
redemptions
of
the
Funds'
shares
for
the
year:
e.
Transfer
Agent
Fees
Each
class
of
shares
pays
transfer
agent
fees,
calculated
monthly
and
paid
monthly, to
Investor
Services
for
its
performance
of
shareholder
servicing
obligations. The
fees
are based
on
a
fixed
margin
earned
by
Investor
Services
and
are allocated
to
the Funds
based
upon
relative
assets
and
relative
transactions. In
addition,
each
class reimburses
Investor
Services
for
out
of
pocket
expenses
incurred
and,
except
for
Class
R6, reimburses
shareholder
servicing
fees
paid
to
third
parties.
These
fees
paid
to
third
parties
are
accrued
and
allocated
daily
based
upon
their
relative
proportion
of
such
classes'
aggregate
net
assets.
Class
R6
pays
Investor
Services
transfer
agent
fees
allocated
specifically
to
that
class
based
upon
its
relative
assets
and
relative
transactions.
For
the
year
ended
April
30,
2026,
the Funds
paid
transfer
agent
fees
as
noted
in
the
Statements of
Operations
of
which
the
following
amounts
were
retained
by
Investor
Services:
f.
Investments
in
Affiliated
Management
Investment
Companies
Certain
or
all
Funds
invest
in
one
or
more
affiliated
management
investment
companies.
As
defined
in
the
1940
Act,
an
investment
is
deemed
to
be
a
“Controlled
Affiliate”
of
a
fund
when
a
fund
owns,
either
directly
or
indirectly,
25%
or
more
of
the
affiliated
fund’s
outstanding
shares
or
has
the
power
to
exercise
control
over
management
or
policies
of
such
fund.
The
Funds
do
not
invest
for
purposes
of
exercising
a
controlling
influence
over
the
management
or
policies.
Management
fees
paid
by
the
Funds
are
waived
on
assets
invested
in
the
affiliated
management
investment
companies,
as
noted
in
the
Statements
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Franklin
Growth
Opportunities
Fund
Sales
charges
retained
net
of
commissions
paid
to
unaffiliated
brokers/
dealers
..................................................
$52,630
$52,907
$217,954
CDSC
retained
............................................
$8,887
$27,743
$26,969
Franklin
Natural
Resources
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Sales
charges
retained
net
of
commissions
paid
to
unaffiliated
brokers/
dealers
..................................................
$55,347
$79,280
$157,806
CDSC
retained
............................................
$7,772
$7,144
$11,820
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Franklin
Growth
Opportunities
Fund
Transfer
agent
fees
.........................................
$359,690
$1,300,999
$1,248,145
Franklin
Natural
Resources
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Transfer
agent
fees
.........................................
$207,535
$1,133,086
$1,274,363
3.
Transactions
with
Affiliates
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
of
Operations,
in
an
amount
not
to
exceed
the
management
and
administrative
fees,
if
applicable, paid
directly
or
indirectly
by
each
affiliate.
During
the
year
ended
April
30,
2026,
investments
in
affiliated
management
investment
companies
were
as
follows:
aa
Value
at
Beginning
of
Year
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Year
Number
of
Shares
Held
at
End
of
Year
Investment
Income
a
a
a
a
a
a
a
a
Franklin
Biotechnology
Discovery
Fund
Non-Controlled
Affiliates
Dividends
Franklin
Institutional
U.S.
Government
Money
Market
Fund,
3.593%
............
$17,698,635
$263,259,822
$(254,972,920)
$—
$—
$25,985,537
25,985,537
$728,255
Non-Controlled
Affiliates
Income
from
securities
loaned
Franklin
Institutional
U.S.
Government
Money
Market
Fund,
3.593%
............
$6,416,814
$478,451,846
$(453,241,897)
$—
$—
$31,626,763
31,626,763
$1,177,751
Total
Affiliated
Securities
...
$24,115,449
$741,711,668
$(708,214,817)
$—
$—
$57,612,300
$1,906,006
Franklin
Core
Plus
Bond
Fund
Non-Controlled
Affiliates
Dividends
Franklin
BSP
Real
Estate
Debt
BDC
..................
$24,292,230
$—
$(23,568,878)
$338,565
$(1,061,917)
$—
—
$663,723
Franklin
Institutional
U.S.
Government
Money
Market
Fund,
3.593%
............
20,674,651
790,237,907
(575,917,125)
—
—
234,995,433
234,995,433
3,592,300
Non-Controlled
Affiliates
Income
from
securities
loaned
Franklin
Institutional
U.S.
Government
Money
Market
Fund,
3.593%
............
$—
$10,224,000
$(10,224,000)
$—
$—
$—
—
$4,804
Total
Affiliated
Securities
...
$44,966,881
$800,461,907
$(609,710,003)
$338,565
$(1,061,917)
$234,995,433
$4,260,827
Franklin
Growth
Opportunities
Fund
Non-Controlled
Affiliates
Dividends
Franklin
Institutional
U.S.
Government
Money
Market
Fund,
3.593%
............
$40,512,033
$1,007,079,188
$(1,000,035,717)
$—
$—
$47,555,504
47,555,504
$1,104,970
3.
Transactions
with
Affiliates
(continued)
f.
Investments
in
Affiliated
Management
Investment
Companies
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
aa
Value
at
Beginning
of
Year
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Year
Number
of
Shares
Held
at
End
of
Year
Investment
Income
Franklin
Growth
Opportunities
Fund
(continued)
Non-Controlled
Affiliates
Income
from
securities
loaned
Franklin
Institutional
U.S.
Government
Money
Market
Fund,
3.593%
............
$9,816,000
$391,493,861
$(381,359,111)
$—
$—
$19,950,750
19,950,750
$759,446
Total
Affiliated
Securities
...
$50,328,033
$1,398,573,049
$(1,381,394,828)
$—
$—
$67,506,254
$1,864,416
Franklin
Natural
Resources
Fund
Non-Controlled
Affiliates
Dividends
Franklin
Institutional
U.S.
Government
Money
Market
Fund,
3.593%
............
$12,963,979
$98,547,424
$(103,924,724)
$—
$—
$7,586,679
7,586,679
$372,469
Non-Controlled
Affiliates
Income
from
securities
loaned
Franklin
Institutional
U.S.
Government
Money
Market
Fund,
3.593%
............
$8,457,500
$343,725,970
$(339,314,855)
$—
$—
$12,868,615
12,868,615
$459,264
Total
Affiliated
Securities
...
$21,421,479
$442,273,394
$(443,239,579)
$—
$—
$20,455,294
$831,733
Franklin
Small
Cap
Growth
Fund
Non-Controlled
Affiliates
Dividends
Franklin
Institutional
U.S.
Government
Money
Market
Fund,
3.593%
............
$27,922,674
$729,777,542
$(746,272,666)
$—
$—
$11,427,550
11,427,550
$1,668,928
Non-Controlled
Affiliates
Income
from
securities
loaned
Franklin
Institutional
U.S.
Government
Money
Market
Fund,
3.593%
............
$19,765,870
$908,752,513
$(876,599,558)
$—
$—
$51,918,825
51,918,825
$1,928,892
Total
Affiliated
Securities
...
$47,688,544
$1,638,530,055
$(1,622,872,224)
$—
$—
$63,346,375
$3,597,820
3.
Transactions
with
Affiliates
(continued)
f.
Investments
in
Affiliated
Management
Investment
Companies
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
g.
Waiver
and
Expense
Reimbursements
Effective
May
8,
2025,
Advisers
has
contractually
agreed
in
advance
to
waive
or
limit
its
respective
fees
and
to
assume
as
their
own
expense
certain
expenses
otherwise
payable
by
Franklin
Core
Plus
Bond
Fund
so
that
the
operating
expenses
(excluding
interest
expense,
distribution
fees,
acquired
fund
fees
and
expenses
and
certain
non-routine
expenses
or
costs,
such
as
those
relating
to
litigation,
indemnification,
reorganizations
and
liquidations)
for
each
Class
do
not
exceed
0.47%,
and
for
Class
R6
do
not
exceed
0.37%,
based
on
the
average
net
assets
of
each
Class
until
August
31,
2026.
Total
expenses
waived
or
paid
are
not
subject
to
recapture
subsequent
to
the
Fund’s
fiscal
year
end.
Prior
to
May
8,
2025,
the
expenses
(excluding
certain
fees
and
expenses
as
previously
disclosed)
for
each
Class
of
Franklin
Core
Plus
Bond
were
limited
to
0.58%
and
for
Class
R6
were
limited
to
0.48%
based
on
average
net
assets
of
each
Class.
Effective
September
1,
2025,
operating
expenses
include
acquired
fund
fees
and
expenses.
Transfer
agent
fees
on
Class
R6
shares
of
the
Funds have
been
capped
so
that
transfer
agent
fees
for
that
class
do
not
exceed
0.03%
based
on
the
average
net
assets
of
the
class
until
August
31,
2026.
h.
Interfund
Transactions
Certain
or
all
Funds
engaged
in
purchases
and
sales
of
investments
with
funds
or
other
accounts
that
have
common
investment
managers
(or
affiliated
investment
managers),
directors,
trustees
or
officers.
These
purchases,
sales
and
the
related
net
realized
gains
(losses),
if
any,
(excluding
in-kind
transactions)
for
the
year
ended
April
30,
2026,
were
as
follows:
aa
Value
at
Beginning
of
Year
Purchases
Sales
Realized
Gain
(Loss)
Net
Change
in
Unrealized
Appreciation
(Depreciation)
Value
at
End
of
Year
Number
of
Shares
Held
at
End
of
Year
Investment
Income
Franklin
Small-Mid
Cap
Growth
Fund
Non-Controlled
Affiliates
Dividends
Franklin
Institutional
U.S.
Government
Money
Market
Fund,
3.593%
............
$67,276,399
$596,622,727
$(588,939,521)
$—
$—
$74,959,605
74,959,605
$2,630,648
Non-Controlled
Affiliates
Income
from
securities
loaned
Franklin
Institutional
U.S.
Government
Money
Market
Fund,
3.593%
............
$8,437,275
$394,069,592
$(402,506,867)
$—
$—
$—
—
$373,347
Total
Affiliated
Securities
...
$75,713,674
$990,692,319
$(991,446,388)
$—
$—
$74,959,605
$3,003,995
Franklin
Small
Cap
Growth
Fund
Purchases
..............................
$2,011,609
Sales
..................................
—
Net
Realized
Gains
(Losses)
.................
—
3.
Transactions
with
Affiliates
(continued)
f.
Investments
in
Affiliated
Management
Investment
Companies
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
4.
Income
Taxes
For
tax
purposes,
capital
losses
may
be
carried
over
to
offset
future
capital
gains.
At
April
30,
2026,
the
capital
loss
carryforwards
were
as
follows:
During
the
year
ended April
30,
2026,
the
utilized
capital
loss
carryforwards
were
as
follows:
For
tax
purposes,
the
Funds
may
elect
to
defer
any
portion
of
a
post-October
capital
loss
or
late-year
ordinary
loss
to
the
first
day
of
the
following
fiscal
year.
At April
30,
2026,
the
deferred
losses
were
as
follows:
The
tax
character
of
distributions
paid
during
the
years
ended
April
30,
2026
and
2025,
was
as
follows:
Franklin
Core
Plus
Bond
Fund
Franklin
Natural
Resources
Fund
1
1
1
Capital
loss
carryforwards
not
subject
to
expiration:
Short
term
...............................................................
$
156,787,169
$
—
Long
term
...............................................................
892,305,908
130,116,851
Total
capital
loss
carryforwards
..............................................
$1,049,093,077
$130,116,851
Franklin
Core
Plus
Bond
Fund
Franklin
Natural
Resources
Fund
Capital
loss
utilized
carryforwards
...............................................
$9,879,476
$24,920,135
Franklin
Growth
Opportunities
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Late-year
ordinary
loss
...........................................
$8,322,509
$6,079,144
$2,892,994
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
2026
2025
2026
2025
Distributions
paid
from:
Ordinary
income
........................
$23,180,444
$23,129,664
$111,500,570
$119,623,480
Long
term
capital
gain
....................
77,442,568
48,180,837
—
—
$100,623,012
$71,310,501
$111,500,570
$119,623,480
Franklin
Growth
Opportunities
Fund
Franklin
Natural
Resources
Fund
2026
2025
2026
2025
Distributions
paid
from:
Ordinary
income
........................
$—
$15,984,820
$6,461,794
$7,347,186
Long
term
capital
gain
....................
741,721,494
432,641,293
—
—
$741,721,494
$448,626,113
$6,461,794
$7,347,186
Franklin
Strategic
Series
Notes
to
Financial
Statements
At
April
30,
2026,
the
cost
of
investments,
net
unrealized
appreciation
(depreciation)
,
undistributed
ordinary
income
and
undistributed
long
term
capital
gains
for
income
tax
purposes
were
as
follows:
Differences
between
income
and/or
capital
gains
as
determined
on
a
book
basis
and
a
tax
basis
are
primarily
due
to
differing
treatments
of
foreign
currency
transactions,
wash
sales,
passive
foreign
investment
company
shares,
paydown
losses,
payments-in-kind,
bond
discounts
and
premiums,
derivative
financial
instruments,
corporate
actions,
net
operating
losses
and
in-kind
transactions.
The
Funds
except
for
Franklin
Core
Plus
Bond
Fund
utilized
a
tax
accounting
practice
to
treat
a
portion
of
the
proceeds
from
capital
shares
redeemed
as
a
distribution
from
net
investment
income
and realized
capital
gains.
Franklin
Small
Cap
Growth
Fund
Franklin
Small-Mid
Cap
Growth
Fund
2026
2025
2026
2025
Distributions
paid
from:
Ordinary
income
........................
$—
$—
$—
$619,958
Long
term
capital
gain
....................
186,170,133
—
268,116,040
459
$186,170,133
$—
$268,116,040
$620,417
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Franklin
Growth
Opportunities
Fund
a
a
a
a
Cost
of
investments
........................................
$560,575,683
$3,434,784,833
$2,126,355,381
Unrealized
appreciation
......................................
$545,633,836
$33,072,041
$2,374,512,544
Unrealized
depreciation
......................................
(34,186,434)
(138,047,837)
(88,751,688)
Net
unrealized
appreciation
(depreciation)
........................
$511,447,402
$(104,975,796)
$2,285,760,856
Distributable
earnings:
Undistributed
ordinary
income
.................................
$22,915,030
$440,424
$—
Undistributed
long
term
capital
gains
............................
47,067,252
—
227,641,315
Total
distributable
earnings
...................................
$69,982,282
$440,424
$227,641,315
Franklin
Natural
Resources
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
a
a
a
a
Cost
of
investments
........................................
$310,295,982
$1,811,356,098
$2,389,603,262
Unrealized
appreciation
......................................
$254,773,699
$907,419,139
$1,238,300,507
Unrealized
depreciation
......................................
(12,463,230)
(223,973,595)
(131,014,797)
Net
unrealized
appreciation
(depreciation)
........................
$242,310,469
$683,445,544
$1,107,285,710
Distributable
earnings:
Undistributed
ordinary
income
.................................
$10,953,923
$67,778,784
$—
Undistributed
long
term
capital
gains
............................
—
207,031,075
67,523,676
Total
distributable
earnings
...................................
$10,953,923
$274,809,859
$67,523,676
4.
Income
Taxes
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
5.
Investment
Transactions
Purchases
and
sales
of
investments
(excluding
short
term
securities
and
in-kind
transactions)
for
the
year
ended
April
30,
2026,
were
as
follows:
At
April
30,
2026,
in
connection
with
securities
lending
transactions,
certain
or
all
Funds
loaned
investments
and
received
cash
collateral
as
follows:
6.
Credit
Risk
and
Defaulted
Securities
At
April
30,
2026,
Franklin
Core
Plus
Bond
Fund
had 9.2% of
its
portfolio
invested
in
high
yield
securities,
senior
secured
floating
rate
loans,
or
other
securities
rated
below
investment
grade
and
unrated
securities.
These
securities
may
be
more
sensitive
to
economic
conditions
causing
greater
price
volatility
and
are
potentially
subject
to
a
greater
risk
of
loss
due
to
default
than
higher
rated
securities.
Franklin
Core
Plus
Bond
Fund held
a defaulted
securities
and/or
other
securities
for
which
the
income
has
been
deemed
uncollectible.
At
April
30,
2026,
the
value
of
these
securities represents
less
than
0.1% of
the
Fund's net
assets.
The
Fund
discontinues
accruing
income
on
securities
for
which
income
has
been
deemed
uncollectible
and
provides
an
estimate
for
losses
on
interest
receivable.
The
securities
have
been
identified
in
the
accompanying
Schedule
of
Investments.
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Franklin
Growth
Opportunities
Fund
Purchases
...............................................
$327,287,523
$10,863,346,451
$1,745,001,151
Sales
...................................................
$432,213,700
$10,647,482,976
$2,281,579,353
a
Franklin
Natural
Resources
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Purchases
...............................................
$166,483,610
$1,152,570,981
$1,201,163,393
Sales
...................................................
$103,189,120
$1,586,946,987
$1,706,729,543
a
Sales
of
investments
excludes
in-kind
transactions
of
$79,782,475.
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Franklin
Growth
Opportunities
Fund
Securities
lending
transactions
a
:
Equity
investments
b
.........................................
$31,626,763
$—
$19,950,750
Franklin
Natural
Resources
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-
Mid
Cap
Growth
Fund
Securities
lending
transactions
a
:
Equity
investments
b
.........................................
$12,868,615
$53,117,575
$—
a
The
agreements
can
be
terminated
at
any
time.
b
The
gross
amount
of
recognized
liability
for
such
transactions
is
included
in
payable
upon
return
of
securities
loaned
in
the
Statements
of
Assets
and
Liabilities.
Franklin
Strategic
Series
Notes
to
Financial
Statements
7.
Restricted
Securities
Certain
or
all
Funds
invest
in
securities
that
are
restricted
under
the
Securities
Act
of
1933
(1933
Act).
Restricted
securities
are
often
purchased
in
private
placement
transactions,
and
cannot
be
sold
without
prior
registration
unless
the
sale
is
pursuant
to
an
exemption
under
the
1933
Act.
Disposal
of
these
securities
may
require
greater
effort
and
expense,
and
prompt
sale
at
an
acceptable
price
may
be
difficult.
The
Funds
may
have
registration
rights
for
restricted
securities.
The
issuer
generally
incurs
all
registration
costs.
At
April
30,
2026,
investments
in
restricted
securities,
excluding
securities
exempt
from
registration
under
the
1933
Act,
were
as
follows:
Shares
/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Biotechnology
Discovery
Fund
706,649
a
Achieve
Life
Sciences,
Inc.
.....................
4/17/26
$
2,568,669
$
2,976,339
706,649
a
Achieve
Life
Sciences,
Inc.,
4/10/28
..............
4/17/26
71
621,851
223,305
b
Acumen
Pharmaceuticals,
Inc.
..................
3/16/26
736,906
533,699
2,735,200
Candid
Therapeutics,
Inc.
......................
3/02/26
2,735,200
3,046,668
1,519,609
Candid,
Inc.,
B
..............................
8/19/24
1,823,531
2,372,462
69,673
c
IN8bio,
Inc.,
C,
10/04/27
.......................
10/10/24
—
5,665
859,370
Lycia
LLC,
C
...............................
4/26/24
1,754,576
3,017,589
1,389,029
Ray
Therapeutics,
Inc.,
B.
.....................
4/17/26
3,671,204
3,399,269
132
d
Sensei
Biotherapeutics,
Inc.,
B
..................
2/20/26
1,827,374
3,363,564
Total
Restricted
Securities
(Value
is
1.9%
of
Net
Assets)
...............
$15,117,531
$19,337,106
Shares
Issuer
Acquisition
Date
Cost
Value
Franklin
Growth
Opportunities
Fund
117,526
Anduril
Industries,
Inc.,
B
......................
7/22/25
$
4,804,792
$
8,103,418
55
Anduril
Industries,
Inc.,
C
......................
7/22/25
2,249
3,792
180,222
Anduril
Industries,
Inc.,
G
......................
5/08/25
7,367,980
12,426,307
49,656
Anthropic
PBC,
F-1
..........................
8/29/25
6,999,887
12,867,677
38,589
Anthropic
PBC,
G-1
..........................
2/12/26
9,999,815
9,999,815
3,094
Canva
Australia
Holdings
Pty.
Ltd.,
A
.............
3/18/24
3,300,249
5,093,157
11,829
Canva
Australia
Holdings
Pty.
Ltd.,
B
.............
12/22/21
20,158,531
19,472,190
4,619
Celonis
SE
.................................
6/16/21
1,708,060
416,631
25,571
Celonis
SE,
D
..............................
6/16/21
-
10/04/22
9,427,681
2,306,491
6,309,366
ClearMotion,
Inc.
............................
11/06/17
-
12/21/18
15,500,000
650,899
417,667
ClearMotion,
Inc.,
A-3
.........................
3/23/23
—
60,170
2,606,463
ClearMotion,
Inc.,
A-4
.........................
12/21/21
251,500
341,496
338,280
Databricks,
Inc.,
G
...........................
2/01/21
20,000,005
64,623,462
750,387
Flock
Group,
Inc.,
B
..........................
3/26/25
11,082,616
11,729,975
80,684
Flock
Group,
Inc.,
C
..........................
3/26/25
1,191,638
1,261,244
21,303
Flock
Group,
Inc.,
F-1
........................
3/26/25
314,628
333,006
517,056
OneTrust
LLC,
C
............................
4/01/21
10,139,623
4,805,902
8,668
OpenAI
Foundation
..........................
10/03/25
3,727,240
5,960,897
56,433
Plaid,
Inc.,
A
................................
3/31/25
11,511,011
13,666,978
142,857
Space
Exploration
Technologies
Corp.,
A
..........
5/25/22
9,999,990
75,227,068
Franklin
Strategic
Series
Notes
to
Financial
Statements
Shares
Issuer
Acquisition
Date
Cost
Value
Franklin
Growth
Opportunities
Fund
(continued)
260,482
Stripe,
Inc.,
B
...............................
4/30/25
$
9,377,352
$
16,635,683
Total
Restricted
Securities
(Value
is
6.1%
of
Net
Assets)
...............
$156,864,847
$265,986,258
Shares
Issuer
Acquisition
Date
Cost
Value
Franklin
Natural
Resources
Fund
39,802
Redwood
Materials,
Inc.,
E
.....................
10/20/25
$
1,899,983
$
1,899,983
Total
Restricted
Securities
(Value
is
0.4%
of
Net
Assets)
...............
$1,899,983
$1,899,983
Shares
Issuer
Acquisition
Date
Cost
Value
Franklin
Small
Cap
Growth
Fund
3,436,485
1661,
Inc.,
F
................................
5/28/21
$
19,999,999
$
3,786,378
311,952
Astranis
Space
Technologies
Corp.,
E
............
2/10/26
5,999,994
5,999,994
382,306
Benchling,
Inc.,
F
............................
10/20/21
12,499,992
1,803,489
1,388,889
Checkr,
Inc.,
E
..............................
8/24/21
25,000,002
21,170,063
410,500
Chinook
Therapeutics,
Inc.,
CVR,
6/30/30
.........
8/14/23
—
—
3,698,772
ClearMotion,
Inc.
............................
12/21/18
10,000,000
381,580
1,037,942
ClearMotion,
Inc.,
A-3
.........................
3/23/23
—
149,527
6,477,294
ClearMotion,
Inc.,
A-4
.........................
12/21/21
625,000
848,649
987,540
Flock
Group,
Inc.,
G
..........................
3/08/24
9,999,899
15,437,126
709,046
Newsela,
Inc.,
D
.............................
1/21/21
15,000,010
12,707,441
625,361
OneTrust
LLC,
A
............................
3/10/23
6,878,971
5,812,569
56,457
OneTrust
LLC,
A-1
...........................
3/10/23
621,027
524,753
1,542,673
Smule,
Inc.,
144A,
G
.........................
5/31/16
11,099,995
177,103
352,675
Smule,
Inc.,
144A,
H
.........................
4/27/17
2,999,995
47,866
162,712
Smule,
Inc.,
J
...............................
8/05/22
-
11/28/22
764,393
1,603,972
361,111
Tula
eTechnology,
Inc.
........................
11/01/18
—
—
3,611,111
Tula
eTechnology,
Inc.,
E
......................
9/08/17
6,500,000
3,872,916
Total
Restricted
Securities
(Value
is
3.1%
of
Net
Assets)
...............
$127,989,277
$74,323,426
Principal
Amount
*
/
Shares
/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Small-Mid
Cap
Growth
Fund
414,483
Anduril
Industries,
Inc.,
F
......................
7/17/24
$
9,009,451
$
28,578,603
347,106
Benchling,
Inc.,
F
............................
10/20/21
11,349,082
1,637,436
227,829
Databricks,
Inc.,
G
...........................
2/01/21
13,469,851
43,523,409
423,782
Newsela,
Inc.,
D
.............................
1/21/21
8,965,193
7,594,972
767,526
OneTrust
LLC,
C
............................
4/01/21
15,051,415
7,133,956
2,970,061
Phononic
Devices,
Inc.,
F-S
....................
6/06/19
7,499,998
6,046,293
513,050
Phononic
Devices,
Inc.,
G-2-S
..................
1/17/20
-
11/03/20
47
1,824,398
7.
Restricted
Securities
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
8.
Unfunded
Loan
Commitments
Certain
or
all
Funds
enter
into
certain
credit
agreements,
all
or
a
portion
of
which
may
be
unfunded.
The
Funds
are
obligated
to
fund
these
loan
commitments
at
the
borrowers’
discretion.
Unfunded
loan
commitments
and
funded
portions
of
credit
agreements
are
marked
to
market
daily
and
any
unrealized
appreciation
or
depreciation
is
included
in
the
Statements
of
Assets
and
Liabilities
and
the
Statements
of
Operations.
Funded
portions
of
credit
agreements
are
presented
in
the
Schedules
of
Investments.
At
April
30,
2026,
unfunded
commitments
were
as
follows:
Principal
Amount*/
Shares/
Warrants
Issuer
Acquisition
Date
Cost
Value
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
66,235
Phononic,
Inc.,
5.31%,
11/30/27
.................
2/11/25
$
66,235
$
79,754
117,763
Phononic,
Inc.,
H-S
..........................
10/17/22
460,645
584,839
23,970
Phononic,
Inc.,
H-S,
12/31/29
...................
5/15/24
-
2/11/25
2
32,191
66,235
Phononic,
Inc.,
H-S,
5.31%,
11/30/27
.............
10/01/24
66,235
81,015
66,235
Phononic,
Inc.,
H-S,
5.31%,
11/30/27
.
............
5/15/24
66,235
82,304
47,104
Phononic,
Inc.,
H-S-X,
12/31/29
.................
10/17/22
44,029
63,259
30,940
Plaid,
Inc.,
A
................................
3/31/25
6,311,036
7,493,068
Total
Restricted
Securities
(Value
is
3.0%
of
Net
Assets)
...............
$72,359,454
$104,755,497
*
In
U.S.
dollars
unless
otherwise
indicated.
a
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$8,152,586
as
of
April
30,
2026.
b
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$1,975,096
as
of
April
30,
2026.
c
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$488,162
as
of
April
30,
2026.
d
The
Fund
also
invests
in
unrestricted
securities
of
the
issuer,
valued
at
$1,298,284
as
of
April
30,
2026.
Borrower
Unfunded
Commitment
Franklin
Core
Plus
Bond
Fund
First
Eagle
Holdings,
Inc.
$
82,642
7.
Restricted
Securities
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
9.
Other
Derivative
Information
At
April
30,
2026,
investments
in
derivative
contracts
are
reflected
in
the
Statements
of
Assets
and
Liabilities
as
follows:
For
the
year
ended
April
30,
2026
,
the
effect
of
derivative
contracts
in
the
Statements
of
Operations
was
as
follows:
Asset
Derivatives
Liability
Derivatives
Derivative
Contracts
Not
Accounted
for
as
Hedging
Instruments
Statement
of
Assets
and
Liabilities
Location
Fair
Value
Statement
of
Assets
and
Liabilities
Location
Fair
Value
Franklin
Core
Plus
Bond
Fund
Interest
rate
contracts
.......
Investments
in
securities,
at
value
$
1,593,943
a
Options
written,
at
value
$
1,611,285
Variation
margin
on
futures
contracts
650,496
b
Variation
margin
on
futures
contracts
4,429,112
b
Foreign
exchange
contracts
..
Unrealized
appreciation
on
OTC
forward
exchange
contracts
28,768
Unrealized
depreciation
on
OTC
forward
exchange
contracts
54,638
Credit
contracts
............
Variation
margin
on
centrally
cleared
swap
contracts
1,083,799
b
Variation
margin
on
centrally
cleared
swap
contracts
692,788
b
OTC
swap
contracts
(upfront
payments)
—
OTC
swap
contracts
(upfront
receipts)
1,291,228
Unrealized
appreciation
on
OTC
swap
contracts
—
Unrealized
depreciation
on
OTC
swap
contracts
123,303
Total
....................
$3,357,006
$8,202,354
a
Purchased
option
contracts
are
included
in
investments
in
securities,
at
value
in
the
Statement
of
Assets
and
Liabilities.
b
This
amount
reflects
the
cumulative
appreciation
(depreciation)
of
futures
contracts
and
centrally
cleared
swap
contracts
as
reported
in
the
Schedule
of
Investments.
Only
the
variation
margin
receivable/payable
at
year
end
is
separately
reported
within
the
Statement
of
Assets
and
Liabilities.
Prior
variation
margin
movements
were
recorded
to
cash
upon
receipt
or
payment.
Derivative
Contracts
Not
Accounted
for
as
Hedging
Instruments
Statement
of
Operations
Location
Net
Realized
Gain
(Loss)
for
the
Year
Statement
of
Operations
Location
Net
Change
in
Unrealized
Appreciation
(Depreciation)
for
the
Year
Franklin
Core
Plus
Bond
Fund
Net
realized
gain
(loss)
from:
Net
change
in
unrealized
appreciation
(depreciation)
on:
Interest
rate
contracts
..........
Investments
$(1,631,260)
a
Investments
$111,909
a
Written
options
—
Written
options
(106,771)
Futures
contracts
(2,182,585)
Futures
contracts
(2,216,598)
Swap
contracts
357,057
Swap
contracts
—
Foreign
exchange
contracts
.....
Investments
(1,389,903)
a
Investments
—
Written
options
548,510
Written
options
—
Forward
exchange
contracts
(339,383)
Forward
exchange
contracts
144,902
Franklin
Strategic
Series
Notes
to
Financial
Statements
For
the
year
ended
April
30,
2026,
the
average
month
end
notional
amount
of
futures
contracts,
swap
contracts
and
options,
and
the
average month
end
contract
value
for forward
exchange
contracts,
were as
follows:
See
Note
1(d) regarding
derivative
financial
instruments.
10.
Upcoming
Reorganization
On
May
19,
2026,
the
Board
for
Franklin
Total
Return
Fund
approved
a
proposal
to
reorganize
Franklin
Total
Return
Fund
with
and
into
Franklin
Core
Plus
Bond.
Upon
completion
of
the
reorganization
on
or
about
October
2,
2026,
assets
in
Franklin
Total
Return
Fund
will
be
transferred
into
Franklin
Core
Plus
Bond
Fund.
11.
Credit
Facility
The
Funds,
together
with
other
U.S.
registered
and
foreign
investment
funds
(collectively,
Borrowers),
managed
by
Franklin
Templeton,
are
borrowers
in
a
joint
syndicated
senior
unsecured
credit
facility
totaling
$2.995
billion
(Global
Credit
Facility)
which
matures
on
January
29,
2027.
This
Global
Credit
Facility
provides
a
source
of
funds
to
the
Borrowers
for
temporary
and
emergency
purposes,
including
the
ability
to
meet
future
unanticipated
or
unusually
large
redemption
requests.
Under
the
terms
of
the
Global
Credit
Facility,
the
Funds
may,
in
addition
to
interest
charged
on
any
borrowings
made
by
the
Funds
and
other
costs
incurred
by
the
Funds,
pay
their
share
of
fees
and
expenses
incurred
in
connection
with
the
implementation
and
maintenance
of
the
Global
Credit
Facility,
based
upon
their
relative
share
of
the
aggregate
net
assets
of
all
of
the
Borrowers,
including
an
annual
commitment
fee
of
0.15%
based
upon
the
unused
portion
of
the
Global
Credit
Facility.
These
fees
are
reflected
in
other
expenses
in
the
Statements
of
Operations.
During
the
year ended
April
30,
2026,
the
Funds
did
not
use
the
Global
Credit
Facility.
Derivative
Contracts
Not
Accounted
for
as
Hedging
Instruments
Statement
of
Operations
Location
Net
Realized
Gain
(Loss)
for
the
Year
Statement
of
Operations
Location
Net
Change
in
Unrealized
Appreciation
(Depreciation)
for
the
Year
Credit
contracts
...............
Investments
(2,325,086)
a
Investments
—
Written
options
1,223,062
Written
options
—
Swap
contracts
(2,539,864)
Swap
contracts
(252,763)
Total
.......................
$(8,279,452)
$(2,319,321)
a
Purchased
option
contracts
are
included
in
net
realized
gain
(loss)
from
investments
and
net
change
in
unrealized
appreciation
(depreciation)
on
investments
in
the
Statements
of
Operations.
Franklin
Core
Plus
Bond
Fund
Futures
contracts
............................................................................
$322,252,528
Swap
contracts
..............................................................................
100,565,574
Forward
exchange
contracts
....................................................................
10,416,184
Options
....................................................................................
184,083,762
9.
Other
Derivative
Information
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
12.
Redemption
In-Kind
During
the
period
ended
April
30,
2026,
Franklin
Growth
Opportunities
Fund
realized
$65,126,047
of
net
gains
resulting
from
non-pro
rata
redemptions
in-kind
in
which
shareholders
redeemed
fund
shares
for
cash
and
selected
portfolio
securities
held
by
the
Fund,
whereby
portfolio
securities
selected
by
the
investment
manager
were
distributed
to
the
redeeming
shareholders
of
the
Fund.
As
such
gains
are
not
taxable
to
the
Fund
and
are
not
distributed
to
remaining
shareholders,
they
are
reclassified
from
accumulated
net
realized
gain
to
paid-in
capital.
During
the year
ended
April
30,
2025,
Franklin
Small
Cap
Growth
Fund
realized
$11,579,715
of
net
gains
resulting
from
redemptions in-kind
in
which
shareholders
redeemed
fund
shares
for
cash
and
securities
held
by
the
Fund.
Because
such
gains
are
not
taxable
to
the
Fund,
and
are
not
distributed
to
remaining
shareholders,
they
are
reclassified
from
accumulated
net
realized
gains
to
paid-in
capital.
During
the year
ended
April
30,
2025,
Franklin
Small-Mid
Cap
Growth
Fund
realized
$5,735,544
of
net
gains
resulting
from
a
redemption in-kind
in
which
a
shareholder
redeemed
fund
shares
for
cash
and
securities
held
by
the
Fund.
Because
such
gains
are
not
taxable
to
the
Fund,
and
are
not
distributed
to
remaining
shareholders,
they
are
reclassified
from
accumulated
net
realized
gains
to
paid-in
capital.
13.
Fair
Value
Measurements
The Funds
follow
a
fair
value
hierarchy
that
distinguishes
between
market
data
obtained
from
independent
sources
(observable
inputs)
and
the Funds'
own
market
assumptions
(unobservable
inputs).
These
inputs
are
used
in
determining
the
value
of
the Funds' financial
instruments
and
are
summarized
in
the
following
fair
value
hierarchy:
Level
1
–
quoted
prices
in
active
markets
for
identical
financial
instruments
Level
2
–
other
significant
observable
inputs
(including
quoted
prices
for
similar
financial
instruments,
interest
rates,
prepayment
speed,
credit
risk,
etc.)
Level
3
–
significant
unobservable
inputs
(including
the Funds'
own
assumptions
in
determining
the
fair
value
of
financial
instruments)
The
input
levels
are
not
necessarily
an
indication
of
the
risk
or
liquidity
associated
with
financial
instruments
at
that
level.
A
summary
of
inputs
used
as
of
April
30,
2026,
in
valuing
the
Funds'
assets
and
liabilities carried
at
fair
value,
is
as
follows:
Level
1
Level
2
Level
3
Total
Franklin
Biotechnology
Discovery
Fund
Assets:
Investments
in
Securities:
a
Common
Stocks
:
Biotechnology
.........................
$
785,500,471
$
533,699
$
2,976,339
$
789,010,509
Capital
Markets
........................
1,542,374
—
—
1,542,374
Health
Care
Providers
&
Services
..........
21,681,614
—
—
21,681,614
Life
Sciences
Tools
&
Services
............
4,108,998
1,866,598
—
5,975,596
Pharmaceuticals
.......................
172,179,993
—
—
172,179,993
Convertible
Preferred
Stocks
................
—
—
9,135,295
9,135,295
Preferred
Stocks
:
Life
Sciences
Tools
&
Services
............
—
2,350,384
—
2,350,384
Real
Estate
Management
&
Development
....
—
—
3,017,588
3,017,588
Warrants
...............................
—
—
8,983,143
8,983,143
Escrows
and
Litigation
Trusts
...............
—
—
534,289
b
534,289
Short
Term
Investments
...................
57,612,300
—
—
57,612,300
Total
Investments
in
Securities
...........
$1,042,625,750
$4,750,681
c
$24,646,654
$1,072,023,085
Franklin
Strategic
Series
Notes
to
Financial
Statements
Level
1
Level
2
Level
3
Total
Franklin
Biotechnology
Discovery
Fund
(continued)
Assets:
(continued)
Other
Financial
Instruments:
Unfunded
Commitments
..................
$—
$—
$311,468
$311,468
Total
Other
Financial
Instruments
.........
$—
$—
$311,468
$311,468
Franklin
Core
Plus
Bond
Fund
Assets:
Investments
in
Securities:
a
Common
Stocks
:
Machinery
............................
$
—
$
—
$
738,049
$
738,049
Oil,
Gas
&
Consumable
Fuels
.............
33,843
267,821
—
301,664
Corporate
Bonds
:
Aerospace
&
Defense
...................
—
29,538,970
—
29,538,970
Air
Freight
&
Logistics
...................
—
909,258
—
909,258
Automobile
Components
.................
—
2,839,614
—
2,839,614
Automobiles
..........................
—
7,276,043
—
7,276,043
Banks
...............................
—
131,711,208
—
131,711,208
Beverages
...........................
—
1,327,410
—
1,327,410
Biotechnology
.........................
—
14,900,544
—
14,900,544
Broadline
Retail
.......................
—
7,456,305
—
b
7,456,305
Building
Products
......................
—
8,717,304
—
8,717,304
Capital
Markets
........................
—
71,767,334
—
71,767,334
Chemicals
...........................
—
7,155,888
—
7,155,888
Commercial
Services
&
Supplies
...........
—
13,522,831
—
13,522,831
Communications
Equipment
..............
—
7,399,781
—
7,399,781
Construction
&
Engineering
...............
—
1,954,328
—
1,954,328
Consumer
Finance
.....................
—
44,363,310
—
44,363,310
Consumer
Staples
Distribution
&
Retail
......
—
2,251,194
—
2,251,194
Containers
&
Packaging
.................
—
6,370,996
—
6,370,996
Diversified
Consumer
Services
............
—
1,688,571
—
1,688,571
Diversified
REITs
......................
—
7,952,367
—
7,952,367
Diversified
Telecommunication
Services
.....
—
38,231,189
—
38,231,189
Electric
Utilities
........................
—
72,654,075
—
72,654,075
Electrical
Equipment
....................
—
4,776,694
—
4,776,694
Electronic
Equipment,
Instruments
&
Components
........................
—
16,604,145
—
16,604,145
Energy
Equipment
&
Services
.............
—
7,053,761
—
7,053,761
Entertainment
.........................
—
5,157,184
—
5,157,184
Financial
Services
......................
—
9,783,302
—
9,783,302
Food
Products
........................
—
19,363,283
—
19,363,283
Gas
Utilities
..........................
—
1,894,327
—
1,894,327
Ground
Transportation
..................
—
14,992,828
—
14,992,828
Health
Care
Equipment
&
Supplies
.........
—
10,760,172
—
10,760,172
Health
Care
Providers
&
Services
..........
—
44,811,799
—
44,811,799
Health
Care
REITs
.....................
—
7,303,357
—
7,303,357
Health
Care
Technology
.................
—
3,058,938
—
3,058,938
Hotel
&
Resort
REITs
...................
—
2,566,842
—
2,566,842
Hotels,
Restaurants
&
Leisure
.............
—
19,466,434
—
19,466,434
Household
Durables
....................
—
7,657,770
—
7,657,770
Independent
Power
and
Renewable
Electricity
Producers
..........................
—
15,568,780
—
15,568,780
Insurance
............................
—
52,499,113
—
52,499,113
Interactive
Media
&
Services
..............
—
3,071,592
—
3,071,592
IT
Services
...........................
—
5,463,203
—
5,463,203
Leisure
Products
.......................
—
1,133,408
—
1,133,408
Life
Sciences
Tools
&
Services
............
—
1,366,649
—
1,366,649
Machinery
............................
—
4,976,362
—
4,976,362
13.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Level
1
Level
2
Level
3
Total
Franklin
Core
Plus
Bond
Fund
(continued)
Assets:
(continued)
Investments
in
Securities:
a
(continued)
Corporate
Bonds:
(continued)
Media
...............................
$
—
$
30,449,453
$
—
$
30,449,453
Metals
&
Mining
.......................
—
9,410,205
—
9,410,205
Multi-Utilities
..........................
—
18,553,820
—
18,553,820
Oil,
Gas
&
Consumable
Fuels
.............
—
115,972,296
—
115,972,296
Paper
&
Forest
Products
.................
—
2,051,461
—
2,051,461
Personal
Care
Products
.................
—
9,791,314
—
9,791,314
Pharmaceuticals
.......................
—
31,699,820
—
31,699,820
Residential
REITs
......................
—
2,644,537
—
2,644,537
Semiconductors
&
Semiconductor
Equipment
.
—
18,622,973
—
18,622,973
Software
.............................
—
20,459,087
—
20,459,087
Specialized
REITs
......................
—
5,696,673
—
5,696,673
Specialty
Retail
........................
—
1,892,026
—
1,892,026
Technology
Hardware,
Storage
&
Peripherals
.
—
14,051,566
—
14,051,566
Textiles,
Apparel
&
Luxury
Goods
..........
—
1,829,278
—
1,829,278
Tobacco
.............................
—
13,843,198
—
13,843,198
Trading
Companies
&
Distributors
..........
—
3,634,592
—
3,634,592
Transportation
Infrastructure
..............
—
149,940
—
149,940
Wireless
Telecommunication
Services
.......
—
21,236,652
30,370
21,267,022
Senior
Floating
Rate
Interests
...............
—
82,495,991
—
b
82,495,991
Marketplace
Loans
.......................
—
—
2,232,026
b
2,232,026
Foreign
Government
and
Agency
Securities
....
—
72,813,357
—
72,813,357
U.S.
Government
and
Agency
Securities
.......
—
400,634,101
—
400,634,101
Asset-Backed
Securities
...................
—
251,776,335
—
251,776,335
Commercial
Mortgage-Backed
Securities
......
—
171,598,242
—
171,598,242
Mortgage-Backed
Securities
................
—
841,950,219
—
841,950,219
Residential
Mortgage-Backed
Securities
.......
—
82,603,731
—
82,603,731
Agency
Commercial
Mortgage-Backed
Securities
—
124,772,681
—
124,772,681
Municipal
Bonds
.........................
—
25,908,343
—
25,908,343
Escrows
and
Litigation
Trusts
...............
—
30,300
9,813
b
40,113
Options
Purchased
.......................
—
1,593,943
—
1,593,943
Short
Term
Investments
...................
234,995,433
—
—
234,995,433
Total
Investments
in
Securities
...........
$235,029,276
$3,117,752,418
$3,010,258
$3,355,791,952
Other
Financial
Instruments:
Forward
Exchange
Contracts
...............
$—
$28,768
$—
$28,768
Futures
Contracts
.......................
650,496
—
—
650,496
Swap
Contracts
.........................
—
1,083,799
—
1,083,799
Total
Other
Financial
Instruments
.........
$650,496
$1,112,567
$—
$1,763,063
–
–
–
–
Liabilities:
Other
Financial
Instruments:
TBA
Sale
Commitments
...................
$
—
$
21,469,454
$
—
$
21,469,454
Options
Written
..........................
—
1,611,285
—
1,611,285
Forward
Exchange
Contracts
...............
—
54,638
—
54,638
Futures
Contracts
........................
4,429,112
—
—
4,429,112
Swap
Contracts
.........................
—
816,091
—
816,091
Unfunded
Loan
Commitments
...............
—
92
—
92
Total
Other
Financial
Instruments
.........
$4,429,112
$23,951,560
$—
$28,380,672
13.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Level
1
Level
2
Level
3
Total
Franklin
Growth
Opportunities
Fund
Assets:
Investments
in
Securities:
a
Common
Stocks
:
Aerospace
&
Defense
...................
$
173,242,643
$
—
$
83,334,278
$
256,576,921
Automobiles
..........................
85,179,816
—
—
85,179,816
Beverages
...........................
25,723,803
—
—
25,723,803
Biotechnology
.........................
71,019,242
—
—
71,019,242
Broadline
Retail
.......................
231,609,958
—
—
231,609,958
Building
Products
......................
54,502,014
—
—
54,502,014
Capital
Markets
........................
31,307,298
—
—
31,307,298
Chemicals
...........................
40,510,654
—
—
40,510,654
Commercial
Services
&
Supplies
...........
43,926,367
—
2,723,122
b
46,649,489
Communications
Equipment
..............
73,565,569
—
—
73,565,569
Construction
&
Engineering
...............
23,582,804
—
—
23,582,804
Construction
Materials
..................
33,164,818
—
—
33,164,818
Consumer
Staples
Distribution
&
Retail
......
95,083,292
—
—
95,083,292
Electric
Utilities
........................
29,706,717
—
—
29,706,717
Electrical
Equipment
....................
99,881,618
—
—
99,881,618
Electronic
Equipment,
Instruments
&
Components
........................
146,223,484
—
—
146,223,484
Entertainment
.........................
93,166,155
—
—
93,166,155
Financial
Services
......................
63,662,128
—
—
63,662,128
Ground
Transportation
..................
36,276,034
—
—
36,276,034
Health
Care
Equipment
&
Supplies
.........
40,392,590
—
—
40,392,590
Health
Care
Providers
&
Services
..........
70,048,506
—
—
70,048,506
Hotels,
Restaurants
&
Leisure
.............
30,900,559
—
—
30,900,559
Interactive
Media
&
Services
..............
490,272,653
—
—
490,272,653
IT
Services
...........................
52,256,184
—
24,565,347
76,821,531
Life
Sciences
Tools
&
Services
............
20,847,485
—
—
20,847,485
Machinery
............................
43,059,218
—
—
43,059,218
Pharmaceuticals
.......................
139,753,249
—
—
139,753,249
Semiconductors
&
Semiconductor
Equipment
.
1,085,414,760
—
—
1,085,414,760
Software
.............................
248,708,703
—
36,914,457
285,623,160
Specialty
Retail
........................
43,866,264
—
—
43,866,264
Technology
Hardware,
Storage
&
Peripherals
.
343,071,707
—
—
343,071,707
Trading
Companies
&
Distributors
..........
18,697,433
—
—
18,697,433
Convertible
Preferred
Stocks
................
—
—
105,179,711
105,179,711
Preferred
Stocks
.........................
—
—
13,269,343
13,269,343
Escrows
and
Litigation
Trusts
...............
—
—
—
b
—
Short
Term
Investments
...................
67,506,254
—
—
67,506,254
Total
Investments
in
Securities
...........
$4,146,129,979
$—
$265,986,258
$4,412,116,237
Level
1
Level
2
Level
3
Total
Franklin
Natural
Resources
Fund
Assets:
Investments
in
Securities:
a
Common
Stocks
:
Agricultural
Products
&
Services
...........
$
4,409,329
$
—
$
—
$
4,409,329
Coal
&
Consumable
Fuels
................
4,441,744
—
—
4,441,744
Construction
&
Engineering
...............
2,785,272
—
—
2,785,272
Construction
Materials
..................
10,586,097
—
—
10,586,097
Copper
..............................
19,726,940
4,296,899
—
24,023,839
Diversified
Metals
&
Mining
...............
35,819,407
14,948,688
—
50,768,095
Electrical
Components
&
Equipment
........
3,383,040
1,751,734
—
5,134,774
Electronic
Equipment
&
Instruments
........
2,865,567
—
—
2,865,567
13.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Level
1
Level
2
Level
3
Total
Franklin
Natural
Resources
Fund
(continued)
Assets:
(continued)
Investments
in
Securities:
a
(continued)
Common
Stocks:
(continued)
Fertilizers
&
Agricultural
Chemicals
.........
$
20,542,352
$
—
$
—
$
20,542,352
Gold
................................
57,759,260
—
—
57,759,260
Heavy
Electrical
Equipment
..............
5,816,818
—
—
5,816,818
Industrial
Gases
.......................
21,959,015
—
—
21,959,015
Industrial
Machinery
&
Supplies
&
Components
2,575,888
—
—
2,575,888
Integrated
Oil
&
Gas
....................
83,029,854
—
—
83,029,854
Metal,
Glass
&
Plastic
Containers
..........
5,091,927
—
—
5,091,927
Oil
&
Gas
Drilling
......................
4,175,142
—
—
4,175,142
Oil
&
Gas
Equipment
&
Services
...........
38,907,620
2,748,523
—
41,656,143
Oil
&
Gas
Exploration
&
Production
.........
88,082,893
7,275,081
—
95,357,974
Oil
&
Gas
Refining
&
Marketing
............
22,854,925
—
—
22,854,925
Oil
&
Gas
Storage
&
Transportation
.........
45,494,540
—
—
45,494,540
Paper
&
Plastic
Packaging
Products
&
Materials
3,564,615
—
—
3,564,615
Precious
Metals
&
Minerals
...............
—
458,862
—
458,862
Specialty
Chemicals
....................
3,124,408
—
—
3,124,408
Steel
................................
7,183,640
—
—
7,183,640
Convertible
Preferred
Stocks
:
Environmental
&
Facilities
Services
.........
—
—
1,899,983
1,899,983
Specialty
Chemicals
....................
2,400,552
—
—
2,400,552
Warrants
..............................
690,045
—
—
690,045
Convertible
Bonds
.......................
—
1,500,497
—
1,500,497
Short
Term
Investments
...................
20,455,294
—
—
20,455,294
Total
Investments
in
Securities
...........
$517,726,184
$32,980,284
d
$1,899,983
$552,606,451
Level
1
Level
2
Level
3
Total
Franklin
Small
Cap
Growth
Fund
Assets:
Investments
in
Securities:
a
Common
Stocks
:
Aerospace
&
Defense
...................
$
150,992,893
$
—
$
—
$
150,992,893
Banks
...............................
51,474,885
—
—
51,474,885
Biotechnology
.........................
273,465,412
—
—
273,465,412
Building
Products
......................
80,919,002
—
—
80,919,002
Capital
Markets
........................
89,824,809
—
—
89,824,809
Commercial
Services
&
Supplies
...........
—
—
—
b
—
Communications
Equipment
..............
43,785,980
—
—
43,785,980
Construction
&
Engineering
...............
153,988,145
—
—
153,988,145
Construction
Materials
..................
7,678,338
—
—
7,678,338
Consumer
Staples
Distribution
&
Retail
......
35,475,340
—
—
35,475,340
Diversified
Consumer
Services
............
1,777,697
—
—
1,777,697
Electrical
Equipment
....................
31,451,524
—
—
31,451,524
Electronic
Equipment,
Instruments
&
Components
........................
112,509,711
—
—
112,509,711
Energy
Equipment
&
Services
.............
62,513,939
—
—
62,513,939
Financial
Services
......................
45,778,002
—
—
45,778,002
Food
Products
........................
19,211,655
—
—
19,211,655
Health
Care
Equipment
&
Supplies
.........
75,818,281
—
—
75,818,281
Health
Care
Providers
&
Services
..........
133,615,523
—
—
133,615,523
Health
Care
REITs
.....................
590,794
—
—
590,794
Hotel
&
Resort
REITs
...................
16,053,080
—
—
16,053,080
Hotels,
Restaurants
&
Leisure
.............
83,438,253
—
—
83,438,253
Household
Durables
....................
25,715,499
—
—
25,715,499
13.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Level
1
Level
2
Level
3
Total
Franklin
Small
Cap
Growth
Fund
(continued)
Assets:
(continued)
Investments
in
Securities:
a
(continued)
Common
Stocks:
(continued)
IT
Services
...........................
$
13,872,516
$
—
$
—
$
13,872,516
Life
Sciences
Tools
&
Services
............
44,334,220
—
—
44,334,220
Machinery
............................
72,265,228
—
—
72,265,228
Media
...............................
39,676,063
—
—
39,676,063
Oil,
Gas
&
Consumable
Fuels
.............
57,925,954
—
—
57,925,954
Passenger
Airlines
.....................
38,233,858
—
—
38,233,858
Personal
Care
Products
.................
15,489,044
—
—
15,489,044
Pharmaceuticals
.......................
85,568,826
—
—
85,568,826
Professional
Services
...................
46,035,034
—
—
46,035,034
Semiconductors
&
Semiconductor
Equipment
.
206,275,723
—
—
206,275,723
Software
.............................
162,349,454
—
381,580
162,731,034
Specialty
Retail
........................
37,694,709
—
—
37,694,709
Textiles,
Apparel
&
Luxury
Goods
..........
15,418,305
—
—
15,418,305
Trading
Companies
&
Distributors
..........
25,914,145
—
—
25,914,145
Convertible
Preferred
Stocks
................
—
—
68,845,785
68,845,785
Preferred
Stocks
.........................
—
—
5,096,061
b
5,096,061
Rights
.................................
—
—
—
b
—
Escrows
and
Litigation
Trusts
...............
—
—
—
b
—
Short
Term
Investments
...................
63,346,375
—
—
63,346,375
Total
Investments
in
Securities
...........
$2,420,478,216
$—
$74,323,426
$2,494,801,642
Franklin
Small-Mid
Cap
Growth
Fund
Assets:
Investments
in
Securities:
a
Common
Stocks
:
Aerospace
&
Defense
...................
264,973,242
—
—
264,973,242
Banks
...............................
43,227,216
—
—
43,227,216
Biotechnology
.........................
190,626,344
—
—
190,626,344
Building
Products
......................
55,712,882
—
—
55,712,882
Capital
Markets
........................
250,197,230
—
—
250,197,230
Construction
&
Engineering
...............
113,482,697
—
—
113,482,697
Consumer
Staples
Distribution
&
Retail
......
62,009,791
—
—
62,009,791
Electrical
Equipment
....................
239,145,742
—
—
239,145,742
Entertainment
.........................
73,990,874
—
—
73,990,874
Financial
Services
......................
26,770,808
—
—
26,770,808
Ground
Transportation
..................
51,936,586
—
—
51,936,586
Health
Care
Equipment
&
Supplies
.........
103,917,218
—
—
103,917,218
Health
Care
Providers
&
Services
..........
71,207,600
—
—
71,207,600
Health
Care
Technology
.................
26,005,502
—
—
26,005,502
Hotels,
Restaurants
&
Leisure
.............
410,440,073
—
—
410,440,073
Household
Durables
....................
29,791,959
—
—
29,791,959
Independent
Power
and
Renewable
Electricity
Producers
..........................
75,005,726
—
—
75,005,726
Interactive
Media
&
Services
..............
8,605,988
—
—
8,605,988
IT
Services
...........................
75,900,596
—
—
75,900,596
Life
Sciences
Tools
&
Services
............
35,070,042
—
—
35,070,042
Machinery
............................
32,569,268
—
—
32,569,268
Media
...............................
46,272,144
—
—
46,272,144
Oil,
Gas
&
Consumable
Fuels
.............
117,667,174
—
—
117,667,174
Professional
Services
...................
53,708,175
—
—
53,708,175
Real
Estate
Management
&
Development
....
19,731,377
—
—
19,731,377
Residential
REITs
......................
12,514,585
—
—
12,514,585
Semiconductors
&
Semiconductor
Equipment
.
219,371,372
—
—
219,371,372
Software
.............................
257,486,053
—
7,493,068
264,979,121
13.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
A
reconciliation
in
which
Level
3
inputs
are
used
in
determining
fair
value
is
presented
when
there
are
significant
Level
3
assets
and/or
liabilities
at
the
beginning
and/or
end
of
the year.
At
April
30,
2026,
the
reconciliations
are
as
follows:
Level
1
Level
2
Level
3
Total
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
Assets:
(continued)
Investments
in
Securities:
a
(continued)
Common
Stocks:
(continued)
Specialty
Retail
........................
$
241,764,693
$
—
$
—
$
241,764,693
Technology
Hardware,
Storage
&
Peripherals
.
36,049,454
—
—
36,049,454
Trading
Companies
&
Distributors
..........
71,011,299
—
—
71,011,299
Convertible
Preferred
Stocks
................
—
—
94,514,669
94,514,669
Preferred
Stocks
.........................
—
—
2,409,237
2,409,237
Warrants
...............................
—
—
95,450
95,450
Convertible
Bonds
.......................
—
—
243,073
243,073
Senior
Floating
Rate
Interests
...............
—
—
1,010,160
1,010,160
Escrows
and
Litigation
Trusts
...............
—
—
—
b
—
Short
Term
Investments
...................
74,959,605
—
—
74,959,605
Total
Investments
in
Securities
...........
$3,391,123,315
$—
$105,765,657
$3,496,888,972
a
For
detailed
categories,
see
the
accompanying
Schedule
of
Investments.
b
Includes
financial
instruments
determined
to
have
no
value.
c
Includes
foreign
securities
valued
at
$4,216,982,
which
were
categorized
as
Level
2
as
a
result
of
the
application
of
market
level
fair
value
procedures.
See
the
Financial
Instrument
Valuation
note
for
more
information.
d
Includes
foreign
securities
valued
at
$31,479,787,
which
were
categorized
as
Level
2
as
a
result
of
the
application
of
market
level
fair
value
procedures.
See
the
Financial
Instrument
Valuation
note
for
more
information.
Balance
at
Beginning
of
Year
Purchases
a
Sales
b
Transfer
Into
Level
3
c
Transfer
Out
of
Level
3
Net
Accretion
(Amortiza-
tion)
Net
Realized
Gain
(Loss)
Net
Unr
ealized
Appreciatio
n
(
Depreciation
)
Balance
at
End
of
Year
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Year
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Biotechnology
Discovery
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Biotechnology
......
$
—
$
2,568,669
$
—
$
—
$
—
$
—
$
—
$
407,670
$
2,976,339
$
407,670
Convertible
Preferred
Stocks
:
Biotechnology
......
—
5,498,578
—
—
—
—
—
1,264,255
6,762,833
1,264,255
Household
Products
..
1,275,136
—
—
—
—
—
—
1,097,326
2,372,462
1,097,326
Preferred
Stocks
:
Real
Estate
Management
&
Development
.....
1,311,980
—
—
—
—
—
—
1,705,608
3,017,588
1,705,609
Warrants
:
Biotechnology
......
289,723
1,020,208
(9)
d
4,224,842
—
—
(13)
3,448,392
8,983,143
3,659,042
Escrows
and
Litigation
Trusts
:
400,031
d
—
(838,547)
—
—
—
838,547
134,258
534,289
d
134,258
Total
Investments
in
Securities
............
$3,276,870
$9,087,455
$(838,556)
$4,224,842
$—
$—
$838,534
$8,057,509
$24,646,654
$8,268,160
Other
Financial
Instruments:
Unfunded
Commitments
......
$—
$—
$—
$—
$—
$—
$—
$311,468
$311,468
$311,468
13.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Balance
at
Beginning
of
Year
Purchases
a
Sales
b
Transfer
Into
Level
3
c
Transfer
Out
of
Level
3
Net
Accretion
(Amortiza-
tion)
Net
Realized
Gain
(Loss)
Net
Unrealized
Appreciation
(Depreciation)
Balance
at
End
of
Year
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Year
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Core
Plus
Bond
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Broadline
Retail
.....
$
—
d
$
—
$
—
d
$
—
$
—
$
—
$
(986,430)
$
986,430
$
—
$
—
Machinery
.........
750,386
—
—
—
—
—
—
(12,337)
738,049
(12,337)
Management
Investment
Companies
:
Capital
Markets
.....
24,292,230
—
(23,568,844)
—
—
—
338,532
(1,061,918)
—
—
Warrants
:
Machinery
.........
1,787
—
—
d
—
—
—
(1,272)
(515)
—
—
Oil,
Gas
&
Consumable
Fuels
..........
—
d
—
—
d
—
—
—
—
—
—
—
Software
..........
—
d
—
—
d
—
—
—
(750,000)
750,000
—
—
Corporate
Bonds
:
Broadline
Retail
.....
—
d
—
—
—
—
—
—
—
—
d
—
Financial
Services
...
—
d
—
(20,345)
—
—
—
(1,446,931)
1,467,276
—
—
Wireless
Telecommunication
Services
........
30,370
—
—
—
—
22,053
—
(22,053)
30,370
(22,053)
Senior
Floating
Rate
Interests
:
Software
..........
—
d
—
—
—
—
—
—
—
—
d
—
Marketplace
Loans
:
Financial
Services
...
29,226,804
115,577
(27,046,640)
—
—
—
269,176
(332,891)
2,232,026
d
(5,273,594)
Escrows
and
Litigation
Trusts
...........
8,787
—
d
—
—
—
—
—
1,026
9,813
d
1,026
Total
Investments
in
Securities
............
$54,310,364
$115,577
$(50,635,829)
$—
$—
$22,053
$(2,576,925)
$1,775,018
$3,010,258
$(5,306,958)
Franklin
Growth
Opportunities
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Aerospace
&
Defense
.
26,428,545
4,807,041
—
—
—
—
—
52,098,692
83,334,278
52,098,692
Commercial
Services
&
Supplies
........
6,471,119
—
d
(13,532)
—
—
—
13,532
(3,747,997)
2,723,122
d
(3,747,997)
IT
Services
........
19,175,724
—
—
—
—
—
—
5,389,623
24,565,347
5,389,623
Leisure
Products
....
55,397,163
—
(51,496,420)
—
—
—
31,766,190
(35,666,933)
—
—
Software
..........
21,592,488
3,727,240
—
—
—
—
—
11,594,729
36,914,457
11,594,729
Convertible
Preferred
Stocks
:
Aerospace
&
Defense
.
—
7,367,980
—
—
—
—
—
5,058,327
12,426,307
5,058,327
Automobile
Components
12,588,882
—
—
—
—
—
—
735,343
13,324,225
735,343
Software
..........
37,296,393
9,999,815
—
—
—
—
—
32,132,971
79,429,179
32,132,971
Preferred
Stocks
:
Commercial
Services
&
Supplies
........
7,445,041
—
(549,993)
—
—
—
(10,392,598)
3,497,550
—
—
Software
..........
5,669,986
6,999,887
(3,223,200)
—
—
—
(777,033)
4,599,703
13,269,343
5,877,087
Escrows
and
Litigation
Trusts
:
—
d
—
—
d
—
—
—
—
—
—
d
—
Total
Investments
in
Securities
............
$192,065,341
$32,901,963
$(55,283,145)
$—
$—
$—
$20,610,091
$75,692,008
$265,986,258
$109,138,775
13.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Balance
at
Beginning
of
Year
Purchases
a
Sales
b
Transfer
Into
Level
3
c
Transfer
Out
of
Level
3
Net
Accretion
(Amortiza-
tion)
Net
Realized
Gain
(Loss)
Net
Unrealized
Appreciation
(Depreciation)
Balance
at
End
of
Year
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Year
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Small
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Commercial
Services
&
Supplies
........
$
—
$
—
d
$
(13,504)
$
—
$
—
$
—
$
13,504
$
—
$
—
d
$
—
Software
..........
412,783
—
—
—
—
—
—
(31,203)
381,580
(31,203)
Convertible
Preferred
Stocks
:
Automobile
Components
14,585,176
—
—
—
—
—
—
851,950
15,437,126
851,950
Communications
Equipment
.......
—
5,999,994
—
—
—
—
—
—
5,999,994
—
Diversified
Consumer
Services
........
11,929,905
—
—
—
—
—
—
777,536
12,707,441
777,536
Software
..........
36,310,373
—
—
—
—
—
—
(5,395,527)
30,914,846
(5,395,527)
Specialty
Retail
.....
5,047,362
—
—
—
—
—
—
(1,260,984)
3,786,378
(1,260,984)
Preferred
Stocks
:
Automobile
Components
7,317,732
d
—
—
—
—
—
—
(3,444,816)
3,872,916
d
(3,444,816)
Commercial
Services
&
Supplies
........
7,429,670
—
(548,858)
—
—
—
(10,371,141)
3,490,329
—
—
Software
..........
1,456,951
—
—
—
—
—
—
(233,806)
1,223,145
(233,806)
Rights
:
Biotechnology
......
802,045
—
(821,000)
—
—
—
660,906
(641,951)
—
d
(641,951)
Escrows
and
Litigation
Trusts
...........
—
d
—
—
d
—
—
—
—
—
—
d
—
Total
Investments
in
Securities
............
$85,291,997
$5,999,994
$(1,383,362)
$—
$—
$—
$(9,696,731)
$(5,888,472)
$74,323,426
$(9,378,801)
Franklin
Small-Mid
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Common
Stocks
:
Leisure
Products
....
42,691,367
—
(39,684,882)
—
—
—
25,632,821
(28,639,306)
—
—
Software
..........
6,311,036
—
—
—
—
—
—
1,182,032
7,493,068
1,182,032
Convertible
Preferred
Stocks
:
Aerospace
&
Defense
.
16,944,894
—
—
—
—
—
—
11,633,709
28,578,603
11,633,709
Diversified
Consumer
Services
........
7,130,256
—
—
—
—
—
—
464,716
7,594,972
464,716
Semiconductors
&
Semiconductor
Equipment
.......
135,046
—
—
—
—
—
—
5,911,247
6,046,293
5,911,247
Software
..........
35,005,434
—
—
—
—
—
—
17,289,367
52,294,801
17,289,367
Preferred
Stocks
:
Semiconductors
&
Semiconductor
Equipment
.......
180,297
—
—
—
—
—
—
2,228,940
2,409,237
2,228,940
Warrants
:
Semiconductors
&
Semiconductor
Equipment
.......
6,183
—
—
—
—
—
—
89,267
95,450
89,267
Convertible
Bonds
:
Semiconductors
&
Semiconductor
Equipment
.......
198,705
—
—
—
—
—
—
44,368
243,073
44,368
13.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Significant
unobservable
valuation
inputs
for
material
Level
3 assets
and/or
liabilities and
impact
to
fair
value
as
a
result
of
changes
in
unobservable
valuation
inputs
as
of
April
30,
2026,
are
as
follows:
Balance
at
Beginning
of
Year
Purchases
a
Sales
b
Transfer
Into
Level
3
c
Transfer
Out
of
Level
3
Net
Accretion
(Amortiza-
tion)
Net
Realized
Gain
(Loss)
Net
Unrealized
Appreciation
(Depreciation)
Balance
at
End
of
Year
Net
Change
in
Unrealized
Appreciation
(Depreciation)
on
Assets
Held
at
Year
End
a
a
a
a
a
a
a
a
a
a
a
Franklin
Small-Mid
Cap
Growth
Fund
(continued)
Assets:
(continued)
Investments
in
Securities:
(continued)
Senior
Floating
Rate
Interests
:
Semiconductors
&
Semiconductor
Equipment
.......
$
824,303
$
109,594
$
—
$
—
$
—
$
(14,078)
$
—
$
90,341
$
1,010,160
$
90,341
Escrows
and
Litigation
Trusts
:
—
d
—
—
—
—
—
—
—
—
d
—
Total
Investments
in
Securities
............
$109,427,521
$109,594
$(39,684,882)
$—
$—
$(14,078)
$25,632,821
$10,294,681
$105,765,657
$38,933,987
a
Purchases
include
all
purchases
of
securities
and
securities
received
in
corporate
actions.
b
Sales
include
all
sales
of
securities,
maturities,
paydowns
and
securities
tendered
in
corporate
actions.
c
Transferred
into
Level
3
as
a
result
of
the
unavailability
of
a
quoted
market
price
in
an
active
market
for
identical
securities
or
as
a
result
of
the
unreliability
of
the
foreign
exchange
rate
and
other
significant
observable
valuation
inputs.
May
include
amounts
related
to
a
corporate
action.
d
Includes
financial
instruments
determined
to
have
no
value.
Description
Fair
Value
at
End
of
Year
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
Impact
to
Fair
Value
if
Input
Increases
a
Franklin
Growth
Opportunities
Fund
Assets:
Investments
in
Securities:
Convertible
Preferred
Stocks:
Software.
.
.
.
.
.
.
$64,623,462
Market
comparables
Discount
for
lack
of
marketability
12.4%
Decrease
EV
/
Revenue
multiple
27.9x
Increase
Revenue
$5.7
bil
Increase
Trade
price
$190.0
Increase
All
Other
Investments.
.
.
.
201,362,796
b,c,d
Total.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
$265,986,258
13.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Description
Fair
Value
at
End
of
Year
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
Impact
to
Fair
Value
if
Input
Increases
a
Franklin
Small
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Convertible
Preferred
Stocks:
Diversified
Consumer
Services.
.
.
.
.
$12,707,441
Market
comparables
Discount
for
lack
of
marketability
9.1%
Decrease
EV
/
EBITDA
multiple
5.8x
Increase
EV
/
Revenue
multiple
1.3x
Increase
Volatility
41.9%
Increase
Software
.
.
.
.
.
.
.
.
.
.
.
.
.
.
21,170,063
Market
comparables
Discount
for
lack
of
marketability
11.0%
Decrease
EV
/
Revenue
multiple
2.5x
Increase
Volatility
48.9%
Increase
All
Other
Investments.
.
.
.
40,445,922
b,c,d
Total.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
$74,323,426
Description
Fair
Value
at
End
of
Year
Valuation
Technique
Unobservable
Inputs
Amount
/
Range
(Weighted
Average)
Impact
to
Fair
Value
if
Input
Increases
a
Franklin
Small-Mid
Cap
Growth
Fund
Assets:
Investments
in
Securities:
Convertible
Preferred
Stocks:
Software
.......................
$43,523,409
Market
comparables
Discount
for
lack
of
marketability
12.4%
Decrease
EV
/
Revenue
multiple
27.9x
Increase
Revenue
$5.7
bil
Increase
Trade
price
$190.0
Increase
All
Other
Investments.
.
.
.
.
.
.
.
.
62,242,248
b,c,d
Total.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
$105,765,657
a
Represents
the
directional
change
in
the
fair
value
of
the
Level
3
financial
instruments
that
would
result
from
a
significant
and
reasonable
increase
in
the
corresponding
input.
A
significant
and
reasonable
decrease
in
the
input
would
have
the
opposite
effect.
Significant
increases
and
decreases
in
these
inputs
in
isolation
could
result
in
significantly
higher
or
lower
fair
value
measurements.
b
Includes
the
fair
value
of
immaterial
assets
and/or
liabilities
developed
using
various
valuation
techniques
and
unobservable
inputs.
c
Includes
financial
instruments
determined
to
have
no
value.
d
Includes
the
fair
value
of
assets
and/or
liabilities
derived
from
recent
transactions,
private
transaction
prices,
or
non-public
third-party
pricing
information
that
is
unobservable.
Abbreviations
List
EBITDA
-
Earnings
before
interest,
taxes,
depreciation
and
amortization
EV
-
Enterprise
value
13.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Level
3
financial
instruments,
for
the
Franklin
Biotechnology
Discovery
Fund,
include
the
fair
value
of
immaterial
assets
and/or
liabilities
developed
using
various
valuation
techniques
and
unobservable
inputs.
14.
Operating
Segments
Each
Fund
operates
as
a
single
operating
segment,
which
is
an
investment
portfolio.
The
portfolio
managers
assigned
to
the
Fund
within the
Funds'
investment
manager
serve
as
the
Chief
Operating
Decision
Maker
(“CODM”)
and are
responsible
for
evaluating each
Fund's
operating
results
and
allocating
resources
in
accordance
with each
Fund’s
investment
strategy.
Internal
reporting
provided
to
the
CODM
aligns
with
the
accounting
policies
and
measurement
principles
used
in
the
financial
statements.
For
information
regarding
segment
assets,
segment
profit
or
loss,
and
significant
expenses,
refer
to
the
Statements
of
Assets
and
Liabilities
and
the
Statements
of
Operations,
along
with
the
related
notes
to
the
financial
statements.
The
Schedules
of
Investments
provides
details
of
the
Funds'
investments
that
generate
returns
such
as
interest,
dividends,
and
realized
and
unrealized
gains
or
losses.
Performance
metrics,
including
portfolio
turnover
and
expense
ratios,
are
disclosed
in
the
Financial
Highlights.
15.
Subsequent
Events
The
Funds
have
evaluated
subsequent
events
through
the
issuance
of
the
financial
statements
and
determined
that
no
events
have
occurred
that
require
disclosure
other
than
those
already
disclosed
in
the
financial
statements.
13.
Fair
Value
Measurements
(continued)
Franklin
Strategic
Series
Notes
to
Financial
Statements
Abbreviations
Counterparty
BOFA
Bank
of
America
NA
CITI
Citibank
NA
JPHQ
JPMorgan
Chase
Bank
NA
Cu
r
rency
CAD
Canadian
Dollar
EUR
Euro
USD
United
States
Dollar
Index
CDX.NA.HY.
Series
number
CDX
North
America
High
Yield
Index
CDX.NA.IG.
Series
number
CDX
North
America
Investment
Grade
Index
Selected
Portfolio
ADR
American
Depositary
Receipt
BDC
Business
Development
Company
CLO
Collateralized
Loan
Obligation
CME
Chicago
Mercantile
Exchange
CMT
Constant
Monthly
U.S.
Treasury
Securities
Yield
Curve
Rate
Index
CVR
Contingent
Value
Right
ETM
Escrowed
to
Maturity
FFCB
Federal
Farm
Credit
Banks
Funding
Corp.
FHLMC
Federal
Home
Loan
Mortgage
Corp.
FNMA
Federal
National
Mortgage
Association
FRN
Floating
Rate
Note
GNMA
Government
National
Mortgage
Association
GO
General
Obligation
IO
Interest
Only
MBS
Mortgage-Backed
Security
NATL
National
Reinsurance
Corp.
PIK
Payment-In-Kind
REIT
Real
Estate
Investment
Trust
REMIC
Real
Estate
Mortgage
Investment
Conduit
SOFR
Secured
Overnight
Financing
Rate
STACR
Structured
Agency
Credit
Risk
T-Note
Treasury
Note
Franklin
Strategic
Series
Report
of
Independent
Registered
Public
Accounting
Firm
To
the
Board
of
Trustees
of
Franklin
Strategic
Series
and
Shareholders
of
Franklin
Biotechnology
Discovery
Fund,
Franklin
Core
Plus
Bond
Fund,
Franklin
Growth
Opportunities
Fund,
Franklin
Natural
Resources
Fund,
Franklin
Small
Cap
Growth
Fund
and
Franklin
Small-Mid
Cap
Growth
Fund
Opinions
on
the
Financial
Statements
We
have
audited
the
accompanying
statements
of
assets
and
liabilities,
including
the
schedules
of
investments,
of
Franklin
Biotechnology
Discovery
Fund,
Franklin
Core
Plus
Bond
Fund,
Franklin
Growth
Opportunities
Fund,
Franklin
Natural
Resources
Fund,
Franklin
Small
Cap
Growth
Fund
and
Franklin
Small-Mid
Cap
Growth
Fund
(six
of
the
funds
constituting
Franklin
Strategic
Series,
hereafter
collectively
referred
to
as
the
"Funds")
as
of
April
30,
2026,
the
related
statements
of
operations
for
the
year
ended
April
30,
2026,
the
statements
of
changes
in
net
assets
for
each
of
the
two
years
in
the
period
ended
April
30,
2026,
including
the
related
notes,
and
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
April
30,
2026
(collectively
referred
to
as
the
“financial
statements”).
In
our
opinion,
the
financial
statements
present
fairly,
in
all
material
respects,
the
financial
position
of
each
of
the
Funds
as
of
April
30,
2026,
the
results
of
each
of
their
operations
for
the
year
then
ended,
the
changes
in
each
of
their
net
assets
for
each
of
the
two
years
in
the
period
ended
April
30,
2026
and
each
of
the
financial
highlights
for
each
of
the
five
years
in
the
period
ended
April
30,
2026
in
conformity
with
accounting
principles
generally
accepted
in
the
United
States
of
America.
Basis
for
Opinions
These
financial
statements
are
the
responsibility
of
the
Funds’
management.
Our
responsibility
is
to
express
an
opinion
on
the
Funds’
financial
statements
based
on
our
audits.
We
are
a
public
accounting
firm
registered
with
the
Public
Company
Accounting
Oversight
Board
(United
States)
(PCAOB)
and
are
required
to
be
independent
with
respect
to
the
Funds
in
accordance
with
the
U.S.
federal
securities
laws
and
the
applicable
rules
and
regulations
of
the
Securities
and
Exchange
Commission
and
the
PCAOB.
We
conducted
our
audits
of
these
financial
statements
in
accordance
with
the
standards
of
the
PCAOB.
Those
standards
require
that
we
plan
and
perform
the
audit
to
obtain
reasonable
assurance
about
whether
the
financial
statements
are
free
of
material
misstatement,
whether
due
to
error
or
fraud.
Our
audits
included
performing
procedures
to
assess
the
risks
of
material
misstatement
of
the
financial
statements,
whether
due
to
error
or
fraud,
and
performing
procedures
that
respond
to
those
risks.
Such
procedures
included
examining,
on
a
test
basis,
evidence
regarding
the
amounts
and
disclosures
in
the
financial
statements.
Our
audits
also
included
evaluating
the
accounting
principles
used
and
significant
estimates
made
by
management,
as
well
as
evaluating
the
overall
presentation
of
the
financial
statements.
Our
procedures
included
confirmation
of
securities
owned
as
of
April
30,
2026
by
correspondence
with
the
custodians,
transfer
agent,
private
placement
agents,
agent
banks,
portfolio
companies
and
brokers;
when
replies
were
not
received
from
private
placement
agents,
agent
banks,
or
brokers,
we
performed
other
auditing
procedures.
We
believe
that
our
audits
provide
a
reasonable
basis
for
our
opinions.
/s/PricewaterhouseCoopers
LLP
San
Francisco,
California
June
17,
2026
We
have
served
as
the
auditor
of
one
or
more
investment
companies
in
the
Franklin
Templeton
Group
of
Funds
since
1948.
Franklin
Strategic
Series
Tax
Information
(unaudited)
By
mid-February,
tax
information
related
to
a
shareholder's
proportionate
share
of
distributions
paid
during
the
preceding
calendar
year
will
be
received,
if
applicable.
Please
also
refer
to
www.franklintempleton.com
for
per
share
tax
information
related
to
any
distributions
paid
during
the
preceding
calendar
year.
Shareholders
are
advised
to
consult
with
their
tax
advisors
for
further
information
on
the
treatment
of
these
amounts
on
their
tax
returns.
The
following
tax
information
for
the
Funds
is
required
to
be
furnished
to
shareholders
with
respect
to
income
earned
and
distributions
paid
during their
fiscal
year.
The
Funds
below hereby
report
the
following
amounts,
or
if
subsequently
determined
to
be
different,
the
maximum
allowable
amounts,
for
the
fiscal
year
ended
April
30,
2026:
Note
(1)
-
The
Law
varies
in
each
state
as
to
whether
and
what
percentage
of
dividend
income
attributable
to
Federal
obligations
is
exempt
from
state
income
tax.
Shareholders
are
advised
to
consult
with
their
tax
advisors
to
determine
if
any
portion
of
the
dividends
received
is
exempt
from
state
income
taxes.
Pursuant
to:
Franklin
Biotechnology
Discovery
Fund
Franklin
Core
Plus
Bond
Fund
Franklin
Growth
Opportunities
Fund
Long-Term
Capital
Gain
Dividends
Distributed
§852(b)(3)(C)
$77,442,568
—
$776,486,096
Income
Eligible
for
Dividends
Received
Deduction
(DRD)
§854(b)(1)(A)
$3,229,092
$778,002
$13,529,794
Qualified
Dividend
Income
Earned
(QDI)
§854(b)(1)(B)
$3,467,481
$778,002
$15,057,578
Short-Term
Capital
Gain
Dividends
Distributed
§871(k)(2)(C)
$11,766,876
—
—
Section
163(j)
Interest
Dividends
Earned
§163(j)
—
$121,271,847
—
Interest
Earned
from
Federal
Obligations
Note
(1)
—
$17,545,319
—
Pursuant
to:
Franklin
Natural
Resources
Fund
Franklin
Small
Cap
Growth
Fund
Franklin
Small-Mid
Cap
Growth
Fund
Long-Term
Capital
Gain
Dividends
Distributed
§852(b)(3)(C)
—
$203,398,002
$283,156,503
Income
Eligible
for
Dividends
Received
Deduction
(DRD)
§854(b)(1)(A)
$4,573,547
$7,816,686
$15,980,516
Qualified
Dividend
Income
Earned
(QDI)
§854(b)(1)(B)
$8,009,347
$7,869,850
$15,988,209
Short-Term
Capital
Gain
Dividends
Distributed
§871(k)(2)(C)
—
$7,530,976
—
Section
163(j)
Interest
Dividends
Earned
§163(j)
$58,692
$1,308,109
—
Franklin
Strategic
Series
Changes
In
and
Disagreements
with
Accountants
For
the
period
covered
by
this
report
Not
applicable.
Results
of
Meeting(s)
of
Shareholders
For
the
period
covered
by
this
report
Not
applicable.
Remuneration
Paid
to
Directors,
Officers
and
Others
For
the
period
covered
by
this
report
Refer
to
the
financial
statements
included
herein.
Remuneration
to
officers
is
paid
by
the
Funds'
investment
manager
according
to
the
terms
of
the
agreement.
Board
Approval
of
Management
and
Subadvisory
Agreements
For
the
period
covered
by
this
report
Not
applicable.
©
2026
Franklin
Templeton.
All
rights
reserved.
|
ITEM 8. |
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS FOR OPEN-END MANAGEMENT INVESTMENT COMPANIES. |
The information is disclosed as part of the Financial Statements
included in Item 7 of this Form N-CSR.
|
ITEM 9. |
PROXY DISCLOSURES FOR OPEN-END MANAGEMENT INVESTMENT COMPANIES. |
The information is disclosed as part of the Financial Statements
included in Item 7 of this Form N-CSR.
|
ITEM 10. |
REMUNERATION PAID TO DIRECTORS, OFFICERS, AND OTHERS OF OPEN-END MANAGEMENT INVESTMENT
COMPANIES. |
The information is disclosed as part of the Financial Statements
included in Item 7 of this Form N-CSR.
|
ITEM 11. |
STATEMENT REGARDING BASIS FOR APPROVAL OF INVESTMENT ADVISORY CONTRACT. |
The information is disclosed as part of the Financial Statements
included in Item 7 of this Form N-CSR, as applicable.
|
ITEM 12. |
DISCLOSURE OF PROXY VOTING POLICIES AND PROCEDURES FOR CLOSED-END MANAGEMENT INVESTMENT
COMPANIES. |
Not applicable.
|
ITEM 13. |
PORTFOLIO MANAGERS OF CLOSED-END MANAGEMENT INVESTMENT COMPANIES. |
Not applicable.
|
ITEM 14. |
PURCHASES OF EQUITY SECURITIES BY CLOSED-END MANAGEMENT INVESTMENT COMPANY AND AFFILIATED
PURCHASERS. |
Not applicable.
|
ITEM 15. |
SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS. |
There have been no changes to the procedures by which shareholders
may recommend nominees to the Registrant’s Board of Trustees that would require disclosure herein.
|
ITEM 16. |
CONTROLS AND PROCEDURES. |
|
(a) |
The Registrants acknowledge the Staff’s comment. In future filings on Form N-CSR,
the certifications required by Rule 30a-2 and Item 19(a)(3) will include the designations “principal executive officer” and
“principal financial officer” in the signature blocks, reflecting the capacity in which each signatory executes the certification,
in conformity with the language of the Rule and Form N-CSR. The Registrants may also include each signatory’s actual title with
respect to the Funds alongside the required designation. |
|
(b) |
There were no changes in the Registrant’s internal control over financial reporting
(as defined in Rule 30a-3(d) under the 1940 Act) that occurred during the period covered by this report that have materially affected
or are likely to materially affect the Registrant’s internal control over financial reporting. |
|
ITEM 17. |
DISCLOSURE OF SECURITIES LENDING ACTIVITIES FOR CLOSED-END MANAGEMENT INVESTMENT COMPANIES. |
Not applicable.
|
ITEM 18. |
RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION. |
(a) (1) Code of Ethics attached hereto.
Exhibit 99.CODE ETH
(a) (3) Certifications
pursuant to section 302 of the Sarbanes-Oxley Act of 2002 attached hereto.
Exhibit 99.CERT
(b) Certifications
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 attached hereto.
Exhibit 99.906CERT
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this Report to be signed on its behalf by the undersigned,
there unto duly authorized.
Franklin Strategic Series
| By: |
/s/
Christopher Kings |
|
| |
Christopher Kings |
|
| |
Chief Executive Officer – Finance and Administration |
|
| |
|
|
| Date: |
June 25, 2026 |
|
Pursuant to the requirements of the Securities Exchange Act of 1934 and
the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the
capacities and on the dates indicated.
| By: |
/s/
Christopher Kings |
|
| |
Christopher Kings |
|
| |
Chief Executive Officer – Finance and Administration |
|
| |
|
|
| Date: |
June 25, 2026 |
|
| By: |
/s/
Jeffrey White |
|
| |
Jeffrey White |
|
| |
Chief Financial Officer, Chief Accounting Officer
and Treasurer |
|
| |
|
|
| Date: |
June 25, 2026 |
|